Development of a novel co-culture based in vitro model system to study the wound healing process by Abraham, Suraj
DEVELOPMENT OF A NOVEL CO-CULTURE BASED IN VITRO MODEL 
SYSTEM TO STUDY THE WOUND HEALING PROCESS 
 
 
 
Submitted to the College of Graduate Studies and Research in partial fulfillment of the 
requirements for the degree of 
 Doctor of Philosophy  
in the 
Department of Anatomy and Cell Biology, College of Medicine,  
University of Saskatchewan, Saskatoon 
 
By 
 
SURAJ ABRAHAM 
 
 
 
 
 
 
 
 
 Copyright Suraj Abraham, April 2010. All rights reserved. 
 i 
PERMISSION TO USE 
 
 
In presenting this thesis in partial fulfillment of the requirements for a Doctor of 
Philosophy degree from the University of Saskatchewan, I agree that the libraries of this 
university may make it freely available for inspection. I further agree that permission for 
copying of this thesis in any manner, in whole or in part, for scholarly purposes may be 
granted by professors who supervised my thesis work or, in their absence, by the Head of 
the Department or the Dean of the College in which my thesis work was done. It is also 
understood that any copying or publication or use of this thesis or parts thereof for 
financial gain shall not be allowed without my written permission. It is also understood 
that due recognition shall be given to me and to the University of Saskatchewan in any 
scholarly use which may be made of any materials in my thesis. 
 
Requests for permission to copy or to make other use of material in this thesis in whole or 
part should be addressed to: 
 
Head of the Department of Anatomy and Cell Biology 
University of Saskatchewan, 107 Wiggins Road 
Saskatoon, Saskatchewan S7N 5E5 
CANADA 
 
 ii 
ABSTRACT 
Drug development research on wound repair is challenging and inefficient due to 
the complex nature of wound healing and scarring processes and the limitations of 
available in vitro or in vivo models used for preclinical drug testing. Many patients who 
undergo elective back surgery develop post-surgical complications resulting from excess 
peridural scarring in and around the site of operation. We tested the effects of two anti-
inflammatory compounds, quercetin and L-2-oxothiazolidine-4-carboxylate (OTC), in 
ameliorating peridural scar formation following spinal laminectomy surgery in laboratory 
rats. Western blot and immunocytochemical analyses indicated that the peridural scar 
tissue contained MyoD-positive myoblast cells and expressed prolyl-4-hydroxylase 
(P4H), a fibroblast marker. Treatment with 1 mM OTC reduced activation of ERK1/2 
and p38 mitogen-activated protein kinases (MAPK) at 21 days post-surgery suggesting 
potential anti-scarring mechanism. However, large animal to animal variation in the 
expression levels of collagen biosynthesis markers made it difficult to demonstrate any 
efficacy of quercetin or OTC in reducing peridural scar formation. The shortcomings of 
this live animal approach led us to develop a novel three-dimensional (3-D) in vitro 
wound repair model for evaluating quercetin and OTC effects. High-density “micromass” 
co-cultures seeded at a 1:3 ratio of FR 3T3 fibroblast cells and L8 myoblast cells formed 
3-D microtissues in vitro that expressed MyoD, P4H, and -smooth muscle actin. The 
micromass tissue layer remained adherent to the culture plate when inflicted with a single 
laceration injury, which allowed monitoring of cell migration into the wound site. 
Wounded cultures were treated with quercetin, OTC and other agents (TGF-1, 
mitomycin, p38 inhibitor SB202190, ERK inhibitor PD184352) to determine their effects 
on collagen accumulation, wound closure rates, MAPK activation, and gene transcript 
expression. Both OTC and quercetin treatments reduced collagen biosynthesis in dose-
dependent manner. In addition, 1.5 mM OTC accelerated wound closure and significantly 
reduced p38 MAPK activation without affecting ERK1/2. In contrast, 40 µM quercetin 
delayed wound closure in micromass co-cultures and reduced ERK1/2 activation. Our in 
vitro findings suggest that OTC might have potential as an anti-scarring agent. 
Importantly, our novel micromass co-culture system shows promise as an improved 3-D 
scaffold-free in vitro model for use in preclinical drug development research. 
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CHAPTER 1.  INTRODUCTION 
 
Wound healing is a normal biological response to any type of tissue injury. It is a 
complex process involving cells, cellular products, and extracellular components that act 
in concert to restore the structural and functional integrity of the tissue (Lazarus et al., 
1994). The normal wound healing response involves a sequence of functionally 
coordinated events comprised of cell proliferation, synthesis and release of extracellular 
matrix proteins, production of growth factors, cell-substratum interactions mediated by 
cell surface receptors, and cytoskeletal reorganizations accompanied by cell motility 
(Bhalla, 1999). This combination of cellular and molecular interactions usually results in 
the formation of a transient fibrous scar. The scar tissue formed will have a different 
texture and be of inferior functional quality compared to the original tissue (Clark, 1996; 
Diegelmann and Evans, 2004) . For example, scar tissue in the skin does not have sweat 
glands or hair follicles, and due to reduced skin pigmentation, is more susceptible to UV 
damage  
Excessive scar formation following injury can sometimes lead to pathological 
complications that have serious medical and cosmetic implications (Clark, 1996). For 
example, excessive peridural scar formation frequently occurs in human patients 
recovering from elective spinal surgery. A prolonged fibrotic healing process is triggered 
in which the hematoma from the surgical act and traumatized paravertebral muscles 
invade the posterior dural tissue overlying the spinal cord (Hinton et al., 1995; Taylor et 
al., 2005). The invading fibrous tissue compresses the adjacent nerve roots, which leads 
to the post-surgical complication known as “failed back surgery syndrome” (FBSS). 
FBSS is characterized by debilitating back pain and numbness of the lower extremities. 
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As a result, clinicians and orthopedic surgeons are in need of effective therapeutic 
modalities to mitigate peridural fibrosis following elective spinal surgery. Anti-scarring 
drug development research has been directed towards identifying potential cellular 
mechanisms that can be effectively targeted for the prevention or reduction of fibrosis 
(Nanney et al., 2006), and also towards the isolation of appropriate pharmacologically 
active agents that can be safely administered during the post-operative period. 
Our current understanding of the wound healing process is predominantly based 
on the widely studied models of cutaneous wound healing. Moreover, most research on 
anti-scarring drug therapies has been directed towards cutaneous wound healing rather 
than skeletal muscle scarring. Although certain mechanisms of wound repair are common 
to both cutaneous and skeletal muscle healing, there are also important differences in the 
nature of wound environment and the tissues response to injury. A cutaneous wound is 
exposed to atmospheric oxygen that plays a crucial role in determining healing outcome, 
while skeletal muscle repair involves interaction with components of the immune system 
that may play a vital role in activating satellite cells and muscle derived stem cells 
(MDSCs). In addition, the interaction of skeletal muscle cells with fibroblasts from 
surrounding connective tissue may play an important role in the development of muscle 
fibrosis (Ambrosio et al., 2008;  Jankowski et al., 2002; Clark, 1996; Lehto et al., 1985a; 
Lehto et al., 1985b; Sasse et al., 1981). 
The inherent complexities of the wound healing process, in which multiple cell 
types interact to regenerate normal tissue structure make it difficult to predict the 
potential efficacy of candidate wound modulatory drugs (Nanney et al., 2006). Thus 
wound healing based drug discovery and pre-clinical drug screening is an expensive and 
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time-consuming process. A large number of new chemical entities (NCEs) tested for a 
range of therapeutic applications fail to reach the market because the NCEs are either 
unexpectedly toxic or prove to be ineffective during clinical trials. Current practice in 
drug development studies involves preliminary drug screening and dose optimization 
based on pre-clinical in vitro studies using monolayer cell culture systems as well as in 
vivo live animal models (Gottrup et al., 2000; Nanney et al., 2006). Increased ethical and 
social concerns about conducting drug research on animals and humans have led to more 
strictly enforced animal rights legislation and increasingly stringent human clinical trial 
procedures based on International Conference on Harmonization (ICH) regulations 
(Garthoff, 2005). This has placed immense pressure on drug development researchers to 
reduce, as much as possible, their dependence on laboratory animals in early drug 
screening studies. These concerns along with a desire to reduce the heavy costs involved 
in the overall drug development process have created a critical need for improved in vitro 
experimental models that better mimic in vivo conditions.  
Most currently available in vitro models for studying the wound healing process 
utilize monolayer cell culture systems (Gottrup et al., 2000). These have obvious 
limitations, as a monolayer system cannot mimic cell-cell interactions, cell-matrix 
associations and cell migration in the three-dimensional (3-D) context of in vivo wound 
repair. Some in vitro 3-D model systems are commercially available; however they are 
expensive and usually employ artificial scaffolds. The synthetic materials that are used in 
these artificial scaffolds may have immunogenic or toxicological properties that affect 
cell phenotype, which is undesirable for drug development studies.   
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The next chapter reviews the complex sequence of cellular changes that lead to 
wound repair and scar formation, the pharmacotherapeutic approaches to ameliorate this 
scarring process, and the potential utility of micromass co-culture technology in 
developing a novel 3-D scaffold-free in vitro wound model for drug evaluation studies. 
 
CHAPTER 2. REVIEW OF PERTINENT LITERATURE 
 
2.1 Current understanding of the wound healing process 
 
Wound healing is a natural biological response to any form of tissue trauma 
(Clark, 1996). The disruption of intact tissue architecture can elicit four distinct types of 
wound healing response, which may culminate either in complete tissue repair or 
pathological changes at the site of injury. 
 
2.1.1  Types of wound healing response following injury: normal and pathological  
According to Diegelmann and Evans (2004), the four basic categories of healing 
response are: 
i.) Regeneration 
ii.) Normal repair  
iii.) Deficient healing/ Chronic ulceration  
iv.) Excessive healing/ Fibrosis 
 
The following sections describe the characteristic features of different wound 
healing responses. 
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2.1.1.1   Regeneration  
Regeneration is an advanced type of wound healing, in which an entire organ or a 
major portion of a body structure that has been lost due to injury or surgical excision is 
able to re-grow and restore the original structure with full functionality. Many 
invertebrate groups (e.g. echinoderms, arthropods, coelenterates, etc.) have extensive 
abilities for organ regeneration. Among vertebrates, regeneration capacities are highest in 
the urodele amphibians (salamanders and newts) and some lizard species that are able to 
regenerate entire limbs, tails and other body parts following amputation. Recent studies in 
amphibians have highlighted a set of genes that appears to play important roles in 
regeneration through regulation of cellular plasticity. Three such genes are Msx1, BMP4, 
and Notch1 which encode, respectively, a transcriptional repressor, a signaling ligand, 
and a signaling cell surface receptor (Poss et al., 2002; Raya et al., 2003; Simon et al., 
1995).  
Although mammals have a much lower overall regenerative ability compared to 
lower animal forms, certain mammalian tissues exhibit limited regenerative capacity as 
individual components within the body. In humans, the liver, epidermis, and to some 
extent, peripheral nerves, can be partially regenerated after injury (Diegelmann and 
Evans, 2004). In addition, the tips of the digits, skeletal muscle tissue, the urinary bladder 
and bone tissue (Muneoka et al., 2008) have some regenerative properties. The 
regenerating mammalian tissue is often derived from a population of progenitor cells 
associated with that tissue, such as prechondrocytic cells of bone and cartilage, hepatic 
progenitor cells of liver, and satellite cells involved in skeletal muscle repair. 
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2.1.1.2  Normal repair 
Normal repair (sometimes known as “acute wound healing”) is the typical wound 
healing response that becomes activated in mammalian tissue following most types of 
injury such as lacerations, burns and crush injuries (Lazarus et al., 1994). It is an intricate 
physiological process that can be subdivided into three distinct but overlapping temporal 
phases: the inflammatory phase, the proliferative phase and the tissue-remodeling phase 
(Clark, 1996; Diegelmann and Evans, 2004).  
The following sections will summarize the features of these wound repair phases 
in the system where they have been most extensively studied, cutaneous wound repair. 
 
2.1.1.2.1  Phase-I: Inflammatory phase  
Inflammation is the initial phase of the normal wound repair process which occurs 
immediately following injury and persists until approximately 4 days post-injury (Clark, 
1996). The purpose of the inflammatory response is to destroy, dilute or isolate the 
injurious agent and the injured tissues. Inflammation is characterized by pain, heat, 
redness, swelling and temporary loss of function at the wound site (Clark, 1996). These 
signs can be observed after any type of tissue injury and are exacerbated by the presence 
of an infection or a foreign body in the wound site.  
The inflammatory phase begins following injury when changes in Na
+
 and Cl
-
 
ions within the cells of the tissue create a difference in ionic potential across the edges of 
the wound (Ojha et al., 2008; Ojingwa and Isseroff, 2003; Reid et al., 2005). This change 
in ionic potential acts as the stimulant for a plasma based enzyme of the serine protease 
class, Hageman Factor XII, which initiates a clotting cascade and leads to clot formation 
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(Leaper et al., 1996). The effector systems within this response, such as the plasminogen 
cascade, the complement cascade, and the kinin cascade, may interlink to control 
infection and eventually promote regeneration of tissue (Leaper et al., 1996). The 
infiltrated leukocytes and platelets become engulfed in the clot triggering the release of 
chemical mediators such as complement C5a, fibrin degradation factors, platelet activity 
factors and vasoconstrictors  such as histamine and serotonin (Leaper et al., 1996).  
Local vasoconstriction followed by activation, adhesion and aggregation of 
platelets at the site of injury prevents excessive loss of blood following injury. The 
platelet membrane provides a surface to which serum-derived thrombin is bound and 
activated. The activated thrombin in turn accelerates the clotting cascade by converting 
fibrinogen to fibrin. The activated platelets also stimulate the intrinsic coagulation system 
that converts soluble fibrinogen into a fibrin mesh that produce a thrombus (clot), which 
stabilizes the initial platelet plug (Bennett and Schultz, 1993). The provisional matrix 
created by the clotting process described above also entraps blood components including 
mast cells and platelets, providing bulk to the clot (Clark et al., 1982; O'Leary and Wood, 
2003).  
Several growth factors such as platelet derived growth factor (PDGF), platelet 
derived epidermal growth factor (PDEGF), epidermal growth factor (EGF), transforming 
growth factors (TGF- and TGF-), heparin binding epidermal growth factor (HB-EGF), 
insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) are 
also released by the platelets (Kiritsy et al., 1993). PDGF and TGF- stimulate the 
recruitment of neutrophils and monocytes from the vasculature, further exacerbating the 
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inflammatory response and stimulating fibroblast cell proliferation and migration at the 
injured site.  
A breakdown fragment generated from complement C5a protein and the bacterial 
waste product f-Met-Leu-Phe, provide chemotactic signals for the recruitment of 
neutrophils to the site of injury. VEGF, TGF- and basic fibroblast growth factor (bFGF) 
are released from the neutrophils and the surrounding uninjured tissue (Clark et al., 1982; 
Clark et al., 1997; Clark, 1996). These biomolecules may activate endothelial cells to 
initiate angiogenesis and also stimulate the orderly migration of cells (additional 
neutrophils, followed by macrophages and then fibroblasts) into the wound site (Kiritsy 
et al., 1993). Fibroblasts are then activated by PDGF, released by clot entrapped platelets, 
initiating production of collagen, glycosaminoglycans (GAGs) and other extracellular 
matrix (ECM) proteins that augment the provisional matrix and further facilitate cellular 
migration. 
Neutrophils recruited along with macrophages ingest cell debris and bacteria by 
phagocytosis. Though neutrophils have a very short life, they are capable of producing 
superoxides and hypochlorous acid that further stimulate the inflammatory response and 
may promote the differentiation of macrophages from infiltrated monocytes (Martin and 
Leibovich, 2005).  
Macrophages modulate the immune response by generating interleukin-1 (IL-
1) (Bates and Jones, 2003) and lipoxygenase products through the arachidonic acid 
cascade (Thuillier et al., 2002; Xaymardan et al., 2002). Macrophages may play an 
important role in the process of fibrosis or scarring (Martin and Leibovich, 2005). It is 
shown that when the number of macrophages was reduced fibroblast migration ceased. 
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Macrophages produce TGF- which directs fibroblasts to proliferate and synthesize 
collagen (Ghassemifar et al., 1995). The resolution of inflammation is characterized by a 
gradual reduction in the number of inflammatory cells (macrophages and neutrophils) 
and an increase in fibroblast cells in the wound site. This heralds the next stage of healing 
process, the proliferative phase. 
 
2.1.1.2.2  Phase –II: Proliferation or repair phase 
The proliferative phase usually starts 2 or 3 days post-injury and may persist for 4 
weeks (Clark, 1996).  The initial stage of the proliferative phase involves angiogenesis, 
i.e the restoration of vascular integrity through the migration, proliferation and 
organization of endothelial cells. This initial stage is influenced by the following growth 
factors: acidic fibroblast growth factor (aFGF), tumor necrosis factor- (TNF-), wound 
angiogenesis factor (WAF), VEGF and EGF (Kiritsy et al., 1993).  
Capillaries formed by endothelial budding lead to formation of a capillary-rich 
fibrous connective tissue known as granulation tissue, which eventually fills the wound 
and replaces the fibrin clot (Clark, 1996) . Besides new blood vessels, the granulation 
tissue also contains macrophages, fibroblasts and loose connective tissue. The 
regeneration of capillaries and arterioles continues until an equilibrium of arterial and 
venous blood pressure is attained within the microcirculation of the granulation tissue 
(Bloch et al., 2000). 
Cytokines such as TGF-, TGF-, interleukin-4 (IL-4), and PDGF, along with 
chemoattractants such as EGF and FGF,  and ECM molecules such as  hyaluronan, have 
been proposed as causes of granulation tissue induction (Krummel et al., 1988; Mustoe et 
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al., 1987). The provisional ECM of the fibrin clot promotes granulation tissue formation 
by providing a collagen-rich and fibronectin-rich scaffold for contact guidance, a 
reservoir for cytokines, a low impedance hyaluronan-rich matrix for cell mobility and 
direct signals to cells through integrin receptors (Damsky and Werb, 1992).  
Increased deposition of ECM components during the proliferative phase leads to 
the formation of fibrous tissue at the site of injury. This occurs after the migration of 
fibroblasts into the wound site, which proliferate and synthesize collagen, fibronectin, 
hyaluronan and other extracellular matrix components. The collagen-rich and fibronectin-
rich fibrous tissue mass provides a further scaffold or conduit for cell migration (Clark, 
1988; Clark et al., 1982). In fact, the appearance of the fibronectin and the appropriate 
integrin receptors on fibroblasts which bind fibronectin and fibrin may act as a rate-
limiting step in the formation of granulation tissue (Clark, 1988; Aota et al., 1991, Clark 
et al., 2004).  
Both PDGF and TGF- upregulate integrin receptors (Hertle et al., 1992) and 
stimulate fibroblast migration (Seppa et al., 1982). Expression of 41 integrin is 
believed to promote fibroblast migration into the wound space while a switch to 
expression of 51 ceases their migration, and establishes links to granulation tissue 
(Hertle et al., 1992). In vitro studies indicate that fibroblast migration is also enhanced by 
a variety of chemoattractants such as IL-4, FGFs, fragments of complement c5a, type I, II 
and III collagen-derived peptides, fibronectin fragments, and elastin derived peptides 
(Clark et al., 1982; Clark et al., 2004; Clark et al., 1997).  
After the granulation tissue has been established, angiogenesis ceases and many 
of the newly formed blood vessels disintegrate through apoptosis. In cutaneous healing, 
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re-epithelization occurs whereby the epithelial cells from the wound edges migrate and 
proliferate to cover the granulation tissue, thus forming a barrier between the wound and 
the external environment. The completion of granulation tissue formation and re-
epithelization act as the template for the last stage of the wound healing process – tissue 
remodeling.  
 
2.1.1.2.3 Phase-III: Tissue remodeling phase 
The remodeling phase usually starts 2 weeks post-injury and can last for months 
or years. Once the fibroblasts have migrated into the wound, their migratory phenotype is 
supplanted by a profibrotic phenotype characterized by an abundant endoplasmic 
reticulum and golgi apparatus filled with procollagen protein (Clark, 1996). The 
fibroblasts express high levels of the TGF-1 growth factor that stimulates further 
synthesis of collagen, which accumulates within the granulation tissue. The production of 
IL-4 by mast cells, a blood component trapped within the fibrotic tissue, can also induce 
modest increase in type I and III collagens as well as fibronectin. Once the collagen 
matrix has been deposited in the wound, the fibroblasts cease collagen production despite 
continued expression of TGF- (Clark et al., 1997). From this point onwards collagen 
remodeling occurs, leading to replacement of granulation tissue with fibrotic scar tissue. 
Any disruption during the remodeling process may also lead to excessive scar tissue 
formation through continued collagen synthesis and catabolism of collagen at a low rate. 
Matrix metalloproteinases (MMPs) which are secreted by macrophages, epidermal and 
endothelial cells, as well as fibroblasts, catalyze the degradation of collagen in the wound 
(Clark et al., 1997). Studies have shown that IL-4 and IL-10 down regulate expression of 
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matrix metalloproteinase in macrophages while IL-1 and TNF- up regulate expression 
of matrix metalloproteinase (Agren et al., 1998; Liu et al., 2009; Nwomeh et al., 1998). 
The rate of collagenolytic activity is further regulated by tissue inhibitors of 
metalloproteinases (TIMP-1), released by neutrophils and fibroblasts.  
A relatively acellular scar gradually replaces the fibroblast-rich granulation tissue. 
The fibroblast cells within the wound undergo apoptosis in response to cellular signals 
that are not clearly understood (Clark, 1996; Lee et al., 2005a). It has been proposed that 
interferon gamma (IFN-) released by activated T-lymphocytes could be one of the 
factors responsible for the down-regulation of fibroblast proliferation and fibroblast-
collagen synthesis (Falanga, 1993; Lee et al., 2005a). 
The final stage of the tissue-remodeling phase consists of wound contraction. This 
involves a complex and well-orchestrated interaction of cells, extracellular matrix and 
cytokines. During the second week of cutaneous wound healing, fibroblasts acquire a 
myofibroblast phenotype characterized by the presence of large bundles of actin 
microfilaments beneath the plasma membrane of the cells (Moulin et al., 2000). The 
appearance of the myofibroblasts promotes tissue compaction and therefore wound 
contraction.  
The contraction probably requires stimulation by TGF-1 or TGF-2 and PDGF, 
attachment of fibroblasts to the collagen matrix through integrin receptors, and formation 
of cross-links between bundles of collagen (Clark et al., 1997; Cox, 1995). Contraction 
continues until the wound edges are pulled together and there may be continued 
deposition of type III and type I collagen, while the hyaluronic acid within the resulting 
scar matrix is replaced by chondroitin sulfate (Chen and Abatangelo, 1999; Fraser et al., 
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1997; Lovvorn et al., 1998; Maytin et al., 2004; Spicer and McDonald, 1998; Thibeault 
et al., 2004; Toole, 1990).  
Eventually the myofibroblast cells undergo apoptosis under the influence of TGF-
1 and PDGF (Clark, 1996). The maturation of collagen fibrils occurs when levels of 
collagen production and degradation become equalized within the scar tissue. Collagen 
maturation is an oxidative deamination process, whereby collagen peptidyl-lysyl residues 
are converted to semialdehyde, generating an intermolecular cross-link that leads to 
collagen fibril aggregation and stabilization (Fukae and Mechanic, 1980). The overall 
maturation process may last for years following injury. The maturation of collagen and 
contraction of the scar tissue is a gradual time-dependent process resulting in scar tissue 
that has a tensile strength close to 80% of the original tissue (Clark et al., 1997; Cox, 
1995). The scar tissue formed might persist for years or eventually contract to be replaced 
by normal tissue.  
The overall normal wound healing cascade is a well-orchestrated interaction of 
cellular and molecular components in a time-dependent manner that eventually leads to 
restoration of the injured tissue. However, anomalies may occur within any of the above 
tissue repair phases that can lead to pathological healing responses, as discussed in the 
next section.  
 
2.1.1.3  Deficient healing and chronic ulceration 
Deficient healing refers to a situation where there is insufficient deposition of 
connective tissue matrix at the wound repair site so that the tissue is weakened to the 
point where it could disintegrate. Chronic non-healing dermal ulcers, such as decubitus 
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ulcers, exemplify deficient healing (Keller et al., 2002). Excessive neutrophil infiltration 
in these ulcers appears to be a significant biological marker, and is responsible for 
chronic inflammation, which is characteristic of ulcers (Diegelmann and Evans, 2004). 
The neutrophils release significant amounts of enzymes such as collagenase (MMP-8), 
which are responsible for destruction of the connective tissue matrix (Nwomeh et al., 
1999; Nwomeh et al., 1998), along with elastase which is capable of destroying important 
healing factors such as PDGF and TGF- (Yager et al., 1996). Presence of excessive 
reactive oxygen species is another factor that further damages the cells and healing 
tissues (Wenk et al., 2001). Hence, chronic ulcers will not heal until the inflammation is 
reduced. Chronic ulcers will not respond to the current treatment practice of using skin 
substitutes and topical cytokines such as PDGF, unless the wound bed is debrided of any 
underlying infection or inflammatory stimulus (Falanga, 1993; Robson et al., 1998). 
 
2.1.1.4.  Excessive healing and fibrosis- keloids and hypertrophic scars 
Fibrosis, strictures, adhesions and contractures are examples of excessive healing. 
Fibrosis can be defined as the replacement of the normal structural elements of the tissue 
by distorted, non-functional and excessive scar tissue. Unlike normal fibrous connective 
tissue found in the body, which is of high tensile strength and elasticity, fibrotic tissue 
has low tensile strength and is inelastic in nature (Bock and Mrowietz, 2002; Rahban and 
Garner, 2003).  
Contraction is part of the normal process of healing, but if excessive it becomes 
pathologic and is then termed a contracture (Nedelec et al., 2000).  A contracture is 
developed when normal elastic connective tissues are replaced by inelastic fibrotic tissue 
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that prevents stretching and normal movement. Contractures may occur in skin, muscle, 
tendons, and joints.  
Many clinical problems are associated with excessive scar formation such as 
tendon adhesions that immobilize joints, esophageal strictures and urethral strictures, 
capsule formation around breast implants, liver fibrosis and cirrhosis, and fibrotic non-
union in bone (Kovacs, 1991). Both hypertrophic dermal scars and keloids are clinical 
examples of fibrotic skin healing that result from an extended inflammatory phase in the 
wound repair process which leads to excessive collagen deposition (Rahban and Garner, 
2003; Shaffer et al., 2002). Fibroblasts isolated from keloids produce 2 to 3 times more 
collagen compared to fibroblasts isolated from normal skin of the same patient (Clark, 
1996). Keloids exhibit increased expression of TGF-1 and also an up-regulation of 
TGF-1 receptors (Babu et al., 1992; Chin et al., 2001). Hypertrophic scars are also 
characterized by excessive accumulation of collagen. A biological marker that 
distinguishes keloids from hypertrophic scars is the absence of myofibroblast cells in 
keloids and an abundance of these contractile cells in hypertrophic scars (Ehrlich et al., 
1994).  
Most conditions of fibrosis are characterized by an increased density of mast cells 
(Gruber, 2003; LeRoy et al., 1990). Mast cells contain enzymes such as chymase and 
tryptase are capable of processing procollagen to abnormal collagen fragments. It has 
been suggested that the production of these abnormal collagen peptides stimulates 
excessive collagen synthesis in fibroblasts, resulting in fibrosis (Kofford et al., 1997). 
Therefore, the extracellular matrix collagen accumulation in fibrotic scarring is a logical 
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target for pharmacological intervention and many researchers have attempted to modify 
collagen synthesis and degradation pathways (Meier and Nanney, 2006a).  
Another clinical condition that results from excessive fibrotic healing is “failed 
back surgery syndrome” (FBSS) in humans. FBSS is a post-operative complication, that 
occurs as a result of excessive peridural scarring in patients who have undergone spinal 
surgery to treat spinal cord trauma, or lumbar disc herniation surgery (Taylor et al., 
2005). Following surgery, a hematoma is formed at the site of surgery and the dissected 
paraspinal and paravertebral muscles start to heal, gradually forming granulation tissue 
that invades the posterior and lateral aspects of the spinal foramina reaching the dural sac 
and nerve roots (Hinton et al., 1995; Taylor et al., 2005). The granulation tissue gradually 
matures into dense fibrous scar. An excessive deposition of ECM proteins occurs 
following interaction of the connective tissue fibroblasts with injured paraspinal and 
paravertebral muscles, which further contributes to invasiveness of the peridural scar 
tissue (Almeida et al., 2008; Taylor et al., 2005). This fibrous scar tissue invades the 
spinal processes and compresses the nerve roots, leading to FBSS.  The key symptom of 
FBSS is chronic back pain, although some individual patients also experience disabling 
pain in the hip, thigh and leg, or numbness in the lower extremities.  
In the subsequent sections, I will review the process of skeletal muscle repair 
following injury and the potential molecular interactions that may play a critical role in 
peridural fibrosis. 
2.2.  Skeletal muscle injury and repair processes 
 
Skeletal muscle tissue is composed of long, cylindrical multinucleated muscle 
fibre cells surrounded by a fibrous endomysium. Anatomically, parallel muscle fibres are 
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grouped into fascicles enclosed in a perimysium, while another connective tissue layer, 
the epimysium, surrounds the entire muscle. These connective tissue layers carry the 
blood supply to the tissue and have rich capillary networks that surround the muscle 
fibres.  
Skeletal muscle fibres contain contractile proteins, myosin and actin, which are 
arranged in repeating units known as sarcomeres (Garrett, 1990; Schiaffino and Reggiani, 
1994, Smerdu et al., 1994). Human muscles contain a mixture of physiologically distinct 
type I and type II muscle fibre cells. Type I fibres have a relatively slow contraction rate, 
a high resistance to fatigue, and rely largely on aerobic metabolism. Type II fibres are 
used for both short- and long-term anaerobic activities. Type IIa fibres have a moderately 
fast contraction rate and fairly high fatigue resistance. Type IIb fibres have a faster 
contraction rate and lower resistance to fatigue. Type IIx fibres exhibit a fast contraction 
rate with intermediate fatigue resistance (Smerdu et al., 1994). There is a correlation 
between the function of each specific skeletal muscle and its relative fiber type 
composition. Muscles involved in rapid activities have a greater percentage of type II 
fibres than type I fibres.  
Mature skeletal muscle fibres are terminally differentiated and contain post-
mitotic nuclei. In order to restore muscle function after injury, the damaged muscle fibres 
must be replaced with regenerated fibres and this is primarily a function of satellite cells. 
Lying in close apposition to the plasmalemma of muscle fibres are the satellite cells. 
These are muscle stem cells that are committed to the myogenic lineage. Satellite cells 
can differentiate into myoblasts, which subsequently fuse to form myotubes and mature 
into new multinucleated muscle fibres. The satellite cells are characterized by their 
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expression of the proto-oncogene, c-Met, the cell surface protein, CD34, and the 
transcription factor, Pax 7 (Ambrosio et al., 2008; Jankowski et al., 2002; Seale et al., 
2000). Another characteristic of satellite cells is their capacity for self-renewal, i.e. the 
ability to undergo numerous cell division cycles while maintaining the undifferentiated 
state (Kaufmann et al., 1999). The self-renewal of satellite cells can occur via 
mechanisms dependent or independent of muscle regulatory factors (MRFs), such as 
Myf5 and MyoD. The Myf5 and MyoD may show either a simultaneous or alternating 
expression pattern during the self-renewal process. It has been suggested that their 
expression may represent a developmental stage of satellite cell division (Kaufmann et 
al., 1999). It has also been proposed that it is Myf5 alone that drives the self-renewal 
phase of satellite cells (Seale et al., 2000) . 
Recent studies indicate that skeletal muscle tissue also contains a population of 
multipotent muscle-derived stem cells (MDSC) that are distinct from satellite cells and 
may also play an important role in muscle tissue regeneration (Jankowski et al., 2002). 
The MDSCs are considered to be a predecessor to the committed satellite cells, however 
they also have the capability to differentiate into other mesodermal cell types such as fat, 
bone and cartilage in vitro on stimulation with the synthetic glucocorticoid, 
dexamethasone (Williams et al., 1999). Conflicting claims have been made that MDSCs 
typically express CD34 and myogenic regulatory factors (MRFs) such as MyoD, Myf-5, 
myogenin and MRF4 (Bosch et al., 2000; Jackson et al., 1999; Jankowski et al., 2002; 
Okada et al., 1992). It has been shown that MDSCs consistently express stem cell 
antigen-1 (Sca-1) which is absent in committed satellite cells (Bosch et al., 2000; Jackson 
et al., 1999; Jankowski et al., 2002; Okada et al., 1992). However, Sca-1 is expressed in 
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myoblasts that arise from Sca-1 negative satellite cells. Also, Sca-1 levels increase 
following differentiation of myoblasts in vivo (Mitchell et al., 2005).  
Muscle injuries fall into a number of categories; muscle strain involving complete 
or partial tears, lacerations, contusions, exercise-induced soreness and compartment 
syndrome. Compartment syndrome is an acute condition caused by inflammation in a 
confined region of the body. Muscles with a greater percentage of type II fibres, those 
which cross two joints and those working eccentrically, are more susceptible to strain 
injuries (Almekinders and Gilbert, 1986; Garrett, 1990; Nikolaou et al., 1986). Elevated 
blood levels of creatinine kinase, lactate dehydrogenase, hydroxyproline and myoglobin 
are clinical indices for skeletal muscle injury. These components are often released into 
the blood stream following trauma to skeletal muscle tissue.  
Many of the events pertaining to skeletal muscle tissue repair are common to the 
cutaneous wound healing phases discussed in Section 2.1.1.2.1. However, muscle healing 
also involves some unique features such as activation of satellite cells, fusion of satellite 
cells into muscle fibres, degeneration of the injured muscle fibres and development of 
fibrosis as discussed below. 
 
2.2.1  Phases in skeletal muscle healing.  
2.2.1.1  Degeneration of the injured muscle fibres and subsequent inflammation. 
 
Skeletal muscle injury involves disruption of the muscle fibres, their plasma 
membrane, and the surrounding connective tissue. This disruption leads to leakage of 
calcium ions into the extracellular space, resulting in an intracellular serine protease 
enzyme activation and focal necrosis of the myofibres through autodigestion (Jones et al., 
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1984). This response occurs within hours to a few days from the time of injury (Jones et 
al., 1984). To prevent the autodigestion of surrounding healthy muscle tissues, a response 
known as “contraction zone” formation occurs at the boundary of injury (Hurme et al., 
1991; Rantanen et al., 1995). Histologically, the contraction zone is observed as 
retraction of ruptured muscle fibres that serve as a physical mechanism to limit the area 
of autodigestion. This response is usually visible within 12 hours following injury.  
Muscle fibre degeneration is accompanied by local swelling and hematoma. The 
injured area is infiltrated with activated macrophages, mononuclear cells and T-
lymphocytes (Hurme et al., 1991; Rantanen et al., 1995). The macrophages phagocytose 
the muscle debris and release factors such as IL-6, IL-8 and TNF- causing increased 
vascular permeability thus further stimulating inflammation. The phagocytosis of the 
injured region results in a “moth eaten appearance” of the muscle tissue, which 
establishes the scaffold-like framework necessary for subsequent muscle fibre 
regeneration (Hill et al., 2003).  
A calcium ion influx that results from disruption of the myofibre’s structure 
causes activation of a calcium-dependent protease, calpain, that leads to proteolysis of the 
myofibrillar apparatus (Dedieu et al., 2002). Activation of calpain is also implicated in 
the activation of quiescent MDSCs which are involved in muscle regeneration (Raynaud 
et al., 2004). A schematic representation suggesting the role of calcium ions in the 
mechanism of muscle repair process is shown in Figure 1.  
The influx of calcium ions within damaged muscle fibres also initiates the 
subsequent release of phospholipase A2. Phospholipase A2 promotes the breakdown of 
membrane phospholipids into arachidonic acid, which is then transformed into 
  
 
 
 
Figure 1. Role of Calcium ions in skeletal muscle repair.  Following muscle tissue injury, the ruptured muscle fibre cells release 
calcium ions to the injured site. The increased extracellular calcium ion level activates the calcium-dependent protease, calpain in the 
adjacent uninjured muscle cells. The activated calpain further activates quiescent MDSCs. Myofibril degradation within the injured 
muscle fibre cells is initiated through an extra-lysosomal degradation pathway involving a serine protease, Protease M, which causes 
conformational changes in myofibril structure. It is postulated that this helps to activate the quiescent MDSCs, though the mechanism 
is not fully understood. (Figure adapted and modified from Ambrosio et al. 2008) 
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prostaglandins by the cyclooxygenase pathway. The prostaglandins formed induce 
inflammation by activating peroxisome proliferator-activated receptor (PPAR) 
transcription factors that are involved in regulation of macrophage and endothelial cell 
responses (Clark, 2002) and modulation of thec-AMP signaling pathway (Horsley and 
Pavlath, 2003; Shen et al., 2006). Other mediators of the inflammatory response are 
blood borne neutrophils, activated macrophages and T-lymphocytes that occur in the 
hematoma formed following injury. 
 
2.2.1.1.1  Role of neutrophils in skeletal muscle repair. 
Neutrophils are the first inflammatory cells to respond to the chemoattractants 
released by platelets during the coagulation cascade following injury. They serve as the  
first line of defense against infection through phagocytosis of bacteria and removal of 
foreign bodies and necrotic tissue. Neutrophils rapidly invade injured muscle tissue and 
their activation by chemoattractants stimulates elastase and collagenase release. They 
also attract monocytes to the site of injury, and the monocytes in turn amplify the 
inflammatory response by releasing pro-inflammatory cytokines subsequently 
transforming into macrophages. 
Neutrophils can undergo a respiratory burst and degranulation which generates 
reactive oxygen species (Ambrosio et al., 2008). Although the neutrophils assist in 
removal of damaged tissue, this oxidizing reaction may inflict collateral damage to 
healthy muscle during the early inflammatory period. Neutrophils can generate 
hypochlorous acid from hydrogen peroxide via a myeloperoxidase (MPO)-mediated 
reaction and superoxide (O2
-
) via NADPH oxidase that has the potential to further 
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attenuate muscle damage (Horikawa et al., 1999). MPO is commonly used as a marker of 
neutrophil accumulation within tissue, although macrophages and monocytes also express 
small amounts of MPO (Tidball, 1995).  Superoxide is a mild oxidant that can be rapidly 
removed by reaction with other free radicals or converted to hydrogen peroxide by 
superoxide dismutase (SOD) (Horikawa et al., 1999). 
The majority of evidence for in vivo neutrophil-mediated myofibre damage comes 
from ischaemia-reperfusion (I/R) studies in which animals are rendered leukopenic using 
anti-neutrophil serum, anti-tumor agents, radiation or leukopak filters (Korthuis et al., 
1988; Lescaudron et al., 1999). Neutrophil depletion prior to I/R can attenuate 
histologically detectable damage by up to 40% in certain cases (Korthuis et al., 1988; 
Kosonen et al., 2000; Toumi et al., 2006). Neutrophil-mediated damage during I/R and 
muscle stretch is largely mediated by free radicals. Reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) also contribute to skeletal muscle injury and necrosis 
associated with muscular dystrophies (Rando, 2001) as well as contraction-induced 
muscle injury (Reid and MacGowan, 1998).  
 
2.2.1.1.2  Role of monocytes and macrophages in the skeletal muscle repair. 
 
Macrophages are the largest immune cell population present in the injured muscle 
at 12 hours post injury. They release chemokines, such as CXCL16, that promote a 
satellite cell response (Merly et al., 1999; Warren et al., 2004). During the proliferative 
phase, circulating monocytes are attracted to the wound site by growth factors released by 
neutrophils and platelets, and the monocytes differentiate into macrophages. As platelets 
are gradually removed from the wound site, the activated macrophages take over the 
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regulatory role during tissue repair process (Arnold et al., 2007). The macrophages also 
remove debris by phagocytosis and secrete cytokines that promote further wound healing 
events (McLennan, 1996; Pimorady-Esfahani et al., 1997).  
Studies using rats have shown that ED1+ macrophages are associated with muscle 
necrosis (McLennan, 1996), while ED2+ macrophages are associated with myofibre 
regeneration  after necrotic tissue is removed (St Pierre and Tidball, 1994). ED2+ 
macrophages sustain myogenic differentiation and myofibre growth in addition to their 
protective effect on differentiating myotubes (Sonnet et al., 2006) and subsequent fibre 
membrane repair (Tidball and Wehling-Henricks, 2007). The macrophages can release 
heparin-binding EGF-like growth factor that induces terminal myotubes to differentiate 
(Miyagawa et al., 1995) and promotes muscle cell survival in a high oxidative stress 
condition (Horikawa et al., 1999). Monocyte derived macrophages also release 
chemotactic factors such as VEGF, macrophage derived chemokine, monocyte 
chemoattractant protein–1 (MCP-1), and fractalkine (CX3CL1) that help arouse satellite 
cells from quiescence (Chazaud et al., 2003) and protect them from apoptosis (Chazaud 
et al., 2003; Sonnet et al., 2006). The invasion of muscle by macrophages, particularly 
the ED2+ subpopulation, is essential for satellite cell activation and satellite cell-
mediated muscle repair (Merly et al., 1999). 
 
2.2.1.2   Muscle regeneration and development of fibrosis. 
Regeneration of damaged muscle is initially triggered through the interaction of 
macrophages and satellite cells following injury. The interaction of VLA-4 expressed on 
the macrophage cell surface with VCAM1,  a cell adhesion molecule expressed by 
  25 
quiescent satellite cells (Seale and Rudnicki, 2000), serves to activate the quiescent 
satellite cells.  
The process of muscle regeneration usually takes place seven to ten days post-
injury and begins once the phagocytic cells have ingested the necrotic tissue and the 
quiescent satellite cells have been activated by macrophages (Hill et al., 2003). Various 
growth factors such as basic fibroblast growth factor (bFGF), nerve growth factor (NGF), 
hepatocyte growth factor (HGF), leukemia inhibitory factor (LIF) and IGF-1 have also 
been shown to promote or enhance self-renewal and differentiation of satellite cells into 
myoblasts in vitro (Kami and Senba, 2002; Menetrey et al., 2000). LIF was found to not 
only induce satellite cell proliferation but also myoblast cell fusion (Engert et al., 1996). 
In contrast myostatin, a growth factor belonging to the TGF-beta superfamily and 
expressed in skeletal muscle, is a negative regulator of skeletal muscle regeneration that 
blocks satellite cell activation (McCroskery et al., 2003; McCroskery et al., 2005). 
Myostatin levels are often elevated in muscle atrophy (Carlson et al., 1999). HGF is 
released from the basal lamina following muscle damage, interacts with its receptor c-
Met, in quiescent satellite cells (Seale and Rudnicki, 2000) and may promote satellite cell 
activation by downregulating myostatin production (McCroskery et al., 2005). Satellite 
cell activation results in expression of MyoD and/or Myf5 which promotes their 
differentiation into myoblasts (Seale and Rudnicki, 2000; Seale et al., 2000). The 
subsequent differentiation of myoblasts into myotubes is coordinated by several growth 
factors, although IGF-1 is particularly critical in this process (Engert et al., 1996). 
While attempting to regenerate the damaged muscle fibres, the injured tissue 
provides temporary tensile resistance through scar formation. Even in the absence of 
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muscle loading, such as conditions of immobilization, some fibrosis develops (Menetrey 
et al., 2000). Fibrosis usually occurs between the second and third week post injury. The 
ECM of the resulting scar is largely composed of types I and III collagen and its synthesis 
is increased following skeletal muscle injury (Lehto et al., 1985a; Lehto et al., 1985b; 
Sasse et al., 1981). Fibrosis decreases the muscle contractility and energy absorbing 
capacity predisposing the healed muscle to re-injury (Croisier, 2004).  
TGF-1 is the major profibrotic cytokine involved in skeletal muscle fibrosis (Li 
et al., 2004). TGF-1 is released by lymphocytes, macrophages and fibroblasts which 
infiltrate the injured site during the inflammatory response. The release of TGF-1 
activates connective tissue growth factor (CTGF)-mediated synthesis of collagen and 
prevents the degradation of ECM proteins through induction of tissue inhibitor of matrix 
metalloproteases (TIMP). Muscle regeneration is the body’s natural response to skeletal 
muscle injury; however this repair is often incomplete. A study in a mouse model 
demonstrated the presence of large areas of non-regenerated muscle with fibrotic scar 
tissue even at 35 days post-injury (Kasemkijwattana et al., 1998; Ochoa et al., 2007). 
 
2.3. Biomolecules implicated in tissue repair process 
This section will review several biomolecules that have been shown to play 
crucial roles in tissue repair and scarring processes. These include extracellular matrix 
molecules such as collagen, fibronectin, and hyaluronans; growth factors such as TGF-s 
and VEGF; and downstream signal transduction proteins, such as the mitogen-activated 
protein kinases (MAPKs).  
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2.3.1  Role of collagen and prolyl-4-hydroxylase in tissue repair 
As mentioned before, collagen is necessary for muscle tissue repair. It forms a 
sheath around fusing myoblasts and also during myotube formation (Allbrook, 1973; 
Bailey et al., 1979). However, when a large volume of muscle is devitalized by major 
trauma, the proliferation of fibroblasts may lead to rapid formation of scar tissue which 
then acts as a dense mechanical barrier to the regenerating muscle fibres (McMinn, 
1967).  
Both type I and type III collagen are important components of the wound healing 
process and the balance in the relative amount of these collagen types determines the 
nature of scar formation. In the early stages of tissue repair, type III collagen levels 
increase around the site of the wound. This is perhaps due to the migrating endothelial 
and epithelial cells that are capable of synthesizing this collagen. As the repair process 
progresses to later stages of healing, there is an increased predominance of type I 
collagen (McMinn, 1967; Clark 1996; Kinbara et al., 2002).  
Biosynthesis of collagen is a complex process involving multiple post-
translational modifications that are catalyzed by specific enzymes. Prolyl-4-hydroxylase 
(P4H) and galactosylhydroxylysyl glucosyltransferase (GGT) are two of the critical 
enzymes involved in post-translational modifications of collagen. P4H catalyzes the 
hydroxylation of proline residues in newly synthesized procollagen chains, which is 
important for their assembly into tropocollagen triple helices.  P4H is a tetramer 
composed of two  and two  subunits. The -subunits of P4H, which are identical to the 
chaperone protein, disulfide isomerase (Kivirikko and Pihlajaniemi, 1998; Myllyharju, 
2003) are required to maintain the -subunit in a soluble configuration (Lumb and 
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Bulleid, 2002).
 
The -subunits of P4H contain its catalytic domains and are rate limiting 
in the formation of active P4H (Kivirikko et al., 1990). Three different -subunit 
isoenzymes
 
are known to exist, designated
 
P4H (I), (II), and (III) (Myllyharju, 2003). The 
type I-subunit is the most abundant form in most cells, except chondrocytes and 
endothelial
 
cells (Annunen et al., 1998). Nevertheless, the enzymatic properties of types 
I–III isoenzymes are very similar (Annunen et al., 1997; Kukkola et al., 2003). Increased 
P4H levels are associated with increased collagen protein expression in tissues.Therefore, 
P4H is a potential target for anti-scarring pharmacological intervention (Meier and 
Nanney, 2006a). 
Other post-translational modifications of collagen include hydroxylation of lysl 
residues as well as glucosylation and galactosylation of lysyl and hydroxylysyl residues. 
The collagen hydroxylation
 
process is regulated by iron (Fe) ions, 2-oxoglutarate, and 
oxygen (O2) (Kivirikko and Pihlajaniemi, 1998). Ascorbate is essential for maintaining 
the iron in its biologically
 
active Fe
2+
 form and for maintaining the P4H activity during 
the hydroxylation process by protecting the enzyme from inactivation by 2-oxoglutarate 
and O2 (Nietfeld and Kemp, 1981). Moreover, ascorbate acts as an alternative oxygen 
acceptor in the uncoupled decarboxylation cycles in which 2-oxoglutarate is 
decarboxylated without subsequent hydroxylation of the collagen peptide substrate 
(Myllyharju and Kivirikko, 1997).  
After intracellular post-translational modifications and assembly of procollagens 
into triple helices, the tropocollagen molecules are secreted into the extracellular space 
where the procollagen propeptides are removed by N- and C- procollagen peptidases. The 
tropocollagen molecules are then aggregated into fibrils that are stabilized by the 
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formation of intermolecular cross-links catalyzed by lysyl oxidase (Fukae and Mechanic, 
1980; Myllyharju and Kivirikko, 1997). This process is known as collagen maturation as 
mentioned earlier in Section 2.1.1.2.3. 
 
2.3.2  Role of fibronectin in tissue repair 
Fibronectin is closely associated with the newly synthesized collagen fibrils and also 
found during the initial phases of wound healing along with type III collagen. Fibronectin 
is a high molecular weight dimeric glycoprotein that interacts strongly with other ECM 
components such as collagen, fibrin and sulfated proteoglycans. Two types of fibronectin 
have been identified: plasma fibronectin, which is expressed by hepatocytes and secreted 
in soluble form into the plasma, and cellular fibronectin which is expressed locally by 
fibroblasts and many other cell types and then deposited in insoluble form into the local 
ECM (Clark, 1988). Fibronectin is involved in a myriad of biologic processes such as cell 
adhesion, motility, differentiation, hemostasis and wound repair (Clark et al., 1982; Clark 
et al., 2004; McKeown-Longo and Mosher, 1984; Tamkun and Hynes, 1983). 
Fibronectin plays several key roles in wound healing. In the initial fibrin clot 
formed after injury, soluble plasma fibronectin and deposits of insoluble cellular 
fibronectin at the wound site assist in creating a fibrin-fibronectin network (Clark et al., 
2004; Knox et al., 1986).  This provided scaffold for platelet adhesion and aggregation as 
well as anchorage for invading fibroblasts (Donaldson and Mahan, 1983). Fibronectin 
also appear to stimulate migration of epidermal cells such as keratinocytes (Donaldson 
and Mahan, 1983; Takashima et al., 1986).  
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It has been found consistently that fibronectin deposition precedes the 
accumulation of collagen in young granulation tissue (Clark et al., 2004; Clark, 1996). 
During the subsequent development of granulation tissue the collagenous proteins are 
organized into bundles and the fibronectin is co-distributed with type I collagen. The 
fibronectin content gradually diminishes as the granulation tissue is remodeled coincident 
with a rapid turnover of collagen (Clark et al., 2004; Clark, 1996). Fibronectin may play 
a vital role in collagen removal by binding to collagen fragments generated by 
collagenase digestion. The binding of fibronectin to the collagen fragments facilitates the 
phagocytosis and recycling of collagen proteins by macrophages and fibroblasts (Grinnell 
et al., 1981).  
 
2.3.3  Role of hsp-47 in tissue repair 
The heat shock proteins are a diverse family of proteins with activities that 
include chaperoning nascent peptides within the cell and the protection of cellular 
machinery from environmental, physiological and chemically induced stress. Heat shock 
protein 47 (hsp-47) is a 47 kDa collagen-specific molecular chaperone localized in the 
endoplasmic reticulum, that plays a critical role in facilitating the correct folding and 
stabilization of procollagen triple helices within collagen secreting cells. Hsp-47 
associates with many types of collagen, including types I and III collagen.  
The level of hsp-47 protein is an important determinant of scar formation during 
wound healing. Numerous studies have shown that there is a strong association between 
excessive collagen accumulation and increased hsp-47 expression in the scar tissue of 
human and experimental fibrotic lesions (Naitoh et al., 2001; Razzaque and Taguchi, 
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1999; Taguchi and Razzaque, 2007). Hsp-47 protein levels were found to be up-regulated 
during porcine dermal wound healing (Wang et al., 2002). Increased numbers of hsp-47 
positive cells were present in injured neonatal rat skin as compared to the normal fetal rat 
skin (Wang et al., 2002). Hsp-47 levels are also increased in keloid lesions (Naitoh et al., 
2001).  
Hsp-47 is also involved in skeletal muscle repair (Higuchi et al., 2007). In the 
histological sections of injured muscle, hsp-47 protein was localized in the basement 
membrane of the regenerating muscle fibres (Higuchi et al., 2007).  
 
2.3.4  Role of hyaluronan in tissue repair 
Hyaluronan (HA) is a large, non-sulfated extracellular matrix polysaccharide that 
is abundant in heart valves, skin, skeletal tissue, the vitreous humor of the eye, the 
umbilical cord and synovial fluid (Fraser et al., 1997). It is also present at lower levels in 
most other tissues. HA is a linear polymer composed of alternating D-glucuronic acid and 
N-acetylglucosamine monosacchrides linked together through alternating -1, 4 and -1, 
3 glycosidic bonds. HA belong to a family of glycosaminoglycans that also includes 
chondroitin, heparin, heparan sulfate and keratin sulfate.  
A significant property of hyaluronan is the capacity to bind huge amounts of 
water (1000-fold of its own weight). HA functions as a biological lubricant in joints by 
reducing friction during movement (Engstrom-Laurent, 1997).  By creating a hydrating 
low impedence ECM, HA also functions in promoting cell motility during growth, 
embryonic development, inflammation and tumor invasion. HA binds to cell-surface 
receptors such as CD44, and RHAMM (receptor for hyaluronic acid-mediated motility), 
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and to extracellular matrix proteoglycans including aggrecan and versican (Sherman et 
al., 1994; Toole, 1990). 
HA is synthesized by membrane-bound hyaluronan synthase (HAS) enzymes at 
the inner surface of the plasma membrane, and the polysaccharide chains are extruded 
through pore-like structures into the extracellular space (Watanabe and Yamaguchi, 
1996). There are three distinct forms of HAS (HAS 1, HAS 2 and HAS 3) that are 
encoded by separate genes located on different autosomes (Spicer and McDonald, 1998; 
Spicer and Tien, 2004). HAS 3 synthesizes HA with a molecular weight of 1 x 10
5
 to 1 x 
10
6
 Da, while HAS 1 and HAS 2 synthesize HA with a molecular weight of 2 x 10
5
 to 2 x 
10
6
 Da (Itano et al., 1999). Pro-inflammatory cytokines such as TGF- regulate 
expression of all three HAS isoforms (Funderburgh et al., 2001). 
HA is involved in various phases of the wound healing process. During both the 
early inflammatory phase of wound repair and the period of granulation tissue formation, 
the wounded tissue is typically rich in hyaluronan reflecting an increased synthesis of this 
molecule. This is beneficial for tissue repair processes as HA has been shown to stimulate 
the production of pro-inflammatory cytokines like TNF-, IL-1 and IL-8 by endothelial 
cells (Funderburgh et al., 2001; Funderburgh et al., 2005; Thibeault et al., 2004) and to 
promote fibroblast cell migration into the wound tissue.   
An increased level of HA can negatively influence collagen deposition and it was 
observed that exogenous hyaluronan promotes scarless healing in several model systems 
(Funderburgh et al., 2005). Conversely, increased synthesis and expression of dermatan 
sulfate and heparan sulfate proteoglycans is associated with increased scarring (Lovvorn 
et al., 1998). HA levels influence epidermal response to injury; an absence of HA causes 
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terminal differentiation of keratinocytes without disrupting their proliferation (Maytin et 
al., 2004; Passi et al., 2004). The cell surface hyaluronan receptors, CD44 and RHAMM, 
have been identified as fibrogenic factors that are required for temporal and spatial 
regulation of granulation tissue formation and resolution (Tolg et al., 2006). RHAMM is 
necessary for the recruitment and differentiation of myofibroblasts leading to wound 
contraction (Tolg et al., 2006) while increased expression of CD44 is associated with 
scarring (Lovvorn et al., 1998). 
 
2.3.5  Role of Vascular endothelial growth factor (VEGF) in tissue repair  
During the proliferative phase of wound healing, new capillary vessels are formed 
through a process known as angiogenesis (Bates and Jones, 2003). The newly formed 
vessels will help deliver nutrients and oxygen to proliferating cells at the wound site. 
VEGF, an important biochemical marker of angiogenesis, is a member of the platelet-
derived growth factor super-family. VEGF production in cells is induced under hypoxic 
conditions. Hypoxic stimuli promote new capillary formation that is characterized by 
increased VEGF expression, collagen biosynthesis and fibronectin levels at the wound 
site (Bates and Jones, 2003).  
Release of ROS through a respiratory burst from infiltrating neutrophils and 
macrophages also promotes VEGF production following injury (Sen et al., 2002). In 
addition, other angiogenic factors released by the macrophages sustain VEGF production 
in the early phases of wound healing (Bates and Jones, 2003). Fibroblasts produce VEGF 
under hypoxic conditions and this accounts for its presence during the later phases of 
wound healing (Takamiya et al., 2002).  
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A certain level of angiogenesis appears to be required for wound healing, 
however  excess angiogenesis may lead to scar tissue formation (Szpaderska et al., 2005). 
Excessive angiogenesis was shown to promote scar formation in skin while lesser 
angiogenesis in oral mucosa led to rapid healing without scar formation (Szpaderska et 
al., 2003). However, a different study found that anti-angiogenic agents reduced 
angiogenesis in skin wounds without affecting the quality of healing (Roman et al., 
2002).  
VEGF has also been shown to influence skeletal muscle repair. VEGF receptors 1 
and 2 are present on satellite cells and regenerating muscle fibres (Arsic et al., 2004; 
Germani et al., 2003). VEGF enhances myoblast migration in vitro and prevents 
apoptosis of myoblasts in cell culture and in skeletal muscle following ischemia 
(Germani et al., 2003). One study has shown that delayed angiogenesis may lead to 
impaired skeletal muscle regeneration (Ochoa et al., 2007). Hence, new capillary vessel 
formation and its associated biochemical factors are a vital component of the healing 
process.  
 
2.3.5  Role of TGF-s in tissue repair 
TGF-ßs are multifunctional cytokines with diverse effects on cell motility, 
proliferation, differentiation, cellular apoptosis and expression of ECM proteins (Cox, 
1995). The TGF-ß signaling cascade is initiated after TGF-ß ligands bind to type II (TßII) 
and type I (TßI) TGF-ß receptors at the cell surface (Soo et al., 2000). The type I and II 
TGF-ß receptors heterodimerize and then induce the phosphorylation of receptor-
regulated Smad (R-Smad) proteins, such as Smad2 and Smad3. The association of these 
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phosphorylated R-Smad proteins with co-Smads, such as Smad4, permits their 
subsequent translocation to the nucleus where they promote the transcription of various 
target genes (Shi and Massague, 2003). While TGF-ßs exerts their effects through TßI 
and TßII receptors, various modulators such as latent TGF-ß binding protein-1 (LTBP-1), 
decorin, biglycan, and fibromodulin may bind and potentially inhibit TGF-ß activity 
(Clark, 1996). 
TGF-ß1 is usually produced in response to injury (Border and Noble, 1994). Both 
TGF-ß1 and TGF-ß2 are implicated in promoting scarring (Adzick and Lorenz, 1994; 
Krummel et al., 1988; Shah et al., 1995) while TGF-ß3 was shown to decrease scarring 
in a rat incisional cutaneous wound model (Shah et al., 1995). TGF-ß1 stimulates 
collagen synthesis, fibroblast proliferation, and angiogenesis, which promote scarring 
(Cannon and St Pierre, 1998; Ignotz et al., 1987; Massague, 1990). TGF-ß1 also prevents 
collagen degradation through inhibition of matrix metalloprotease-9 (MMP-9) and 
activation of TIMP. In addition, increased TGF-ß1 and TGF-ß2 expression is associated 
with tissue fibrosis in many organ systems (i.e., lung, kidney, skin, liver).  
Very high levels of TGF-ß1 have been implicated in conditions of excessive scar 
formation such as keloid and hypertrophic scars (Clark, 1996), while low levels of TGF-
ß1 expression are associated with deficient wound healing conditions such as diabetic 
foot ulcers (Liu et al., 2009). TGF-ß1 promotes cell proliferation and inhibits cell 
apoptosis in keloid scars (Chodon et al., 2000).  
In skeletal muscle, TGF-ß has the ability to inhibit myogenic differentiation, 
myoblast fusion and the expression of various muscle specific proteins (Florini et al., 
1991; Liu et al., 2001). Myostatin, a member of the TGF-ß superfamily, is a negative 
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regulator of skeletal muscle growth which co-localizes with TGF-ß1 in the myofibres in 
the early stages of muscle tissue injury (Zhu et al., 2007). The combined action of 
myostatin with TGF-ß1 may promote skeletal muscle scarring (Zhu et al., 2007). Use of 
TGF-ß3 which has anti-scarring potential (Occleston et al., 2008) and modulation of the 
TGF-ß mediated signaling pathway may be potential targets for pharmacological 
intervention for anti-scarring properities (Leask and Abraham, 2004) 
 
2.3.6  Role of ERK and p38 MAPK signaling in tissue repair 
Various growth factors such as IGF, PDGF, EGF, and FGFs regulate the wound 
healing process through effects on cell migration, proliferation, apoptosis and protein 
synthesis (Clark et al., 1997; Clark, 1996) . The mitogen-activated protein kinases 
(MAPKs) are critical intracellular enzymes in the signal transduction pathways which 
relay the effects of these growth factors to the cell interior. There are three major types of 
MAPKs in mammalian cells: the extracellular signal regulated kinases (ERK), c-jun-N-
terminal kinases (JNK) and p38 MAPK.  
Each MAPK signaling cascade shares an evolutionarily conserved organization 
and consists of three sequentially acting protein kinases: a MAPK kinase kinase 
(MAPKKK) which phosphorylates/activates a MAPK kinase (MAPKK) which then 
phosphorylate/activates a MAPK (Xiao et al., 2002; Bobick and Kulyk, 2004). Within 
this triple kinase system, each downstream kinase functions as a substrate for the 
upstream activator and is regulated through phosphorylation within the activation loop of 
its kinase domain. The MAPK at the bottom of this phosphorylation cascade is 
selectively activated by dual phosphorylation on specific threonine and tyrosine sites 
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within a characteristic Thr-X-Tyr motif of its catalytic domain, which is unique for each 
specific MAPK. ERK 1 and 2 are phosphorylated at a Thr-Glu-Tyr site, while p38 and 
JNK are activated at Thr-Gly-Tyr and Thr-Pro-Tyr dual phosphorylation motifs 
respectively.  
Following phosphorylation, the activated MAPK regulates cellular responses by 
phosphorylation of numerous cytosolic and nuclear protein substrate targets, including 
transcription factors (e.g. Elk-1, Sap1, c-Jun, NF- or ATF2), cytoskeletal proteins (e.g. 
actin, tubulin, neurofilament, vimentin or keratins) and other cytoplasmic protein kinases 
(e.g. RSK1, cytoplasmic phospholipase A2 or calcium-dependent calmodulin protein 
kinases).  
ERK 1 and ERK 2 (also known as p44 and p42 MAPK, respectively) are typically 
activated by mitogenic stimuli such as growth factors and some cytokines. The p38 
MAPKs consist of four members (p38-, p38-, p38-, p38-) with apparent molecular 
weights between 38 and 43 kDa. The JNKs consist of 10 isoforms with molecular 
weights of 46 to 57 kDa which are derived from three different genes, jnk-1 through jnk-
3, by alternative splicing. The JNK and p38 pathways are frequently activated in response 
to stress stimuli including ultraviolet irradiation, heat shock, osmotic shock and tissue 
injury.  However, under non-stress conditions these pathways may also be activated by 
growth factors, adenosine diphosphate (ADP) and phosphatidyl inositol (Pi).  
In a Drosophila embryo dorsal wound closure model, JNK signaling plays a 
crucial role in AP-1 activation at the leading edges of epithelial cells, while the JNK 
pathway is down-regulated in the amnioserosal substratum that covers the dorsal punch 
wound (Reed et al., 2001). In both Drosophila and mammalian wound repair, it was 
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found that the JNK mediated AP-1 activation accompanied the re-epithelialization 
process (Glise and Noselli, 1997; Hou and Perrimon, 1997; Martin and Parkhurst, 2004).  
Activation of both p38 MAPK and ERK1/2 was found to suppress the formation 
of keloid-like scars by promoting apoptosis of keloid fibroblasts (Kuo et al., 2005). The 
p38 MAPK/ JNK pathway was found to be necessary for mediating human keratinocyte 
migration on collagen matrix in vitro (Li W et.al, 2001). Growth factor-stimulated p38 
activation induced keratinocyte migration, while ERK1/2 activation induced 
keratinocytes proliferation (Sharma et al., 2003). During the early phases of corneal 
wound healing (Imayasu and Shimada, 2003; Sharma et al., 2003), ERK1 and ERK2 
activation are involved in the initiation of corneal cell migration and proliferation. 
Inhibition of either the ERK1/2 or p38 pathway caused a delay in corneal epithelium 
repair, while a combination of both p38 MAPK and ERK1/2 inhibitor treatments resulted 
in additional inhibition of the wound healing process (Sharma et al., 2003). Another 
study involving lipopolysaccharide (LPS)-stimulated macrophage cells reported that 
TGF-ß inhibited inflammatory cytokine production through cross-talk between the 
ERK1/2 and p38 MAPK pathways. ERK-dependent inhibition of p38 MAPK was 
achieved by up-regulation of MAP kinase phosphatase-1 (MKP-1) (Xiao et al., 2002). 
In skeletal muscle, the p38 /ß MAPKs are believed to function as a molecular 
switch for satellite cell activation (Jones et al., 2005). p38 / ß MAPK activation 
promotes the proliferation of satellite cells  and their transformation into myoblasts, or 
myonuclei leading to formation of muscle fibres, and eventually muscle repair (Chen et 
al., 2007). Conversely, inhibition
 
of p38 /ß MAPKs promotes exit of satellite cells from 
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the cell cycle,
 
prevents their differentiation and insulates these cells from
 
external stimuli 
to maintain
 
a quiescent state (Jones et al., 2005). 
 
2.4  Pharmacotherapeutic approaches in scar reduction research 
 
Currently available treatment modalities for the management of excessive wound 
scarring include corrective surgery to remove scar tissue, corticosteroid injections and 
laser therapy (Meier and Nanney, 2006a; Meier and Nanney, 2006b). These treatments 
are often inconvenient, painful and have unwanted side effects. The development of 
optimal therapeutic agents for scar reduction remains an elusive goal for drug 
development researchers. This is attributed to the intrinsically complex nature of the 
wound healing process, the high variability of responses between patients during healing, 
and the multiple genetic factors involved in aberrant scar formation (Meier and Nanney, 
2006a). 
Most literature pertaining to anti-scarring strategies is focused on improving the 
healing response rather than the complete elimination of scarring (Clark, 1996; 
Diegelmann and Evans, 2004). This may be achieved through ameliorating pro-
inflammatory events during the initial phase of wound repair that might help to reduce 
collagen synthesis and deposition.  
The ideal anti-scarring drug therapy would be one that is inexpensive, curative in 
most patients with an existing scar and may be able to prevent excessive scarring by 
replicating the scarless nature of fetal wound healing (Meier and Nanney, 2006b). It 
should also lack the adverse side effects seen in currently available treatment options.  
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Corticosteroids, such as dexamethasone, have been used as anti-fibrotic and anti-
inflammatory agents in the therapeutic management of keloid and hypertrophic scars. 
Intra-lesional administration of corticosteroids is an effective treatment modality for 
keloidal scarring (reviewed in Jalali and Bayat, 2007). However, the mechanism of 
ameliorating abnormal scar formation by use of corticosteroids is poorly understood, and 
their long-term topical use may lead to adverse effects such as hypertrichosis, wound 
atrophy, altered pigmentation and striae. In addition, topical corticosteroid administration 
may be associated with adverse systemic effects, including hyperglycemia, glaucoma and 
adrenal insufficiency.  Systemic administration of corticosteroids has been documented to 
cause a wide range of  adverse effects such as heart disease, drug-induced obesity, 
diabetes mellitus, high blood pressure, myopathy, Cushing’s syndrome, and increased 
risk of infections (Jalali and Bayat, 2007).  
Traditional non-steroidal anti-inflammatory drugs (NSAID), such as 
indomethacin, ibuprofen, ketorolac, diclofenac as well as selective cycloxygenase-2 
(COX-2) inhibitors, such as meloxicam, rofecoxib, parecoxib and valdecoxib, have been 
used in treating inflammation and associated pain following bone fractures and/or post-
operative pain after cardiac and orthopedic procedures (Meier and Nanney 2006a). The 
use of NSAIDs in anti-scarring therapy is controversial because both beneficial and 
detrimental effects on wound healing have been reported (Reish and Eriksson, 2008). It 
was observed that animals treated with COX-2 inhibitors (both selective and non-
selective) and transgenic mice which lack COX-2 gene showed impaired or delayed bone 
fracture repair (Vuolteenaho et al., 2008). Moreover, some of the selective COX-2 
inhibitors, such as rofecoxib, parecoxib and valdecoxib, have been reported to cause 
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cardiac distress in humans, leading to their ban in clinical use by United States Food and 
Drug administration (US-FDA).  Hence, there is a critical need for alternative drug 
therapies to reduce excessive scar formation following injuries and surgeries. 
Research on alternative anti-scarring drugs has been chiefly focused on the 
following potential drug targets: 
i.) Modulators of extracellular matrix collagen production such as inhibitors of 
prolyl-4-hydroxylase (Meier and Nanney, 2006a; Meier and Nanney, 2006b). 
ii.) Novel anti-inflammatory and anti-oxidant molecules including certain plant 
flavanoids such as curcumin, epicatechin, quercetin and cellular glutathione 
(Davidson and Breyer, 2003; Middleton et al., 2000), 
iii.) Cytokine/growth factors such as TGF- (Meier and Nanney, 2006b; Mustoe et 
al., 1987), interferon (Lee et al., 2005a), interleukin-10 and imiquimod (Meier 
and Nanney, 2006a; Meier and Nanney, 2006b; Mustoe et al., 1987)  
iv.) Anti-proliferative agents such as bleomycin, 5-fluorouracil and tamoxifen 
(Meier and Nanney, 2006a). 
 
2.4.1  Antioxidants and anti-inflammatory molecules.  
Dietary flavanoids, glutathione precursors, and procysteine compounds have both 
anti-oxidant and anti-inflammatory properties, and may have potential as anti-scarring 
agents (Juurlink, 2001; Juurlink and Paterson, 1998; Kempuraj et al., 2005). These 
molecules can inhibit oxidative stress and inflammatory tissue responses by inducing 
endogenous phase–2 enzymes and promoting cellular glutathione synthesis (Juurlink, 
2001; Juurlink and Paterson, 1998; Kempuraj et al., 2005). The following sections will 
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focus on two candidate anti-inflammatory and antioxidant compounds, specifically 
quercetin and L-2-oxothiazolidine-4-carboxylate (OTC), which were investigated in my 
thesis research as potential modulators of wound healing and scar formation. 
 
2.4.1.1  Quercetin. 
Quercetin is a naturally occurring polyphenolic flavonoid, which has anti-
inflammatory, anti-oxidant, anti-proliferative and Fe
3+
chelating properties (Davidson and 
Breyer, 2003; Middleton et al., 2000). The human body cannot synthesize flavanoids 
including quercetin, therefore the only available sources are through the diet. Dietary 
quercetin is most abundant in onions (1407 mg/kg), cranberries (121 mg/kg), broccoli (74 
mg/kg), apple skin (21 mg/kg), olives (18 mg/kg), red wine (3.5 mg/kg) and green tea (1 
mg/kg) (Hertog and Hollman, 1996; Hollman et al., 1995; Rice-Evans and Miller, 1996). 
Quercetin has a molecular weight of 338.3 Da and is hydrophobic in nature.  
Knowledge of the pharmacokinetic parameters of quercetin is still quite limited. It 
appears that quercetin can undergo extensive biotransformation during metabolism 
through conjugation reactions by liver and intestinal enzymes leading to the formation of 
glucuronated, sulfated and methylated quercetin conjugates. Each of these quercetin 
conjugates has specific physiochemical properties which might exert distinct 
pharmacological actions (Davidson and Breyer, 2003; Middleton et al., 2000).  
Quercetin consists of three ring structures (designated A, B and C) which bear 
substitutions at specific positions that influence the therapeutic capacity and mechanism 
of metabolic degradation molecules (Fig. 2 A). Structure-activity relationship studies, 
using both in vitro and in vivo models, suggest that the presence of an oxy group at 
position 4 in the quercetin C ring and a double bond between carbon atoms 2 and 3 of the  
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FIGURE 2
Quercetin
IUPAC name: 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-cromen-4-one
L-2-oxothiazolidine-4-carboxylate (OTC)
IUPAC name: (4R)-2-oxothiazolidine-4-carboxylic acid
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Figure 2. Chemical structures of Quercetin and L-2-oxothiazolidine-4-carboxyl-
ate (OTC) and their International Union of Pure and Applied Chemistry (IUPAC) 
nomenclature. (A) Quercetin is a polyphenolic flavanoid containing three ring struc-
tures with hydroxyl functional groups at positions that enable the molecule to have anti-
inflammatory, anti-oxidant, and iron chelating properties (B)  OTC, a procysteine com-
pound, is an analog of 5-oxo-L-proline that has the methylene group replaced with sulphur 
atom at position 1. Thus OTC act as an excellent substrate for 5-oxoprolinase enzyme 
that converts it into L-cysteine, a rate limiting aminoacid in cellular glutathione synthesis. 
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C ring may confer antioxidant properties, enabling quercetin to protect cells from H2O2-
induced oxidative stress and calcium dysregulation (Cotelle, 2001; Hertog and Hollman, 
1996; Huk et al., 1998; Theoharides et al., 2001; Wang and Joseph, 1999). The presence 
of a hydroxyl group at position 3 of ring C could be critical in determining the anti-
inflammatory activity of quercetin be critical in determining the anti-inflammatory 
activity of quercetin (Theoharides et al., 2001).  
Studies have demonstrated that quercetin can inhibit inflammation by several 
different pathways such as inhibition of the Janus Kinase (JAK) pathway (Uchida et al., 
1999), myeloperoxidase and xanthine oxidase (Pietta, 2000), certain MAP kinases such 
as JNK and p38 MAPK (Uchida et al., 1999), as well as by directly scavenging strong 
oxidants (Middleton et al., 2000). 
It  has been demonstrated that intraperitoneal administration of quercetin 
promotes partial recovery of the motor functions in rats subjected to an experimentally 
induced spinal cord injury (Schultke et al., 2003). This study showed that 25 micromoles 
quercetin (0.025 mmol/kg) was effective in reducing inflammation in spinal cord injury 
and suggested that this anti-inflammatory activity was due to the Fe
3+
 chelating properties 
of quercetin.  In fibroblasts isolated from hypertrophic and keloid scars, treatment with 
25 microgram quercetin/mL (0.074 mmol/kg) reduced cell proliferation (Phan et al., 
2001) and decreased the production of fibronectin protein (Phan et al., 2003). These 
authors subsequently demonstrated that quercetin reduced the proliferation of keloid-
derived fibroblasts by suppressing TGF-/ SMAD signaling (Phan et al., 2004). In 
addition, in vitro studies on human dermal fibroblast cells showed that quercetin reduced 
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both total collagen and total DNA levels in a dose-dependent manner with maximal effect 
observed at 80 microgram quercetin/mL treatment (Stipcevic et al., 2006).  
In skeletal muscle cells, it was observed that quercetin could retard muscle cell 
differentiation by delaying myogenin expression, and by scavenging superoxide anions 
and hydroxyl radicals that create conditions conducive for muscle cell differentiation 
(Orzechowski et al., 2001). Quercetin was also found to inhibit both Ca
2+
 -dependent 
ATP hydrolysis and ATP-dependent Ca
2+
 uptake in skeletal muscle fibres (Shoshan et al., 
1980). Quercetin was also shown to reduce oxidative stress responses following I/R 
injury in rabbits (Huk et al., 1998).  Quercetin was found to have a positive inotropic 
effect on rat cardiac tissue, while it inhibited contraction of rat hemidiaphragm muscle 
(Apisariyakul et al., 1999). At high doses, quercetin was also found to stimulate DNA 
synthesis in myoblast cells (Orzechowski et al., 2001). The effects of quercetin on 
collagen synthesis in muscle cells have not been reported.  
 
2.4.1.2  L-2-Oxothiazolidine-4-carboxylate (OTC). 
L-2-Oxothiazolidine-4-carboxylate (OTC) is a synthetic procysteine compound 
which can act as a precursor for glutathione (GSH) synthesis (Fig 2 B). OTC has a 
molecular weight of 147.15 Da and is hydrophilic in nature. OTC is more stable in 
solution than cysteine, but is converted to cysteine by 5-oxoprolinase. The reactions 
mediating conversion of OTC to cysteine and subsequent gluthatione formation are 
shown below.  
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L-2-oxothiazolidine-4-carboxylate                                                                 L-cysteine 
 
 
 
L-cysteine    +   L-glutamate                                                                         GLUTATHIONE 
 
Since OTC is an excellent substrate of 5-oxoprolinase it may serve as intracellular 
delivery system for generation of cysteine, a rate-limiting aminoacid for intracellular 
glutathione (GSH) synthesis. GSH plays an important role in various cellular homeostatic 
processes such as DNA synthesis, protein synthesis, leukotriene synthesis, enzyme 
catalysis reactions involving conjugation of xenobiotics, regulation of cellular redox 
balance, cell growth and cell maturation (Hwang et al., 1992; Kamencic et al., 2001; Lee 
et al., 2005b; Meister, 1994; Winkler et al., 1994).  It has been proposed that treatments 
which promote synthesis of GSH might be effective in minimizing inflammation 
following tissue injury. Increased GSH may inactivate oxistress genes, the NF- 
transcription factor and MAP Kinases signaling pathways, that lead to the production of 
pro-inflammatory molecules (Juurlink, 2001; Juurlink and Paterson, 1998; Kamencic et 
al., 2001; Lee et al., 2005b; Winkler et al., 1994).  
Systemic administration of 1.0 mM OTC was shown to minimize oxidative stress 
and accompanying inflammation in a rat model of severe spinal cord compression injury 
HS CH2 
CHCOO
- 
+NH3 
-glutamylcysteine synthase 
Glycine + 2 ATP           2 ADP + 2 Pi 
ATP           ADP + Pi 
5-oxoprolinase 
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(Kamencic et al., 2001). In this study, the surgically-induced paraplegic rats treated with 
OTC were able to recover their locomotory abilities significantly better than the 
corresponding saline-treated control animals.  
Unlike N-acetylcysteine, OTC can readily cross the blood-brain barrier and is 
therefore an appropriate procysteine compound to use when targeting the central nervous 
system (Hwang et al., 1992; Kamencic et al., 2001; Lee et al., 2005b; Meister, 1994; 
Winkler et al., 1994). Other studies have shown that OTC administration reduced levels 
of ROS, VEGF, vascular permeability (Lee et al., 2005b) and decreased airway 
inflammation in a murine asthma model (Lee et al., 2006).  In human peritoneal 
mesothelial cells which were exposed to a period of hyperglycemia, OTC was found to 
partially restore glutathione levels and reduce oxidative stress. This was due to reduction 
in the levels of senescence-associated beta galactosidase (SA-beta-Gal) and 8-hydroxy-2'-
deoxyguanosine while diminishing TGF-1 and fibronectin levels (Ksiazek et al., 2007). 
Ferreira et al. (2009) also demonstrated that OTC increased intracellular GSH levels in 
myocytes and muscles fibres of diaphragmmatic muscle in vitro. These OTC treated 
muscles were protected against muscle fatigue through thiol reduction (Ferreira et al., 
2009).  
No studies published to date have directly examined OTC effects on collagen 
biosynthesis and whether OTC might have potential as an anti-fibrotic agent.  
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2.5  Experimental models for wound healing studies 
An experimental wound healing model should ideally reproduce the pathogenesis 
of the trauma in the chosen wound site and it should mimic the sequence of the repair 
processes in clinically relevant tissue as closely as possible. The choice of an appropriate 
experimental model system is crucial for efficiency of the drug development process in 
respect to determining a drug’s efficacy (safety, pharmacotherapeutic potential and toxic 
side effects) in treating a particular pathological condition (e.g. fibrosis, deficient 
healing). Unfortunately, none of the existing experimental wound repair models fulfill all 
the ideal criteria or fully replicate the human clinical situation. 
The choice of an experimental model in wound healing and drug development 
research is dependent on several factors, as discussed by Gottrup et al. (2000): 
1.) Purpose of the investigation: This includes the type of tissue repair that is being 
investigated (e.g. bone, cutaneous, liver, kidney, lungs, cardiac and skeletal 
muscle tissue repair processes); determining the physiological or 
pathophysiological changes involved in these tissue repair processes; evaluating 
the efficacy, toxicity and safety of the pharmacological or other bioactive agents, 
as well as their pharmacokinetic parameters following systemic and local 
administration. 
2.) Type of method: This includes use of in vitro versus in vivo models to study acute 
and chronic wound healing as well as adult and fetal wound healing processes. 
The choice of method will depend on the type of injury inflicted, such as 
excisional, incisional, thermal burn, chemical burn or blunt trauma wounds. 
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3.) Choice of experimental organism. This includes consideration of an appropriate 
biological species ranging from insects to primates for specific studies. With rare 
exceptions, the use of humans is generally precluded during the initial stages of 
drug development study because of ethical and human rights issues. Hence, the 
choice of a suitable organism and experimental system depends on identifying 
anatomical, physiological, biochemical or molecular parameters that can be 
extrapolated to humans. However, in most cases, the use of alternative 
experimental organisms for drug development studies does not guarantee the 
efficacy of the drug in humans. 
4.) Outcome of measurement. This includes selection of appropriate parameters to 
assess the outcome of treatment such as wound size (area and volume), wound 
strength, granulation tissue mass, collagen levels, blood supply, epithelial 
resurfacing and visual assessment. 
5.) Recruitment criteria. This includes determining the effects of conditions such as 
aging or metabolic disease (e.g diabetes mellitus) on the wound healing process. 
Moreover, drug development studies often take into consideration sex, species, 
strain and sample size for uniformity and statistical consideration. 
 
The current wound repair models available can be classified as either in vitro or in 
vivo systems. Each group can be further divided into different types of models (see Table 
1 a and 1 b).  
  
  
Table 1 a. Current in vivo wound model system available for wound healing research (adapted and modified from Gottrup, 
2000). 
 Study parameters Type of tissue defect/materials Reference 
In vivo models 
 
Artificial models 
 
Subcutaneous 
chamber/sponges 
 
 
 
 
Subcutaneous implant 
tubes 
 
 
 
 
 
Evaluation of growth factor effects, 
pharmacological agents,  granulation tissue 
studies 
 
 
 
Interventional studies to determine the effect of 
growth factors, collagenase on implants, trauma, 
surgery. 
 
 
 
 
Polvinyl alcohol, wire mesh chamber 
 
 
 
 
 
Expanded polytetrafluoroethylene 
tubes, viscous sponges soaked in 
exogenous chemicals within silicone 
tube (Cellstick). 
 
 
 
 
Woessner et al., 1961 
Holm-Pedersen et al., 1964 
Hunt et al., 1967 
Pallin et al., 1975 
Alaish et al., 1995 
 
Viljanto , 1976 
Jorgensen et al., 1996 
Jorgensen et al., 1998 
Argen et al., 1998. 
 
Injury  models 
 
Excisional wound 
 
Incisional wound 
 
Superficial wound 
 
Thermal burn wounds 
 
Chemical burn wounds 
 
 
 
 
Epithelization, wound contraction, dermal 
reconstitution, inflammation, chemotaxis, 
angiogenesis, matrix production/organization, 
evalution of pharmacological agents for 
cosmetic and functional outcomes,  
 
 
 
Full thickness dermal wound, ear 
wound models 
 
Incision in skin, retina, GI-tract 
 
Blister wounds, dermatome wounds 
 
Partial and full thickness skin 
 
 
 
 
Kiistala et al., 1964 
Jiborn et al., 1978 
Ehrlich and Needle, 1983 
Baker, 1987 
Ahn and Mustoe, 1990 
De Vries et al., 1993 
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Table 1 b. Current in vitro wound model system available for wound healing research (adapted and modified from Gottrup, 
2000) 
 Study parameters Cell types & lineages Reference 
In vitro model 
        
Single cell monolayer 
        
 
  
 
 
Co-culture monolayer 
  
 
 
 
Three dimensional 
 
 
 
Cell migration, proliferation, protein synthesis 
 
 
 
 
 
Cell-Cell interaction, Cell migration, proliferation 
 
 
 
 
Cell matrix interaction, migration, proliferation, 
protein synthesis and wound contraction. 
 
 
 
Keloid & hypertrophic. 
fibroblasts, keratinocytes, 
Epidermal, endothelial, 
macrophages 
 
 
Human dermal microvascular 
endothelial cell and human 
dermal fibroblast 
 
 
Fibroblast, keratinocytes, 
epidermal cells. 
 
 
Calderon et al., 1996 
Cha et al., 1996 
Kheradmand et al., 1994 
Ghassemifar et al., 1995 
 
 
Oberringer et al., 2007 
 
 
 
 
Mariappan et al., 1999 
 
 
Organ culture 
 
Explant culture 
 
 
Artificial scaffold-based 3-D 
culture system 
 
Integra
®
(artificial bilayer skin 
substitute) 
 
Chitosan-Gelatin-hyaluronic 
acid (skin substitute) 
 
 
 
 
Epithelialisation, wound contraction, wound margin, 
wound closure 
 
 
 
 
Re-epithelialisation, wound closure 
 
 
Re-epithelialisation, polysaccharide interaction  
 
 
 
Intact skin, Cornea 
 
 
  
 
 
Tissue engineered proprietary 
bilayer matrix  
 
Fibroblast cells, keratinocytes,  
 
 
 
Moll, 2003 
Zhao et al., 2006 
 
 
 
 
(Yannas, 1990) 
U.S. Patent 4,947,840 
 
Liu et al, 2006 
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2.5.1  In vivo models for wound research. 
A variety of different in vivo models are available for wound research to study 
various aspects of the healing process. The choice of the in vivo model employed is 
dependent on the type of investigation and the desired outcome. Most studies that have 
utilized in vivo models have focused on three aspects of the wound healing process: 
i.) To study the process of epithelialization, neovascularization and dermal 
reconstitution in cutaneous tissue healing. 
ii.) To evaluate fibrotic response and scar formation in both normal and 
pathological wound repair of various tissue types including bone, liver, 
kidney, skeletal muscle, cardiac muscle and smooth muscle. 
iii.) To assess the formation of granulation tissue and its subsequent contraction 
during wound repair. 
 
2.5.1.1  Animal models 
Commonly used animal species employed in wound healing research include 
horses (Cochrane et al., 1996; Gottrup et al., 2000), pigs (Gottrup et al., 2000; Lindblad, 
2000; Sullivan et al., 2001), rabbits (Gottrup et al., 2000; Kim et al., 2003), dogs 
(Gottrup et al., 2000), mice and rats (Dorsett-Martin, 2004; Gottrup et al., 2000). In using 
pig models, researchers generally acknowledge the fact that porcine dermis has some 
anatomical similarities to human dermis. Nevertheless, there are certain histological and 
molecular differences between the skin structures of young adult humans and the skin of 
adult pigs, such that the latter may not completely replicate age-dependent molecular 
responses observed in human cutaneous wound healing (Lindblad, 2000).  
  53 
Small rodents such as rats and mice have been used in various types of wound healing 
research because of their ready availability, low cost, and small size, which results in a 
more economical and efficient use of limited laboratory resources and housing facilities 
(Dorsett-Martin, 2004; Gottrup et al., 2000). The availability of rodent strains with well-
defined genetic backgrounds, single gene mutations, and target gene knockouts along 
with extensive literature correlating biological responses of mice and rats with certain 
human genetic traits allow them to serve as valuable models in wound healing research 
(Dorsett-Martin, 2004). 
With the advent of transgenic technology, genetically modified mice have been 
used to study the specific effects of proteins on normal and impaired wound healing in 
pathological conditions such as diabetes mellitus (Gottrup et al., 2000). This technology 
has many advantages in terms of simplifying the understanding of wound healing 
mechanism and also in estimating the effects of NCEs on the gene and protein 
expressions. However, the use of transgenic mice in drug development studies may 
increase the overall cost of the drug development process in wound healing research. 
Moreover, it may be difficult to determine the pharmacokinetics of NCEs using 
transgenic or knock-out mice, which could have altered systems of drug metabolism, 
which are not reflective of the NCEs response in normal mice.  
Similar to pigs and horses, the tissues of rodents have some differences from 
human tissues in regard to anatomical, genetic and physiological features. Such 
differences make it difficult for drug development researchers to directly extrapolate the 
safety, toxicity and efficacy profiles of pharmaceutical therapies developed in animal 
models to use in human subjects.  
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None of the currently available animal models perfectly replicates the biological 
process occurring in humans during normal wound healing (Gottrup et al., 2000). 
Nevertheless, researchers have used various animals extensively in wound repair 
investigations and to test the efficacy of potential wound healing modulators. One 
disadvantage of the in vivo wound model system is that it is difficult to directly examine 
the response of single tissue components to potential anti-scarring pharmacological 
agents or NCEs because of the complex composition of natural animal tissues and the 
multiple cell types involved in the in vivo wound healing process (Gottrup et al., 2000; 
Lindblad, 2000).  Animal to animal variability is another factor which makes it difficult 
to determine the overall outcome of measurement in anti-scarring drug development 
studies.   
 In injury models, the normal tissue of the animal forms an integral part of the 
experimental wound model system, with measurement of outcomes often made 
discontinuously. There are two types of tissue models that can be described as excisional 
and incisional wound models. In excisional wound models, a segment of tissue is 
surgically removed from the animal. An example of an excisional wound model is 
injuring the skin or ear of an experimental animals (e.g. pig, rat, rabbit, mouse) by taking 
a small full thickness punch-biopsy (Gottrup et al., 2000). Incisional wound models 
involve infliction of one or more incisions on the organism.  An example is the infliction 
of full thickness dermal incisions on the back of pigs (Singer and McClain, 2006) or rats 
(Adamson et al., 1996) using a scalpel. Incisional wound models have also been 
employed to study wound repair in other organs such as the retina and gastrointestinal 
tract (Table 1 a).  
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Other types of injury models that have been well studied are thermal burns, 
chemical burns, blistering skin lesions, and pressure sores (Gottrup et al., 2000). These 
models are often used to test the efficacy of different types of dressings, dermal 
substitutes, and drug delivery agents such as medicated ointments and creams. The 
outcome of measurements applied to these models includes evaluation of wound size, 
changes in wound area, scar tissue strength and histological changes.  
The rat spinal laminectomy wound repair model that was employed in my thesis 
research is an adaptation of a method that was initially developed to study epidural scar 
formation following surgically-induced spinal cord trauma (Hinton et al., 1995; Taylor et 
al., 2005). It involves a combination of both incisional and excisional wound repair 
features. In this model a dorsal skin incision is made, the underlying muscles retracted 
and ligaments dissected to expose the bony structures of the spine. The spinal cord and 
dural sac were exposed by chipping of the laminae of lumbar vertebrae L1 through L3 (as 
described in Section 3.1.1). This procedure induces peridural scar formation that invades 
the posterior aspect of the dural sac, the surrounding paraspinal musculature, and 
compressing the nerve roots (Hinton et al., 1995; Taylor et al., 2005). This whole animal 
wound repair model was employed in the first phase of this project to evaluate the ability 
of systemically administered quercetin and OTC to ameliorate peridural fibrosis in vivo. 
 
2.5.2  In vitro models for wound research. 
In vitro models that have been employed in wound healing studies include both 
cell culture and organ culture systems (Gottrup et al., 2000). The most commonly 
investigated cells in wound healing research are fibroblasts, keratinocytes, macrophages, 
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and endothelial cells. The available in vitro model systems can be divided into three 
types: systems utilizing a single cell type cultured in monolayer or three dimensional 
formats; multicellular systems utilizing co-cultures of two or more cell types in 
monolayer or three-dimensional format; and “ex-vivo” systems, such as organ and explant 
cultures utilizing a segment of intact tissue excised from live animals. The outcome of 
measurements in these systems includes determination of cell proliferation, cell 
migration, cell-matrix interactions, cell-cell interactions, protein synthesis, wound 
contraction and expression of specific biochemical and molecular markers appropriate for 
the cells/tissues under investigation. 
Many current in vitro models for the study of the wound healing process utilize 
monolayer cultures of fibroblasts, endothelial cells, or keratinocytes isolated from animal 
tissues or human wound sites (Bhalla, 1999; Gottrup et al., 2000). Typically, the cells are 
first cultured to complete confluence and the resulting monolayer is then subjected to 
local denudation by scraping off the cells from a small portion of the culture (Gottrup et 
al., 2000; Ronot et al., 2000). This type of in vitro assay is often used to determine the 
effects of exogenous chemical or biological factors on wound closure. The differential 
expression of proteins such as collagens and cytokines, cell morphology changes such as 
cell spreading, cell migration and cell contractility, and the metabolic response of cells to 
exogenous factors following injury are conveniently analyzed using this method. A list of 
other in vitro model systems used for specific wound repair studies is provided in Table 
1 b. 
Specialized in vitro wound models such as perfusion cell culture systems have 
been developed to study specific issues such as the impact of plasminogen on endothelial 
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cell proliferation and the regulation of MMPs following trauma in the scraped endothelial 
cell cultures (Hayashi et al., 2009).  To study periodontal wound healing, a confluent 
stratified culture of human periodontal ligament and gingival fibroblasts was subjected to 
a mechanical wound by removing a 3 mm wide band of the cell layer and then incubating 
the cells for a defined period of time to determine the wound closure rate (Lackler et al., 
2000). However, such systems have significant limitations as they are based on a 
monolayer configuration and cannot adequately replicate cellular behavior in the three-
dimensional (3-D) context of in vivo wound repair. Only one cell type is tested in most of 
these studies, although a recent study examined the interaction between dermal fibroblast 
cells and microvascular endothelial cells following trauma in a monolayer co-culture 
system (Oberringer et al., 2007).  In another investigation, fibroblast cells were 
incorporated into a 3-D collagen lattice and a punch biopsy was taken to study fibroblast 
repopulation at the wound site (O'Leary and Wood, 2003). This study had the limitations 
of using only one cell type, and relying on an artificial 3-D based scaffold to support cell 
growth. Artificial 3-D scaffold systems that are currently available are expensive and 
have the potential problem that the scaffold materials used might have immunogenic 
properties which could disrupt cell morphology and phenotype (Handschel et al., 2007). 
One commercially available artificial 3-D scaffold system consists of a tissue engineered 
bilayer matrix known as Integra
®
, which contains bovine tendon collagen fibrils cross-
linked with glycosaminoglycans. The Integra
®
 matrix is manufactured to achieve a 
controlled porosity to enable cells to migrate within the biomaterial matrix and to have a 
defined matrix degradation rate after the cells populate the pores (Yannas, 1990). The 
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Integra
®
 system has been used clinically as a scaffold for skin regeneration in burn 
victims.  
Another commonly used experimental scaffold system utilizes a chitosan-gelatin-
hyaluronic acid (Cs-Gel-HA) hydrogel that has high water binding capacity and 
biocompatible properties. Fibroblasts and keratinocytes that are co-cultured within this 
Cs-Gel-HA scaffold have been used to form artificial skin in vitro (Liu et al., 2007). A 
dermal scaffold prepared from a co-polymer of polyethylene glycol-terephtalate (PEGT) 
and polybuthylene-terephtalate (PBT), known as Polyactive, leads to the formation of 
fully differentiated stratified epidermis and basement membrane (El-Ghalbzouri et al., 
2004), which are repopulated with human fibroblasts and keratinocytes.  
Integra
®
, Cs-Gel-HA and Polyactive are primarily used as bilayer skin substitutes 
or tissue scaffolds and have not been reported to be used for anti-scarring based drug 
development studies. One limitation is that the source and nature of materials used in 
preparing such scaffolds might potentially cause immunogenic interactions with the cells 
of interest that make certain 3-D artificial scaffold based in vitro models unsuitable for 
some drug evaluation studies (Handschel et al., 2007).  
 
2.6  Use of co-culture systems in developing functional tissue models in vitro 
 
Homogenous cultures composed of a single cell type usually behave differently 
than the same cells under in vivo conditions where they are able to interact with cells of 
other phenotypes. When grown alone, cells in primary culture often lose their ability to 
proliferate over a period of time and undergo programmed cell death. Alternatively, the 
cells may undergo more rapid differentiation. Studies have shown that the use of a co-
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culture system can be beneficial in maintaining more normal cell functions including 
proliferation, differentiation and normal physiology (Bhatia et al., 1997; Gerstenfeld et 
al., 2003; Khetani and Bhatia, 2008).  
For example, a microscale culture model of human liver tissue was developed by 
surrounding hepatocyte cell colonies with various liver or non-liver derived stromal cells 
to create an in vitro liver model that permits heterotypic cell interactions (Khetani and 
Bhatia, 2008). A novel system of creating micropatterned co-cultures of 3T3-J2 fibroblast 
cells and human hepatocytes in a microchip format has been developed for application in 
high throughput drug screening (Khetani and Bhatia, 2008). Similarly, a 3-D culture 
system utilizing co-cultures of rat hepatocyte spheroids together with NIH/3T3 
fibroblasts was reported to promote enhanced hepatocyte function by overcoming the 
drawbacks of short-term survival and rapid de-differentiation of isolated hepatocytes in 
vitro (Lu et al., 2005).  
Examples of co-culture systems of differentiated muscle cells combined with a 
second differentiated cell type are shown in Table 2. In most cases, each cell type helps 
to maintain the normal physiology and phenotypic features of the other cell type present. 
A recent study introduced a monolayer co-culture system for the study of wound healing 
based on the interaction of dermal fibroblast cells and microvascular endothelial cells 
following trauma (Oberringer et al., 2007). However, this monolayer model did not 
replicate the interaction of co-cultured cells in the 3-D context of in vivo wound healing. 
Accordingly, cells that are grown in monolayer may behave differently when treated with 
exogenous chemicals, compared to cells maintained in a 3-D configuration that facilitates 
cell-cell and cell-matrix interactions.  
Table 2. Co-cultures of differentiated muscle cells with a second differentiated cell type used in tissue engineering studies. 
 
Tissue 
 
Cell types used for co-culturing 
 
 
Culture system 
interaction 
 
Effect of co-culturing on the cell types 
 
Reference 
Cell type I Cell type II 
 
Heart 
 
Rat fibroblastic 
immature 
ventricular fraction 
 
Immature rat 
cardiomyocytes 
 
Cell-Cell contact 
 
Cell type I supports the differentiation or 
physiology of Cell type II 
 
Van Luyn et al., 2002 
 
Heart 
 
Murine mature 
mesenchymal stem 
cells 
 
Rat mature 
cardiomyocytes 
 
Cell-cell contact 
 
Cell type I trans differentiates towards the 
lineage of the cell type II with which it is co-
cultured 
 
 
Fukuhara et al., 2003 
Heart Human embryonic 
stem cells 
Murine visceral 
endoderm like cells 
(embryonic) treated 
with mitomycin 
 
Cell-cell contact Cell type I differentiates into a tissue specific 
lineage which is different from the cell that 
initiates or enhances the differentiation. 
Mummery et al., 2003 
Heart Murine immature 
cardiomyocytes 
Murine mature 
microvascular 
endothelial cells 
 
Cell-Cell contact Both Cell type I and Cell type II support 
physiology or differentiation of one another. 
Narmoneva et al., 2004 
Heart Rat mature 
mesenchymal stem 
cells 
Rat immature 
cardiomyocytes 
No cell-cell contact Cell type I trans differentiates towards the 
lineage of the cell type II with which it is co-
cultured 
 
Yoon et al., 2005 
Heart Murine mature 
bone marrow cells 
Avian embryonic 
cardiac explants 
Cell-cell contact Cell type I trans differentiates towards the 
lineage of the cell type II with which it is co-
cultured 
 
Eisenberg et al., 2006 
Muscle Murine myoblast 
cell line (C2C12) 
Embryonic 
endothelial cells 
and HUVEC 
endothelial cells  
Cell-cell contact Both Cell type I and Cell type II support 
physiology or differentiation of one another 
Levenberg et al., 2005 
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The in vitro model employed in this thesis project combines the strategy of 
heterotypic cell co-culture together with 3-D “micromass” culture technology to generate 
an artificial microtissue based wound model for evaluating the effects of quercetin and 
OTC on collagen deposition and other parameters of wound repair. 
 
2.7  Micromass culture technology 
Research has demonstrated that a cellular reaggregation approach using a 
“micromass” culture technique can promote the formation of in vitro microtissues, 
including myocardial (Zimmermann and Eschenhagen, 2003), hepatic (Kelm and 
Fussenegger, 2004) and cartilaginous tissues (Ahrens et al., 1977; Cottrill et al., 1987; 
Edwall-Arvidsson and Wroblewski, 1996; Hattori and Ide, 1984; Hoffman and Kulyk, 
1999; Kulyk and Hoffman, 1996; Mello and Tuan, 1999). Ahrens et al. (1977) originally 
developed this technique for studying in vitro cartilage differentiation in primary cultures 
of mesenchymal cells isolated from embryonic chick limb buds.  
In the micromass method, “ex-vivo” tissue formation is achieved by isolating cells 
from a tissue or organ of interest then dissociating the cells to create a high density cell 
suspension, and subsequently plating the cells at superconfluent cell density to encourage 
their reaggregation to form a 3-D “microtissue”. High density micromass cultures of 
embryonic limb bud and facial mesenchyme cells from both mouse and chicken embryos 
have been used to examine the mechanism of cartilage differentiation and to determine 
the effect of various pharmacological agents on chondrogenesis (Bobick and Kulyk, 
2004; Cottrill et al., 1987; Edwall-Arvidsson and Wroblewski, 1996; Hoffman and 
Kulyk, 1999; Kulyk and Hoffman, 1996; Mello and Tuan, 1999; Motoyama and Eto, 
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1994). Neuronal and hepatic precursor cells are some of the non-skeletal cell types which 
have been examined to determine their differentiation potential using micromass culture 
technology (Boess et al., 2003; Flint, 1983; MacDonald et al., 2003; Pluchino et al., 
2003).  
In addition, studies have also shown that a high density micromass cultures can be 
generated using engineered or immortalized lines of cardiac myocytes (HL-1 cells) and 
chondrogenic progenitor cells (C3H10T1/2 and ATDC5 cell lines) (Denker et al., 1995; 
van Luyn et al., 2002; Watzka et al., 2000; Zimmermann and Eschenhagen, 2003).  
The potential of the “micromass” technology for use in soft tissue regeneration 
and engineering applications was suggested in a recent publication (Handschel et al., 
2007). Micromass technology can be adapted for use in tissue engineering applications 
because it permits the formation of scaffold-free  3-D microtissues ex-vivo (Ahrens et al., 
1977; Bobick, 2006; Bobick and Kulyk, 2004; Carlberg et al., 2001; Cottrill et al., 1987; 
DeLise et al., 2000; Edwall-Arvidsson and Wroblewski, 1996; Handschel et al., 2007; 
Hattori and Ide, 1984; Hoffman and Kulyk, 1999; Kulyk and Hoffman, 1996; Mello and 
Tuan, 1999). This technology utilizes the natural extracellular matrix secreted by cells to 
generate tissue that are devoid of any artificial scaffold materials in order to more closely 
mimic in vivo conditions (Handschel et al., 2007).  
Various other methods have been used to generate scaffold-free microtissues in 
vitro, as summarized in Table 3. One approach utilizes cell reaggregation in suspension 
culture to form spheroid- shaped microtissues. For example, autologous spheroid systems 
have been used to generate transplantable cartilage or bone tissues (Anderer and Libera, 
2002). Spheroid systems for cardiac, liver and other cell types have also been developed 
Table 3.  Examples of methods reported to have utilized scaffold-free and cell reaggregration based cell culture method to 
develop microtissue. 
 
 
Cell type used 
 
Species 
 
Technology used 
 
References 
 
Cardiomyocytes 
 
Chicken 
Chicken, rat 
Mouse 
 
Suspension culture,  
Stacking of monolayer 
Static culture 
 
Sperelakis, 1978 
Shimizu et al., 2003 
Watzka et al., 2000 
 
 
Hepatocytes 
 
Rat 
Rat 
Porcine 
Human 
 
Spinner flask 
Eudragit containing culture 
suspension 
Spinner flask 
Rotary cell culture system 
Stacking of monolayers 
 
 
Okubo et al., 2002 
Kamihira et al., 1997 
Sakai et al., 1996 
Khaoustov et al., 1999 
Harimoto et al., 2002 
 
Chondrocytes Human 
Chicken 
Mouse 
Hydrogel coated 96 well plates 
Pellet culture 
Gyratory shaker 
High density “micromass” culture 
 
Anderer and Libera , 2002 
Kafienah et al., 2003 
Bassleer et al., 1986 
Ahrens et al., 1977 
Carlberg et al., 2002 
Endothelial cells Human, Bovine 
 
Static culture Korff and Augustin, 1998 
Vascular cells Human Stacking of monolayers 
 
Hoerstrup et al., 2002 
Dermal fibroblasts Human Suspension culture 
 
Furukawa et al., 2001 
Pancreatic cells Human 
Rat 
Tissue fragments of defined size 
Rotational and static cultures 
Hoem et al., 2002 
Matta et al., 1994 
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Table 3.  Examples of methods reported to have utilized scaffold-free and cell reaggregration based cell culture method to 
develop microtissue (Contd..). 
 
 
Cell type used 
 
Species 
 
Technology used 
 
References 
 
Osteoblast 
 
Human 
Mouse 
 
Static culture 
Suspension culture 
 
 
Kale et al., 2000 
Keller, 1995 
 
Smooth muscle cells 
 
Human 
 
Static culture 
Suspension culture 
 
 
Korff et al., 2001 
Bjorkerud et al., 1994 
 
 
Embryonic retina cells 
 
 
Chicken 
 
Gyratory shaker 
 
Rothermel and Layer, 2001 
 
Neural precursor cells 
 
Mouse 
Rat 
 
Static culture 
“Micromass” culture 
 
 
Pluchino et al., 2003 
Flint, 1983 
 
Spinal cord precursor cells 
 
Mouse 
 
Static culture 
 
 
MacDonald et al., 2003 
 
Human bone marrow stromal cells 
 
Human 
 
Centrifugation pellet culture 
 
 
Muraglia et al., 2003 
 
Embryonic stem cells 
 
Human 
 
Suspension culture 
 
 
Itskovitz-Eldor et al., 2000 
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(Sperelakis, 1978; Furukawa et al., 2001; Keller, 1995; Bjorkerud et al., 1994; Itskovitz-
Eldor et al., 2002). Reaggregated microtissues derived from suspension cultures of tumor 
cells have been employed in cancer research (Kelm and Fussenegger, 2004).  
The multicellular tumor spheroids show increased proliferative activity and drug 
resistance similar to solid tumors (Kelm and Fussenegger, 2004).  
Another scaffold-free high-density culture strategy is to generate microtissues in 
pellet culture (Kafienah et al., 2003; Muraglia et al., 2003). For example, high-density 
pellet cultures were established after centrifuging dissociated chondrocytes or bone 
marrow cell suspensions in a sterile culture tube (Kafienah et al., 2003; Muraglia et al., 
2003). 
Reaggregated microtissues are becoming increasingly popular as models for 
neurodegenerative disorders, toxicology, nutrition and environmental monitoring 
(Bhadriraju and Chen, 2002; Layer et al., 2002). Thus, the engineered tissues from non-
skeletal origin confirm that it is feasible to create tissue substitutes based on re-
aggregation technology. Examples of these strategies include liver reconstruction, 
synthesis of an artificial pancreas, restoration of heart valve tissue and cardiac 
organogenesis in vitro (Lu et al., 2005).  
 
2.7.1 Micromass co-culture technology – Potential for in vitro tissue regeneration 
and drug development research 
 
In addition to its use in developmental and tissue engineering studies, micromass 
culture technology has been utilized for several pharmacological and toxicological 
evaluation studies. The high-density micromass culture system developed by Ahrens et al 
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(1977) has been used for the evaluation of potential teratogens, pharmacological 
inhibitors of regulatory signaling pathways and siRNA knock down of gene expression in 
various cell types (Bobick and Kulyk, 2004; Hoffman and Kulyk, 1999; Jin et al., 2006; 
Kulyk and Hoffman, 1996; Wang et al., 2005). Several studies have suggested that the 
experimental approach of generating 3-D microtissues using micromass culture 
technology could be a valuable tool in the initial screening of chemical or metabolic 
libraries for therapeutic compounds in a microscale format  (Bobick and Kulyk, 2004; 
Watzka et al., 2000; Cottrill et al., 1987; Edwall-Arvidsson and Wroblewski, 1996; 
Hoffman and Kulyk, 1999; Kulyk and Hoffman, 1996; Mello and Tuan, 1999; Motoyama 
and Eto, 1994; Flint, 1983; MacDonald et al., 2003 ). 
The micromass culture approach can be adapted for co-culturing two or more 
distinct cell types at high density to allow formation of heterogeneous microtissues in 
vitro (Muraglia et al., 2003). For example, co-cultures of osteoblasts and endothelial cells 
were used in one study to form a bi-cellular micromass tissue in vitro (Muraglia et al., 
2003).  Hence, micromass cultures may be a superior replacement for 2D monolayer 
cultures in classical drug discovery applications. To date, there are no published reports 
describing the application of micromass technology in wound healing studies. 
 
2.8 Experimental objectives of this Ph.D. thesis project 
 The main objective of my doctoral research project was to test the hypothesis that 
quercetin and OTC would reduce scar formation during peridural tissue repair through 
direct inhibition of collagen biosynthesis and modulation of fibrosis-associated signaling 
cascades.  The specific experimental aims of my project were:   
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1. To determine the effects of two potential anti-inflammatory compounds, quercetin and 
OTC, on parameters of peridural fibrosis in an in vivo model of peridural scar 
formation, the rat spinal laminectomy model. The parameters examined include the 
levels of collagen distribution and biosynthesis along with the changes in potential 
regulatory molecules such as Transforming Growth Factor-ßs (TGF-ßs), fibronectin 
and mitogen-activated protein kinases (MAPKs). 
 
2. To develop a novel 3-D co-culture based in vitro wound healing model system that 
mimics features of in vivo peridural tissue repair.  
The second phase of the thesis project involved adapting the micromass culture 
strategy to generate high-density co-cultures of skeletal myoblast and dermal 
fibroblast cell lines. The rationale was to encourage the skeletal myoblast and dermal 
fibroblast cell micromass culture conditions to form a 3-D microtissue layer that 
mimics in vivo peridural scar tissue. This artificial microtissue was then be 
traumatized to examine the effects of quercetin and OTC treatments on collagen 
deposition, cell migration, and other aspects of wound repair. This experimental 
system was chosen because it is a stationary culture that maintains separation of the 
wound edges following a scrape wound injury and allows for tracking cell migration 
during the time course.  
 
3. To employ this in vitro wound repair model to evaluate the effects of quercetin and 
OTC on in vitro wound closure, and to determine their effects on various molecular 
parameters of scar formation and wound healing such as TGF-ßs and MAPKs. 
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CHAPTER 3. MATERIALS AND METHODS 
 
 
3.1  In vivo studies using a rat spinal laminectomy model 
All protocols and procedures involving animals were conducted in accordance 
with the guidelines of Canadian Council on Animal Care (CCAC), and approved by the 
Animal Resources Centre at the University of Saskatchewan, Saskatoon, SK, Canada.   
Fifty-eight male Wistar rats (~ 150-200 gm body weight) were purchased from 
Charles River, Laval, QC.  The rats were reared in the animal care facility at the College 
of Medicine on a 12 h light/ 12 h dark cycle. Laboratory chow and water were given ad 
libitum throughout the experiment. 
 
3.1.1  Preparation of the animals for spinal laminectomy surgery 
Prior to surgery, each animal was weighed and then anesthetized with 5% 
halothane (MTC Pharmaceuticals, Cambridge, ON, Canada) in 95% oxygen. The dorsal 
skin was shaved and disinfected with  2% chlorhexidine gluconate (Hibitane, Wyeth 
Animal Health, Canada) followed by  70% ethanol, before a surgical incision was made. 
As a pain management measure, a 0.05 mg/kg dose of buprenorphine (CDMV Inc, St 
Hyacinthe, QC, Canada) was administered to each rat prior to surgery. Then a 
maintenance dose of 1.5 - 2.0% halothane in oxygen was administered to prevent animals 
from regaining consciousness during the surgical procedure. 
 
3.1.2.  Procedure for spinal laminectomy surgery 
Using a sterile scalpel, an approximately 2 inch long incision was made through 
the dorsal skin surface overlying the lumbar region of the vertebral column of each rat. 
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The supraspinous ligaments were cut to expose the spinous processes of vertebral bodies 
L1 to L3. Using scissors, the adjacent erector spinae muscles were spread away on both 
sides from the vertebral column and held back using a chest spreader. Using a scalpel, the 
transversospinalis muscles were bilaterally cut at their point of attachment to the L1-L3 
spinous processes, then a blunt flat-head screwdriver was used to spread the detached 
transversospinalis muscles laterally to permit unobstructed access to the bony spinal 
process (See Figure 3 C).  
Due to the small size of the laminae (~ 2 mm), the laminectomy procedure was 
performed under an operative microscope (Super-Lux 400, Carl Zeiss Inc.). The general 
location of the spinal laminectomy surgery and the lumbar region is illustrated in Figure 
3 B. The dorsal portions (spinal laminae along with the spinous process) of lumbar 
vertebrae L1 through L3 were removed by chipping away the bone using a bone rongeur 
(Figure 3 A). Any bone debris was removed from the surgical site after the laminectomy 
procedure. The adjacent muscle tissues were then sutured together at the dorsal midline 
using absorbable 3.0 vicryl sutures and the overlying skin incision was closed using a 
surgical stapler. 
To restore body fluids lost during the surgery, each rat was subcutaneously 
administered 2 mL of lactated Ringer‟s solution (Cat #: 07953; Abbott Animal Health, 
Saint Laurent, QC, Canada) soon after the procedure. For post-surgery pain management, 
buprenorphine was administered four times at 12 h intervals following surgery for a total 
of 48 h. A buprenorphine dose of 0.04 mg/kg was initially administered and the dose was 
decreased by 0.01 mg/kg at each subsequent interval. The suture staples were removed on 
the seventh day following surgery. 
Figure 3
Figure 3. Location of spinal laminectomy surgery in adult male Wistar rat. (A) Superior view of lumbar vertebrae
shows the segment of lamina between the dotted lines were excised out during spinal laminectomy surgery (B) Rat skeletal
system shows the location of region L1-L3 of the rat lumbar spine. (C) shows the exposed L1-L3 region of the rat lumbar
prior to the laminectomy procedure. The blue square shows the area where the peridural scar tissue is usually formed during
the post-surgical recovery period.
cranialcaudal
C
L1-L3B
A
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3.1.3  Treatment groups 
Following the laminectomy surgery, animals were randomly assigned to one of 
the three treatment groups: 
Group A (Saline Control) animals received intraperitoneal (i.p.) injections of 3 mL 
normal saline (Cat #: 07983; Abbott Animal Health, St Laurent, QC, Canada) beginning 
at 30 min post-surgery and repeated every 12 h for a total of either 36 h (for animals 
sacrificed at 3 days post-surgery, n =10) or 120 h (for animals sacrificed at 21 days or 63 
days post surgery, n = 9).  
 
Group B (OTC-treated) animals received i.p. injections of 1 mmol/kg of L-2-
oxothiazolidine-4-carboxylate (OTC, Cat #: O6254, Sigma Aldrich, St. Louis, MO, USA) 
dissolved in 3 mL normal saline. The treatment was started at 30 min post-surgery and 
repeated every 12 h for a total of either 72 h (for animals sacrificed at 3 days post-
surgery, n =10) or 120 h (for animals sacrificed at 21 or 63 days post surgery, n = 10).  
 
Group C (Quercetin-treated) animals received i.p. injections of 0.025 mmol/kg of 
quercetin (Cat #: Q-0125, Sigma Aldrich, St. Louis, MO, USA) suspended in 3mL 
normal saline. The treatment was started at 1 h post-surgery and repeated every 12 h for 
either 36 h (for animals sacrificed at 3 days post-surgery, n =10) or 120 h (for animals 
sacrificed at 21 or 63 days post surgery, n = 9).   
 
An illustration of the dosing regimen used for the different treatment groups is shown in 
Figure 4. 
Figure 4
Figure 4. Systemic administration of L-2-oxothiazolidine-4-carboxylate (OTC) and Quercetin, shows the
dosing regimen used for 3, 21 and 63 day treatment groups. The red bar shows the drug administration period in
which 3 mL Saline for 36 h or 120 h (Group A), 1.0 mmol/kg OTC for 72 h or 120 h (Group B) and 0.025 mmol/kg
Quercetin (Group C) for 36 h or 120 h were administered intraperitoneally to the laminectomized rats. The 3 day
saline and quercetin treated animals had 36 h to recover after drug administration while all 21 day post-surgical
treatment groups had 384 h ( approx. 16 days). This dosing regimen and recovery period was followed based on
Schultke et.al (2003) and Kamenic et.al (2001).
= Euthanasia and tissue harvest time-points
= Drug treatment
= Recovery period
Group A
(Saline, 3 mL)
36 h or 120 h
3 day 21 day 63 day
Group B
(OTC, 1.0 mmol/kg)
72 h or 120 h
3 day 21 day 63 day
Group C
(Quercetin, 0.025 mmol/kg)
36 h or 120 h
3 day 21 day 63 day
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3.1.4  Animal perfusion and harvesting of peridural wound and granulation tissue 
At representative time points of treatment (3 days, 21 days and 63 days), animals 
from each of the treatment groups were euthanized for collection of peridural wound 
tissues. For euthanasia, the rats were first anesthetized using 5% Halothane, and then an 
incision was made on the anterior region of the abdomen to open up the abdominal 
cavity. Two further incisions were made laterally through the rib cage and the diaphragm 
was excised to expose the heart. The left ventricle was punctured using a blunt-end 
needle, which was connected to an intravenous (IV) line containing cold saline. The 
needle was passed through the heart until it reached the aorta, held with a hemostat, and 
then the right atrium of the heart was cut to allow the release of blood. A cold saline drip 
perfusion was performed until the fluid ran clear through the right atrium of the heart to 
ensure blood removal from the circulatory system. No fixatives were used in the 
perfusion procedure to prevent interference with our subsequent tissue analyses (mRNA 
and protein analyses; Fourier-transformed infra-red [FTIR] spectromicroscopy).  
After the perfusion was complete, an incision was made around the skin lateral to 
the original laminectomy wound site to expose the peridural scar tissue at lumbar region 
L1 through L3. The scar tissue was excised using surgical scissors. Some spinal bone 
fragments and healthy skeletal muscle tissue initially surrounded the excised scar. The 
bone fragments were removed with surgical bone rongeurs, and the healthy muscle tissue 
was trimmed away using a scalpel blade and fine scissors. Most of the isolated scar 
tissues (n=34) were weighed, then minced into small pieces (~ 1 mm
3
) using sterile 
surgical scalpel. Equal portions of the minced tissue fragments were submerged in 
RNAlater ICE
®
 solution (Ambion Inc, Austin TX Cat #: 7031) and kept at -20°C as per 
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manufacturer‟s instruction, or transferred into polypropylene tubes, snap frozen in liquid 
nitrogen and stored at -80°C freezer until needed. The tissue fragments submerged in 
RNAlater ICE
®
 solution were used for RNA analysis, while the snap frozen tissue 
fragments stored at -80°C were used for western blot protein analysis.   
Another group of isolated scar tissues (n = 24) was processed for histological 
analysis. The excised scar tissues were placed in plastic molds containing O.C.T
®
 
embedding compound, (VWR Scientific, West Chester, PA) and then flash frozen by 
immersion in a bath of iso-pentane cooled with liquid nitrogen. The frozen tissue blocks 
were serially sectioned at 10-micron thickness in a transverse plane, in a sequence 
corresponding to successive positions along the animal‟s rostral-caudal axis. 
Most tissue sections were placed on precleaned Superfrost Plus glass microscope 
slides (VWR Scientific, Westchester, OH), two sections per slide, for a total of forty 
slides per animal. The slides were numbered in their order of section and stored at -80C. 
The pairs of sections that were numbered ten, twelve, thirty and forty were instead 
mounted on MirrIR slides (Kevley Technologies, Chesterland, OH) and  were 
subsequently used for FTIR spectral analysis of total collagen and sugar distribution by 
our research collaborators at the University of Mantioba. The sections on slide eleven 
from each animal were used for histochemical staining of fibrillar collagen using the 
picrosirius red polarization method (described below).  
In addition, contiguous sections from each animal were used by Nicole Cox 
(Department of Anatomy and Cell Biology, University of Saskatchewan) for standard 
histological staining (e.g. hematoxylin and eosin; toluidine blue) and for 
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immunocytochemical staining to detect mast cells, activated macrophages, CD4 and CD8 
T-lymphocytes (Cox, 2008).  
 
3.1.5  Picrosirius red- polarization method for histochemical detection of collagen 
fibril distrbution. 
 
The picrosirius red-polarization method is a specific histochemical procedure for 
collagen detection in tissue sections (Junqueira et al., 1979). Sirius red dye binds to 
interstitial fibrillar collagens at acidic pH and the stained collagen fibrils display 
birefringence when observed by polarized light microscopy. This procedure is useful for 
studying total fibrillar collagen distribution in histological sections of routinely fixed and 
embedded tissues.  Moreover, it has been reported that picrosirius red staining may even 
allow for some discrimination between structurally distinct collagen types in histological 
sections and reveal collagen fibril orientation in tissue sections. Interstitial type I 
collagen, which characteristically forms thick fibres, appears as strongly birefringent 
yellow or red fibres under polarized light when viewed by picrosirius red-polarization 
method (Montes and Junqueira, 1991; Montes et al., 1980). In contrast, collagen type III, 
which forms loosely dispersed thin fibrils, displays a weaker birefringence of greenish 
hue. Type II collagen fibrils within hyaline and elastic cartilage exhibit weak 
birefringence of varying color (Junqueira and Montes, 1983). The spatial distribution and 
orientation of collagen fibrils in tissue sections are more prominently revealed when the 
stained sections are visualized under circularly polarized light.  
For picrosirius red staining, cryosections of peridural scar tissues on glass slides 
were thawed, fixed with 10% buffered formalin, and washed twice with 1X PBS 
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(Phosphate Buffered Saline). The sections were stained for 90 min in 0.1% Sirius Red 
(Gurr

, C.I 35780; BDH Laboratory Supplies, England) dissolved in saturated picric acid 
solution, then washed three times for 2 min each in 5% glacial acetic acid, followed by 
two 5 min washes in 0.001N hydrochloric acid (method of Junqueira et al.,1979). Finally, 
the sections were dehydrated in a graded series of ethanol solutions, cleared with xylene 
and mounted under glass coverslips in Entellan

 mounting medium (EM Science, NJ, 
USA; Lot #: OB 103602).  
Stained slides were examined on a Nikon Optiphot.1 light microscope (Nikon, NJ, 
USA) equipped with two polarizing filters to yield a circularly polarized light. The lower 
polarizing filter was aligned such that a uniform dark background was obtained in 
absence of a mounted slide. The entire area of each tissue section was systematically 
photographed at 4X magnification using a digital camera (Nikon Coolpix 995, Nikon, NJ, 
USA) in a series of contiguous fields of view. 
The total amount of picrosirius red positive birefringent collagen in a given area 
of scar tissue was quantified using Image J 1.37 G software following the image analysis 
protocol described in the website of the Department of Cardiovascular Physiology, 
University of California, San Diego, CA, 
(http://cardprint.ucsd.edu/CV_Lab_Web_Page/HowToDocs/ImageJProtocol.pdf) and 
using the automated threshold macros obtained from this source. A total of 12 separate 
fields of view for each scar tissue section were photographed and digitized to determine 
the area of picrosirius red-positive collagen within the total cross-sectional area of the 
scar tissue sections. 
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In brief, the individual digitized raw images obtained from picrosirius red 
polarization microscopy were imported into Image J 1.37 G software. The raw images 
(2048 X 1536 pixel dimension) were opened in Adobe Photoshop Elements 3.0, then 
converted to grayscale mode and saved in high quality jpeg format. The resulting 
grayscale images were opened in NIH Image J software and segmented using the Image > 
Adjust image > threshold function. The threshold values were selected as “auto” and the 
area of each image containing picrosirius red-positive pixels were then calculated using 
the Analyze > Set Measurement function in the Image J software and selecting the Area 
(i.e number of picrosirius red positive pixels within the threshold range), min and max 
gray values, Area Fraction (i.e. % of total field of view containing picrosirus red) data 
output options. Finally, the “measure” function was selected to output data. The resulting 
measurement was expressed as the “collagen area fraction”, which is the picrosirius red 
positive area divided by the total tissue area multiplied by 100. 
 
3.1.6  Synchrotron FTIR mapping for scar tissue sections 
 Synchrotron FTIR mapping was performed in collaboration with Dr Gough‟s 
laboratory at the University of Manitoba. The Synchrotron FTIR data collection and 
collagen spectral analysis in scar tissue sections are described in Wiens et al (2007). In 
brief, 8 to 10 maps were generated for each tissue section. Synchrontron FTIR maps were 
generated from histological sections using a Nicolet 860 FTIR instrument with a 
continuum microscope (National Synchrotron Light source, Brookhaven National 
laboratory, NY, USA) or Nicolet Magna 500 FTIR instrument with a Nic-Plan 
microscope (Synchrotron Radiation Center, Stoughton, WI, USA). All spectra were 
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collected at 4 cm
-1
 spectral resolution with a 12 X 12 m aperture and 10 m step size. 
Nicolet OMNIC/Alts software was used for all data acquisition and map analyses. 
 
3.1.7 Total RNA isolation from the scar tissues for mRNA analysis 
 
Total RNA was isolated from samples of minced, frozen scar tissue following a 
modification of the methods of Chomczynski and Sacchi (1987) and Reno et al. (1997). 
In brief, the scar tissue were homogenized in 2-3 mL of 4 M guanidine isothiocyanate 
solution containing 25 mM sodium citrate, 0.5% sodium lauryl sarcosinate and 0.1 M 2-
mercaptoethanol using a Brinkmann Polytron PT 10/35 tissue homogenizer. The 
homogenate was centrifuged (11,000 rpm, 10 min, 4 C) and the resulting supernatant 
was mixed with an equal volume of aqueous saturated phenol (Cat #: P-4682, Sigma 
Chemical Co, St Louis, MO), 1/10
th
 volume of 2 M sodium acetate (pH 4.0), and 2/10
th
 
volume of 49:1 (w/v) chloroform/isoamyl alcohol. Following centrifugation at 11,000 
rpm for 10 min at 4 C, the upper aqueous layer was carefully removed and then mixed 
with an equal volume of 70% ethanol. This aqueous ethanol mixture was then passed 
through a Qiagen RNeasy
 
Plus spin column. The column was washed and the RNA was 
eluted as per the manufacturer‟s instructions. To determine the quality of the isolated 
total RNA, an aliquot of each sample was subjected to denaturing gel electrophoresis, 
then stained with 1/1,000 dilution of Radiant Red
®
 (BioRad, Cat # 170-3122) and 
examined under UV transillumination to visualize the 18S and 28S rRNA bands.  
Most RNA samples showed notable band smearing and streaks within the running lanes, 
suggesting the presence of residual DNA or protein impurities. To remove these 
impurities, the RNA samples were dissolved in a final volume of 100 L RNase-free 
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water, then mixed with 300 L Trizol LS (Cat #: 10296-010, Invitrogen, Carlsbad CA) 
and 80 L 49:1 (w/v) chloroform/isoamyl alcohol. After centrifugation for 10 min at 
11,000 rpm, 4°C, the upper aqueous layer was removed, combined with an equal volume 
of 70% ethanol, and then passed through a second RNeasy
 
Plus spin column (Cat #: 
74134, Qiagen GmBH, Hilden). The total RNA yield from each sample was estimated by 
measuring the optical density (OD) at 260 nm using a SmartSpec3000 
spectrophotometer (Biorad, Hercules, CA) and the OD 260 nm/ 280 nm ratio was 
measured to assess RNA purity. Since the OD 260 nm readings for most samples were 
quite low and potentially unreliable, a more sensitive Ribogreen fluorometric RNA 
quantification assay was used to accurately quantify the relative amounts of total RNA in 
the various scar tissue samples. 
 
3.1.8 RiboGreen RNA quantification assay. 
The relative total RNA contents of the scar tissue RNA samples after the clean up 
procedure were determined by the RiboGreen fluorescence assay (Molecular Probes) as 
per manufacturer‟s instructions. In brief, a 2 L aliquot of each RNA sample was 
combined with 18 L of deionized formamide and 500 L of TE buffer. A “1X RNA 
standard” was generated by pooling RNA aliquots from several scar tissue samples in a 
final volume of 200 L TE.  A dilution series of this standard (1/2X, 1/4X, 1/8X, 1/16X, 
1/32X) was prepared by successive 2-fold dilutions of the 1X standard with equal 
volumes of TE buffer containing 3.6% formamide. 100 L aliquots of each diluted RNA 
sample and each RNA standard were transferred to individual wells of a black 96-well 
microtiter plate, and then mixed with an equal volume of 1% RiboGreen reagent 
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dissolved in TE. The fluorescence intensity of each sample was measured using a Dynex 
Fluorolite 1000 flurometric plate reader set at 485 nm excitation and 530 nm emission 
wavelengths. A standard curve was obtained by plotting the fluorescence values of the 
RNA standard series against their relative RNA contents in arbitrary units (i.e. 1, 2, 4, 8, 
16, 32 RNA units). The relative RNA content of each sample was then determined from 
the linear regression equation of this standard curve using InStat 2.01 software. 
 
3.1.9 Analysis of gene-specific mRNA transcripts by RNA dot blot and Northern 
blot hybridization. 
 
3.1.9.1 Primer design and generation of antisense cDNA probes to specific genes of 
interest using PCR cloning strategy. 
 
The cDNA sequences for rat Collagen type 1 ( 2), Collagen type 3 ( 1), 
Collagen type 4 ( 1), CD44, receptor hyaluronan mediated motility (RHAMM), 
hyaluronan synthases (HAS 1, HAS 3), heat shock proten-47, TGF-1, TGF-3 and 
GAPDH were obtained from GenBank
® 
and used to design pairs of specific forward and 
reverse PCR primers. A degenerate PCR primer designed by Pearson et al (1996) was 
used for the isolation of rat hsp-47 cDNA in this study. All oligonucleotide primers were 
custom synthesized by Sigma Genosys, Canada or Integrated DNA Technologies. A 
complete list of the gene-specific PCR primers designed and the predicted size of their 
corresponding PCR amplicons is shown in Table.4.  
Total RNA was isolated from the heads and torsos of 18 day rat embryos and 
reverse transcribed into cDNA using RevertAid M-MuLV reverse transcriptase (Cat #: 
EP0441, Fermentas Life Sciences,) as per the manufacturer‟s procedure. In brief, 0.5 g 
of oligo(dT)18 primer was combined with 2 g rat embryo RNA in a final volume of 11 
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L nuclease free water, and incubated at 70C for 5 min. Then 4 L 5X reaction buffer, 2 
L 10 mM dNTP mix and 20 units of ribonuclease inhibitor (Promega) were added and 
the volume was adjusted to 19 L using nuclease free water. Following incubation for 5 
min at 37C, 200 units (1 L) of RevertAid M-MuLV reverse transcriptase were added 
and the reaction mixture was incubated at 42C for 60 min in a MJ Research 
thermocycler. The reaction was stopped by heating at 70C for 10 min and then chilled 
on ice.  
Aliqouts of the above cDNA reaction mixture were used in combination with the 
gene-specific primer pairs listed in Table 4 to amplify cDNA fragments corresponding to 
our various genes of interest. Amplifications were carried out in a 100 L reaction 
solution containing 2 L rat embryo cDNA template, 1 unit of Platinum Taq polymerase 
(Invitrogen, Cat.no: 10966-018), 1X Taq buffer, 1.5-2.0 mM MgCl2, 0.2 mM mixed 
dNTP, and 20 pmol of gene-specific forward primer and 20 pmol gene-specific reverse 
primer.  
The amplification conditions were an initial “hotstart” of one min at 94 C 
followed by 30 cycles of 95 C denaturing for 30 sec, 58 C annealing for 30 sec, and 72 
C primer extension for 45 sec in a MJ Research thermocycler. The PCR products 
obtained were seperated on 1.5% agarose gels, stained with ethidium bromide (0.5 
µg/mL) and examined by ultraviolet light in order to verify that the reactions amplified 
DNA fragments of the predicted size. 
The resulting PCR products were then ligated into plasmid pBluescript 
(Stratagen) using a TA cloning strategy. First, 10 g of pBluescript vector was digested 
with EcoRV (Boehringer Mannheim). Then “T” overhangs were added by combining 10 
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g digested vector with 10 X PCR buffer, 6 L 25 M MgCl2, 2 L 10 mM dTTP and 10 
Units of Taq polymerase (Invitrogen) into a total reaction volume of 100 L. The 
reaction mixture was incubated for 2 h at 70C after which the vector was purified by 
phenol:chloroform extraction and ethanol precipitation. Amplified cDNA fragments 
corresponding to our various genes of interest were ligated into the modified EcoRV site 
of the pBluescript vector. The ligation reaction mixture consisted of 0.5 L or 1.5 L of 
fresh RT-PCR products combined with 50 ng pBluescript plasmid and 4 units T4 DNA 
ligase (Invitrogen, 4 Units/L) in 1X ligation buffer ( provided with ligase enzyme). The 
ligation reactions were incubated overnight at 14 C. 
The ligated plasmids were transformed into chemically competent DH5 E. coli 
(Invitrogen) as per manufacturer‟s procedure. To a 50 L aliquot of competent DH5 
cells, 2 L of ligation mixture was added and then incubated on ice for 30 min. The 
mixture was incubated at 37C for exactly 20 sec, and chilled on ice for 2 min. Then 950 
L of room temperature SOC medium (2% Tryptone, 0.5% yeast extract, 10mM NaCl, 
2.5mM KCl, 10mM MgCl2-6H2O, 20 mM Glucose)  was added and the bacteria were 
then incubated in a shaking incubator at 37C for 1 h. Approximately 100 L  of each 
transformation mixture was plated onto labeled LB agar plates (1.0% Tryptone, 0.5% 
yeast extract, 1.0% NaCl, 15 gm/L agar) containing 75 g/mL ampicillin and 80 g/mL 
X-gal (for blue/white color screening) and incubated overnight at 37C.  
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TABLE.4. Synthetic oligonucleotide PCR forward and reverse primer design. Primer 
sequences were determined from the GenBank accession numbers for rat specific genes and the 
rat specific primers for the genes of interest were designed and used for cDNA probe synthesis (in 
vivo studies – Northern and RNA dot blot hybridization) and RT-PCR (for in vitro studies) 
  
Primer sequences 
 
NCBI 
Accession 
number 
 
Correspon
ding 
nucleotide 
sequence 
 
Amplified 
cDNA 
segment 
 
Collagen 
1(2) 
 
FORWARD: 5‟GGTCGCCCTGGAGAACCTG-3‟       
REVERSE: 5‟GGACCTCGGATTCCAATAGG-3‟ 
 
NM_0533
56.1 
 
1333-1850 
 
518 bp 
 
Collagen 
3(1) 
 
FORWARD: 5‟-GAAGTCTCTGAAGCTGATGG-3‟               
REVERSE: 5‟-CGTCAACCAGTGAAAGTGAC-3‟ 
 
AJ005395 
 
1015-1637 
 
623 bp 
 
Collagen 
4(1) 
 
 
FORWARD: 5‟-TTCCTTTGTGATGCACACCAGC-3‟ 
REVERSE: 5‟-CGAGAACTCACAAGAAACC-3‟ 
 
XM21440
0 
 
4596 - 5191 
 
596 bp 
 
CD-44 
 
 
FORWARD: 5‟-CCAGGACTGAAGCAGCTGACC-3‟ 
REVERSE: 5‟-GGATGACGCCTTCTTTATTGG -3‟ 
 
NM 
012924 
 
255-765 
 
511 bp 
 
GAPDH 
 
 
FORWARD:  5‟-CATTGACCTCAACTACATGG-3‟ 
REVERSE:  5‟-CAGTGAGCTTCCCGTTCAGC-3‟ 
 
 
M17701.1 
 
135-712 
 
578 bp 
 
hsp-47 
 
FORWARD: 5‟-
CGGGGCGGCCGCGAPGTNANARGAYGT-3‟ 
REVERSE: 5‟-
GCCCGCGGCCGCARRTGYTTTTCNARRTC-3‟ 
 
(Degenera
te 
sequence 
used) 
 
- 
 
~ 400 bp 
 
HAS-1 
 
FORWARD: 5‟-CTATGAAGCCGTGGTTTCTG-3‟              
REVERSE: 5‟-AGCAGCAGTAGAGCCCAGAGTGC-3‟ 
 
NM_1723
23 
 
1263-1598 
 
336 bp 
 
HAS-3 
 
FORWARD: 5‟-TCTTGTATGGCTGCTACTGG-3‟       
REVERSE: 5‟-TGAGCCTACAGAACCAGTGC-3‟ 
 
NM_1723
19 
 
1727-2014 
 
288 bp 
 
RHAMM 
 
FORWARD: 5‟-GGAGCATGATGGCTAAACAGG-3‟ 
REVERSE: 5‟-CCACTGTGATTGCGCAAGAG-3‟ 
 
AF 
133037 
 
572-1351 
 
780 bp 
 
TGF-1 
 
FORWARD: 5‟-CTGCAAGACCATCGACATGG-3‟                     
REVERSE: 5‟-TGGTAGAGTTCTACGTGTTGC-3‟ 
 
NM02157
8 
 
508-926 
 
419 bp 
 
TGF -3 
 
FORWARD: 5‟-CAGTTGTTACACATCCTCTGG-3‟                    
REVERSE: 5‟-CCACATATGCCAGTGGTGATCAG-3‟ 
 
AF153012 
 
1615-2038 
 
424 bp 
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 Positive clones (white coloured colonies) on the LB agar plates were numbered, 
and using sterile toothpicks, cells from a portion of the positive clones were removed, and 
lysed in lysis buffer. The colony lysates were screened by PCR amplification using gene 
specific forward and reverse primers, and the products subsequently separated on a 1.5% 
agarose gel to verify that plasmids had successfully incorporated the desired cDNA 
inserts. The lysates were also subjected to PCR screening using M13 Forward and gene-
specific reverse primers or M13 Reverse and gene specific forward primers to determine 
the orientation of the cDNA insert. The bacterial colonies containing the correct gene 
insert were identified and grown overnight in liquid LB medium containing 75 g/mL 
ampicillin for plasmid isolation. The plasmid isolation was performed using a Qiagen 
MIDI prep kit according to manufacturer‟s detailed protocol. The isolated plasmid DNA 
pellets were dissolved in 50 L of TE buffer (pH 8.0).  
The resulting cloned cDNA plasmids were sequenced at the DNA sequencing 
core facility of the University of Calgary to confirm their identity with the Genebank 
sequences for rat Collagen type 1 ( 2) (GenBank accession #: NM_053356.1), Collagen 
type 3 ( 1) (GenBank accession #: AJ005395), Collagen type 4 ( 1) (GenBank 
accession #: XM214400), GAPDH (GenBank accession #: M17701.1), TGF-1 
(GenBank accession #: NM021578) and TGF-3 (GenBank accession #: AF153012). 
The cloned cDNA plasmids were used as templates to generate single stranded 
32
P-
labelled antisense cDNA probes for use in Northern and RNA dot-blot hybridization 
analysis are described below (Kulyk et al., 2000). 
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3.1.9.2 Generation of 32P radio-labeled antisense cDNA probes using LPCR method 
Single stranded 
32
P labeled antisense cDNA probes were prepared by the “linear 
PCR” (LPCR) method of Konat (1996). Each LPCR reaction mixture consisted of 20 - 30 
ng of double-stranded cDNA template for the gene of interest, 25 pmol of the 
corresponding gene-specific reverse oligonucleotide primer, 2 L each of 0.5 mM dTTP, 
0.5 mM dGTP and 0.5 mM dATP, 5 L of 10 M non-radioactive dCTP, 75 Ci of -
32
P-dCTP (10 µCi/µl), 5 L of 10X PCR buffer, 2 L 50 mM MgCl2, and 1 L (5 units) 
Taq polymerase in a final volume of 50 L. Following 30 amplification cycles at 94 ºC 
for 2 min; 55 ºC for 2 min; and 72 ºC for 5 min in an MJ Research thermocycler, the 
reaction mixture was passed through a Sephadex G-25 or Sephadex G-50 spin column 
packed in a Costar spin-X 0.2 m micropore filtration unit in order to remove 
unincorporated label. The
 
specificities of the resulting 
32
P-labeled antisense cDNAs 
probes for target mRNAs of correct size were confirmed on preliminary Northern blots of 
total RNA isolated from heads and torsos of 18 day old rat embryos. Equal amounts (5-10 
g) of total RNA were separated by electrophoresis through 1.2% agarose gels containing 
6% formaldehyde in 1X MOPS buffer running at 5 V/cm of gel. The RNA was 
transferred to nylon membranes by standard upward capillary transfer, pre-hybridized in 
Ultrahyb
®
 solution (Cat #: 8669, Ambion, Austin, TX) and hybridized with 
32
P-labeled 
antisense cDNAs probes as detailed in Section 3.1.9.3.  
The cDNA probes hybridized to mRNA transcripts of appropriate lengths based 
on published reports (see Figure 5). The antisense cDNA probes for collagen type 1( 2)  
 
FIGURE 5
Transforming growth factor- b3
(TGF-b3)
~ 3.8 kb
Collagen type 4 (a 1)
~7.5 kb
Collagen type 3 (a 1)
~5.8 kb
Glyceraldehyde-3-phosphate 
dehydrogenase
~ 1.4 kb
Transforming growth factor- b1
(TGF-b1)
~ 2.5 kb
Collagen type 1 (a 2)
~5.8 kb
~4.8 kb
Figure 5. Specificity of  the cDNA probes developed. Northern blot analysis using 18 day 
old rat embryo head and/or torso RNA shows specificity of anti-sense cDNA probes generated 
against rat collagen type 1 (a 2), collagen type 3 (a 1), collagen type 4 (a 1), glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), TGF-b1 and TGF-b3 transcripts. The antisense cDNA 
probes recognized mRNA transcript of appropriate lengths based on previously published re-
ports.
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hybridized to transcripts of 4.8 and 5.8 kb length, while collagen type 3 ( 1) cDNA 
hybridized to transcripts of 5.8 kb length (Annoni et al., 1998; Stewart et al., 1994). A 
single transcript of 7.5 kb was recognized by the collagen type 4 ( 1) cDNA probe 
(Olsen and Uitto, 1989). The GAPDH probe hybridized to a 1.4 kb mRNA transcript 
(Annoni et al., 1998; Oikarinen et al., 1991). The TGF- β1 cDNA probe recognized a 2.4 
kb transcript (Annoni et al., 1998; di Mola et al., 2002) and a single faint band of 3.8 kb 
was recognized by the TGF-β3 probe (Annoni et al., 1998; di Mola et al., 2002; Wildi et 
al., 2007). 
 
 
3.1.9.3. Analysis of mRNA transcripts using RNA dot blot analysis. 
 
For RNA dot-blot analysis, equal aliquots of total RNA (as determined by the 
RiboGreen assay) were spotted
 
onto MagnaGraph 0.45 micron nylon membrane 
(Osmonics Inc, MA) using a 96-well BioDot
 
(Bio-Rad) vacuum filtration unit. Following 
transfer, all blots were baked in a vacuum oven for 1.5-2.0 hours at 80C, then 
prehybridized overnight with Ultrahyb
®
 solution (Cat #: 8669,Ambion, Austin, TX) at 42 
C. Next, the blots were hybridized at 55 C overnight in Ultrahyb® solution containing 
32
P labeled cDNA probes specific probes for Collagen Type 1 ( 2), Collagen Type 3 ( 
1), Collagen Type 4 ( 1), TGF-1, TGF-3 or GAPDH. All the probes were labeled by 
the LPCR method (Konat, 1996) as described in Section 3.1.9.2. The blots were washed 
4 times (5 min each) at 42-55 C in 2X SSC (0.3 M NaCl and 0.03 M Sodium citrate) / 
0.1% sodium docedyl sulfate (SDS) (w/v), then 4 times (15 min each) at 42-55 C in 
0.1X SSC (0.015 M NaCl and 0.0015 M Sodium citrate) / 0.1% SDS (w/v), and exposed 
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to Kodak BioMax-AR film at -80 C.  Hybridization signals were quantified by 
densiometric measurements at 540 nm wavelength on the exposed autoradiographs using 
a Tecan SLT Spectra II spectrophotometric plate reader. To correct for any variations in 
sample loading, the hybridization signals for Collagen Type 1 ( 2), Collagen Type 3 ( 
1), Collagen Type 4 ( 1), TGF-1, and TGF-3 mRNAs were normalized against 
signals for the constitutively expressed GAPDH transcript. 
 
3.1.10  Analysis of proteins from scar tissue  
3.1.10.1 Tissue preparation for protein analysis  
Minced tissues for protein analysis that had been stored frozen as described in 
Section 3.1.4 were homogenized using a Polytron tissue homogenizer in Western lysis 
buffer consisting of 50 mM Tris, pH
 
7.4, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 
supplemented with
 
protease and phosphatase inhibitors (Sigma). Homogenates were 
mixed with an equal volume of 2X SDS-Urea loading buffer (50 mM Tris, pH 7.5, 50 
mg/mL SDS, 8M Urea, 0.4% bromophenol blue, 0.1% 2-mercaptoethanol) and then 
sonicated for 30 to 45 seconds using a VibraCell
TM 
sonicator (Sonic & Materials Inc., 
Danbury, CT, USA). The homogenates were centrifuged to remove any insoluble 
material, and frozen at -20ºC until needed for analysis. 
 
3.1.10.2 Total protein estimation using filter-paper dye binding assay 
The total protein content of the tissue homogenates was determined by the method 
of Minamide and Bamburg (1990). This filter paper-based adaptation of the Bradford 
protein dye-binding assay (Bradford, 1976) has much greater resistance to interference by 
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reagents commonly used in tissue lysis buffers such as SDS, Triton X-100, and urea. 
Protein samples dissolved in gel loading buffer were applied to a grid of 1.5 cm X 1.5 cm 
squares drawn on a sheet of Whatman filter paper, at volumes between 0.5 - 10 L per 
square. Each sample was applied in quadruplet. A series of protein standards in gel 
loading buffer (0 - 25 g per square) were applied in triplicate on the same piece of filter 
paper. Squares to which 1X SDS-Urea gel loading buffer alone were applied served as 
blanks. The spotted sheet of filter paper was dried then rinsed in methanol for 20 – 60 sec 
until the loading buffer dye was washed away. After air-drying, the sheet was stained for 
30 min at room temperature in a solution of 0.5% Coomaise Brilliant Blue-G in 7% acetic 
acid. The filter paper was then destained in 7% acetic acid for about 90 min with gentle 
agitation until the background staining was adequately reduced.  The sheet was air-dried 
overnight, then individual squares were cut out and placed in microfuge tubes containing 
1 mL extraction buffer (66% methanol, 33% distilled water, 1% ammonium hydroxide). 
Tubes were vortexed until the bound dye was completely eluted into the extraction 
buffer, then 300 L aliquots of eluate were transferred to individual wells of a 96-well 
microtiter plate. The absorbance of each sample at 600 nm wavelength was determined 
using a Tecan Spectra II plate reader. A standard curve was obtained by plotting the 
absorbance values of the protein standard series against their protein content. The protein 
content for each scar tissue sample was determined from the linear regression equation of 
the standard curve using InStat ® software. 
Preliminary experiments were performed to determine a suitable protein standard 
for quantifying the relative protein contents of scar tissue homogenates as well as 
cultured rat cell homogenates. Bovine serum albumin (BSA), -globulin, and various 
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combinations of these two proteins were tested. A dilution series of each protein standard 
or protein standard mixture (0 - 25 g content) were spotted in quadruplicate onto the 
filter paper grid. Aliquots of 1 - 8 L of scar tissue homogenate and cultured rat cell 
homogenates were applied to the same sheet of filter paper. The filter paper was 
processed as described above and absorbance values at 600 nm were determined. The 
slopes for the tissue homogenates and for each series of protein standards were obtained 
by plotting individual absorbance values against their appropriate relative volume or 
protein content. The slope of the regression line for the 3 day scar tissue homogenate was 
0.9999, while slopes of 0.9967 and 0.9999 were obtained for 21 day scar tissue 
homogenate and cultured rat cell homogenates respectively. A 1:3 mixture (w/w) of BSA 
and -globulin yielded a slope of 0.9998, corresponding well with both the scar tissue 
homogenates and cultured rat cell homogenates (Figure 6). Therefore, a 1:3 mixture of 
BSA:-globulin mixture was used as the protein standard in all subsequent protein 
determinations. 
 
3.1.10.3 SDS-PAGE gel preparation for Western blot analysis 
Proteins were separated by denaturing SDS-polyacrylamide gel electrophoresis 
following standard methods (Ausubel et al., 1994) with the following modification. In 
order to simultaneously resolve high molecular weight proteins (100 - 300 kDa) and low 
molecular weight proteins (20 - 99 kDa ) within the gel, a dual concentration (5% / 
12.5%, pH 8.8) SDS-polyacrylamide (PA) 'resolving' split gel was prepared in a Bio-Rad 
Protean III Minigel apparatus. Briefly, a 12.5% gel was poured into the lower 2.5 cm of 
the casting plates and allowed to solidify for 4 hours before pouring a 5% gel layer (~ 2.5  
FIGURE 6
Figure 6. Regression line analysis of rat tissue homogenates. (A) shows that when BSA
and -globulin were combined in a ratio of 1:3 (w/w) gave a slope of 0.9998 which
corresponds well with 3 day peridural scar homogenate (B) with slope of 0.9999 and 21 day
peridural scar homogenate ( C) with slope of 0.9967 as well as cultured rat cell homogenates
(D) with slope of 0.9999. In subsequent experiments where protein quantification is required
the 1:3 (w/w) ratio of BSA and -globulin mixture was used as standard protein standard.
Regression line for 1:3 (BSA: -globulin)
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cm) above. The split gel was then allowed to solidify in presence of 0.1% SDS overlay 
overnight to allow pH equilibration. Then a 4 % „stacking‟ gel (pH 6.8) was poured at the 
top of the casting plates and a 1.5 mm thick protein loading comb was inserted. The 
stacking gel was allowed to solidify for 45 min prior to sample loading. The rationale of 
this split gel method was to minimize procedural errors (such as sample loading, 
variability during protein resolution and transfer to nitrocellulose membranes) when 
performing repetitive western blotting for analyzing multiple proteins of varying 
molecular weight.  
 
3.1.10.4  Gel electrophoresis and immunoblotting 
Samples were loaded into SDS-PA gels at equivalent amounts of total protein (10-
20 g). Electrophoresis and subsequent protein transfer onto nitrocellulose was 
performed using a Bio-Rad Protean III Minigel apparatus according
 
to a standard 
protocol. The nitrocellulose membrane was incubated for 1 h at room temperature in 
blocking solution (10 % w/v blotting grade nonfat dry skimmed milk [BioRad] in 
PBS/Tween-20 [PBST]) to prevent non-specific binding of antibodies to the membrane. 
Primary and secondary antibodies were diluted in 1% blotting grade nonfat dry milk in 
PBST. A variety of primary antibodies were used to detect the proteins of interest on the 
western blots, as tabulated in Table 5. A rabbit polyclonal antibody against the human 
type I procollagen was obtained from Dr. Larry Fisher (LF-67, NIDCR-NIH, Maryland, 
USA). This antibody was generated against a 26 amino acid synthetic C-terminal 
telopeptide of the human  1 (I) procollagen chain (Fleischmajer et al., 1990) and was 
shown to recognize rat type I collagen in tissue samples.  Commerical polyclonal or 
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monoclonal primary antibodies were used to detect fibronectin, MyoD, myogenin, 
MyHC, hsp-47, VEGF, total ERK1/2, dual phosphorylated ERK1/2, dual phosphorylated 
p38 MAPK, total p38 MAPK, P4H and GAPDH in tissue homogenates as detailed in 
Table 5. The primary antibodies were detected using compatible horseradish peroxidase-
conjugated secondary antibodies (BioRad) together with the Western Blot 
Chemiluminescence Reagent Plus detection system (Perkin-Elmer Life Sciences) as per 
the manufacturer‟s instructions. The specificities of the primary antibodies were 
confirmed by performing western blot analysis using tissue homogenate obtained from 18 
day old rat embryos.  
  
3.1.11  Statistical analysis 
Quantitative data pertaining to levels of picrosirius red stainable collagen, mRNA 
expression and
 
relative protein abundance were analyzed using one-way analysis of 
variance (ANOVA) together
 
with Kruskal-Wallis non-parametric test and Dunnett‟s 
multiple comparison post-tests
  
(GraphPad Prism 4 software). 
Table 5. Primary antibodies used for western blot analysis (WB) and immunohistochemistry (IHC). 
 
 
Antisera 
 
Type and source of the antibody 
 
Dilution used 
 
Catalog number and Source 
 
Anti-type I 
Collagen 
 
Rabbit polyclonal antibody raised against C-terminal 
telopeptide of human type I (1) collagen chain. 
 
1:10,000 (WB) 
1: 1000 (IHC) 
 
LF 67, a gift by Dr Larry Fisher, NIH-
NIDCR, MD, USA 
 
Anti-P4H 
 
Mouse monoclonal antibody raised against the beta 
subunit of rat prolyl-4-hydroxylase. 
 
1:20,000 (WB) 
 
AF-5150, Medicorp Inc, Montreal, Canada 
 
Anti-hsp 47 
 
Mouse monoclonal antibody raised against rat Hsp-47. 
 
1: 10,000 (WB) 
 
M16.10A1; Stressgen, Ann Arbor MI, USA. 
 
Anti-fibronectin 
 
Rabbit polyclonal antibody raised against C-terminus of 
human fibronectin. 
 
1:1000 (WB) 
1: 100 (IHC) 
 
sc-9068,  Santa Cruz Biotech, CA, USA. 
 
Anti-MyoD 
 
Rabbit polyclonal antibody raised against mouse MyoD 
protein. 
 
1:1000 (WB) 
1: 250 (IHC) 
 
sc-760, Santa Cruz Biotech, CA, USA. 
 
Anti-MyHC 
 
Mouse monoclonal antibody raised against human 
myosin heavy chain (MyHC). 
 
1:1000 (WB) 
1: 250 (IHC) 
 
F1.652, 
Developmental Studies Hybridoma Bank, 
Iowa, USA 
 
Anti-myogenin 
 
Mouse monoclonal antibody raised against rat myogenin 
protein. 
 
1: 500 (WB) 
1:250 (IHC) 
 
F5D, 
Developmental Studies Hybridoma Bank, 
Iowa, USA 
 
Anti-osteopontin 
 
Mouse monoclonal antibody raised against rat 
osteopontin. 
 
1: 100 (WB) 
1: 25 (IHC) 
 
 
MPIIIB10,  
Developmental Studies Hybridoma Bank, 
Iowa, USA 
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Table 5. Primary antibodies used for western blot analysis (WB) and immunohistochemistry (IHC) (Contd…) 
 
 
 
Antisera 
 
Type and source of the antibody 
 
Dilution used 
 
Catalog number and Source 
 
Anti--sma 
 
Mouse monoclonal antibody raised against rat -sma. 
 
1: 1000 (WB) 
1: 500 (IHC) 
 
Gifted by Dr. Ronald Doucette, Dept of 
Anatomy and Cell Biology, University of 
Saskatchewan. 
 
Anti-  actin 
 
Mouse monoclonal antibody raised against chicken -
 
 
1: 1000 (WB) 
1: 250 (IHC) 
 
JLA 20, Developmental Studies hybridoma 
Bank, Iowa, USA. 
 
Anti-VEGF 
 
Mouse monoclonal antibody raised against human 
VEGF. 
 
1: 1000 (WB) 
 
sc-7269, Santa Cruz Biotech, CA, USA 
 
Anti-GAPDH 
 
Mouse monoclonal antibody raised against rabbit 
GAPDH 
 
1: 10, 000 (WB) 
 
MAB374, (Chemicon Intl) Cedarlane, ON, 
Canada. 
 
Anti-phospho 
ERK1/2  
 
Rabbit polyclonal antibody raised against synthetic KLH 
coupled Thr202/ Tyr 204 of human p44 MAP kinase 
 
1: 1000 (WB) 
1: 500 (IHC) 
 
#9101, Cell Signaling Technology, MA, 
USA. 
 
Anti-total ERK2  
 
Rabbit polyclonal antibody raised against C-terminus of 
rat ERK 2 
 
1: 1000 (WB) 
1: 500 (IHC) 
 
sc-154, Santa Cruz Biotech, CA, USA. 
Anti-phospho 
p38 MAPK 
Rabbit monoclonal antibody raised against KLH coupled 
Thr180/Tyr182 of human p38 MAPK 
1: 1000 (WB) 
1: 500 (IHC) 
#4631, Cell Signaling Technology, MA, 
USA. 
Anti-total p38 
MAPK 
Rabbit polyclonal antibody raised against C-terminus of 
mouse p38-  
1: 1000 (WB) 
1: 500 (IHC) 
sc-535, Santa Cruz Biotech, CA, USA. 
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3.2 In vitro studies using micromass co-culture technology 
 
The peridural scarring caused by lumbar spinal laminectomy in rats is likely to 
involve interactions of fibroblasts and injured muscle tissue at the wound region.  Hence, 
the in vitro model system developed for our studies employed co-culturing fibroblasts 
(FR 3T3 fibroblasts) and myoblast cells (adult rat L8 myoblasts) at high cell density to 
generate a “micromass” tissue layer. These cell-lines were obtained from the American 
Type Cell Culture (ATCC) repository. All tissue culture reagents were obtained from 
Sigma-Aldrich, unless otherwise stated. Cell cultures were maintained aseptically at 
Biosafety level 1 and level 2 facilities at the Gene Expression Mapping using 
Synchrotron light (GEMS) laboratories maintained by the Department of Anatomy and 
Cell Biology, University of Saskatchewan and at Dr. Kulyk‟s research laboratory. 
 
3.2.1  Cell culture propagation and maintenance. 
Rat L8 myoblasts (ATCC no. CRL-1769) were cultured at 37C , 5% CO2 in “L8 
medium” consisting of Dulbecco‟s modified Eagle‟s medium-Nutrient mixture HAM F12 
(Cat # D-8900, Sigma Aldrich) supplemented with 10% fetal bovine serum (FBS), 200 
g/mL kanamycin (Invitrogen), and 2% antibiotic-antimycotic (Invitrogen; 200 U/mL 
penicillin, 200 U/mL streptomycin, and 0.25 g/mL amphotericin B). Rat FR fibroblast 
cells (ATCC no. CRL-1213) were cultured at 37C, 5% CO2 in “FR medium” consisting 
of Minimum Essential Medium (Cat #: 41500-034, Invitrogen) supplemented with 10% 
FBS, 1 mM Sodium pyruvate (Sigma Aldrich), 0.1 mM Non-essential amino acids 
(Sigma Aldrich), 200 g/mL kanamycin (Invitrogen), and 2 % antibiotic-antimycotic 
(Invitrogen). The culture conditions and media that were used for initial propagation and 
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maintenance of the rat L8 myoblast and FR fibroblast cell-lines were based on the 
recommended protocols by the ATCC. 
 
3.2.2  Preparation of micromass co-cultures  
High-density micromass co-cultures of rat L8 myoblast and rat FR fibroblast cells 
were established following a modification of the strategy of Ahrens et al., (1977).  In 
brief, rat L8 myoblast cells were grown in L8 medium in two separate sterile 75 cm
2
 
Falcon flasks (Cat#: 353136, BD Biosciences, Bedford, MA) and rat FR fibroblast cells 
were grown in FR media in three separate sterile Falcon flasks. All cells were grown to 
80% confluence prior to trypsinization. Next the cells were detached by incubation for 5 
min in a solution of 0.025 mg/mL trypsin, 10 mM EDTA and dissociated into a single 
cell suspension. The trypsin was neutralized by addition of FBS to final concentration of 
5%. Cells of the same type were pooled together, then pelleted by centrifugation at 800 
rpm for 10 min (Sorvall

 LegendRT, Thermo Electron Corp, Germany).   
The pelleted rat L8 myoblasts were resuspended in L8 media and adjusted to a 
final density of 2  107 cells/mL using a hemocytometer. Similarly, the pelleted FR 
fibroblast cells were resuspended in FR medium at final density of 2  107 cells/mL. The 
L8 myoblast and FR fibroblast cell suspensions were then mixed together in the 
following relative ratios: 1 volume of FR fibroblast cells + 1 volume of L8 myoblasts; 1 
volume of FR fibroblasts + 2 volumes of L8 myoblasts; and 1 volume of FR fibroblasts + 
3 volumes of L8 myoblasts.  To establish micromass cultures, a single 10 l drop of cell 
suspension was spotted on to each 15 mm diameter well of sterile NUNC 4 well tissue 
culture dishes (Cat.no: 176740). After spotting, the dishes were pre-incubated for 4-6 
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hours at 37C in 5% CO2 incubator to permit cell attachment. Then each micromass 
culture was fed with 750 L L8 media and incubated at 37C, 5% CO2 for a period of 1-2 
days prior to the wound manipulation step. 
 
3.2.3  Wounding the micromass co-cultures 
After 1-2 days of incubation, a single scrape wound was inflicted across the 
diameter of the culture using a ~ 0.59  0.041 mm diameter plastic microcapillary pipette 
tip (Cat #: 37001-270, VWR International). To eliminate cell debris, the original culture 
medium was removed, the wounded culture was washed with 37C Hank‟s balance 
buffered salt solution, and the medium was replenished with 750 L fresh L8 medium. 
The cultures were incubated at 37C, 5% CO2 for up to 8 days after wounding with a 
medium change at every third day (Figure 7). 
 
3.2.4  MTT /Cell viability assay 
MTT assay is a standard colorimetric method to determine cell viability in vitro. 
A soluble yellow MTT substrate (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) is reduced to insoluble purple formazan by a reductase enzyme present in living 
cells. Thus the level of MTT conversion provides a quantitative measure of cell viability. 
Our MTT assay was based on the method of Plumb et al., 1989. In summary, the culture 
medium was replaced with L8 medium containing 5 g/ml MTT and the cultures were 
incubated for a period of 4 hours. The MTT containing medium was removed, and the 
formazan crystals deposited on the cell layer were dissolved in 200 l of DMSO. To the 
formazan-DMSO solution, 25 l of Sorensen‟s glycine buffer (solution of 0.1M glycine  
Added in different 
proportion of FR:L8 
cells
e.g: 1:1, 1:2 and 1:3
Trypsinize & neutralized with 10% 
FBS DMEM-F12 media
FR cells @ 80% confluence L8 cells @ 80% confluence
2 X 107 cells per ml 2 X 107 cells per ml
Spotted 10 L
Added 10%FBS-
DMEM/F-12 HAM media 
after 6 hrs of incubation
After 24-36 hrs incubation,micromass was 
wounded using needle pipette & cell debris 
washed off using HBSS and replenished
Scale- 0.5 mm
10 L
(unwounded micromass culture) (1 day post- unwounded micromass culture)
FIGURE 7
Figure 7. Illustration showing the setting up of micromass co-culture of FR 3T3 fibroblast and L8 myoblast cells based on 
the modification of Ahrens et al. (1977) method. Initially the cultures were set up with different proportions of fibroblast and 
myoblast cells and the cultures were incubated for 24-36 hours prior to inflicting a single scrape wound across the diameter of the 
micromass co-culture.
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and 0.1 M NaCl, adjusted to pH 10.5) was added and the absorbance was measured at 
560 nm using 96-well format plate reader (SpectraMax 190, Molecular Devices).  
 
3.2.5 Determination of total cellular DNA by flurometric assay 
Total cellular DNA accumulation in micromass co-cultures was quantified using a 
flurometric assay as described by Labarca and Paigen (1980). In brief, micromass 
cultures were collected in 400 L of Hanks buffered saline solution and homogenized by 
sonication.  A 100 L aliquot of each cell homogenate or a chicken DNA standard (0 g, 
0.25 g, 0.5 g, 1.0 g, 1.5 g, 2.0 g and 4.0 g) was combined with 200 L of 2X 
assay buffer (0.1 M sodium phosphate, 4M NaCl, pH 7.4) and 100 L of 4 g/mL 
Hoechst 33258 dye solution. Then, 200 L aliquots of each sample and standard were 
transferred to individual wells of a 96-well black microtitre plate and the relative 
fluorescence intensities were determined at an excitation wavelength of 365 nm and 
emission wavelength of 458 nm using a Dynex Fluorolite 1000 flurometric plate reader. 
The µg DNA content of each sample was calculated from the linear regression equation 
of the standard curve using InStat software.  
 
3.2.6.  Histochemistry and Immunostaining 
3.2.6.1  Picrosirius red staining and quantification of total collagen in vitro 
To determine the total collagen levels in the micromass co-culture and to identify 
the collagen deposition at the wound site, we performed histochemical staining for with 
picrosirius red dye following a modification of the method of Marotta and Martino 
(1985). At representative time points of culture, the culture medium was removed and the 
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micromass cultures were washed with Hank‟s buffered salt solution. The cultures were 
incubated for 90 min at room temperature in a 300 L of picrosirius red stain solution, 
and then washed several times with 0.5% glacial acetic acid.  The stained micromass 
cultures were observed under a phase-contrast light microscope to visualize collagen 
fibril formation at the wound site and photographed using an attached CCD camera.  
Total collagen deposition was quantified by eluting the bound picrosirius red dye 
from the culture using 0.1 M NaOH and determining the absorbance of the eluate at 400 
nm using a spectrophotometric plate reader (SpectraMax 190, Molecular Devices). A 1X 
dye-eluant standard was prepared by combining 50 L of the eluted dyes from each 
culture. A serial dilution series (1/2X, 1/4X, 1/8X, 1/16X and 1/32X) was prepared by 
diluting the 1X dye standard with 100 L of 0.1 M NaOH. The absorbance reading at 400 
nm was normalized against total cellular DNA levels (in g) to correct for differences in 
total cell number between treatment groups. The presence of glycosaminoglycans was 
determined by staining another set of unwounded and wounded cultures at pH 2.5 using 
Alcian blue (5 mg/mL Alcian blue in 3% acetic acid).  
 
3.2.6.2  Immunostaining for dual phosporylated p38, dual phosphorylated 
ERK1/2, type I collagen and fibronectin.  
 
In situ immunostaining was performed to examine the distribution of dual 
phosphorylated p38 MAP kinase, dual phosphorylated ERK1/2, fibronectin, and type I ( 
1) collagen protein in wounded and unwounded micromass co-cultures. After removing 
culture medium, the micromass cultures were washed with Hank‟s buffered salt solution 
supplemented with protease and phosphatase inhibitors, then fixed in 95% ethanol 
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containing 2% glacial acetic acid for 30 minutes. The fixed cultures were washed twice 
with 70% ethanol and stored in 70% ethanol. In preparation for immunostaining, the 
cultures were rehydrated through a graded ethanol series, and then post-fixed for 1 h in 
4% paraformaldehyde. The fixed cultures were washed three times for 5 min in PBST 
and then incubated for 2 h in 5% sheep serum (Sigma)/PBST solution at room 
temperature. All primary and secondary antibodies were dissolved in 5% sheep 
serum/PBST solution.  
The cultures were incubated for an hour with 1: 500 dilution of the rabbit 
monoclonal antibody against phosphorylated p38 MAP kinase (Cell Signaling Inc) and 
rabbit polyclonal antibody against phosphorylated ERK1/2 (Cell Signaling Inc). A 1: 100 
dilution of rabbit polyclonal antibody against fibronectin (Santa Cruz Biotech) and 1: 
1000 dilution of rabbit polyclonal antibody against type I ( 1) collagen were used to 
detect fibronectin and type I collagen protein distribution in the micromass culture.   
The subsequent steps were performed as previously described (Bobick and Kulyk, 
2004). In brief, the cultures were washed 4 times, 5 min each in PBST and the primary 
antibodies were detected by incubating for 1 h with compatible alkaline phosphatase-
conjugated secondary antibodies. Next, the cultures were washed thrice, 10 min per wash 
in PBST containing 0.05% levamisole and twice, 15 min per wash in NTMT (100 mM 
Tris Hcl, pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Triton X-100, 0.05% levamisole). 
Colour development was performed using nitroblue tetrazolium chloride (0.34 mg/mL) 
and 5-bromo-4-chloro-3-indolylphosphate (0.175 mg/mL) dissolved in NTMT. Colour 
development was stopped by three washes with PBST and the cultures were stored in 
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CMFET (0.137 NaCl, 0.003 M KCl, 0.008 M Na2HPO4, 0.0015 M KH2PO4, 0.7 mM 
EDTA, 0.1% Tween-20) at 4C for up to 2 weeks prior to photographing. 
 
3.2.6.3  Actin filament and nuclear staining. 
The filamentous actin and nuclei of the cells within the micromass co-cultures 
were visualized using Oregon green 488-conjugated phalloidin and cell permeable 
Hoechst 33342 dye, respectively. The micromass cultures were fixed in 500 L 3.7% 
formaldehyde dissolved in PBS overnight at 4 C. The fixed cultures were rinsed three 
times with PBS then incubated overnight in 500 L of 0.1% Triton X-100 in PBS. The 
cultures were rinsed thrice with PBS, then incubated at 4 C overnight in 500 L 1% 
BSA in PBS to reduce background fluorescence. The cultures were then incubated at 4 
C for 24 h in a solution of 200 Units/mL Oregon Green 488-conjugated phallodin in 
PBS to stain filamentous actin. The stained cultures were washed thrice with PBS and 
incubated at 4 C overnight in 20 g/mL Hoechst 33342 dye to stain nuclei. Finally, the 
cultures were rinsed three times in PBS, about 10 drops of AquaPerm mounting medium 
(Immunon, Shandon, Pittsburgh, PA) was added, and the cultures were visualized 
using a phase contrast fluorescent microscope. 
 
3.2.6.4  Scanning electron microscopy (SEM) 
Micromass co-cultures used for electron microscopy were grown on 12 mm 
diameter glass cover slips (Cat #: 12-545-82, Fisher Scientific Co) within 4-well NUNC 
tissue culture dishes. The cover slips were sterilized by soaking for 15 minutes in 70% 
ethanol then air-dried for 1 h in a sterile biosafety cabinet, prior to spotting the cultures. 
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At representative time points, the cultures were fixed overnight at 4 °C in 3.7% 
formaldehyde in PBS, pH 7.5. After fixation the micromass co-cultures were washed 
thrice with PBST, the cover slips were removed from the 4-well NUNC culture plates 
and transferred to glass vials. The cells were dehydrated through a graded series of 
PBST: acetone mixtures (20%; 40%; 60% and 80% acetone) at10 min per step. Then the 
cultures were washed twice with 100% acetone and stored at –20 °C in 100 % acetone. 
The dehydrated micromass cultures were critical point dried with liquid carbon dioxide 
using a Polaron Critical Point dryer and gold coated with Edwards S150B (BOC 
Edwards, Crawley, UK) sputter coater. The critical point drying and gold coating 
procedures were conducted with the assistance of Dr. Guosheng Liu (Department of 
Biology, University of Saskatchewan). 
The processed samples were examined using a JEOL JSM 840A scanning 
electron microscope with the assistance of Dr. Thomas Bonli (Department of Geological 
sciences, University of Saskatchewan). The imaging of the samples was performed with 
an accelerator voltage set at 20 kV and an 8 mm working distance for image acquisitions. 
The images were captured digitally using Gellar Microanalytical dPICT software.  
 
3.2.7  DiI and DiO labeling of cells. 
The  fluorescent lipophilic tracer dyes, 1,1‟-dioctadecyl-3,3,3‟,3‟-
tetramethylindocarbocyanine perchlorate (DiI) and 3,3‟-dioactadecyloxacarbocyanine 
perchlorate (DiO) are commonly used in cell fate mapping because they are easily 
incorporated into the plasma membranes of live cells and exhibit distinct red and green 
fluorescence, respectively. DiI and DiO are highly fluorescent and photostable when 
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incorporated into membranes, and diffuse laterally within the plasma membrane, 
resulting in complete staining of the cells. The two dyes can be used in combination for 
multicolour imaging because dye transfer between intact membranes of DiI labeled cells 
and DiO labeled cells is negligible (Agmon et al., 1995). Hence they are commonly used 
in long term tracer applications such as cell transplantation, migration, adhesion and 
fusion studies (Ledley et al., 1992; Serbedzija et al., 1989; Tajbakhsh et al., 1994). In my 
studies, DiI and DiO were used to selectively label L8 myoblast and FR fibroblast cells in 
micromass co-cultures and to track the patterns of fibroblast and myoblast cell migration 
following wounding.  
Rat L8 myoblast cells or rat fibroblast FR cells were grown to 80% confluence 
and then dissociated in 0.025 mg/mL trypsin,10 mM EDTA solution. The dissociated 
cells were incubated for 1-2 hours at 37C in culture medium containing either 25 ng/mL 
DiI or 25 ng/mL DiO tracker dyes. The labeled FR and L8 cells were washed 3 times in 
Hank‟s buffered salt solution to remove excess unbound dye, and then plated in 
micromass culture in varying ratios. 
 
3.2.8.  Treatment of micromass co-cultures with mitomycin, TGF-1, Quercetin, L-
2-oxothiazolidine-4-carboxylate (OTC), Anisomycin, SB202190 and PD 
184352 
 
In some experiments, wounded micromass co-cultures were treated with either 
mitomycin (10 g/mL for 72 hours), TGF-1 (final concentrations of 0, 0.1, 0.2, 0.4 and 
0.8 ng/ml), quercetin (final concentrations of 0, 25 and 45 M), OTC (final 
concentrations of 0, 1 or 1.5 mM), anisomycin (final concentrations of 0, 100 or 200 
ng/mL), SB202190 (final concentration of 0, 10, 15, 20 M) or PD 184352 (final 
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concentrations of 0, 2 or 4 M) after wounding. An equivalent volume of medium was 
added to parallel control cultures. The medium for all cultures treated with TGF-1, 
quercetin, anisomycin, SB202190 and PD184352 contained a final concentration of 0.1% 
DMSO (v/v). An equivalent amount of DMSO vehicle was administered to parallel 
control cultures. 
 
 
3.2.9  Gene expression analysis of wounded and unwounded micromass cultures 
using RT-PCR 
 
 3.2.9.1  Isolation and purification of total RNA from micromass co-cultures 
Total RNA was isolated from wounded and unwounded micromass co-cultures 
using an RNeasy

 Plus Mini kit (Qiagen, Cat. No: 74134) according to the 
manufacturer‟s procedure. The micromass co-cultures were solubilized in Buffer RLT 
(provided with the kit) and homogenized by centrifugation through QIAShredder 
columns. The homogenates were mixed with an equal volume of 70% ethanol and passed 
through RNeasy Plus columns to isolate total RNA, in accordance with the 
manufacturer‟s protocol. The total RNA yield for each sample was determined from the 
optical density (OD) measurement at 260 nm. The (OD) 260 nm / (OD) 280 nm ratios were 
between 1.6-1.9, consistent with high purity RNA.   
Two micrograms total RNA from each sample was converted to cDNA using 
oligodT-18 and RevertAid M-MuLV reverse transcriptase (Fermentas Life Sciences, 
Cat no: EP0441) as described in Section 3.1.9.1. The cDNA product was used to perform 
semi-quantitative RT-PCR analysis as described below. 
 
  107 
3.2.9.2  RT-PCR analysis of gene transcript expression. 
Semi-quantitative RT-PCR analysis was used to examine the expression patterns 
of the gene transcripts for collagen type 1 ( 2), collagen type 3 ( 1) and collagen type 4 
( 1), hyaluronan synthase 1, hyaluronan synthase 3, receptor for hyaluronan-mediated 
motility (RHAMM), CD 44, TGF-1, TGF-3, hsp-47 and GAPDH in wounded and 
unwounded micromass co-cultures. PCR was performed in a 100 L reaction mixture 
containing 2 L of micromass co-culture cDNA as template, together with gene-specific 
forward and reverse primers listed previously in Table 4. The denaturing, annealing, and 
extension conditions for each amplification cycle were 94C for 30 sec, 55C for 30 sec, 
and 72C for 45 sec respectively.  
In order, to identify the exponential phase of the amplification reaction for each 
particular gene transcript being examined, a series of PCR experiments was performed 
using 2 g cDNA template (obtained from each micromass co-cultures) in a 100 l PCR 
reaction mixture. PCR was performed using the amplification conditions described in 
Section 3.1.9.1 and the gene-specific primer pairs indicated in Table 4. However, the 
reaction was paused after every 5 cycles beginning at PCR cycle 10 and a 10 l aliquot 
was removed at each time-points. These aliquots were electrophoretically resolved in 
1.5% agarose gels stained with EtBr, and photographed under UV transilluminator to 
visualize the relative amount of PCR product generated after 10, 15, 20, 25, 30, 40, 45, 
50, 55, 60 and 65 amplification cycles.  
The relative band intensities were quantified densiometrically using NIH Image J 
software and the values for each time-point were plotted to determine the exponential 
phase of PCR amplification for each specific gene of interest. The number of cycles that 
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was corresponded to be the exponential phase of PCR amplification for each gene was 
determined to be: 55 cycles for Collagen type 1 ( 2); 45 cycles for Collagen type 3 ( 
1); 50 cycles for Collagen type 4 ( 1); 35 cycles for Hyaluronan synthase 1; 40 cycles 
for Hyaluronan synthase 3; 50 cycles for RHAMM; 35 cycles for CD 44; 45 cycles for 
TGF-1; 35 cycles for TGF-3; 30 cycles for heat shock protein 47 (hsp-47); 25 cycles 
for GAPDH.   
Finally the PCR products obtained at these cycles were separated on 1.5% agarose 
gels and stained with EtBr and photographed under UV illumination. Densiometric 
measurements of relative band intensities were performed using NIH Image J software. 
The band intensities for the PCR products corresponding to the sequences of collagen 
type 1 ( 2), collagen type 3 ( 1), collagen type 4 (1), Hyaluronan synthase 1, 
Hyaluronan synthase 3, RHAMM, CD 44, TGF-1, TGF-3, hsp-47 were normalized to 
that for GAPDH.  
 
3.2.10  Western blot analysis of wounded and unwounded micromass co-cultures 
For determination of specific protein expression patterns, micromass co-cultures 
were collected in Western lysis buffer supplemented with protease and phosphatase 
inhibitors, as described in Section 3.1.10.1 and homogenized by sonication for 45-60 sec 
using a VibraCell
TM 
(Sonic & Materials Inc., Danbury, CT, USA). After sonication, the 
samples were mixed with equal volume of 2X SDS-Urea buffer and kept at -20 ºC until 
use. For analysis of ERK1/2 and p38 MAPK expression, gel electrophoresis was 
performed on 8.5 % SDS-PA gels. For all other proteins of interest, electrophoresis was 
performed on resolving split gels as described in Section 3.1.10.3. 
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3.2.11  In vitro “micromass” co-culture wound closure assay 
To compare rates of wound closure in micromass cultures, we used an adaptation 
of a planimetric in vitro wound closure assay previously employed for monolayer culture 
systems (Gottrup et al., 2000; Stojadinovic et al., 2005; Tomic-Canic et al., 2007). This 
method uses image analysis to quantify the progressive reduction in the open surface area 
(i.e. total cell free area) of the wounded region during the time course of in vitro wound 
closure. In brief, the micromass co-culture was inflicted with single scrape wound and the 
cell debris was removed as described in Section 3.2.3.  
Each wounded culture was observed by phase contrast microscopy at various time 
points after wounding (0, 12 h, 1 d, 2 d, 3 d, 4 d, 5 d, 6 d, 7 d, 8 d, and 9 d) and 
photographs of the wound region including the wound edges were digitally captured at 
10X magnification. The edges of the wound were manually traced using Image J 1.37G 
software‟s Freehand selection function. The traced wound areas were then calculated 
using the Analyze particle function in the Image J software and selecting the Area 
parameters. The changes in the wound surface area at each time point, and treatment 
conditions were thus quantified using the Analyze particle and Measure function. The 
progressive quantitative reduction in the open wound area was plotted as a graph using 
Microsoft Excel. The experiments were performed in quadruplicate for all treatment 
conditions. 
 
3.2.12  Dual color fluorescent image analysis  
DiI and DiO labeled cells in micromass co-cultures were imaged in real-time 
using a close circuit digital camera attached to a fluorescent phase-contrast microscope. 
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Using Image J 1.37G software, the relative intensities of DiI labeled FR cells (red) and 
DiO labeled L8 myoblast (green) cells located at the wound site (including wound edges) 
and the outer periphery of the micromass co-culture were quantified at 1 day, 3 days and 
8 days post-wounding to examine the patterns of fibroblast and myoblast migration. A 
total of twelve wounded micromass cultures were used for the migration studies. The cell 
migration pattern was determined by taking DiI and DiO fluorescence measurements at 
six different positions in the region of the wound site, which included the wound edges, 
and six defined positions in the peripheral region of the micromass culture as shown in 
Figure 8. The relative numbers of labeled cells in region were quantified using the 
procedures described for cell counting using NIH Image J software from the McMaster 
Biophotonics facility website (http://www.macbiophotonics.ca/imagej/). Plugins and 
automated macros for cell counting using NIH Image J were obtained from this website. 
In brief, the individual raw images obtained for red fluorescent DiI labeled cells and 
green fluorescent DiO labeled cells at each position within the wound site and the 
periphery of the micromass co-culture were converted to grayscale images using the 
Image > Type > 8-bit function of the Image J software. The threshold was automatically 
set for each grayscale images using Image > Adjust > Threshold functions. The threshold 
values were selected as “auto” and images were converted to a binary image by applying 
the Process > Binary > Watershed function. To define and count positive fluorescent 
cells, the images were deconvoluted by applying the Plugin > Color function >Color 
deconvolution function and selecting “vectors” from the region of interest (ROI) on the 
pop window. Finally, the fluorescent cells were counted using the program‟s Analyze 
particle function after selecting “outline” option. 
FIGURE 8
Figure 8. Illustration of the regions of the wounded micromass co-culture imaged to determine cell migration
pattern at the wound site(red) and the periphery (blue). In vitro micromass wound assay was performed by taking a
phase contrast images of the wound site including the wound edges to perform planimetry. DiI and DIO stained cells were
determined by NIH Image J analysis by counting the red fluorescent cells (DiI-FR 3T3) and green fluorescent cells (DiO-
L8).
Regions of the wound including wound 
edges used for analysis
Regions of the periphery of the micromass co-
cultures used for analysis
Direction of wounding
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3.2.13  Statistical Analysis 
All quantitative data obtained from the in vitro experiments were analyzed using 
one-way analysis of variance (ANOVA) with either Dunnett or Tukey multiple 
comparison post-tests (GraphPad Prism 4 software). The graphs were prepared using 
Microsoft Excel software.  
 
CHAPTER 4.   RESULTS 
 
4.1 Effects of Quercetin and OTC on overall scar formation following 
experimental spinal laminectomy surgery in rats. 
 
Based on their previously demonstrated anti-inflammatory properties, we 
hypothesized that both quercetin and OTC might have potential as anti-scarring agents. 
We performed the following qualitative comparisons to examine the effects of quercetin 
and OTC on the extent of cutaneous scar tissue formation in adult rats that were subjected 
to a spinal laminectomy surgery. The laminectomized rats were randomly administered 
i.p. injections of 0.025 mmol/ kg quercetin (b.i.d [twice daily] for 120 h), 1.0 mmol/ kg 
OTC (b.i.d for 72 h) or 3 mL saline solution (b.i.d for 120 h). At 21 days, 63 days and 7 
months post-surgery, a cutaneous scar was visible along the length of the dorsal skin 
incision and the associated wound suture staples. The effects of OTC and quercetin on 
scar formation and the recovery of normal skin pigmentation at the cutaneous wound site 
were visually assessed. These qualitative observations were made in collaboration with 
Ms. Nicole Cox, a graduate student from Dr. B. Juurlink‟s laboratory (Anatomy and Cell 
Biology, University of Saskatchewan), who was investigating the anti-inflammatory 
actions of quercetin and OTC in the same group of animals. Her findings in regard to 
expression of inflammatory markers are detailed in her recent M.Sc thesis (Cox, 2008).  
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In animals observed at 3 day post-surgery, the skin incision wounds were not 
completely closed and the presence of suture staples at this time-point made qualitative 
evaluation of cutaneous scar formation difficult in all treatment groups. The suture 
staples were not removed till 7 days post-surgery. By 21 and 63 days post-surgery, the 
extent of scar formed in the vicinity of the dorsal skin incision and at the site of the 
former staple wounds was more readily visible. Our qualitative observations suggested 
that the animals from the quercetin and OTC treatment groups exhibited reduced 
cutaneous scarring as compared to control animals administered saline alone.  
Furthermore, when our collaborating laboratory observed the cutaneous scars at 7 months 
post-surgery, both quercetin and OTC treated animals showed improved recovery of skin 
pigmentation in and around the wound area as compared to saline treated animals 
(Figure 9 B and 9 C). In the OTC treated rats it was comparatively difficult to visualize 
the original incision and staple wound sites as the dorsal skin wound appeared to be 
completely healed and the extent of dorsal skin pigmentation in that region was similar to 
that of the surrounding skin. In contrast, animals from the saline control group typically 
had raised dorsal skin scars with reduced skin pigmentation making the scar very obvious 
at the sites of incision and suture wounds (Figure 9 A) Some quercetin treated animals 
showed improved recovery of skin pigmentation as compared to saline treated control 
animals, however the dorsal incision and staple wound scars were still visible on close 
examination. The subjective grading of relative skin pigmentation can be represented as 
OTC treated rats > quercetin treated rats ≥ saline treated control animals, while the 
relative visibility of dorsal skin incision and wound staple scars was OTC treated rats < 
quercetin treated rats ≤ saline control animals. These qualitative observations suggested  
FIGURE 9
Figure 9. Images of cutaneous scar from (A) Saline, (B)  OTC and (C) Quercetin treated laminectomized rats. The arrows 
show the location of incisional wound and suture wound on the dorsal skin. These images were taken from 7 month post-surgery 
rats by Nicole Cox for her experiments. The images were reproduced and adapted from Cox (2008).
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the possibility that OTC might be able to reduce cutaneous scarring as compared to both 
saline treated and quercetin treated animals. 
At 63 day post-surgery, when the laminectomized region of the sacrificed animals 
was dissected to excise the peridural scar tissue, it was observed that the amount of bone 
regrowth at the site of laminectomy appeared to be more extensive in OTC and quercetin 
treated animals as compared to saline treated rats (OTC ≥ quercetin > saline control).  
When the peridural scar tissues were harvested for subsequent analysis, the bony tissue 
formed at the laminectomized region appeared to be denser in quercetin and OTC treated 
animals. Moreover, it was more difficult to separate the bony structures from the 
peridural scars of quercetin and OTC treated animals.   
When the peridural scar tissues were excised for RNA and protein analysis, their 
total wet mass was measured. At 3 days post-laminectomy, the peridural scar tissue from 
quercetin treated animals had significantly higher wet mass in comparison to peridural 
scars isolated from either saline treated control animals or OTC treated animals (Table 6, 
p < 0.01, n =6). At 21 day post-surgery, the peridural scar tissue harvested from both 
OTC and quercetin treated rats showed significantly lower mean wet mass as compared 
to saline treated controls (Table 6, p < 0.001 for OTC and p < 0.01 for quercetin, n = 5). 
At 63 days, the peridural scar tissue wet mass for OTC treated animals remained 
significantly lower than compared to saline treated animals (Table 6, p < 0.001, n =6), 
whereas the average peridural scar wet mass for quercetin treated rats was not 
significantly different than control. 
 
 
Table 6. Total wet weight, RNA yield, and protein yield of scar tissue samples harvested from Saline, OTC and quercetin 
treated animals. The total wet mass of scar tissue harvested was determined by weighing the excised scar tissue. Total RNA was 
isolated from scar tissue samples and yield was determined by measuring the optical density at 260 nm. The protein concentration of 
scar tissue homogenates was determined by a Coomassie dye binding assay as described in Section 3.1.9.2. Values represent the Mean 
 SD for each treatment groups; n = 6 for 3 day and 63 post-surgical animal groups while n = 5 for 21 day post surgical animal groups. 
Asterisk indicate values that are significantly different than the corresponding saline control group p < 0.05 (*), p < 0.01 (**), or p < 
0.001 (***). 
 
 
 
 
Quantitative parameter 
 
Time after 
laminectomy 
surgery 
 
 
Treatments 
 
Saline 
 
OTC 
 
Quercetin 
 
Total wet mass 
(in mg) 
 
3 days 1192.53  180.2 1239.7  184.7 1699.92  261.87** 
21 days 1331.68  211.07 872.1  108.71*** 1082.18  112.4** 
63 days 1307.95  251.11 953.98  139.93*** 1496.53  122.16 
 
 
 
Total RNA yield 
(in g) 
 
3 days 68.68  24.1 63.75  17.36 53.65  19.4 
21 days 17.7  4.5 24.65  4.72* 31.02  11.35* 
63 days 7.65  2.02 11.45  1.7** 13.55  6.6 
 
 
Total protein yield 
(in g) 
 
3 days 830.1  20.01 921.66  22.3*** 921.6  26.87** 
21 days 1779.1  285.1 1195.65  441.41* 1115.98  412.98** 
63 days 1648.85  1057.21 1340.89  1000.5 1445.56  1011.85 
 
 
1
1
6
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When RNA was isolated from the peridural scar tissues of saline, OTC and 
quercetin treated animals, it was observed that the peridural scar tissues of 21 and 63 day 
animal groups yielded significantly lower amounts of total RNA than a similar amount of 
scar tissue excised from 3 day animal groups (Table 6, p < 0.05, n =18). In contrast, 21 
day and 63 day scar tissue samples yielded significantly higher amounts of total protein 
relative to 3 day scar tissue. These patterns might reflect an increased accumulation of 
collagens and other extracellular matrix proteins within the scar tissue, with a concurrent 
decrease in the relative density of cells containing rRNA and mRNAs (Table 6, p < 0.05, 
n =18).  
Indeed, reproducible tissue homogenization and protein solubilization proved to 
be problematic for 63-day scar tissue samples due to their highly fibrous nature. The 
solubilization of 63-day peridural scar tissues for western blot analysis was highly 
inconsistent as the homogenates formed precipitates even after addition of 2X SDS-urea 
buffer, and there was large variation in final protein yields from 63-day peridural scar 
tissue homogenates of saline, OTC and quercetin treated animals. In addition, total RNA 
yields were very low for 63-day scar tissues from all animal groups. The poor and 
inconsistent RNA and protein yields for 63 day scar tissues prompted us to use only 
samples collected at 3 and 21 days post-laminectomy for subsequent analysis of quercetin 
and OTC effects on the total collagen distribution, mRNA expression and specific protein 
levels (Table 6).  
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4.2. Effects of Quercetin and OTC on collagen distribution and biosynthesis in 
peridural scar tissue of laminectomized rats. 
 
4.2.1  Correlating Vibrational FTIR spectromicroscopy maps of scar tissue 
sections with picrosirius red polarized light microscopy images of scar 
tissue to determine the orientation and distribution of collagen.  
 
Picrosirius red histochemical staining was used to determine collagen fiber 
abundance and distribution in histological sections of peridural scar tissue from quercetin, 
OTC and saline treated rats. The picrosirius-red stained tissue sections were visualized 
under a circularly polarized light microscope and the staining pattern was compared with 
FTIR spectral maps obtained from contiguous scar tissue sections using an advanced 
imaging technique known as synchrotron-based vibrational Fourier Transformed Infra 
Red (FTIR) microspectroscopy. When the picrosirius red stained scar tissue sections were 
visualized using conventional bright field light microscopy, the entire area of the tissue 
was stained with the dye, although there was some regional difference in stain intensities.  
When the same stained tissue sections were visualized under circularly polarized light 
(Figure 10), bright orange to red birefringence was conspicuous within regions of high 
collagen fibril deposition, while regions with lower collagen deposition showed fainter 
green to yellow birefringence.  
To verify the specificity of picrosirius red polarization technique used in this 
study in determining the orientation and distribution of collagen fibrils in the scar tissue, 
contiguous histological sections of the scar were examined for total collagen deposition 
using the synchrotron FTIR spectromicroscopic tissue mapping technique by our 
collaborators at the University of Manitoba, Winnipeg (Wiens et al., 2007).  
 
 
Saline
OTC
Quercetin
Picrosirius red staining
(Bright-field microscopy)
Picrosirius red staining
(Polarization light microscopy)
FIGURE 10
Figure 10. Picrosirius red polarization method showing 21 day scar tissue sections of  Saline, OTC and 
Quercetin treated animals. The light microscopy images shows that picrosirus red non specificially stains both 
collagen rich regions of the scar tissue as well as musculatures. The photomontages of the picrosirius polar-
ized images were prepared with Adobe Photoshop CS imaging software. These images show the specificity of 
the collagen staining as visualized under a circularly polarized light microscope. The polarization images gen-
erated for tissue sections obtained from individual animals for 3 and 21 day treatment groups were used for 
analyzing the total collagen levels following treatment with OTC and Quercetin. Scale corresponds to 100 mm.
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Regions of scar tissue used for FTIR mapping were selected based on a visual 
examination of the tissue section to ensure adequate representation of granulation tissue, 
wound healing matrix and the presence of fibrillar collagen in the area of analysis. 
Synchrotron FTIR maps were generated from contiguous histological sections using a 
Nicolet 860 FTIR instrument with a continuum microscope (National Synchrotron Light 
source, Brookhaven National laboratory, NY, USA) or Nicolet Magna 500 FTIR 
instrument with a Nic-Plan microscope (Synchrotron Radiation Center, Stoughton, WI, 
USA). All spectra were collected at 4 cm
-1
 spectral resolution with a 12 X 12 m aperture 
and 10 m step size. Nicolet OMNIC/Alts software was used for all data acquisition 
and map analyses. The maps were processed based on spectral markers for various tissue 
components (lipids, polysaccharides, nucleotides, collagens) using direct univariate 
analyses and the relative abundance of components of interest were displayed in a false 
color scale from red/white (for lowest level or absence of the components) to blue 
(highest level). The presence of collagen in tissues was determined by the spectral quartet 
band at 1,204, 1,240, 1,284 1,338 cm
-1
 and the sites of relative collagen signal intensity 
within the sections were mapped by integrating the area of 1,204 cm
-1
 peak from 1,198 to 
1,211 cm 
-1
 with a baseline from 1,188 to 1,214 cm
-1
 and a display range of 0.025 to 0.45 
(Figure 11 C and 11 D).  
A comparison of the polarized light images of sirius red stained scar tissue 
sections with contiguous scar tissue sections subjected to FTIR mapping analysis 
demonstrates some correlation between the two techniques in determining the location 
and orientation of collagen fibres (Figure 11). Wiens et al. (2007) found that the 
orientation of the synchrotron light source relative to a tissue section’s plane of axis plays 
a critical role in the ability of FTIR spectral mapping to detect aligned collagen fibrils. In  
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Figure 11. Correlation of Picrosirius red polarization images with Vibrational FTIR spectro-
microscopy maps for oriented collagen fibres in 21 day scar tissue regions. Presence of col-
lagen in scar tissue was determined by Fourier transformed infrared spectral mapping as described 
by Wiens et.al.,2007. The distribution of collagen in a contigous scar tissue section and false color 
images corresponding to the levels of collagen fibril orientation were created using Nicolet Omnic/
Atlus software. Panel A and D are photographs of two different unstained scar tissue sections.The 
rectangular black box in Panel A and red box in Panel D as well as rectangular blue box in Panel B 
and green box in Panel E denotes the position of FTIR map in the corresponding unstained and pic-
rosirius red stained sections. (Panels C & F) shows the false color images processed at 1204 cm-1 for 
FTIR mapping of collagen distribution in these scar tissue sections. Scale corresponds to 100 mm.
FIGURE 11
Unstained scar tissue section Picrosirius red 
polarization image
Synchrontron 
FTIR spectral derived 
False color images for collagen 
distribution and orientation
Images reproduced and adapted from Wiens et al., 2007
A B C
D E
F
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contrast, our picrosirius red polarization images demonstrates that this histochemical 
method was more effective at consistently detecting collagen fibrils within scar tissue 
sections and visualizing their orientation as compared to FTIR spectral maps (Figure 11 
B and 11 C). One limitation of the picrosirius red polarization method was its lower 
sensitivity in identifying sites of low collagen abundance in tissue sections as compared 
to FTIR spectral maps (Figure 11 E and 11 F).  
Our results corroborate previous findings that have validated the picrosirius red 
polarization technique as a routine, reliable histochemical method for detection of 
collagen fibril deposition within tissue sections. 
 
 
4.2.2 Effects of Quercetin and OTC on total collagen distribution in the 
histological sections of peridural scar tissue of laminectomized rats. 
 
Histological sections of peridural scar tissue from quercetin, OTC and saline 
treated animals were stained with picrosirius red and photographed under circularly 
polarized light microscopy. Quantitative image analyses was performed on the captured 
digitalized images to determine whether quercetin and OTC treatments affected levels of 
total collagen accumulation in the histological sections of peridural scar tissue, obtained 
from animals at 3 and 21 days, after laminectomy surgery.   
A visual inspection of the picrosirius red polarization images of 3 day post-
surgery peridural scar tissues from quercetin, OTC and saline treated rats suggested that 
there was a high degree of variation in the abundance of picrosirius red stainable 
collagen fibrils between individual animals within each of the drug treatment groups 
including the saline control group (Figure 12).  Quantitative analysis using NIH Image J 
software revealed no statistically significant effects of either OTC or quercetin treatment  
FIGURE 12
Figure 12. Picrosirius red polarization images showing the corresponding 3 day 
scar tissue regions of Saline, OTC and Quercetin treated animals. The five images 
in each vertical column represent the field of view images from five different animals 
within each treatment groups. A majority of the 3 day  treatment groups showed huge 
variation in total collagen staining with low to high intensity staining at the region of 
scar. All images were taken using circularly polarized light at 10X magnification. Scale 
represents 100 mm
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SALINE OTC QUERCETIN
FIGURE 13
Figure 13. Picrosirius polarization images showing the corresponding 21 
day scar tissue regions of Saline, OTC and Quercetin treated animals. The 
five images in each vertical column represent the field of view images from 5 
different animals within each treatment groups.Low intensity staining of the 
corresponding scar tissue region was observed in OTC treated groups. While 
both quercetin and saline treated animals showed huge variation in total col-
lagen staining at the corresponding scar tissue region. All mages were taken 
using circularly polarized light at 10X magnification. Scale represent 100 mm.
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SALINE OTC QUERCETIN
FIGURE 14
Figure 14. Graph representing the collagen area fraction of the peridural scar 
tissue sections from saline, OTC and quercetin treated animals at 3 days (A) and 
21 days (B) post laminectomy surgery. The individual data points within the treatment 
groups represents the average collagen area fraction calculated from 9 separate fields of 
view within the picrosirius red stained tissue section obtained from each treated 
animals. (A) All 3 day treatment groups when compared with Saline control groups 
showed no statistical significant treatment effects ( p > 0.05, n = 8). (B) While 21 day 
OTC and Quercetin treated animal showed a decrease in the mean total collagen 
stainable area as compared to the saline control group, the differences was not statistical 
significant (Mean ± SD, p> 0.05, n = 8). 
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on the collagen area fraction (picrosirius red positive area) relative to saline treated 
control animals (Figure 14 A, p > 0.05, n =8).  
Visual inspection of picrosirius red polarized light images from 21-day peridural 
scar sections suggested that there might be a reduction in total collagen abundance in the 
scar tissue from OTC and quercetin treated as compared to saline treated animals (Figure 
13). Quantitative image analysis of the polarized light images from 21-day scar tissue 
sections confirmed that the mean collagen area fraction for both OTC and quercetin 
treated animals was lower than for saline treated control animals. However, the reduction 
in picrosirius red staining relative to control levels was not statistically significant for 
quercetin (p> 0.05, n = 8), or for OTC treatment (Figure 14 B, p > 0.05, n =8). The 21-
day peridural scar sections, like those of the 3-day time point, exhibited considerable 
variation in measured levels of picrosirius red positive collagen (i.e. collagen area 
fraction) among the individual animals within each of the drug treatment groups. 
 
4.2.3 Effects of Quercetin and OTC on the expression of extracellular matrix 
proteins (type I collagen, fibronectin) and collagen biosynthesis markers, 
prolyl-4-hydroxylase (P4H) and heat shock protein- 47 (hsp-47). 
 
Since image analysis of picrosirius red histochemical staining was unable to 
reveal differences in total collagen accumulation within the peridural scar tissues of OTC, 
quercetin and saline treated animals, I subsequently employed western blot analysis to 
assess the effects of these drugs on levels of type I collagen and fibronectin proteins and 
on the levels of two proteins involved in procollagen biosynthesis, P4H and hsp-47. 
Specific antibodies for all four proteins were able to detect bands of the correct 
size on western blots of both 3 day and 21 day peridural scar tissue homogenates resolved 
by SDS-PAGE (Figures 15 and 16). The individual animals within each treatment group 
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showed a high degree of variation in their levels of the extracellular matrix proteins type I 
collagen and fibronectin as well as in their expression levels of hsp-47, a procollagen 
chaperone protein, and P4H, an enzyme involved in collagen biosynthesis (Figure 15 and 
16). Densiometric analysis of the western blots revealed no significant effect of either 
OTC or quercetin on the mean levels of any of these proteins tested as compared to saline 
treated control animals in either 3 day or 21 day post-surgical animal groups (Figure 17 
and 18, p > 0.05, n =6).  
Because of the large animal to animal variation seen in levels of protein 
expression, I employed RNA dot blot analysis to determine whether quercetin and OTC 
had any consistent effect on relative levels of the gene transcripts for collagen type 1 ( 
2); collagen type 3 (1) and collagen type 4 (1). The expression level for each of the 
specific collagen mRNAs was normalized against the mRNA level of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), a constitutively expressed gene transcript. Within 
the peridural scar tissue, the hybridization signals for the mRNA transcripts of the 
interstitial fibrillar collagens type 1 (2) and type 3 (1) were consistently higher than 
those of collagen type 4 (1), a predominantly basement membrane collagen (Figure 
19). Detection of collagen type 4 (1) mRNA on autoradiographs required 6 times longer 
exposure as compared to detection of collagen type 1 (2) and collagen type 3 (1) 
mRNAs.  
As seen with the previous protein analysis, the collagen mRNA levels also 
exhibited large animal to animal variation within each treatment group, including the 
saline controls. Densiometric quantification of RNA dot blot autoradiographs revealed no 
statistically significant effects of either quercetin or OTC treatments on type I, III or IV  
FIGURE 15
Figure 15.  Western blot analysis of peridural scar tissue homogenates from 3 day post-surgical animals showing rela-
tive levels of Fibronectin, type I collagen, prolyl-4-hydroxylase, heat shock protein-47 and GAPDH following treat-
ment with Saline, OTC and Quercetin. A total of six animals were used for the western blot analysis of the scar tissue ho-
mogenates obtained from 3 day post surgical animals, the left panel shows a set of western blots obtained from the first three 
animals (Animal # 1-3) for each of the treatment groups (Saline, OTC and Quercetin ) while the right panels shows the west-
ern blots from the rest of the animals (Animal # 4-6)  for each treatment groups. There was a high amount of variablity 
in fibronectin, type I collagen, P4H and hsp-47 expression in  all treatment groups including saline treated control group. The 
GAPDH expression levels in each of the animal showed a high level of consistency as to the equal loading of proteins.
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FIGURE 16
Figure 16. Western blot analysis of peridural scar tissue homogenates from 21 day post-surgical animals showing rel-
ative levels of Fibronectin,  type I collagen, prolyl-4-hydroxylase, heat shock protein-47 and GAPDH following treat-
ment with Saline, OTC and Quercetin. A total of five animals each were used for the western blot analysis of scar tissue 
homogenates obtained from 21 day Saline and Quercetin treated animals while six animals were used for the western blot 
analysis of scar tissue homogenates obtained from 21 day OTC treated animals, the left panel shows a set of western blots 
obtained from the first three animals (Animal # 1-3) for each of the treatment groups (Saline, OTC and Quercetin ) while the 
right panels shows the western blots from the rest of the animals (Animal # 4-6 in case of OTC and Animal # 4 & 5 for Sa-
line and Quercetin) for each the treatment groups. The GAPDH expression levels in each of the animal showed high level of 
consistency as to the equal loading of proteins. Variability in the levels of fibronectin, type I collagen, prolyl-4-hydroxylase 
and heat shock protein-47 expressions within each treatment group including saline treated control group. 
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FIGURE 17
Figure 17. Relative expression levels of type I collagen, prolyl-4-hydroxylase, heat shock protein-47 (hsp-47) and 
Fibronectin proteins in 3 day peridural scar tissue homogenate. Densiometric analysis was performed on the 
western blots shown in Figure 15 using NIH Image J software. Relative protein expression  levels were determined by 
normalizing the densiometric signal for the protein of interest against the GAPDH protein signal. One way ANOVA 
using Kruskal Wallis non-parametric test showed that there was no statistically significant treatment changes in 
expression of (A) type I collagen (B) prolyl-4-hydroxylase, (C) hsp-47 and (D) fibronectin proteins in 3 day animal 
groups treated with OTC and Quercetin as compared to Saline control groups. 
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FIGURE 18
Figure 18. Relative expression levels of type I collagen, prolyl-4-hydroxylase, heat shock protein-47 (hsp-47) and 
Fibronectin proteins in 21 day peridural scar tissue homogenate. Densiometric analysis was performed on the 
western blots shown in Figure 16 using NIH Image J software. Relative protein expression  levels were determined by 
normalizing the densiometric signal for the protein of interest against the GAPDH protein signal. One way ANOVA 
using Kruskal Wallis non-parametric test showed that there was no statistically significant treatment changes in 
expression of (A) type I collagen (B) prolyl-4-hydroxylase, (C) hsp-47 and (D) fibronectin proteins in 21 day animal 
groups treated with OTC and Quercetin as compared to Saline control groups. 
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FIGURE 19
Figure 19. Autoradiographs of RNA dot blots showing hybridization signals for Col 1(a2), 
Col 3(a1) and Col 4(a1) with respect to GAPDH signals for peridural scar tissues isolated 
at 3 day and 21 days following spinal laminectomy surgery. As compared to Col 4 (a1) 
mRNA levels, both Col 1 (a2) and Col 3 (a1) mRNA levels were consistently expressed at 
higher levels in both 3 and 21 day animal groups. Autoradiographs for type IV collagen mRNA 
transcripts were exposed for 36 h, while it took only 6 h for type I and type III collagen mRNA 
transcripts to develop signals. The signal intensities for the individual animals within each of 
the Saline, OTC and quercetin treated groups showed considerable variability in the expression 
of type I, III and type IV collagen mRNA transcripts. Each dot represents expression of colla-
gen mRNAs for individual animals within each treatment groups. For the mRNA  analysis, all 3 
day animal groups had a total of six animals within their treatment groups while 21 day animal 
groups had five animals for Saline and Quercetin group while six animals for OTC group were 
used for analysis. 
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FIGURE 20
Figure 20. Relative expression levels of  Collagen 1 (2) , Collagen 3 (1) mRNA 
and Collagen 4 (1) mRNA in 3 day and 21 day peridural scar tissue homogenates. 
Densiometric analysis was performed on the RNA dot blots to determine the relative 
expression levels of the collagen mRNAs and the values obtained were normalized with 
GAPDH mRNA level values. Statistical analysis revealed no statistically significant 
differences in the expression of collagen mRNAs in peridural scars isolated from 
animals treated with OTC and Quercetin relative to Saline treated control animals (p > 
0.05, n =6)
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collagen mRNA levels relative to the saline control group in both 3 day and 21 day 
animal groups (Figure 20; p > 0.05, n =6).  
The scatter plots for each protein and mRNA assayed indicated large animal to 
animal variability within each treatment group. For each protein (or mRNA) some 
individual animals expressed at comparatively high levels while other expressed at 
relatively low levels. In order, to determine whether those individual animals that 
expressed high levels of a particular protein (e.g type I procollagen) also expressed high 
levels of functionally related proteins (e.g. hsp-47 or P4H) or vice versa. I performed 
Pearson Correlation Coefficient analyses using SPSS 17.0 statistical software on the 
western blot data for type I collagen, P4H, hsp-47 and fibronectin proteins. The results of 
this analysis are tabulated in Appendix 1. The analysis revealed that for 21 day OTC 
treated animals there was a significantly high correlation between levels of P4H and hsp-
47 proteins. This indicates that those individual animals that expressed high levels of P4H 
protein also tended to express high levels of hsp-47 protein, while other animals 
expressed concurrently low levels of both proteins. Our findings suggest a potential 
ability of OTC to balance levels of proteins involved in collagen biosynthesis and post-
translational modification.  
Similarly, correlation coefficient analysis was performed on RNA dot blot data 
for type I, III and IV collagen mRNA transcripts (see Appendix 2). It was observed that 
the 3 day and 21 day saline treated animals showed strong correlation between type I and 
type III collagen mRNA transcript levels. This indicates that in saline treated animals 
when type I collagen mRNA transcript levels were high, the type III collagen mRNA 
transcript levels were also high, while others expressed concurrently low levels of both 
mRNAs. This finding correlates with the previous findings where both collagen type 1 
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(2) and collagen type 3 (1) mRNA transcripts are been co-expressed at high levels in 
early healing tissues (Kinbara et al., 2002) as well as in fibrotic tissues (Stewart et al., 
1994).  
 
4.3  Effects of Quercetin and OTC on the expression of potential regulatory 
molecules such as TGF-ß1, TGF–ß3, VEGF, ERK and p38 MAPK in the rat 
spinal laminectomy model. 
 
4.3.1  Effects of Quercetin and OTC on TGF-1 and TGF-3 mRNA expression 
levels in 3 day and 21 day peridural scar tissues. 
 
Both the TGF-ß1 and TGF-ß2 growth factors have been implicated in promoting 
scarring (Adzick and Lorenz, 1994; Krummel et al., 1988; Shah et al., 1995). TGF-ß1 
stimulates collagen synthesis, fibroblast proliferation and angiogenesis (Cannon and St 
Pierre, 1998; Massague, 1990) that are involved in scar formation. In contrast, TGF-ß3 
has been shown to decrease scarring in a rat incisional wound model (Shah et al., 1995).  
Accordingly, I utilized RNA dot blot analysis to examine whether quercetin and 
OTC treatments would alter the relative levels of TGF-ß1 to TGF-ß3 mRNA expression 
during in vivo peridural wound healing in a manner consistent with scarless tissue repair. 
The hybridization signals for the TGF-ß mRNA were normalized against the GAPDH 
mRNA signal to correct for differences in sample loading. As seen in Figure 21, the 
hybridization signals for TGF-ß1 and TGF-ß3 were relatively low in RNA samples 
isolated from both 3 day and 21 day peridural scar tissue, requiring autoradiographic 
exposure times of ~2 days for detection. This suggests that TGF-ß1 and TGF-ß3 mRNA 
levels were quite low in these tissues. Densiometric analysis of the signal intensities for 
TGF-ß1 and TGF-ß3 mRNA in scar tissue samples from 3-day and 21-day post-surgery  
 
Figure 21. RNA dot blot autoradiograph showing signal intensity for TGF-b1, TGF-b3 and GAPDH 
mRNAs for peridural scar tissues isolated at 3 day and 21 days following spinal laminectomy sur-
gery. The signal intensities for the individual animals within each of the Saline, OTC and Quercetin treat-
ed groups showed considerable variability in relative expression levels of TGF-b1 and TGF-b3. In 3 day 
treatment groups, TGF-b1 expression levels were higher as compared to 21 day treatment groups while 
TGF-b3 was consistently expressed at higher levels in both the treatment groups. Each dot represents ex-
pression of TGF-b mRNAs for individual animals within each treatment groups. It took 48 hours for the au-
toradiograph to develop signals for both TGF-b1 and TGFb3 mRNA transcripts.  For  the  mRNA  analysis, 
all 3 day animal groups had a total of six animals within their treatment groups while 21 day animal groups 
had five animals for Saline and Quercetin group while six animals for OTC group were used for analysis. 
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FIGURE 22
Figure 22. Relative expression levels of TGF-b1 and TGF-b3 mRNA in 3 day and 21 day peri-
dural scar tissue homogenates. Densiometric analysis was performed on the RNA dot blots to 
determine the relative expression levels of the TGF-bs mRNA and the values obtained were nor-
malized with GAPDH mRNA level values. Statistical analysis shows that there was no statisti-
cally significant changes in the expression of TGF-b mRNAs following treatment with OTC (p 
> 0.05, n=6) and Quercetin as compared to Saline control treatment (Mean ± SD, p > 0.05, n =6)
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time points revealed no statistically significant effects of either quercetin and OTC 
treatment (Figure 22; p > 0.05; n = 6). However, in 21-day scar tissue samples from all 
drug treatment groups, there appeared to be a general trend for higher TGF-ß3 expression 
relative to TGF-ß1 (Figure 21).  
Again, I performed Pearson Correlation coefficient analysis to determine whether 
any linear correlation exists between TGF-ß1 and TGF-ß3 or TGF ßs and all collagen 
mRNA transcripts within the animals in the treatment groups. It was observed that no 
significant linear correlation existed between TGF-ßs and the majority of collagen 
mRNA transcripts tested in all treatment groups except for 3 day saline treated animal 
group (see Appendix 2). In 3 day saline treated animals it was observed that when TGF-
ß1 mRNA levels were high there was a linear increase in collagen 1 (2) mRNA levels 
suggesting the potential fibrogenic role of TGF-ß1. This finding directly correlates with 
previous findings that have shown increased TGF-ß1 mRNA transcript levels may lead to 
increase in collagen 1 (2) mRNA transcript levels (Kinbara et al., 2002; Halper et al., 
2005).  
Western blots of 3 and 21-day scar tissue homogenates that were probed with 
commercial antibodies (Santa Cruz Biotech) against TGF-ß1, TGF-ß2, and TGF-ß3 
proteins were unsuccessful in demonstrating detectable levels of any of these growth 
factors (data not shown). This was consistent with the low level of TGF-ß1 and TGF-ß3 
transcript expression detected by standard RNA dot blot analysis.  Due to the absence of 
detectable of TGF-ß protein expression and the weak, variable hybridization signals for 
TGF-ß mRNAs, we were unable to ascertain whether quercetin and OTC treatments were 
able to modulate TGF-ß1 and TGF-ß3 expression during peridural wound repair. 
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4.3.2  Effects of Quercetin and OTC on the expression of VEGF protein and 
myogenic markers in 3 day and 21 day peridural scar tissue. 
 
I also wished to determine whether quercetin and OTC had any effect on the 
expression of vascular endothelial growth factor (VEGF), an angiogenic factor that plays 
a key role in skeletal muscle repair. VEGF was shown to enhance myoblast migration in 
vitro and to prevent apoptosis of myoblasts in cell culture and in skeletal muscle 
following ischemia (Arsic et al., 2004; Germani et al., 2003). Moreover, delayed 
angiogenesis may lead to impaired skeletal muscle regeneration (Ochoa et al., 2007). 
Western blot analysis of peridural scar tissue homogenates confirmed expression of 
VEGF proteins in both 3 day and 21-day post-surgical groups (Figure 23). Visual 
comparison of the blots 3 day and 21 day scar tissue homogenates suggests that the 
VEGF protein levels were usually higher in 21-day peridural scar tissue than in 3-day 
scar tissue (Figure 23). Nevertheless, VEGF protein levels exhibited substantial animal 
to animal variation within each treatment group at both post-surgical time points (Figure 
24). 
Densiometric analysis of the western blots obtained for 3 day peridural scars 
revealed that the mean VEGF protein levels were higher for both OTC and quercetin 
treated animals as compared to the saline control group (Figure 24), however these 
differences were not statistically significant (p > 0.05, n =6). In 21 day peridural scar 
tissue, the mean levels of VEGF protein for OTC and quercetin treated animals were 
significant difference.  
Western blot analysis demonstrated that peridural scar tissue isolated at 3 days 
and 21 days after laminectomy surgery expressed MyoD protein, a marker for immature 
myoblastic cells (Figure 23). In contrast, we did not detect expression of myosin heavy  
FIGURE 23
Figure 23. Western blot analysis of peridural scar tissue homogenates from 3 day and 21 day post-sur-
gical animals showing relative levels of MyHC, MyoD, VEGF and GAPDH following treatment with 
Saline, OTC and Quercetin. Absence of MyHC protein in all treatment groups shows that peridural scar 
tissue homogenates did not have any differentiated muscle cells though presence of MyoD shows that the 
tissue homogenate did contain MyoD positive cells in the granulation tissue isolated for protein analysis. 
This is consistent with muscular healing process. The MyoD expression levels were higher in 3 day post-
surgical groups as compared to 21 day post-surgical groups. The overall VEGF expression in 21 day post-
surgical groups were higher than 3 day post-surgical groups. The variability in the expression of VEGF pro-
teins was observed  in all experimental treatment groups including saline control group in both 3 and 21 day 
post-surgical groups. Each  lane shows protein level expression for individual animals within the treatment 
groups. For the protein analysis of the 3 day post-surgery groups, each treatment groups had six animals.
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FIGURE 24
Figure 24 Relative expression levels of VEGF and MyoD proteins in 3 day and 21 
day peridural scar tissue homogenates. The densiometric analysis was performed on 
western  blots and the relative VEGF and MyoD protein expression  levels were 
determined by normalizing the values with GAPDH protein expression levels. The 
overall mean VEGF protein expression were higher in 21 day post-surgical group as 
compared to 3 day post-surgical group, while overall mean MyoD protein expression 
were higher  in 3 day post-surgical group as compared to 21 day post-surgical group. 
No statistical significant treatment effects of both OTC and quercetin was observed (p > 
0.05, n = 6 ; One way ANOVA using Kruskal Wallis non-parametric test 
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chain (MyHC), a marker for differentiated skeletal muscle fibres (Figure 23). These data 
suggest that both 3 day and 21 day peridural scar tissues contain immature myoblastic 
cells but few if any fully differentiated skeletal muscle fibres. Visual inspection suggests 
that expression of MyoD protein may be lower at 21-day post surgery than in 3-day 
peridural scar tissue. However, densiometric analysis revealed no statistically significant 
slightly lower that in saline treated animals but again statistical analysis revealed no 
effects of either OTC or quercetin treatment on MyoD protein levels (Figure 23, p > 
0.05, n =6).  
Again, to determine whether there was any linear correlation that existed between 
VEGF and MyoD, or between VEGF/MyoD and type I collagen, P4H, hsp-47 and 
fibronectin proteins, within the animals in treatment groups. I performed Pearson 
Correlation analysis on the Western blot data and results are tabulated in Appendix 1. It 
was observed that in both 3 day and 21 day saline and quercetin treated animal groups 
there was no significant relationship between the ECM proteins, type I collagen and 
fibronectin, or P4H and hsp-47, with the VEGF or MyoD proteins which may suggest no 
correlation between these proteins. However, when the analysis was performed on the 21 
day OTC treated animals; it showed strong linear correlation between hsp-47 levels and 
MyoD protein levels. The animals that expressed high levels of VEGF expressed high 
levels of MyoD proteins while animals that expressed low levels of VEGF also expressed 
low levels of MyoD protein. Similarly, 21 day OTC treated animals also showed strong 
linear correlation between P4H and VEGF proteins These findings may suggest that OTC 
could promote fibroblast cells to produce VEGF protein (Takamiya et al.,2002) and also 
help in the migration of myoblast cells that aid in muscle regeneration (Higuchi  et al., 
2007).  
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4.3.3 Effects of Quercetin and OTC on ERK and p38 MAP kinase expression in 3 
and 21 day peridural scar tissue. 
 
Activation of both p38 and ERK1/2 MAPK is necessary for resolution of keloid 
scar through stimulation of keloid fibroblast apoptosis (Kuo et al., 2005). In skeletal 
muscle repair, p38 / ß MAPK activation is necessary to activate quiescent satellite cells 
and promote their proliferation and eventual differentiation into muscle fibres (Chen et 
al., 2007). In corneal wound healing, ERK 1 and ERK 2 activation has been implicated in 
the initiation of cell migration and proliferation during early repair phases (Imayasu and 
Shimada, 2003).  The prominent involvement of MAPK signaling in wound healing 
processes prompted us to examine whether OTC and quercetin treatments altered the 
levels of ERK and p38 MAPK expression and phosphorylation in peridural scar tissues 
following laminectomy surgery. 
 
 
4.3.3.1  Effects of Quercetin and OTC on p38 MAPK expression in peridural 
scar tissue. 
 
Western blot analysis of peridural scar tissue homogenates demonstrated the 
presence of both total p38 MAPK and phosphorylated p38 MAPK in all post-surgical 
animals groups (Figure 25 A and 25 B). At 3 day post-surgery, the blots showed very 
low levels of dual-phosphorylated (active) p38 MAPK protein relative to total p38 
MAPK proteins for animals from all drug treatment groups (Figure 25 A). Densiometric 
analysis of the 3-day peridural scar samples revealed no statistically significant effects of 
either quercetin or OTC on levels of p38 MAPK activation as compared to saline treated 
control animals (Figure 25 C).  
Western blots of 21-day peridural scar tissue showed expression of both total and 
dual phosphorylated p38 MAPK protein (Figure 25 B). Dual phosphorylated (active) p38  
FIGURE 25
Figure 25. Western blot analysis for dual phosphorylated p38 mitogen activated protien kinases (MAPK) and total p38 MAPK in 
3 day and 21 day post-surgical scar tissue homogenates obtained from Saline, OTC and Quercetin treated animals. For both dual 
phosphorylated (active) and total p38 MAPK expression analysis, 12.5 % SDS-acrylamide gels were used to resolve the proteins. Each 
blot represents a set of animals with saline, OTC and quercetin treatment groups. Six animals per drug treatment group (including sa-
line control) were used for 3 day treatment groups, while 5 animals were used for 21 day animals treated with quercetin and saline con-
trol. (A) It was observed that in 3 day treatment groups, dual phosphorylated p38 MAPK were expressed at very low levels as compared 
to 21 day treatment groups, (B) while total p38 MAPK proteins were present in both 3 day and 21 day treatment groups.  Densiometric 
analysis was performed on the western blots shown in Figure 25 a and 25 b using NIH image J software.p38 activation levels were de-
termined by normalizing the densiometric signal for dual phosphorylated p38 MAPK against corresponding total p38 MAPK protein sig-
nal.  It was observed 21 day post-surgical scar tissue from OTC treated animals exhibited significanlty lower p38 activation as compared 
to saline treated control animals. ( Mean ± SD,* indicates significance at p  < 0.05;  Kruskal Wallis non -parametric one way ANOVA)
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MAPK was relatively abundant in 21-day scar samples from all three-treatment groups as 
compared to 3-day scar tissues (Figure 25 B). Densiometric analysis of the 21-day 
peridural scar samples was performed to determine the relative p38 MAPK activation 
levels between the drug treatment and saline control groups (Figure 25 D). At 21-day 
post surgery, peridural scar tissue from OTC treated animals exhibited significantly lower 
p38 MAPK activation levels as compared to saline treated control animals (Figure 25 D; 
p < 0.05; n = 6). In contrast, the level of p38 MAPK activation in peridural scar tissue 
from quercetin treated animals was not statistically different than that of saline treated 
control animals (Figure 25 D; p > 0.05; n = 5). 
 
4.3.3.2.  Effects of Quercetin and OTC on ERK expression in peridural scar 
tissues  
 
We also examined the effects of quercetin and OTC treatments on levels of total 
ERK1/2 protein and dual phosphorylated (active) ERK1/2. Western blot analysis of 
peridural scar tissues collected at 3 days after laminectomy surgery revealed expression 
of total ERK1/2 protein for all drug treatment groups, but dual phosphorylated ERK1/2 
was undetectable (Figure 26 A). In contrast, 21-day peridural scar tissue samples 
expressed dual phosphorylated ERK1/2 as well as total ERK1/2 proteins (Figure 26 B). 
Densiometric analysis of the 21-day peridural scar samples was performed to determine 
the relative ERK1/2 activation levels between the drug treatment and saline control 
groups (Figure 26 C).  At 21-day post-surgery, the levels of ERK1/2 
phosphorylation/activation was significantly lower in peridural scar tissue from OTC 
treated animals as compared to saline treated control animals (Figure 26 C, p < 0.05, n = 
6). In contrast, ERK activation levels for the 21-day scar tissue from the quercetin 
treatment group were equivalent to saline controls. 
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Figure 26. Western blot analysis for  dual phosphorylated ERK 1/2 and total ERK 1/2 in 3 day and 21 day post-surgical scar tissue homog-
enates obtained from Saline, OTC and Quercetin treated animals. For the ERK 1/2 expression analysis ,12.5 % SDS-acrylamide gels were used 
to resolve the proteins. Six animals per drug treatment group (including saline control) were used for 3 day post-surgical groups while 5 animals 
were used for 21 day animals treated with quercetin and saline control. (A) The expression of total ERK 1/2 were present in all 3 day and 21 day 
treatment groups, while dual phosphorylated ERK 1/2 was undetected in 3 day treatment groups (B). Densiometric analysis was performed on the 
western blots shown in Figure 26 b using NIH Image J software (C). ERK1/2 activation levels were determined by normalizing the densiometric 
signal for dual phosphorylated ERK1/2 against corresponding total ERK1/2 protein signal. It was observed that  21 day OTC treated animal showed 
statistically significnat lower levels of ERK1/2 activation as compared to Saline treated animals while ERK 1/2 activation was similiar for both 21 
day saline and quercetin treated animals ( Mean ± SD,  ** indicate significance at p < 0.01; n = 5. Kruskal Wallis non parametric one way ANOVA). 
FIGURE 26
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Our findings suggest that OTC treatment consistently reduced both ERK and p38 
MAPK signaling in our spinal laminectomy model of peridural wound repair. 
 
4.4 Development of a novel in vitro co-culture model to study the wound-healing 
process: Method development and validation 
 
4.4.1 Introduction 
Large animal to animal variation was a persistent problem for most of our assay 
parameters in the rat spinal laminectomy model. Variability was observed for the 
expression levels of a variety of mRNAs and proteins implicated in fibrosis and tissue 
repair including collagens, fibronectin, P4H, hsp-47, VEGF, TGF-1 and TGF-3. As 
such we could not clearly establish whether OTC or quercetin exerted anti-fibrotic effects 
on peridural scarring in vivo. Hence, the focus of my thesis research was shifted toward 
developing an improved in vitro wound repair model for use in drug development studies, 
with specific emphasis on evaluating the effects of quercetin and OTC. Accordingly, my 
experimental strategy was to develop a more consistent and economical in vitro model 
that would mimic characteristics of in vivo peridural scar tissue, and to employ this model 
to examine effects of OTC and quercetin on collagen biosynthesis and other parameters 
of tissue fibrosis.  
In establishing my in vitro wound repair model, I employed “micromass” co-
cultures of an adult rat myoblast cell line and a rat fetal skin fibroblast cell line to permit 
the interaction of these distinct cell types in a 3-D tissue like context that would simulate 
in vivo peridural muscle tissue repair.  
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4.4.1.1 Method development: Characterization of “micromass” co-culture based 
technology as a 3-D scaffold free in vitro wound repair model. 
4.4.1.1.1  Determination of the relative proportions of L8 myoblast cells and FR 3T3 
fibroblast cells that promote micromass adhesion and withstand wounding 
manipulation. 
 
In my initial experiments, I determined the optimum combination of rat L8 
skeletal myoblast cells and rat FR fibroblast cells that would promote adhesion of 
micromass tissue layer to the culture dish and also withstand a scrape wound laceration 
injury.  L8 myoblast and FR fibroblast cells were grown separately to 80% confluence 
and trypsinized. High-density cell suspensions of FR cells and L8 cells were mixed in 
varying relative proportions (1:1; 1:2 and 1:3 respectively), then 10 L droplets of cell 
suspension (2 X 10
5
 cells / 10 L) were plated onto culture dishes to establish micromass 
cultures. Micromass cultures composed either of FR fibroblast or L8 myoblast cells alone 
were also prepared. In order to distinguish the two cell types in micromass co-culture, in 
some experiments the FR fibroblast and L8 myoblast cells were differentially labeled 
with DiI and DiO lipophilic tracking dyes and examined by fluorescence microscopy 
with rhodamine and FITC filters. The specificity of the DiI (red) and DiO (green) 
labeling is shown in Figure 27, which demonstrates that the rhodamine filter eliminated 
signals from DiO labeled L8 myoblast cells while the FITC filter blocked fluorescence 
from DiI labeled FR fibroblast cells. 
The FR fibroblast: L8 myoblast cell mixtures tested were able to form micromass 
spot cultures that adhered to the culture dish, as were cultures comprised of L8 myoblast 
cells alone (Figure 28 A). However the various cultures differed in their ability to remain 
firmly attached to the culture dish following infliction of a single linear scrape wound 
(see Figure 28 B). When micromass of FR fibroblast cells alone were wounded, they 
Rhodamine filter
(550 nm-580 nm)
FITC filter
(494 nm-518 nm)
DiI labeled 
FR 3T3 cells
(Red)
1 part DiI labeled FR 
3T3 cells + 
1 part  DiO labeled 
L8 myoblast
1 part DiI labeled FR 
3T3 cells + 
2 part  DiO labeled 
L8 myoblast
1 part DiI labeled FR 
3T3 cells + 
3 part  DiO labeled 
L8 myoblast
DiO labeled
 L8 myoblast
(Green)
FIGURE 27
Figure 27. Micromass and micromass co-culture of FR 3T3 fibroblast cells and L8 myoblast cells. Images shown here  of 1 day 
micromass spot cultures, with FR 3T3 fibroblast cells (Red) and L8 myoblast cells (Green) labeled with DiI and DiO lipophilic tracer dyes 
respectively. The DiI labeled FR 3T3 cells were detected using standard Rhodamine optical filter (550 nm-580 nm) while DiO labeled L8 
cells were detected using Fluorescein optical filter (494 nm-518 nm) separately.  Rhodamine filter was highly specific in detecting  DiI 
labeled cells while  FITC  filter was highly specific  in detecting  DiO labeled  cells.
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FIGURE  28
Figure 28. Determination of the relative seeding ratio of FR 3T3 fibroblast and L8 myoblast cells 
that could best withstand a scrape wound manipulation. (A) Shows fluorescence microscopy im-
ages taken from 3 day post-wounded micromass cultures and corresponding un-wounded micromass 
cultures. The FR fibroblast cells were labelled with DiI (red) fluorescent tracer dye, and L8 myoblasts 
were labelled with DiO (green). The FR and L8 cells were then combined in varying relative proportions 
(1:0, 1:1, 1:2, 1:3, 0:1). Micromass cultures seeded at a 1:3 ratio of FR fibroblast: L8 myoblasts best 
withstood a laceration or scrape wound injury without detaching from the culture dish. (B)  Micromass 
cultures at 4 day and 8 day post wounding were stained with picrosirius red to show the overall mor-
phology after prolonged culture. The 1FR:3L8 micromass co-cultures seem to better withstand wound 
manipulation and can be used for prolonged analysis of the wound site as compared to 1FR:1L8, 1FR: 
2L8, FR and L8 micromass cultures alone. The 8 day post wounded L8 micromass culture appeared to 
curl up into two halves and eventually detach from culture plates, while the 8 day post wounded FR mi-
cromass culture disintegrated and detached from the culture plates completely. Scale represents 500  mm.
4 day 
post-wounded
8 day 
post-wounded
B
FR fibroblast 
micromass culture
1 part FR : 1 part L8 
myoblast micromass 
co-culture
1 part FR : 2 part L8 
myoblast micromass 
co-culture
1 part FR : 3 part L8 
myoblast micromass 
co-culture
L8 myoblast 
micromass culture
Unwounded
3 day 
post-wounded
A
150
 151 
began to detach from the plate within 2 days post-wounding, with each half of the culture 
usually curling up into a ball-like mass by 4 days post-wounding (Figure 28 A and 28 B).  
When micromass cultures of L8 myoblast cells alone were wounded, they remained 
attached during the initial 3 days post wounding. However, by 8-days post wounding the 
two halves of the L8 myoblast micromass culture would contract and then detach from 
the culture dish (Figure 28 B).  
Micromass co-cultures prepared from 1:1 and 1:2 ratios of FR: L8 cells also 
exhibited significant contraction of the two halves of the wounded micromass tissue 
layer. By 3 days post-wounding, the 1:1 and 1:2 micromass co-cultures had developed 
jagged wound edges (Figure 28 A and 28 B) and after prolonged incubation beyond 4 
days, they too tended to curl up and detach from the culture dishes. In contrast, 
micromass cultures prepared from a 1:3 ratio of FR fibroblast relative to L8 myoblast 
cells were able to withstand the wound manipulation without detachment of the tissue 
layer from the culture dish even after prolonged culture beyond 8 days post wounding 
(Figure 28 A and 28 B).  There was clear demarcation of the wound edges, permitting 
more uniform control of the wound width, which was important for subsequent analysis 
of the wound healing process (Figure 28 B). 
 
4.4.1.1.2 Microtissue formation and the 3-D nature of the micromass co-culture of 1 
part rat FR fibroblast cells and 3 part L8 myoblast cells. 
  
Scanning electron micrography (SEM) was performed on both intact and 
wounded micromass co-cultures (1: 3 ratio of FR fibroblast and L8 myoblast cells) to 
reveal the general morphology and topographic organization of the resulting microtissue 
(Figures 29 and 30). SEM images of the surface of an intact micromass co-culture taken 
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at 500X magnification suggest the integration of both FR and L8 cells into a microtissue-
like structure in vitro (Figure 29 B). It is difficult to distinguish individual cell 
boundaries because of the intermingling and close contacts of the cells comprising the 
microtissue, though some rounded presumably dividing cells were visible on the surface. 
A transverse section of the intact micromass co-culture revealed the multilayer three-
dimensional organization of the microtissue in vitro (Figure 29 C). 
SEM images of 1:3 micromass co-cultures at 5 min post wounding confirm the 3-
D morphology of the microtissue and the absence of cell debris at the wound site (Figure 
30 A, 30 B). At higher magnification (200X- 500X), the wound edges revealed several 
rounded cells suggesting changes in cell morphology following wounding (Figure 30 B 
and 30 C). SEM image from the 8 day post-wounded micromass culture that was 
transversely cut across the closed wound gap suggests that the wound site is comprised of 
compacted cells and extracellular matrix components (Figure 30 F).  
Histochemical staining with picrosirius red and alcian blue (pH 2.5) revealed the 
presence of extracellular matrix collagens and polysaccharides respectively, in the 
unwounded and wounded micromass co-cultures. Unwounded micromass co-cultures of 
1 part FR fibroblast and 3 parts L8 myoblast cells revealed more intense staining for 
picrosirius red positive collagen fibrils as compared to Alcian blue (pH 2.5) stainable 
polysaccharides (Figure 31 A, 31 B). These findings suggest that the micromass tissue 
structure is formed in its natural biomatrix, which comprise of collagen and extracellular 
matrix polysaccharides. Micromass co-cultures (1:3 FR to L8 cells) at 4 days post 
wounding also showed the deposition of picrosirius red stainable collagen fibrils within 
the wound and wound edges of the injury site (Figure 31 C, 31 E), while less intense 
staining for Alcian blue (pH 2.5) positive polysaccharide at the wound region (Figure 31  
FIGURE 29
10 mm
B
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10 mm
Figure 29. Scanning electron micrographs of an intact micromass co-culture seeded at a 1:3 ratio 
of FR fibroblast to L8 myoblast cells. All images were taken from 2 day unwounded micromass cul-
tures. (A) An image photographed at 60X magnification shows the outline of an unwounded micromass 
co-culture in the culture plate. (B) shows a higher magnification image (500 X)  of the region marked 
with a rectangle in Panel A. The topography of the upper surface of the micromass tissue layer is ap-
parent.  (C) the transverse section of the  micromass as observed at 1000 X magnification confirms that 
the micromass co-culture system developed is indeed a multilayer three dimensional model system. 
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Figure 30. Scanning electron micrographs (SEM) of micromass co-cultures ( 1FR: 3L8) at 5 minutes and 8 days after infliction 
of a scrape wound.  (A) shows the image of a micromass cultures at 5 min post-wounding. The two wound edges are clearly visible 
at 60X magnification. The region indicated by the rectangular insert is shown at higher magnification (500 X)  in Panel B below. (B) 
As seen in the micrographs, a high number of rounded cells were visible at the wound edges following wounding. (C) A SEM of the 
wound edge in a 5 min post wounded culture taken at 500 X magnification and at 75 degree angle clearly showing the 3-D nature of the 
micromass culture. (D) A SEM image of an 8 day post wounded micromass co-culture taken at 60X magnification showing the region 
of wound closure in the micromass cultures. The area indicated by the rectangular insert is shown at higher magnification (500 X) in 
Panel E below. (F) a transverse section made perpendicular across the wounded region of the 8 day post wounded culture, taken at 1000 
X magnification, and at 75 degree angle shows compaction of the cells within extracellular matrix components.
FIGURE 30
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FIGURE 31
Figure 31. Picrosirius red and Alcian blue (pH 2.5) staining of 4 day wounded and un-
wounded micromass co-cultures of  1 part FR 3T3 and 3 part L8 myoblast cells. (A, C, 
E) shows picrosirius red stainable collagen fibrils while (B, D, F) shows acidic alcian blue 
(pH 2.5) stainable polysaccharides in the micromass co-cultures. Higher magnification im-
ages of 4 day post-wounded cultures shows strong sirius red stainable collagen fibrils at the 
wound site and intense staining of alcian blue (pH 2.5) stainable extracellular matrix at the 
wound edges and weak staining at the wound site. Scale represents 500 microns.
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D and 31 F). In situ immunostaining was performed to examine the localization of two 
extracellular matrix proteins, type I collagen and fibronectin, in the (1:3) FR: L8 cell 
micromass co-cultures (Figure 32). Intense violet purple staining of type I collagen was 
observed throughout the wounded micromass culture and there was a progressive 
increase in type I collagen accumulation within the wound gap between 2 and 8 days post 
wounding. 
Similarly, immunostaining of fibronectin protein confirmed its presence 
throughout the wounded micromass cultures. Progressive accumulation of fibronectin 
with the wound gap seemed to correlate with that of type I collagen at 2, 4, and 8 days 
post-wounding (Figure 32). However, immunostaining for fibronectin was considerably 
weaker than for type I collagen (see Figure 32 legend), which suggests that fibronectin 
was expressed at lower levels relative to type I collagen.  
Total DNA accumulation in micromass co-cultures over an 8-day period of 
incubation was determined by a fluorometric Hoechst assay. The rise in total cellular 
DNA levels serves as an indirect measure of cell proliferation in the micromass cultures.  
Both unwounded and wounded cultures showed a progressive increase in total DNA 
levels between 1 h and 4 days of culture.  The rise in total DNA was most steep between 
1 day and 4 days, suggesting that there is a rapid cell proliferation at these time points 
(Figure 33). Wounded micromass cultures exhibited significantly lower total DNA levels 
as compared to the corresponding unwounded cultures at 5 min, 1 hr, 1 day and 3 days 
post wounding. The lower total DNA level in the wounded cultures is likely due to the 
initial loss of cells from the wound infliction. However by 4-8 days post wounding, the 
total DNA levels had reached a plateau and were not significantly different in wounded  
 
5 min post wound
(Base time)
2 day post wound
4 day post wound
8 day post wound
Anti-collagen type I (a 1) Anti-fibronectin
FIGURE 32
Figure 32. Localization pattern of type I collagen and fibronectin in the wounded micromass co-
culture of 1 part FR 3T3 fibroblast cells and 3 part L8 myoblast cells. Using AP-conjugated im-
munostaining, the localized expression pattern of type I collagen and fibronectin was detected. type I 
collagen was expressed throughout the micromass cultures, collagen fibres were visible at the wound 
site after 2 day post wounding with gradual increase in collagen fibres visible after 4 day and 8 day 
post wounding. Fibronectin was expressed at lower levels than type I collagen with localized expres-
sion at the wound site visible after 2 day post wounding. The time taken for the colour reaction for 
type I collagen staining was 20-25 minutes as compared to 3 hours for fibronectin staining. Fibro-
nectin localization seem to correlate with type I collagen proteins in the wounded micromass cultures
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and unwounded cultures (Figure 33). This suggests that the micromass co-cultures had 
no further net increase in cell proliferation occurring beyond the 4-day time point. 
In order to determine the metabolic activity of both wounded and unwounded 
micromass co-cultures, an MTT assay was performed on the micromass cultures at 
different time points (Figure 34). The MTT assay measures the mitochondrial activity of 
the cells by determining their ability of the cells to convert soluble MTT into reduced 
formazan precipitate, which can be quantified by absorbance readings at 560 nm.  It was 
observed that unwounded micromass co-cultures remained metabolically active even 
beyond 8 days of incubation (Figure 34).  
The reduced MTT values for wounded cultures were significantly lower at 5 min, 
1 day and 2 days post wounding than the corresponding unwounded cultures. This could 
be attributed to the disruption of the microtissue structure immediately after wounding 
and the initial loss of cells from the site of scrape wound infliction. However by 3-8 day 
time points, the reduced MTT values for wounded cultures had recovered to a level 
approximately equivalent to that of unwounded cultures. Thus the wounded micromass 
co-cultures remained metabolically active even after 8 day post wounding.   
 
4.4.1.1.3 Optimization of the tissue culture media for high-density micromass co-
culture of 1 part FR 3T3 cells and 3 part L8 myoblast cells. 
 
To determine the best culture medium for growing 1: 3 micromass co-cultures of 
FR fibroblast: L8 myoblast cells, unwounded cultures were grown in either “L8 medium” 
consisting of Dulbecco’s modified Eagle’s medium-Nutrient mixture/ HAM F12 
supplemented with 10% FBS and antibiotics or “FR medium” consisting of Minimum 
Essential Medium supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM non-  
FIGURE 33
Figure 33. Total DNA levels of wounded and corresponding unwounded micromass co-
cultures of 1 part FR 3T3 fibroblast and 3 part L8 myoblast cells. Using DNA Hoechst
assay, the total DNA levels were determined for both wounded and corresponding
unwounded micromass co-cultures at each time point. The data points represent Mean ± SD
(n =6). * indicates value significantly different as compared to control at p< 0.05 while **
indicates p value is < 0.01.
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FIGURE 34
Figure 34. Metabolic activity of wounded and corresponding unwounded micromass co-
cultures of 1 part FR 3T3 fibroblast and 3 part L8 myoblast cells. Using the MTT assay,
the metabolic activity was determined by taking the absorbance reading of the reduced MTT
levels in both wounded and corresponding unwounded micromass co-cultures at each time
point. It was observed that both unwounded and wounded cultures were metabolically active.
The data points represent Mean ± SD (n =6). * indicates value significantly different as
compared to control at p< 0.05 while ** indicates p value is < 0.01.
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essential amino acids and antibiotics. In addition, the effects of medium supplementation 
with ascorbate (100 ng/mL) were tested. Ascorbic acid is known to stimulate collagen 
synthesis and cell proliferation in fibroblast cells, although for certain other cell types 
ascorbate supplementation may be toxic. The effects of medium composition on cell 
viability and metabolic activity of unwounded micromass co-cultures were assessed using 
MTT and Hoechst DNA assays, after growing all cultures for 4 days. For the sake of 
comparison, these experiments were also performed on micromass cultures composed of 
either FR 3T3 fibroblast or L8 myoblast cells alone. 
Micromass cultures composed of L8 myoblast cells alone, FR 3T3 fibroblast cells 
alone, and micromass co-cultures of 1 part FR 3T3 and 3 parts L8 myoblast cells were 
propagated in either L8 or FR medium in the presence or absence of 100 ng/mL 
ascorbate. Micromass cultures composed of FR 3T3 fibroblasts alone were observed to 
have highest total cellular DNA accumulation and metabolic activity when cultured in 
either FR or L8 medium. Addition of 100 ng/mL ascorbate to these medium resulted in 
reduced cell viability and MTT values (Figure 35 A and 35 B, p < 0.01 considered 
significant, n = 4).   
 Similarly, L8 myoblast micromass cultures grown in L8 medium were observed 
to have significantly higher DNA values and metabolic activity, as compared to L8 
myoblast micromass cultures grown in media supplemented with 100 ng/mL ascorbate 
(Figure 35 A and 35 B, p < 0.01 considered significant, n = 4).  
Micromass co-cultures seeded at 1: 3 ratio of FR fibroblast: L8 myoblast cells 
exhibited significantly higher metabolic activity when grown in L8 medium alone as 
compared FR medium alone (Figure 35 A and 35 B, p < 0.01 considered significant, n = 
4).  Ascorbate supplementation had no positive or negative effect on either total cellular 
Figure 35. Optimization of the propagation media that were used for all cell culture
experiments involving micromass cultures. (A) MTT assay was performed on the cultures to
show the metabolic activity of the different micromass cultures grown in different media for a
period of 4 days. The absorbance reading of reduced MTT at 550 nm represent relative metabolic
activity (B) shows cell viability of the different micromass cultures grown for 4 days in different
media as represented by the total DNA levels determined by DNA Hoechst assay. Based on the
observations made, the reduced MTT values (metabolic activity) and total DNA levels (cell
viability) suggest that L8 medium to be preferred medium for culturing 1FR 3T3 fibroblast : 3 L8
myoblast micromass cultures ( Mean ± SD, ** suggest statistical significance at p value < 0.05
compared to corresponding cultures grown in FR medium along. Kruskal Wallis non-parametric
One way ANOVA, n =4).
FIGURE 35
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DNA accumulation or MTT values. It was also observed that ascorbate supplementation 
did not alter levels of collagen accumulation in these cultures as determined by 
picrosirius red staining (data not shown). 
To test soluble factors released by L8 myoblast cells into the medium might 
promote better cell proliferation of fibroblast cells within 1:3 micromass co-cultures, the 
cultures were grown in FR medium supplemented with 0.1 % L8 cell conditioned 
medium. The L8 cell conditioned medium was prepared by growing L8 myoblast cells in 
L8 medium for a period of 2 days to condition the medium, after which the conditioned 
medium was removed and sterile filtered. 
Micromass co-cultures that were grown in FR medium supplemented with 0.1% 
L8 cell conditioned medium showed no improvement in DNA accumulation or MTT 
values as compared to cultures grown in standard FR medium or L8 medium (Figure 35 
A, 35 B).  When micromass cultures of FR fibroblast cells alone were grown in FR 
medium supplemented with 0.1% L8 cell conditioned medium, no change in DNA 
accumulation or MTT values was observed as compared to cultures grown in standard FR 
medium or L8 medium (Figure 35 A, 35 B). The wounded micromass co-cultures grown 
in either L8 or FR media, also resulted in similar culture growth profile as was observed 
in unwounded micromass co-culture. Overall, these findings suggested that L8 medium 
alone provided optimum growth conditions for the 1:3 FR fibroblast and L8 myoblast 
micromass co-cultures. Hence, L8 medium was used for propagating micromass co-
cultures in all the subsequent in vitro “micromass” wound-healing experiments. 
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4.4.1.1.4 Muscle specific protein expression pattern in unwounded and wounded 1:3 
fibroblast and L8 myoblast micromass co-cultures. 
 
Western blot analysis was performed to determine how micromass co-culture 
conditions affected the expression patterns of several myogenic and non-myogenic 
proteins by the FR fibroblast and L8 myoblast cells. We examined the expression of the 
myogenic transcription factors, MyoD and myogenin, which are early stage myoblast 
markers, as well as expression of MyHC and tropomyosin, which are markers of 
differentiated skeletal muscle fibers. We also analyzed expression of -smooth muscle 
actin (-sma), a biomarker expressed by fibroblast cells and the extracellular matrix 
protein, osteopontin (OPN).  Both -sma and OPN play critical roles in tissue 
remodeling, and initiating myogenic differentiation during later stages of skeletal muscle 
repair (Uaesoontrachoon et al., 2008).  
Western blot analysis was performed on lysates prepared from 3 day micromass 
cultures composed of either L8 myoblast cells or FR fibroblast cells alone, as well as 
lysates from 1:3 micromass co-cultures of FR fibroblasts and L8 myoblasts.  
Micromass cultures composed of FR fibroblast cells alone expressed only -sma (Figure 
36). Micromass cultures composed of L8 myoblast cells alone expressed low levels of the 
early myoblast marker, MyoD, along with high levels of MyHC, and faintly detectable 
levels of tropomyosin (Figure 36). These cultures also expressed OPN but not -sma. 
This expression pattern indicates that L8 myoblast cells cultured alone under micromass 
conditions express markers of differentiated skeletal muscle fibres.  
In contrast, when the L8 myoblast cells were co-cultured together with FR 
fibroblast cells under micromass conditions only MyoD and -sma expression were 
detectable (Figure 36). Accordingly, the presence of fibroblast cells suppresses the  
FIGURE 36
Figure 36. Expression pattern of muscle specific proteins and fibroblast spe-
cific protein (a-smooth muscle actin) in 1:3 ratio of FR fibroblast and L8 myo-
blast cells. All the micromass cultures were grown for a period of 3 days before 
homogenizing the cultures and the equal protein concentration were used for west-
ern blotting. It was observed that L8 myoblast micromass culture homogenates 
expressed all muscle specific proteins except myogenin while FR fibroblast mi-
cromass culture expressed only a-sma. The 1:3 ratio of fibroblast and L8 myo-
blast cell micromass co-culture showed bands for MyoD and a-sma proteins.
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Figure  37. Determination of the effect of wounding on the expression of muscle specific proteins and osteopontin in 
the wounded 1:3 ratio of fibroblast and myoblast micromass co-culture. Using AP conjugated immunostaining, expres-
sion of (B) MyoD, (C) myogenin, (D) MyHC and (E) osteopontin was determined for 8 day post wounded micromass co-
cultures. It was observed that MyoD protein was expressed within the micromass cultures and it was localized throughout 
the micromass while myogenin protein were expressed at very low levels as compared to MyoD proteins. No expression of 
Osteopontin and MyHC was observed in the wounded micromass cultures. The time taken for the colour reaction for MyoD 
staining was 1 h as compared to 24 h for the myogenin staining.
FIGURE 37
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expression of MyHC and tropomyosin proteins by L8 myoblast cells in micromass 
culture, and it also suppressed OPN expression. Collectively, these results suggest that L8 
myoblast cell interaction with fibroblasts in micromass co-culture encourage the 
myoblast to retain an early stage myogenic phenotype and their differentiation into 
skeletal muscle fibres is suppressed. 
In order to examine whether the expression of myogenic proteins might change 
following wounding of the micromass co-culture, I performed in situ immunostaining on 
FR fibroblast: L8 myoblast micromass co-cultures at 8 days post-wounding. MyoD 
expression was detectable by immunostaining (Figure 37), which was consistent with 
western blots of 8 day post wounded cultures (data not shown). Immunostaining also 
showed very low levels of myogenin protein in FR: L8 micromass co-cultures (Figure 
37), although myogenin was not detected by western blotting (data not shown). Myosin 
heavy chain (MyHC) and osteopontin were absent in the wounded culture (Figure 37), 
suggesting that wounding did not induce differentiation of myoblast cells into myofibres 
in vitro. 
 
4.4.1.1.5 Specific gene expression profiling in both unwounded and wounded 
micromass co-cultures of 1 part FR 3T3 fibroblast cells and 3 part L8 
myoblast cells. 
 
Semi-quantitative RT-PCR was used to examine the gene expression profiles of 
Collagen type 1(2), Collagen type 3 (1), Collagen type 4 (1), TGF-1, TGF-3, 
hyaluronan receptors RHAMM and CD 44, hyaluronan synthases 1 and 3 (HAS 1, HAS 
3), hsp-47 and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as these genes 
have been implicated in wound repair and scarring processes.  
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Preliminary experiments established the appropriate number of amplification 
cycles for each specific gene transcript to ensure that reactions were terminated during 
the exponential phase of PCR (see Section 3.2.9.2 and Figure 38 legend). Based on 
amplicon bands, GAPDH, HAS 1, hsp-47, CD 44, TGF-3, HAS 3 transcripts required 
lesser number of cycles and hence their transcript levels were abundant in both wounded 
and unwounded micromass co-cultures as compared to TGF-1, Collagen type 3 (1), 
Collagen type 4 (1), RHAMM and Collagen type 1 (2), transcripts (Figure 38).  
Using NIH Image J software, the relative expression levels of Collagen type 1 (2), 
Collagen type 3 (1), Collagen type 4 (1), TGF-1, TGF-3, RHAMM, CD 44, HAS 1, 
HAS 3, hsp-47 at all time points for the unwounded micromass co-cultures was 
determined by densiometric measurement of the band intensities for these gene of 
interests and normalized against the corresponding GAPDH band intensity at that same 
time point (Figure 39 A). It was observed that the overall relative expression of TGF-3, 
HAS 1, hsp-47 and collagen type 1( 2) gene transcripts in unwounded cultures were 
higher as compared to TGF-1, RHAMM, CD 44, collagen type 4 (1) and collagen type 
3 (1).  The expression of TGF-3, TGF-1, CD 44, HAS 3, hsp-47, collagen type 4 
(1), collagen type 3 (1) and collagen type 1 (2) were highest in unwounded cultures 
at 4 day time points as compared to other time points (1d, 2 d and 8d) (Figure 39 A). 
To examine changes in the gene transcript levels following wounding, I compared 
the relative expression levels of collagen type 1 ( 2), collagen type 3 (1), collagen type 
4 (1), TGF-1, TGF-3, RHAMM, CD 44, HAS 1, HAS 3, hsp-47 in wounded cultures 
(Figure 39 B) with corresponding unwounded micromass cultures (Figure 39 A). It was 
observed that the expression of TGF-1, TGF-3, HAS 1 and hsp-47 were significantly  
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Figure 38. RT-PCR DNA gels showing relative band intensities for Collagen type 1(a2), Col-
lagen type 3(a1) and Collagen type 4(a1) Hyaluronan synthase 1, Hyaluronan synthase 2, Hy-
aluronan synthase 3, Receptor for hyaluronan-mediated motility (RHAMM), CD 44, Trans-
forming growth factor b-1, Transforming growth factor b-3, heat shock protein 47 (hsp-47) 
and Glyceraldehyde –3-phosphate dehydrogenase (GAPDH). cDNA obtained from 1 day, 2 day, 
4 day and 8 day post-wounded cultures and their corresponding unwounded cultures were used to 
run PCR. The Primer sequences used for the specific genes of interests and the number of cycles 
chosen to be the exponential phase of PCR amplification for each of the genes of interest were de-
termined to be 23 cycles for GAPDH, 32 cycles for HAS-1, hsp47, CD44; 35 cycles for TGF-b3; 
40 cycles for HAS-3, 45 cycles for TGF-b 1 and Collagen type 3(a1); 50 cycles for RHAMM and 
Collagen type 4(a1);.55 cycles for Collagen type 1(a2). The PCR products obtained were seperated 
on 1.5% agarose gel and stained with ethidium bromide and photographed under UV illumination. 
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Figure 39. Gene expression profile of various genes implicated in tissue repair and
regeneration. The bar graph represents densiometric measurements of the relative band
intensities obtained from the DNA gel shown in previous figure using NIH Image J
software. The band intensities for the genes of interest were normalized with
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (A) Shows the relative
expression levels of the genes of interest in the intact micromass co-cultures of 1 part
FR 3T3 and 3 part L8 myoblast cells. (B) shows the relative expression levels of the
genes of interest in the wounded micromass co-cultures. All values are expressed in
Mean ± SD and n = 4.
A
B
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higher in 2 day post-wounded cultures as compared to corresponding unwounded cultures 
(Figure 39 A and 39 B, p < 0.001, n = 4). In 2 day post wounded cultures, the expression 
levels of collagen type 3 ( 1) were lower as compared to corresponding unwounded 
cultures (Figure 39 A and 39 B, p < 0.001, n =4). There was no change in the relative 
expression of RHAMM, CD 44, HAS 3, collagen type 4 ( 1) and collagen type 1 ( 2) 
at the 2-day time point. In contrast, the relative expression levels of RHAMM, CD 44, 
HAS 3, HAS 1 levels were significantly lower in 4 day and 8 day post wounded cultures 
(Figure 39 B, p < 0.001, n = 4) as compared to corresponding unwounded cultures 
(Figure 39 B, p < 0.0001, n = 4). TGF-3 showed no increase or decrease in gene 
transcript levels at 4 day and 8 day time-points for wounded versus unwounded cultures. 
Based on the overall gene expression profiles of RHAMM, CD 44, HAS 1, HAS 
3, hsp-47, collagen type 1 ( 2), collagen type 3 (1), and collagen type 4 (1) it appears 
that a majority of changes in gene transcript levels occurred between the 2 d and 4 d time 
points, when a large percentage of the wound gap in the wounded micromass co-culture 
is repopulated by cells and the integrity of the micromass co-culture is partially restored 
(see Figure 40). Hence, these time points were chosen for subsequent RT-PCR analyses, 
which examined the effects of OTC, and quercetin treatments on the expression of these 
gene transcripts during micromass tissue repair.  
 
4.4.1.1.6 Determination of the rate of wound closure in the micromass co-culture model 
and the effect of cell proliferation on in vitro wound repair. 
  
Experiments were performed to determine the rate of wound closure in 1:3 
micromass co-cultures of FR fibroblasts and L8 myoblasts. Following a scrape wound 
injury, observations were made at the wound region using phase contrast microscopy in 
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real time. When the micromass co-cultures were grown over a period of 8 days following 
wounding, there was a progressive increase in the number of cells occupying the wound 
region (Figure 40). The cells gradually started infiltrating the wound region from 1 day 
post-wounding.  
By 8 days after wounding, cells covered almost the entire region of the wound 
although a few cell-free areas were occasionally visible at the wound site (Figure 40). 
The progression of wound closure in the micromass co-culture was quantified as 
described in Section 3.2.11, by measuring the reduction in the surface area of the wound 
that was unoccupied by cells over time (Figure 41). 
I wished to determine whether wound closure in the micromass co-culture was 
primarily dependent on cell proliferation or cell migration. To inhibit cell proliferation, 
micromass co-cultures were pretreated with 10 g/mL mitomycin for 1 hour, then a 
scrape wound was inflicted and mitomycin treatment was continued for an additional 72 
hours after wounding. Phase contrast images of the same culture were captured over an 8-
day period.  When cell proliferation was inhibited by mitomycin treatment, there was a 
striking reduction in the number of cells that entered the wound site as compared to 
parallel untreated control cultures (Figure 40). Quantitative planimetry analysis 
confirmed that there was a significant inhibition of wound closure in mitomycin treated 
cultures relative to controls (Figure 41, p < 0.01, n = 6). Indeed, even after 9 days of 
culture there was only a slight decrease in total surface area of the wound region. Our 
findings suggest that a wound closure assay based on planimetric image analysis could be 
reliably used to quantify the effects of wound modulating molecules, in this newly  
Figure 40. Wound closure as function of time in micromass co-culture of 1 part FR 
fibroblast cells and 3 part L8 myoblast cells. Micromass cultures were subjected to scrape 
wound injury and then cultured in presence and absence of 10 mg/mL mitomycin, an inhibi-
tor of cell proliferation. The five photographs in each vertical rows are phase contrast im-
ages of the same culture at successive time point after wounding. Using the phase contrast 
light microscopy, the time taken for wound closure was determined. As seen from the phase 
contrast images, the wound site seem to be covered by cells within 4 days after wounding. 
When the wounded micromass cultures were treated with 10 mg/mL mitomycin, the wound 
closure was considerably delayed and the wound was  not covered by the  cell even after 8 
day post wounding. Scale represents 500 microns
FIGURE 40
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FIGURE 41
Figure 41. Effect of cell proliferation on the wound closure in the
wounded micromass co-culture of 1 part FR 3T3 fibroblast and 3 part L8
myoblast cells. Using phase contrast microscopy, the total wound area
unoccupied by cells as function of time was determined using planimetric
image analysis method. The rate of in vitro wound closure was compared in
the presence and absence of mitomycin, an inhibitor of cell proliferation and
thus delay wound closure. It was observed that cell proliferation is essential for
proper wound closure and integrity of the wounded micromass cultures. A total
of 6 replicate cultures were tested and all cultures were grown continuously
and the wound closure in each culture was analyzed on real time using phase
contrast microscopy ( Mean ± SD, ** indicates significant difference at p value
< 0.01 using Kruskal Wallis non parametric One way ANOVA).
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developed in vitro wound repair model. Hence, in subsequent experiments this assay was 
employed to determine the effects of drugs on wound closure as function of time. 
4.4.1.1.7 Studies on the migratory pattern of rat skeletal L8 myoblast cells and rat 
fibroblast FR cells in wounded micromass co-cultures. 
 
To examine the migratory patterns of the myoblast cells and fibroblast cells in 
wounded micromass co-cultures, in some experiments the FR cells and L8 cells were 
differentially labeled with fluorescent lipophilic tracer dyes DiI and DiO just prior to 
plating the micromass layer. The distribution of tracer dye labeled fibroblast and 
myoblast cells was examined in 3 day post wounded cultures and parallel unwounded 
cultures by fluorescence microscopy at 5X magnification. Both fibroblast and myoblast 
cells appeared to be uniformly distributed through the tissue layer in unwounded 
micromass cultures (Figure 42 A, 42 B, 42 E and 42 F). Wounded cultures showed the 
greatest concentrations of labeled fibroblast cells at the wound edges (Figure 42 D and 
42 H), whereas labeled myoblast cells appeared to be more evenly distributed throughout 
the micromass tissue layer (Figure 42 C and 42 G). These findings suggest the 
possibility of preferential migration of fibroblast cells to the micromass wound edges.  
To further confirm this finding, image analysis was performed to measure the 
relative fluorescence intensities of DiI labeled FR fibroblast cells (red) and DiO labeled 
L8 myoblast cells (green) present at the wound site (including the wound edges and a part 
of the wound gap) as compared to the periphery of the micromass co-culture (as shown in 
Figure 8). The DiI and DiO positive cells were identified using the deconvolution 
function of the NIH Image J software and quantitative image analysis was performed at 1 
day, 3 days and 8 days post-wounding. At the wound site, there was a progressive time 
dependent increase in the fluorescence intensity of DiI labeled FR fibroblast cells 
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between 1 and 8 days after wounding, while DiO labeled L8 myoblast cells showed a 
more modest increase in fluorescence intensity (Figure 43 A). Accordingly, the 
fluorescence intensity of DiI labeled FR fibroblast cells was significantly higher than the 
fluorescence intensity of DiO labeled L8 myoblast cells at the wound site at 3 and 8 days 
after wounding (Figure 43 A, p < 0.01, n = 4). These observations are consistent with a 
preferential migration of FR fibroblast cells to the wound edges and possibly to the 
wound gap.  
To examine the presence of labeled cells within the wound gap itself, both 3 day 
and 4 day post-wounded micromass cultures were examined at higher magnification 
(20X), under phase contrast and fluorescence illumination. The fluorescence images were 
captured using a CCD camera with extended shutter exposure times (Figure 44). 
Although phase contrast images confirmed that the wound gap was filled with cells by 3 
– 4 days post wounding, there were surprisingly few DiO labeled (green) L8 myoblast 
cells and DiI labeled  (red) fibroblast cells visible within the wound gap (Figure 44). The 
low number of DiI and DiO positive cells detectable within the wound gap is likely due 
to the ongoing proliferation of cells that migrate into this region, which would 
progressively dilute the concentration of the tracer dye within individual daughter cells. 
Despite the limitations of conventional fluorescence microscopy in determining 
fluorescent labeled cells within a 3-D micromass tissue layer, this study suggests a novel 
approach for using lipophilic dyes and fluorescence microscopy to track the distribution 
pattern of two different cell types within a 3-D in vitro co-culture system. 
 
 
 
 
 
Figure 42. Distribution and localization of FR fibroblast and L8 myoblast cells in the 3 
day post-wounded 1: 3 ratio of FR fibroblast and L8 myoblast cell micromass co-cultures 
and corresponding unwounded cultures. (A, B, C, D) shows images that were taken at 5 X 
magnification showing the distribution of  DiI labeled L8 myoblast cells and DiO labeled FR 
fibroblast in both unwounded and wounded micromass co-cultures, while (E, F, G, H) shows 
images taken at low magnification for DiO labeled L8 myoblast cells and DiI labeled FR fi-
broblast cells. Localization and distribution pattern of both DiI and DiO- labeled FR fibroblast 
cells (D. H)  in the 3 day post wounded micromass cultures at the wound edges suggest possible 
preferential migration of the fibroblast cells towards the wound site. Scale represent 100 mm.
FIGURE 42
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Figure 43. Quantitative analysis of fluorescence intensities of DiI labeled FR fibroblast cell and DiO labeled L8
myoblast cells at wounded region and peripheral regions of micromass co-culture. The relative fluorescence
intensities of DiI labeled FR 3T3 cells (red) and DiO labeled L8 myoblast cells (green) at the wound and peripheral
regions of the 1 day, 3 day and 8 day post wounded micromass co-cultures were determined. (A) shows relative
fluorescence intensities of DiI labeled FR cells (red) were found to be significantly higher at the wound region wound
sites as compared to the DiO labeled L8 myoblast cells, while (B) suggests that the relative fluorescence intensities of
DiO labeled L8 myoblast cells were found to be at significantly higher at the periphery of the micromass cultures as
compared to DiI labeled FR cells. (Mean ± SD, ** indicates significant difference at p < 0.05, n = 4).
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FIGURE 44
Figure 44. Presence of DiI labeled FR 3T3 fibroblast cells and DiO labeled L8 myoblast cells at the wound gap and wound 
edges.  Images of the wound site (wound gap and wound edges) were taken at  20 X magnification for both 3 day and 4 day 
post wounded micromass co-cultures, Phase contrast images shows that the wound gap was completely filled with cells. When 
the same wound region was visualized under fluorescent microscopy using FITC and Rhodamine filters, a few DiO labeled L8 
myoblast cells (Green) and DiI labeled FR 3T3 fibroblast cells (Red) were visible at the wound gap. 
179
DiO labeled 
L8 myoblast cells
(Green)
Dual color
(Merged)
DiI labeled 
FR 3T3 cells
(Red)
Phase contrast images
3 day 
post wounding
4 day 
post wounding
 180 
4.4.1.1.7.1 Effects of exogenous TGF-1 treatment on skeletal myoblast cells and 
fibroblast cells in wounded micromass co-cultures of 1:3 FR fibroblast 
and L8 myoblast cells 
 
 
TGF-1 is a pro-fibrotic cytokine that promotes the synthesis and deposition of 
collagens and other extracellular matrix proteins that are important for wound closure. 
TGF-1 treatment also promotes fibroblast proliferation both in vivo and in vitro. In 
myogenic cells, exogenous TGF-1 has been shown to inhibit myoblast fusion, 
differentiation, and expression of muscle-specific proteins.  
I wished to determine whether TGF-1 treatment could affect cell proliferation 
and collagen biosynthesis within micromass co-cultures of 1:3 FR fibroblast and L8 
myoblast cells. The cultures were incubated in the presence of TGF-1 (0.1-0.8 ng/mL 
final concentration) for a period of 2 days. Total collagen deposition in the micromass co-
cultures was determined by picrosirius red staining as described in Section 3.2.6.1, while 
total cellular DNA was determined by flurometric Hoechst assay (Section 3.2.5). As 
shown in Figure 45 A, TGF-1 treatment resulted in a dose dependent decrease in both 
picrosirius red stainable collagen and total DNA accumulation in the micromass co-
cultures. These declines were statistically significant even at the lowest TGF-1 dose 
tested (0.1 ng/mL) (Figure 45 A, p < 0.01, n =16). When the collagen values were 
normalized against total DNA levels to correct for differences in cell number between the 
various treatment groups, I observed a decrease in total collagen accumulation per 
microgram DNA at all TGF-1 doses. However, the values were not significantly 
different from those of untreated control cultures (0 ng/mL). This indicates that the 
primary effect of TGF-1 treatment in fibroblast:myoblast co-cultures was to reduce cell 
proliferation and or cell viability rather than to affect average levels of collagen synthesis 
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per cell. It was also observed that exogenous TGF-1 concentrations of 0.2 ng/mL and 
higher caused the micromass co-cultures to curl up and detach from the culture plate after 
2 days of incubation (data not shown).  
To determine whether exogenous TGF-1 treatment had differential effects on 
fibroblasts and myoblast cells under micromass conditions, I treated cultures composed 
of FR fibroblast cells alone or L8 myoblasts alone with varying concentration of TGF-1 
(0- 0.8 ng/mL) for a period of 2 days. In micromass cultures of FR fibroblast cells alone, 
TGF-1 treatment caused a dose dependent increase in picrosirius red stainable collagen 
deposition and total DNA accumulation (Figure 46 A and 46 B). In addition, collagen 
accumulation per microgram DNA was modestly elevated in fibroblast cultures at 
concentrations of 0.4 - 0.8 ng/mL TGF-1. In contrast, when micromass cultures 
composed of L8 myoblasts alone were subjected to TGF-1 treatment there was a 
significant reduction in levels of total DNA and picrosirius stainable collagen at doses of 
0.2 ng/ml TGF-1 and higher (Figure 47 A and 47 B).  Collagen accumulation per 
microgram DNA was also significantly reduced. These findings suggest that in FR 
fibroblast: L8 myoblast co-cultures, exogenous TGF-1 treatment may promote FR 
fibroblast cell proliferation but inhibit the proliferation of myoblasts. The fact that L8 
myoblast cells represent the more abundant cell type in 1:3 fibroblast: myoblast co-
cultures is likely to account for the net reduction in total DNA when cultures are exposed 
to TGF-1. I also examined whether exogenous TGF-1 treatment affected the rate of 
wound closure in the micromass co-cultures of 1:3 FR fibroblast and L8 myoblast cells. 
The wounded micromass co-cultures were treated with 0.1 ng/mL TGF-1, because 
higher doses caused contraction and eventual detachment of the micromass layer as 
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mentioned previously. Phase contrast images demonstrated a progressive migration of 
cells into the wound gap starting from 1 to 8 days post-wounding in both TGF-1 treated 
and untreated control cultures and by 8 days the wound gap was almost completely filled 
with cells (Figure 48). Quantification of the wound closure rates by the planimetry 
method revealed that the presence of 0.1 ng/mL TGF-1 stimulated a statistically 
significant increase in the rate of wound closure at 1 day and 2 days post wounding as 
compared to wounded control cultures (Figure 49; p < 0.05, n =16).  However the final 
extent of wound closure in TGF-1 treated cultures was equivalent to wounded cultures 
at later time points (3 to 8 days post wounding) (Figure 49). 
In another experiment, FR fibroblasts and L8 myoblast cells were labeled with 
DiI and DiO lipophilic dyes respectively to determine whether TGF-1 treatment 
affected cell migration at the wound site in fibroblast:myoblast co-cultures. The cultures 
were imaged by fluorescence microscopy at time points of 1, 3 and 8 days post wounding 
(Figure 50), then NIH image analysis software was used to quantify changes in the 
fluorescence intensity of DiI labeled (red) FR fibroblast cells at the wound gap and 
wound edges as compared to DiO labeled (green) L8 myoblast cells. 
As shown in Figure 51 A, both TGF-1 treated cultures and untreated control 
cultures exhibited a progressive increase in the levels of DiI labeled fibroblast cells at the 
wound gap and wound edges between 1 day and 8 day after wounding. At 1 day post-
wounding, the level of DiI labeled fibroblasts in the wound region was significantly 
higher for TGF-1 treated cultures than parallel control cultures (Figure 51 A, p < 0.05 
considered significant, n= 16). In contrast, TGF-1 treated cultures exhibited a decrease 
in DiO labeled myoblasts (red) at the wound edges relative to control cultures (Figure 51  
FIGURE 45
A
B
Figure 45. Dose response effects of Transforming growth factor-  1 (TGF- 
1) on the micromass co-culture of 1 part FR 3T3 fibroblast and 3 part L8
myoblast cells. (A) Total collagen levels as determined by the absorbance reading
@ 400 nm of the Picrosirius red stain eluant and total DNA levels were determined
by DNAHoechst assay. Its been observed that there was a dose dependent decrease
in the absorbance reading and total DNA levels. (B) The relative levels of collagen
was determined by normalizing the absorbance reading to that of total DNA levels,
There seems to be a decrease in total collagen synthesis in a dose-dependent
manner following treatment with TGF-1, though the treatment effects were not
statistically significant. (Mean ± SD, *** indicates significant difference at p <
0.001,** indicates significant difference at p < 0.01, * indicates significant
difference at p < 0.05, n = 16)
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Figure 46. Dose response effects of Transforming growth factor-1 (TGF-  1)
on FR 3T3 fibroblast micromass cultures. (A) Total collagen levels was
determined by taking the absorbance reading @ 400 nm for the picrosirius red stain
eluant, while total DNA levels was determined by DNA Hoechst assay. It is been
observed that there was a dose dependent increase in the absorbance reading and total
DNA levels. (B) The relative levels of collagen was determined by normalizing the
absorbance reading to that of total DNA levels, There was a significant increase in
total collagen synthesis in a dose-dependent manner following treatment with TGF-
1. (*** indicates significant difference at p < 0.001, ** indicates significant
difference at p < 0.01, * indicates significance at p < 0.05, n = 16)
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FIGURE 47
Figure 47. Dose response effects of Transforming growth factor-  1 (TGF-
1) on L8 myoblast micromass cultures. (A) Total collagen levels was
determined by taking the absorbance reading @ 400 nm of the picrosirius red
stain eluant while total DNA levels was determined by DNA Hoechst assay. Its
been observed that there was a dose dependent decrease in the absorbance
reading and total DNA levels. (B) The relative levels of collagen was determined
by normalizing the absorbance reading to that of total DNA levels, There was a
significant decrease in total collagen synthesis in a dose-dependent manner
following treatment with TGF-1. (Mean ± SD,*** indicates significant
difference compared to control at p < 0.001, ** indicates significant difference
compared to control at p< 0.01 while * indicates significant difference compared
to control at p < 0.05, n = 16)
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Figure 48. Effect of TGF-b1 on wound closure in the wounded micromass co-cul-
ture of 1 part FR 3T3 and 3 part L8 myoblast cells. The five photographs in each 
vertical rows are phase contrast images of the same culture at successive time point 
after wounding. Using phase contrast light microscopy, the time taken for wound clo-
sure in 0.1 ng/mL  TGF-b1 treated and untreated control cultures. As seen from the 
phase contrast images the wounded micromass cultures treated with both 0.1 ng/mL 
TGF-b1 and untreated control cultures were repopulated with cells within 3 days af-
ter wounding. The TGF-b1 treated cultures appeared to show improved wound clo-
sure as compared to Control (untreated) cultures. Scale corresponds to 100 microns.
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FIGURE 49
Figure 49. Effect of Transforming growth factor-1 (TGF-1) on wound
migration pattern. In vitro micromass co-culture wound assay was performed to
quantify the wound closure pattern as function of time. It was observed that there
was increased cell migration at the wound site in TGF- 1 treated wounded
cultures as compared to control treated wounded cultures. In comparison to control
treated wounded cultures, the TGF-1 treated wounded cultures had the rate of
wound closure that was significantly higher between 1 day and 2 day post
wounding but by 3 day post-wounding, the wound closure recovered to that of
control treated cultures. (Mean ± SD, ** indicates significant difference compared
to control at p < 0.01, while * indicates significant difference compared to control
at p < 0.05, n = 16)
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FIGURE 50
Figure 50. Migratory pattern of FR fibroblast and L8 myoblast cells to the wound gap and 
wound edges following treatment with 0.1 ng/mL TGF-b1. (Panel 1) shows relative levels of 
DiI labeled FR fibroblast and DiO labeled L8 myoblast at the wound site in the 1 day post wound-
ed cultures treated with 0.1 ng/mL TGF-b1 and their corresponding untreated control wounded 
cultures. (Panel 2) shows relative levels of DiI labeled FR fibroblast and DiO labeled L8 myo-
blast at the wound site in the 8 day post wounded cultures that were treated with 0.1 ng/mL TGF-
b1 and corresponding untreated control wounded cultures. Notice the gradual increase in relative 
levels of DiI labeled FR fibroblast cells (red) in the 3 day and 8 day post wounded cultures treated 
with 0.1 ng/mL TGF-b1.
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B, p < 0.05, considered significant, n =16).  This experiment suggests that TGF-1 
treatment may improve fibroblast cell migration and inhibit myoblast migration to the 
wound site in micromass co-cultures of 1:3 FR fibroblast and L8 myoblast cells. 
 
4.4.1.1.8 Expression of p38 and ERK1/2 mitogen-activated protein kinases in 
wounded and unwounded micromass co-cultures of 1 part FR 3T3 
fibroblast and 3 parts L8 myoblast cells. 
 
As described in Sections 4.3.3.2 and 4.3.3.3, our in vivo studies on the rat spinal 
laminectomy model had demonstrated increased ERK1/2 and p38 MAPK activation 
during the peridural scarring process and that these signaling pathways were attenuated 
by OTC treatment. Moreover, previous studies have implicated ERK1/2 and p38 MAPKs 
in both epithelial and muscular wound healing (Li et al., 2001; Lluis et al., 2006; Sharma 
et al., 2003; Tolg et al., 2006; Zetser et al., 1999). Hence, I wished to determine whether 
activation of ERK1/2 and p38 MAPK was also a feature of our micromass co-culture 
wound repair model.  
Micromass co-cultures were subjected to single scrape wound at approximately 
36 h after initial plating. The cell debris was removed by rinsing with warm saline and 
the culture medium was replaced. Parallel-unwounded control cultures were subjected to 
the saline rinse and medium replacement only. The cultures were harvested at 
representative time points over an 8 day period, and western blot analysis was performed 
to determine the expression of total ERK1/2 protein and active dual phosphorylated 
ERK1/2 in wounded and unwounded cultures. Neither wounding nor the time in culture 
caused any obvious change in the level of total ERK1 (p44) or ERK2 (p42) proteins in 
the micromass co-cultures (Figure 52). The levels of dual phosphorylated (active) ERK1 
and ERK2 exhibited a rapid and transient expression pattern in wounded culture as  
FIGURE 51
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Figure 51. Effect of Transforming growth factor-1 (TGF- 1) on the migratory pattern of myoblast cells and
fibroblast cells at the wound site. The fibroblast and L8 myoblast cells were labeled with DiI and DiO lipophilic dyes
and visualized through a fluorescent microscope at 1 day, 3 day and 8 day post wounding. The relative pixel intensities of
DiI labeled FR fibroblast (red) and DiO labeled L8 myoblast (green) were quantified using NIH image J software. (A)
shows the relative intensity of DiI labeled FR 3T3 fibroblast cells that were present at the wound site including wound
edges, it seems to suggest that at 1 day post wounding 0,1 ng/mL TGF-1 treated wound cultures had significantly higher
levels of DiI labeled FR cells at the wound site as compared to untreated wounded cultures. (B) shows the relative
intensity of DiO labeled L8 myoblast cells that were present at the wound site including wound edges. The observations
suggest that the DiO labeled L8 myoblast cells were significantly lower at the wound site in the 0.1 ng/mL TGF- 1
treated wounded cultures as compared to untreated cultures at all time points. This also suggest that as compared to
untreated wounded cultures, the TGF- 1 treatment could potentially inhibit L8 myoblast cell migration. (Mean ± SD,
*** indicates significance at p value < 0.001 and ** indicates significance at p value < 0.01, n = 16)
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FIGURE 52
Figure 52. Expression of dual phosphorylated ERK1/2 mitogen activated protein kinases in 
wounded micromass co-culture of 1 part FR fibroblast cells and 3 part L8 myoblast cells. 
Cultures were collected at representative time points following wounding, and expression of to-
tal ERK1/2 and dual phosphorylated ERK1/2 were determined by Western blotting.Both total 
ERK1/2  and dual phosphorylated ERK1/2 were present in all culture homogenates at all time 
points. Homogenates that were obtained from 5 min post-wounded cultures seem to show relatively 
higher expression of dual phosphorylated ERK1/2 as compared to the corresponding unwounded 
cultures. However, the ERK activation levels suggest a time-dependent decrease in expression of 
dual phosphorylated ERK1/2. Densiometric analysis of western blots were performed on samples 
from two replicate cultures, and ERK1 and ERK2 activation was determined by normalizing the 
dual active phosphorylated ERK1 and ERK2 protein levels with total ERK1 and ERK2 protein 
levels. The ERK1 and ERK2 activation values are expressed in Mean  ± Range.
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compared to corresponding unwounded culture (Figure 52). In unwounded control 
cultures, phosphorylated ERK1 and ERK2 protein levels were highest at 1 hr and 1 day 
of culture then declined to faintly detectable levels by 8
 
days of culture (Figure 52). In 
comparison to the control cultures, the wounded micromass cultures demonstrated a rapid 
transient increase in ERK1 and ERK2 phosphorylation at 5 min post-wounding (Figure 
52). However, at all subsequent time points tested (1 h, 1 d, 2 d, 4 d and 8 d), the levels of 
ERK1/2 phosphorylation in wounded and unwounded control cultures were virtually 
equivalent.  
I also performed in situ immunostaining for active dual phosphorylated ERK1/2 
on the wounded micromass co-cultures. Highest levels of ERK phosphorylation were 
observed within cells located at the wound edges at 5 min and 1 day time points after 
wounding (Figure 53). Total ERK1/2 protein was more uniformly expressed throughout 
the micromass culture. This preferential distribution of phosphorylated ERK1/2 within 
the cells at the wound edges suggests that ERK1/2 activation is a localized response to 
microtissue injury in the micromass co-culture model. Western blot analysis was also 
performed to examine activation of the p38 MAPK signaling pathway in wounded and 
unwounded micromass co-cultures. Total p38 MAPK protein was expressed at similar 
levels in both wounded and unwounded cultures at all time points (Figure 54). In 
contrast, dual phosphorylated (active) p38 MAPK was not detectable at any time point in 
unwounded cultures. Wounded cultures exhibited a faint band for phosphorylated p38 
MAPK at five minute post-wounding, however phosphorylated p38 was not detectable at 
any subsequent time point (1 h, 1 d, 2 d, 4 d or 8 d post wounding) (Figure 54). These 
data suggest p38 MAPK activation is a rapid transient response to tissue injury in FR 
fibroblast: L8 myoblast micromass co-cultures. 
FIGURE 53
Figure 53. Localization of dual phosphorylated and total ERK1/2 mitogen activated protein kinases in wounded micro-
mass co-culture. Alkaline phosphatase conjugated immunostaining shows the expression of dual phosphorylated ERK1/2 (dark 
brown and black) at the wound edges of the micromass cultures in 5 min post-wounded and 1 day post-wounded cultures, respec-
tively. The arrowheads show the staining where expression of phosphorylated ERK1/2 in the wounded micromass co-culture was 
prominent as compared to control unstained cultures. In contrast, staining for dual phosphorylated ERK1/2 was observed to be 
lower in 4 day and 8 day post-wounded cultures than in 5 min and 1 day post wounded cultures. The staining for total ERK1/2 
was observed throughout the wounded micromass at all time points with low distribution of total ERK1/2 in 8 day post wounded 
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FIGURE 54
Figure 54. Expression of dual phosphorylated p38 mitogen activated protein kinases (p38 MAPK) in wounded micromass co-culture 
and corresponding unwounded micromass co-cultures of 1 part FR fibroblast and 3 parts L8 myoblast cells. Western blot analysis 
was performed on homogenates of wounded micromass co cultures and corresponding unwounded control cultures. Total p38 MAPK was 
expressed in both wounded and unwounded cultures at all time points. In contrast, dual phosphorylated (active) p38 MAPK was not detect-
able in unwounded control cultures, and was faintly expressed at 5 min post injury in wounded  micromass cultures. The experiments was 
performed in quadruplicate cultures with equivalent results.   
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In situ immunostaining was performed to determine the localization of 
phosphorylated p38 MAPK within the wounded micromass co-cultures (Figure 55). 
Expression of active dual phosphorylated p38 MAPK appeared to be highest in cells at 
the wound edges (Figure 55) at 5 min and 1 day after wounding. Levels of 
phosphorylated p38 MAPK declined at the wound edges by 4 d and 8 d post-wounding. 
Total p38 MAPK protein was present throughout the micromass culture, but was 
expressed at highest levels at 5 min post wounding at the wound edges (Figure 55). In 
contrast to phosphorylated p38 MAPK, total p38 protein levels remained quite high 
throughout the micromass cultures at 1 day through 8 days post wounding.  
 
 
 
4.4.1.1.8.1 Effect of ERK inhibitor, PD184352, on wound closure in micromass co-
cultures of 1:3 FR fibroblast and L8 myoblast cells. 
 
In order to investigate the role of ERK1/2 signaling in wound closure within 
micromass co-cultures of 1:3 FR fibroblast and L8 myoblast cells, the wounded 
micromass co-culture were treated with PD184352, a potent and specific 
pharmacological inhibitor of the MEK1/2 enzyme that phosphorylates /activates ERK1/2. 
Western blot analysis confirmed that treatment with 2 M PD184352 was effective in 
blocking ERK1/2 phosphorylation in wounded micromass FR fibroblast: L8 myoblast 
micromass co-cultures (Figure 56). Phase contrast images suggested that when wounded 
micromass co-cultures were treated with 2 M PD184352, there was a noticeable delay 
in the movement of cells into the wound gaps, which resulted in a comparatively lower 
cell density in the wound gap at 3 days and 8 days post-wounding relative to untreated 
control cultures (Figure 57). The quantitative in vitro wound closure assay confirmed 
 
FIGURE 55
Figure 55. Localization and distribution of phosphorylated and total p38 mitogen activated protein kinases (p38  MAPK) in 
wounded micromass co-culture. Alkaline phosphatase conjugated immunostaining shows the expression of dual phosphorylated 
p38 MAPK (dark brown and black) at the wound edges of the cells at the wound site in 5 min post-wounded and 1 day post-wounded 
cultures, respectively. The arrowheads show the staining where expression of phosphorylated p38 MAPK in the wounded micromass 
co-culture was prominent. In contrast, staining for phosphorylated p38 MAPK was observed to be lower in 4 day and 8 day post-
wounded cultures than in 5 min and 1 day post wounded cultures. The staining for total p38 MAPK was observed throughout the 
micromass in all wounded cultures.  
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FIGURE 56
Figure 56. Western blot analysis to detect total ERK2 and dual phosphorylated ERK1/2 
in the wounded micromass co-culture of 1 part FR 3T3 fibroblast cells and 3 part L8 
myoblast cells treated with 2 mM PD 184352, 10 mM SB 202190 and 100 ng/mL Aniso-
mycin. The cultures were incubated in PD184352, SB202190 and anisomycin for 1 day after 
the infliction of scrape wound. The 1 day post wounded culture were lysed and lysates sub-
jected to western blot analysis. Treatment with ERK pathway inhibitor PD184352 was ef-
fective in suppressing phosphorylation of ERK1 and ERK 2, relative to cultures treated with 
0.1% DMSO vehicle alone (control). Treatment with p38 inhibitor compound SB202190 
had no effect on ERK1/2 phosphorylation or total ERK1/2 protein levels. Treatment with 
anisomycin, a protein synthesis inhibitor, reduced both total ERK 2 protein expression as 
well as levels of phosphorylated ERK1/2.
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Figure 57. Effect of PD 184352 on wound closure pattern in the wounded micromass co-
culture of 1 part FR fibroblast and 3 part L8 myoblast cells. Phase contrast images shows 
wounded micromass co-culture treated with 2 mM PD 184352 and corresponding wounded 
control cultures treated with 0.02 % DMSO (Vehicle control). The three photographs in each 
vertical rows are phase contrast images of the same culture at successive time point after 
wounding. The 3 day and 8 day post wounded cultures treated with 2 mM  PD 184352 showed 
a delay in wound closure, with lower cell density at the wound edges and wound gap.
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that treatment with 2 M PD184352 resulted in a significant delay in the rate of wound 
closure as compared to untreated control cultures (Figure 58, p< 0.01, n =16). This 
experiment suggests that ERK1/2 activation is involved in facilitating optimum rates of 
wound closure in 1:3 fibroblast:myoblast micromass co-culture model.  
 
4.4.1.1.8.2 Effect of p38 MAPK inhibitor, SB202190, on wound closure in micromass co-
culture of 1:3 FR fibroblast and L8 myoblast cells. 
 
In order to determine whether p38 MAPK signaling affects wound closure in 
micromass co-cultures of 1:3 FR fibroblast and L8 myoblast cells, the wounded 
micromass co-cultures were treated with SB202190, a potent and selective inhibitor of 
p38 MAPK that does not affect the JNK or ERK1/2 MAPK signaling pathways. Western 
blot analysis performed on micromass co-cultures confirmed that treatment with 10 M 
SB202190 was effective in blocking the transient increase in p38 phosphorylation that 
normally occurred at 5 min post wounding (Figure 59). Because p38 activation after 
wounding was a transient response, phosphorylated p38 MAPK was undetectable at 
subsequent time points (1 to 8 days post wounding) in both the presence and the absence 
(control) of SB202190 (Figure 59). To verify that our primary antibody was indeed 
capable of detecting phosphorylated p38 on western blots, some micromass cultures were 
treated with anisomycin, a protein synthesis inhibitor that is known to elevate p38 
phosphorylation in cells. As seen in Figure 59, treatment with 100 ng/mL anisomycin 
resulted in expression of phosphorylated p38 MAPK even at 1 days post wounding. 
 
 
 
Figure 58. Effect of PD 184352 treatment on the rate of wound closure in the
micromass co-culture of 1 part FR 3T3 fibroblast and 3 part L8 myoblast cells. In
vitro micromass co-culture wound assay was performed to determine the effect of 2
M PD 184352 treatment on wound closure pattern. It was observed that there was
significant delay in the total wound area being covered by cells following treatment
with PD 184352 ( Mean ± SD, *** indicates significant difference compared to
control at p < 0.001, ** indicates significant difference to control at p < 0.01, n =16).
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Figure 59. Western blot analysis to detect total and dual phosphorylated p 38 MAPK in the 
wounded micromass co-culture of 1 part FR 3T3 fibroblast cells and 3 part L8 myoblast cells 
treated with 2 mM PD 184352, 10 mM SB 202190 and 100 ng/mL Anisomycin. In 5 min post 
wounded cultures, the dual phosphorylated p38 MAPK expression was present in 2  mM PD 184352 
and 100 ng/mL Anisomycin treated wounded cultures, while the dual phosphorylated p38 MAPK 
expression was absent in 10  mM SB 202190 treated cultures. In 1 day post wounded cultures, phos-
phorylated p38 MAPK expression was absent in untreated control wounded cultures, SB 202190 
and  PD 184352 treated cultures. However anisomycin treated culture showed presence of dual 
phosphorylated p38 MAPK proteins. The total p38 protein levels were observed in both 5 min and 
1 day post wounded control (untreated), PD 184352 and SB 202190 treated cultures.  The  total p38 
protein levels were  not  detectable in anisomycin treated cultures at 5 min post wounding. Faint 
band for total  p38  protein was observed in 1 day post wounded cultures treated with anisomycin. 
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FIGURE 60
Figure 60. Effect of SB 202190 treatment on the rate of wound closure in the
micromass co-culture of 1 part FR 3T3 fibroblast and 3 part L8 myoblast cells.
In vitro micromass co-culture wound assay was performed to determine the effect of
10 M SB 202190 treatment on wound closure pattern. It was observed that there
was significant acceleration in the total wound being covered following treatment
with SB 202190 ( Mean ± SD, ** indicates significant difference at p value < 0.01,
n =16).
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Treatment of wounded micromass co-cultures with p38 inhibitor, SB202190 
resulted in acceleration of wound closure rate as compared to parallel control cultures 
that were administered with 0.1 % DMSO vehicle alone (Figure 60). Wound closure in 
SB202190 treated cultures was significantly higher than control cultures at 0.5, 1, 2 and 
4-day time points after wounding (Figure 60, p < 0.01, n =16). However by 6 days post 
wounding the extent of wound closure in control and SB 202190 treated cultures was 
equivalent.  
 
4.4.2.  Effects of OTC and Quercetin on unwounded and wounded 
micromass co-cultures of 1 part FR fibroblast and 3 part L8 myoblast 
cells. 
 
The final objective of my thesis project was to test the utility of the newly 
developed micromass co-culture based wound repair model in preclinical drug 
development studies.  OTC and quercetin are anti-inflammatory compounds that were 
used in our initial live animal studies to investigate their potential in ameliorating 
peridural scarring associated with spinal lumbar laminectomy surgery. As a follow up to 
our in vivo experiments, I examined the effects of OTC and quercetin on in vitro wound 
healing in our micromass co-culture model.  
 
4.4.2.1.  Effect of OTC on collagen biosynthesis and DNA accumulation in the 
unwounded FR fibroblast : L8 myoblast micromass co-culture. 
 
Initial experiments examined the effects of OTC and quercetin on total collagen 
production and DNA accumulation in unwounded micromass co-cultures of 1part FR 
fibroblast and 3 parts L8 myoblast cells. The cultures were treated with varying doses of 
OTC (0, 0.25, 0.5, 1.0, 1.5 and 2.0 mM) or quercetin (0, 5, 10, 20, 40, 80 M) and 
analyzed by fluorometric Hoechst DNA assay and picrosirius red histochemical staining.  
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As shown in Figure 61 A, the micromass co-cultures that were treated with OTC 
at concentrations of 1.5 - 2.0 mM exhibited a dose dependent decrease in levels of both 
picrosirius red stainable collagen and total DNA relative to untreated control cultures. (p 
< 0.01, n = 16). OTC concentrations of 0.25 –1.0 mM had no significant effect on either 
total collagen or DNA accumulation. When the levels of total collagen accumulation 
were normalized against total cellular DNA values there was a significant decrease in 
total collagen per microgram DNA at 1.5 mM and 2.0 mM OTC treatment doses relative 
to parallel control cultures (Figure 61 B, p < 0.05, n = 16).  
To determine which of the two cell types (FR fibroblasts versus L8 myoblasts) 
within the micromass co-culture are most sensitive to OTC treatment, micromass cultures 
composed of FR fibroblast cells alone or L8 cells alone were also treated with different 
concentrations of OTC. In cultures of FR fibroblast cells alone, OTC treatment caused a 
dose dependent decrease in picrosirius red stainable collagen levels at concentrations as 
low as 0.25 mM  OTC (Figure 62 A, p < 0.05, n = 16), whereas total DNA levels 
decreased in a dose dependent manner starting at 0.5 mM OTC (Figure 62 A, p < 0.05, n 
=16). Normalization of the collagen levels against total cellular DNA (Figure 62 B) 
revealed that there was a significant decrease in collagen accumulation per microgram 
DNA at all OTC doses from 0.25 - 2.0 mM, suggesting that OTC reduces collagen 
synthesis by FR fibroblast cells. In contrast, low concentrations of OTC (0.25 - 1.0 mM) 
had no significant effect on either total collagen or total DNA accumulation in micromass 
cultures composed of L8 myoblast cells alone (Figure 63 B). Only higher doses of OTC 
(1.5 - 2.0 mM) caused significant decreases in total DNA levels and collagen 
accumulation per microgram DNA (Figures 63 A and 63 B, p < 0.05, n = 16). 
  
Figure 61. Dose dependent effects of OTC on micromass co-cultures of 1 part
FR 3T3 fibroblast and 3 part L8 myoblast cells. Cultures were administered OTC
at doses of 0.25-2.0 mM, parallel control cultures were maintained in standard
medium (0 mM OTC). (A) shows total DNA and total collagen levels as determined
by DNA Hoechst assay and picrosirius red staining, there is was a significant
decrease in total DNA and absorbance reading for total collagen levels in both 1.5
mM and 2.0 mM OTC treated cultures. (B) shows the relative total collagen levels
determined by normalizing with total DNA levels. It seems to suggest that there was
a significant dose-dependent decrease in total collagen synthesis in both 1.5 mM and
2.0 mM OTC treated cultures. (Error bars represent Mean ± SD, * indicates
significance at p value < 0.05 as compared to control and ** indicates significance at
p value < 0.01, n =16).
FIGURE 61
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FIGURE 62
Figure 62. Effect of OTC on FR 3T3 fibroblast micromass cultures. Cultures
were administered OTC at doses of 0.25-2.0 mM, parallel control cultures were
maintained in standard medium (0 mM OTC). (A) shows total DNA and total
collagen levels as determined by DNA Hoechst assay and picrosirius red staining,
there is a dose dependent decrease in total DNA and absorbance reading for total
collagen levels. (B) shows the relative total collagen levels determined by
normalizing with total DNA levels. It seems to suggest that there was a significant
dose-dependent decrease in total collagen synthesis. (Error bars represent Mean ±
SD, * indicates significance at p value < 0.05 as compared to control and ** indicates
significance at p value < 0.01, n =16).
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Figure 63. Effect of OTC on L8 myoblast micromass cultures. Cultures were
administered OTC at doses of 0.25-2.0 mM, parallel control cultures were maintained
in standard medium (0 mM OTC). (A) shows total DNA and total collagen levels as
determined by DNA Hoechst assay and picrosirius red staining, there is was a
significant decrease in total DNA and absorbance reading for total collagen levels in
both 1.5 mM and 2.0 mM OTC treated cultures. (B) shows the relative total collagen
levels determined by normalizing with total DNA levels. It seems to suggest that
there was a significant dose-dependent decrease in total collagen synthesis in both 1.5
mM and 2.0 mM OTC treated cultures. (Mean ± SD, *** indicates significance at p
value < 0.001, n =16).
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The greater sensitivity of FR fibroblast cells to low doses of OTC in comparison 
to L8 myoblast cells is striking. The relatively high proportion of L8 myoblast cells in our 
1:3 FR fibroblast: L8 myoblast co-cultures would account for the observation that OTC 
doses of 1.5 - 2.0 mM were required to significantly reduce collagen and DNA 
accumulation in these co-cultures. 
 
4.4.2.2.  Effects of Quercetin on collagen biosynthesis and DNA accumulation 
in unwounded 1:3 FR fibroblast and L8 myoblast micromass co-
cultures. 
 
When micromass co-cultures of 1:3 ratio FR fibroblast and L8 myoblast cells 
were treated with various doses of quercetin, it was observed that the total DNA levels as 
well as levels of picrosirius red stainable collagen were significantly decreased in cultures 
treated with 40 M and 80 M quercetin as compared to control untreated cultures 
(Figure 64 A, p < 0.05, n =16). Normalized collagen accumulation per microgram DNA 
was also significantly decreased by treatment with 40 M and 80 M quercetin (Figure 
64 B, p < 0.01, n =16), while quercetin doses below 20 M had no significant effect on 
either collagen or total DNA accumulation.  
To determine whether quercetin had differential effects on DNA accumulation 
and collagen synthesis by the two cell types comprising the micromass co-cultures, we 
also tested cultures composed of either FR fibroblasts or L8 myoblasts alone. In 
micromass cultures of FR fibroblasts alone, there was a dose dependent decrease in the 
levels for picrosirius red stainable collagen beginning at a quercetin doses of 5 M, while 
there was a dose dependent decrease in total DNA at quercetin doses of 10 M and above  
(Figures 65 A and 65 B,  p < 0.05, n = 16). 
 
Figure 64. Effect of Quercetin on the micromass co-culture of 1 part FR 3T3
fibroblast and 3 part L8 myoblast cells. (A) shows total DNA and total collagen
levels as determined by DNA Hoechst assay and picrosirius red staining, there is was
a significant decrease in total DNA and absorbance reading for total collagen levels
in both 40 M and 80 M. Quercetin treated cultures. (B) shows the relative total
collagen levels determined by normalizing with total DNA levels. It seems to suggest
that there was a significant dose-dependent decrease in total collagen synthesis in
both 40 M and 80 M Quercetin treated cultures. ( Mean ± SD, ** indicates
significance at p value < 0.01, n =16).
FIGURE 64
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Figure 65. Effect of Quercetin on FR 3T3 fibroblast micromass cultures. (A)
shows total DNA and total collagen levels as determined by DNA Hoechst assay and
picrosirius red staining, there is was a significant dose dependent decrease in total
DNA and absorbance reading for total collagen levels. (B) shows the relative total
collagen levels determined by normalizing with total DNA levels. It seems to suggest
that there was a significant dose-dependent decrease in total collagen synthesis.
(Mean ± SD, ** indicates significance at p value < 0.01, * indicates significance at p
value < 0.05, n =16).
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Figure 66. Effect of Quercetin on L8 myoblast micromass cultures. (A) shows
total DNA and total collagen levels as determined by DNA Hoechst assay and
picrosirius red staining, there is was a significant decrease in total DNA and
absorbance reading for total collagen levels in both 40 µM and 80 µ M Quercetin
treated cultures. (B) shows the relative total collagen levels determined by
normalizing with total DNA levels. It seems to suggest that there was a significant
dose-dependent decrease in total collagen synthesis in both 40 µM and 80 µM
Quercetin treated cultures. (Mean ± SD, p < 0.05 considered significant, n =16).
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In contrast, higher doses of 40 M - 80 M quercetin were required to inhibit 
total collagen and DNA accumulation in micromass cultures composed of L8 myoblast 
cell alone (Figure 66 A, p < 0.05 n= 16). Normalized collagen accumulation per 
microgram DNA showed a dose-dependent decrease in relative total collagen levels 
starting from 40 M concentration of quercetin (Figure 66 B, p < 0.01, n = 16). 
Accordingly, quercetin doses between 5 M - 20 M were sufficient to reduce 
collagen synthesis in FR fibroblast cells, while higher quercetin doses (40 M and above) 
was required to reduce collagen synthesis in the L8 myoblast cells. Again, the relatively 
high proportion of L8 myoblast cells in our 1:3 FR fibroblast: L8 myoblast co-cultures 
would account for the observation that quercetin doses of 40 M and above were 
required to significantly reduce collagen and DNA accumulation in the co-culture model. 
  
4.4.2.3   Effects of OTC and Quercetin on wound closure in the wounded 
micromass co-culture of 1 part FR fibroblast cells and 3 part L8 
myoblast cells. 
 
Experiments were performed to determine whether OTC and quercetin treatment 
affected the rate of wound closure in micromass co-cultures of 1:3 ratio FR fibroblast and 
L8 myoblast cells. Phase contrast microscopy and a quantitative wound closure assay 
were performed to examine the extent of wound closure as a function of time in wounded 
micromass cultures treated with 1.5 mM OTC, 40 M quercetin and a combination of 1.5 
mM OTC and 40 mM quercetin. These doses were chosen based on our previous finding 
that concentrations of 1.5 mM OTC and 40 M quercetin were effective in reducing total 
accumulation and collagen deposition in micromass co-cultures. Phase contrast images of 
OTC treated cultures and control cultures treated with vehicle alone showed generally  
Figure 67. Effect of OTC and Querctin on wound closure in the wounded micromass co-
culture of 1 part FR 3T3 and 3 part L8 myoblast cells. Phase contrast images were tak-
en from the same wounded cultures at different time points to show time-scale changes to the 
wound closure pattern for the wounded micromass cultures were treated with either 1.5 mM 
OTC or 40 mM Quercetin or a mixture of 1.5 mM OTC and 40 mM Quercetin. The Quercetin 
treated cultures showed a delay in the wound closure as compared to Control (untreated), while 
OTC treated cultures shows similiar wound closure as compared to Control (untreated) cultures. 
Quercetin treated cultures showed some contraction at the edges and this was consistent in al-
most all cultures treated with Quercetin.However, the cultures treated with mixture of OTC and 
Quercetin showed initial delay in closure of wound without any wound contraction as seen with 
Quercetin treated cultures until 2 day post-wounding after which the cultures seems to recover 
to wound closure pattern as that of control untreated cultures. Scale corresponds to 100 microns.
CONTROL 1.5 mM OTC 40 mM Quercetin
1.5 mM OTC
+
40 mM Quercetin
0 hour
(Base time)
1 day
post wound
2 day
post wound
4 day
post wound
8 day
post wound
FIGURE 67
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FIGURE 68
Figure 68. Effect of OTC and Quercetin on wound closure pattern (A) the
wounded micromass cultures were treated with 40 M Quercetin, show a delay
in the wound closure as compared to control untreated wounded cultures (B)
when the wounded micromass cultures were treated with 1.5 mM OTC, there
was significant acceleration in the wound closure as compared to control
untreated wounded cultures. (Mean ± SD, ** indicates significance at p value <
0.01, while * indicates significance at p value < 0.05, n = 4)
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FIGURE 69
Figure 69. Effect of the mixture of Quercetin and OTC on wounded micromass co-
culture of 1 part FR 3T3 fibroblast and 3 part L8 myoblast cells. When the
wounded cultures were treated with a mixture of 40 M Quercetin and 1.5 mM OTC , I
observed a initial delay in the wound closure pattern as compared to control untreated
wounded cultures after which the wound closure pattern recovered to that of control
untreated wounded cultures. (Mean ± SD,** indicates significance at p value < 0.01, n
=6).
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similar trends in cell movement into the wound gap over the time (Figure 67). However 
quantitative image analysis revealed a slight acceleration in the rate of wound closure in 
micromass co-cultures treated with 1.5 mM OTC as compared to control cultures 
administered vehicle alone (Figure 68 A, p < 0.05, n = 4). 
Phase contrast observations suggested that 40 M quercetin treatment of wounded 
micromass cultures delayed movement of cells into the wound gap at 1-2 days post-
wounding as compared to control cultures (Figure 67). The quantitative wound closure 
assay confirmed that there were significant delays in wound closure in cultures treated 
with 40 M quercetin treated wounded cultures as compared to control vehicle treated 
wounded cultures relative to controls (Figure 68 B, p < 0.05 considered significant, n 
=4). When wounded micromass co-cultures were treated with a combination of 1.5 mM 
OTC and 40 M quercetin, there were slight delays in wound closure at the 0.5 day time-
point, however the extent of wound closure recovered to that of untreated control cultures 
(Figure 67 and 69). The initial delay in wound closure might be due to quercetin 
exerting its effects during the initial wound healing process, whereas the recovery of 
wound closure at later time points might reflect the counteracting effects of OTC.  
 
 
4.4.2.4.   Effects of OTC and Quercetin on p38 MAPK and ERK 1/2 activation 
in wounded micromass co-cultures of 1 part FR fibroblast cells and 3 
parts L8 myoblast cells. 
 
In our live animal studies, OTC treatment reduced both p38 MAPK and ERK1/2 
activation in peridural scar tissue, while quercetin had no effect on either p38MAPK or 
ERK1/2 activation within peridural scar tissue. Therefore, experiments were performed to 
determine whether OTC and quercetin treatment would influence MAPK activation in the 
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micromass co-culture wound model. The wounded cultures were treated with 40 M 
quercetin or 1.5 mM OTC and western blotting was performed to determine the levels of 
phosphorylated ERK1/2 and p38 MAPK proteins. As seen in Figure 70, micromass co-
cultures treated with 1.5 mM OTC exhibited significantly lower expression of active dual 
phosphorylated p38 MAPK at 5 minutes post wounding in comparison to parallel control 
cultures (p < 0.05, n = 8). 
In contrast, 40 M quercetin had no effect on the expression level of active dual 
phosphorylated p38 MAPK relative to wounded control cultures at 5 min post wounding 
(Figure 70). Phosphorylated p38 MAPK was undetectable at 1 h, 1 d, 2 d, 4 d and 8-day 
time points after wounding in control, OTC and quercetin treated cultures although total 
p38 protein was present (data not shown).  
Western blot analysis indicated that levels of dual phosphorylated ERK1/2 
expression were significantly reduced at 5 min post wounding in OTC treated cultures 
relative to wounded cultures (Figure 71, p < 0.05, n = 8). Cultures treated with quercetin 
also showed significantly decreased levels of active dual phosphorylated ERK1/2 at 5 
min post wounding in comparison to wounded control cultures, however ERK1/2 
expression was lower than that of control cultures at subsequent time points (Figure 71). 
This experiment suggests that OTC administration depresses both the ERK and p38 
MAPK signaling pathways while quercetin inhibits ERK1/2 signaling alone.  
 
 
 
 
 
Figure 70. Effect of OTC and Quercetin on the expression of dual phosphorylated p38 MAPK in 
the 5 minute post-wounded micromass co-cultures of 1 part FR 3T3 and 3 part L8 myoblast cells.  
Dual phosphorylated p38 MAPK was expressed in both quercetin and OTC treated wounded cultures 
with OTC treated wounded cultures showing lower levels of p38 MAPK expression as compared to 
untreated control wounded cultures. However expression of total p38 MAPK protein was equivalent in 
all treated cultures. On densiometric analysis using NIH Image J software, the OTC treated wounded 
cultures showed significantly lower p38 MAPK activation as compared to untreated control cultures. 
However p38 MAPK activation was similiar in both quercetin treated and untreated control wounded 
cultures ( Mean ± SD, ** indicates significance at p value < 0.01, n =8) 
FIGURE 70
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Figure 71. Effect of OTC and Quercetin on the expression of dual phosphorylated ERK1/2 in the 5 minute, 1 day, 3 day and 8 day 
post-wounded micromass co-cultures of 1 part FR 3T3 and 3 part L8 myoblast cells. (A) The quercetin treated cultures at 5 min post 
wounding showed significantly lower levels of dual phosphorylated ERK1/2 as compared to control untreated wounded cultures however 
(B) When densiometric analysis was performed using NIH Image J software to determine the ERK1/2 activation levels, both quercetin 
and OTC treated cultures at 5 min post wounding showed significant decrease in ERK1/2 activation as compared to untreated control 
cultures (C) Total p44/42 MAPK (ERK1/2) was expressed in all treatment groups at all time points, while no change in expression of 
dual phosphorylated ERK1/2 was observed in 1 day, 3 day, and 8 day post wounded OTC or quercetin treated wounded cultures (Mean 
± SD, ** indicates significance at p value < 0.01, while * indicates significance at p value < 0.05, n = 8).
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4.4.2.5.  Effect of OTC and Quercetin on the genes involved in tissue repair and 
regeneration within wounded micromass co-cultures of 1 part FR 
fibroblast and 3 parts L8 myoblast cells. 
 
Our wound closure assay data suggested that at 2 d to 4 day post injury there are 
major changes occurring in the rate of wound closure in the micromass co-culture model. 
Moreover, RT-PCR data on wounded micromass co-cultures suggested that gene 
transcript levels for RHAMM, HAS 1, HAS 3, hsp-47, collagen 1 (2), collagen 3 (1) 
and collagen 4(1) were increased at the 2 – 4 day time points. Hence, I wished to 
determine whether OTC and quercetin treatments altered levels of expression of the gene 
transcripts for TGF-3, TGF-1, RHAMM, CD 44, HAS 1, HAS 3, hsp-47, collagen 4 
(1), collagen 3 (1) and collagen 1 (2) genes in patterns that might account for their 
opposing effects on wound closure in the micromass co-culture model. 
Semiquantitative RT-PCR was performed as described in Section 3.2.9 to analyze 
levels of TGF-3, TGF-1, RHAMM, CD 44, HAS 1, HAS 3, hsp-47, collagen 4 (1), 
collagen 3 (1) and collagen 1 (2) gene transcripts in wounded micromass co-cultures 
treated for 2 or 4 days with 1.5 mM OTC or 40 µM quercetin (Figure 72).  The amplified 
collagen 1 (2), collagen 3 (1), collagen 4 (1), hsp-47, HAS 1, HAS 3, RHAMM, CD 
44, TGF-1, TGF-3 and GAPDH sequences were separated on agarose gels (Figure 72) 
and the relative band intensities for each gene were quantified densiometrically using 
NIH Image J software and normalized against the intensity of the corresponding GAPDH 
band (Figure 73). The appropriate number of PCR cycles for each gene of interest was 
determined in earlier experiments (see Section 4.4.1.1.5). It was observed that the 
wounded cultures treated with OTC showed changes in the expression of RHAMM, HAS 
3, CD 44, HAS 1 and Collagen 3 (1) gene transcripts between 2 day and 4 day post 
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wounded cultures (Figure 73 A and Figure 73 B).  The wounded cultures treated with 
quercetin showed changes in the expression of CD 44, HAS 1 and Collagen 3 (1) gene 
transcripts between 2 day and 4 day post wounded cultures (Figure 73 A and Figure 73 
B). The changes in the gene transcript levels of collagen 1 (2), collagen 3 (1), collagen 
4 (1), hsp-47, HAS 1, HAS 3, RHAMM, CD 44, TGF-1, TGF-3 in 2 day and 4 day 
post wounded cultures treated with OTC and quercetin are summarized in Table 7. 
The 2 day post wounded cultures treated with 1.5 mM OTC showed significantly 
lower levels of TGF-1, CD-44, HAS-1, collagen type 4 ( 1), collagen type 3 ( 1), 
collagen type 1 ( 2) as compared to untreated wounded control cultures (Figure 73 A, p 
< 0.01, Table 7), while significantly higher levels of RHAMM, HAS-3 and hsp-47 was 
observed in OTC treated cultures as compared to controls. TGF-3 gene transcript levels 
were similar in OTC treated and control cultures at 2 days post wounding.  
The 4 day post wounded cultures treated with 1.5 mM OTC showed significantly 
lower levels of RHAMM, HAS 3, collagen type 4 (1) and collagen type 1 (2) (Figure 
73 B, p< 0.01 and Table 7) relative to untreated control cultures, while TGF-1, CD 44, 
HAS 1 and collagen type 3 ( 1) transcript levels were higher. TGF-3 and hsp-47 levels 
were unchanged in OTC treated cultures at 4 days post wounding.  
The 2 day post wounded cultures treated with 40 M quercetin showed 
significantly lower levels of TGF-1, HAS 1, collagen type 3 ( 1) and collagen type 1 
(2) as compared to control untreated wounded cultures (Figure 73 A, p < 0.01 and 
Table 7) while higher levels of RHAMM, CD 44, HAS 3 and hsp-47 were observed in 
quercetin post wounded cultures treated with 40 M quercetin showed significantly lower 
levels of CD44 (Figure 73 B, p< 0.01 and Table 7) though RHAMM, HAS 1, collagen  
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FIGURE 72
Figure 72. RT-PCR DNA Agarose gels showing relative band intensities for Collagen type 1(a2), Collagen type 3(a1) 
and Collagen type 4(a1) Hyaluronan synthase 1, Hyaluronan synthase 2, Hyaluronan synthase 3, Receptor for hyaluro-
nan-mediated motility (RHAMM), CD 44, Transforming growth factor b-1, Transforming growth factor b-3, heat shock 
protein 47 (hsp-47) and Glyceraldehyde–3-phosphate dehydrogenase (GAPDH) in unwounded and wounded micromass 
cultures treated with and without 1.5 mM OTC and 40 mM Quercetin. 
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Figure 73. Effect of Quercetin and OTC on the genes involved in tissue repair and regeneration in the wounded
micromass co-culture of 1 part FR fibroblast and 3 part L8 myoblast cells. Expression profile of GAPDH, TGF 3
and 1, RHAMM, CD 44, HAS 3, HAS 1, hsp 47, Collagen type 4(1)[Col 4 (a) 1], Collagen type 3(1) [Col 3 (a) 1],
and Collagen type 1(2) [Col 1 (a) 2], were determined using semiquantitative RT-PCR. A.) Shows the relative
expression levels of the genes of interest in the 2 day post-wounded cultures. Both OTC and Quercetin treated cultures
showed decreased Collagen type 4(1), Collagen type 3(1) and Collagen type 1(2) expression levels with respect to
wounded and unwounded cultures while Quercetin treated cultures showed increased CD44 expression as compared to
unwounded, wounded and OTC treated wounded cultures.B.) shows the relative expression levels of the genes of interest
in the 4 day post wounded micromass co-cultures. Quercetin treated cultures showed increased RHAMM expression as
compared to OTC treated cultures and untreated wounded culture. (Kruskal Wallis non parametric One way ANOVA;
Mean ± SD, p < 0.01, considered significant, n=4)
FIGURE 73
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TABLE. 7. Effect of OTC and quercetin treatment on the relative gene transcript 
levels in the wounded micromass co-culture. The gene transcript levels of TGF-3, 
TGF-1, RHAMM, CD 44, HAS 1, HAS 3, hsp-47, Collagen 4(1), Collagen 3(1) and 
Collagen 1(2) were determined using semi-quantitative RT-PCR and the relative gene 
transcript levels were compared with vehicle (control) treated wounded micromass co-
culture for 2 day and 4 day post wounding. 
 
 
 
Treatments 
 
Time of culture 
(after wounding) 
 
Relative gene transcript levels  
 
Increased gene 
transcript levels 
Decreased gene 
transcript levels 
Unaffected gene 
transcripts 
 
 
 
 
 
 
 
1.5 mM 
OTC 
 
 
2 day 
 
RHAMM 
HAS 3 
Hsp-47 
 
TGF-1 
CD 44 
HAS 1 
Collagen 3(1) 
Collagen 4(1) 
Collagen 1(2) 
 
 
TGF-3 
 
 
4 day 
 
TGF-1 
CD 44 
HAS 1 
Collagen 3(1) 
 
 
RHAMM 
HAS 3 
Collagen 4(1) 
Collagen 1(2) 
 
TGF-3 
Hsp-47 
 
 
 
 
 
40 µM 
Quercetin 
 
 
2 day 
 
RHAMM 
CD 44 
HAS 3 
Hsp-47 
 
 
TGF-1 
HAS 1 
Collagen 3(1) 
Collagen 1(2) 
 
TGF-3, 
Collagen 4 ( 1) 
 
 
4 day 
 
RHAMM 
HAS 1 
Collagen 4(1) 
Collagen 3(1) 
 
CD 44 
 
TGF-3 
TGF-1 
HAS 3 
Hsp-47 
Collagen 1 ( 1) 
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type 4 (1) and collagen type 3 (1) transcript levels were significantly higher than in 
corresponding control cultures. TGF-1, TGF-3, HAS 3, hsp-47 and collagen type 1 ( 
2) transcript levels were unaffected by quercetin treatment at the 4 day time point. 
 
CHAPTER  5.  DISCUSSION 
 
5.1 Outcome of the in vivo studies using rat spinal laminectomy model 
The first objective of this project was to determine the effects of quercetin and L-
2-oxothiazolidine-4-carboxylate (OTC) on collagen distribution and biosynthesis within 
an in vivo model of peridural scar formation, the rat spinal laminectomy model. The 
changes in potential regulatory molecules (e.g. TGF-ßs, ERK1/2 and p38 MAP kinases) 
involved in the tissue repair were also examined in this animal model. The outcomes of 
these live animal studies are discussed below. 
 
5.1.1 Characterization of the peridural scar tissue indicates the presence of 
myoblastic cells, VEGF protein, hsp-47, P4H and expression of types I and 
III collagen  
 
The peridural scar tissue homogenates obtained from both 3 day and 21 day post-
surgery animal from all three groups showed expression of a single ~ 42 kDa band for 
MyoD protein and the absence of any detectable myosin heavy chain (MyHC) protein 
(see Figure 23). This suggests that the peridural scar tissue contained immature skeletal 
muscle progenitor cells (myoblasts) and few, if any, differentiated muscle fibre cells. The 
MyoD band intensities in 21-day post-surgery scar tissue homogenates were significantly 
lower than those in 3-day post-surgery scar tissue. This finding suggests that progressive 
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maturation of the peridural scar tissue is accompanied by a decline in the relative 
abundance of MyoD positive cells. It is possible that at later stages of peridural scarring, 
some myoblastic cells might have matured to a stage when the cells no longer express 
MyoD but are not yet expressing MyHC. 
In contrast, the mean relative level of VEGF protein was higher in the peridural 
scar tissue obtained from 21 day post-surgery animals when compared to 3 day post-
surgery animals (see Figure 24) suggesting its potential involvement in the later stages of 
peridural wound repair. Moreover, it was observed that p38 MAPK levels were higher in 
21 day post-surgery animals (see Figure 25) which correlates with the expression of 
VEGF protein at that time-point. This finding correlates with a previous study where p38 
MAPK has been shown to induce VEGF synthesis in aortic smooth muscle cells 
(Yamamoto et al., 2001). VEGF is a potent inducer of endothelial cell proliferation and 
angiogenesis (Bates and Jones, 2003).  
Both VEGF and angiogenesis have been shown to play diverse roles in wound 
healing. In a study of a fetal skin wound model, it was observed that exogenous VEGF 
administration stimulated proliferation of both endothelial cells and dermal fibroblasts 
resulting in an increase in scar formation (Wilgus et al., 2008). In contrast, angiogenesis 
has been associated with scarless wound healing in oral mucosa (Szpaderska et al., 2005), 
while a reduction in angiogenesis had little effect on the outcome of wound healing in a 
mouse model of full-thickness excisional dermal wound repair (Bloch et al., 2000).  
Previous studies have suggested that delayed angiogenesis may lead to impaired 
skeletal muscle regeneration (Ochoa et al., 2007) because VEGF is required for myoblast 
migration and regeneration of muscle fibres following injury (Arsic et al., 2004; Germani 
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et al., 2003). Moreover, Germani et al. (2003) found that increased VEGF expression 
within ischemic hind limb muscles of CD1 mice resulted in lower MyoD expression, 
which is consistent with our observations in the peridural scar tissue of the post-surgery 
animals. These authors hypothesized that VEGF might aid skeletal muscle regeneration 
by promoting the differentiation of myoblastic cells to more mature skeletal muscle fibres 
which no longer express MyoD (Germani et al., 2003). 
On comparing the RNA isolated from peridural scar tissue between 3 day, 21 day 
and 63 day post-surgery animals from all three groups, higher total RNA yields for the 3 
day peridural scar tissues were obtained. This suggested a greater cellularity of the scar 
tissue during the early phase of the wound healing process. This finding is consistent with 
previous reports that discussed the cellular events leading to tissue healing (Adzick and 
Lorenz, 1994). A statistically significant lower total RNA yield was obtained from 21 day 
and 63 day peridural scar tissue ( p value < 0.05, n = 5), which suggests that the scar 
matures with a higher proportion of ECM proteins and lower density of cells.  
The texture of the peridural scar tissue had become progressively more fibrous in 
nature in the 63 day peridural scar tissue, as compared to the 3 day peridural scar tissue.  
Compared to 3 day peridural scar tissue, the 21 day and the 63 day peridural scar tissue 
exhibited considerably greater inconsistencies in both total RNA and total protein yields. 
This variability created problems in subsequent RNA and protein analysis of the late 
stage scar tissue samples, limiting our analysis to 3 day and 21 day animal groups. 
Our RNA dot blot analysis indicated that Collagen type 1 ( 2) and Collagen type 
3 ( 1) mRNAs were expressed at higher levels in the peridural scar tissue in comparison 
to Collagen type 4 ( 1) gene transcripts (see Figure 19). This is consistent with earlier 
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reports that type I and type III collagen are the predominant collagen types found in scar 
tissue (Allbrook, 1973; Bailey et al., 1979; Best and Hunter, 2000; McMinn, 1967). In 
contrast, type IV collagen is predominantly formed in basement membranes and would 
be expected to be less abundant in scar tissue matrix (McMinn, 1967). Western blot 
analysis of the 3 day and 21 day peridural scar tissue homogenates showed the presence 
of type I collagen, fibronectin, and fibroblast markers such as hsp-47 and P4H (Figure 15 
and Figure 16). Collectively, the findings suggest the presence of both fibroblast cells 
and immature myoblast cells in peridural scar tissue. 
 
5.1.2. Systemic administration of OTC and quercetin may reduce cutaneous scar 
formation, and promote bone regrowth within the spinal laminae of the 
lumbar laminectomized rats 
 
 Our initial qualitative observations on the extent of cutaneous wound 
repair (see Section 4.1 and Figure 9) in the skin overlying the laminectomized area of the 
spine in 21 day and 63 day animal groups suggested that both OTC and quercetin 
treatments reduced scar formation at the site of the dermal incision, with fewer raised 
structures at the wound site and better restoration of skin pigmentation compared with the 
saline treated control rats (Cox, 2008). The histological appearance of the scar tissue as 
assessed by our research collaborators further suggested that OTC and quercetin 
treatment had beneficial effects on cutaneous wound repair. Furthermore, as described in 
Section 4.1, it appeared that both quercetin and OTC promoted improved bone regrowth 
in the underlying spinal laminae. However, the evidence that OTC and quercetin might 
have anti-scarring potential in rat cutaneous wounds is based entirely on subjective and 
qualitative assessments. Moreover, it does not directly address the issue of whether these 
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drugs influence peridural scar tissue formation. 
Quantitative differences in the wet mass of the peridural scar tissue excised from 
saline, OTC and quercetin treated animals allow for a crude estimation of their relative 
effects on total scar tissue formation.  At 3 days post-surgery, OTC treated animals 
showed no significant difference in scar tissue wet mass in comparison to saline-treated 
control animals. But at both 21 and 63 days post-surgery, OTC treated animals 
demonstrated a significantly lower mean wet mass as compared to peridural scars from 
saline treated control animals (see Table 6). Compared to saline treated rats, the OTC 
treated rats showed a 35% reduction in the wet mass for 21 day peridural scar tissue and a 
27% reduction for 63 day peridural scar tissue 
In contrast, quercetin treatment showed no consistent effects on peridural scar 
tissue wet weight. At 3 days post-surgery, the peridural scar tissue from quercetin-treated 
rats showed significantly higher wet mass compared to saline-treated control animals. 
However, at 21 days the quercetin treated animals showed a significantly lower peridural 
scar mass than controls (see Table 6), while at 63 day there was no significant difference 
between control and quercetin treated rats.  
Collectively, these wet mass findings suggest that the OTC treated animals have 
reduced scar tissue mass as compared to the scar tissues obtained from either saline 
treated control rats or quercetin treated animals. This reduction in scar tissue wet mass 
could result from reduced accumulation of ECM proteins and/or polysaccharides in OTC 
treated scars or, alternatively, might result from reduced fluid retention due to improved 
venous flow in and around the scar tissues of OTC treated animals.  Neither Western blot 
analysis nor RNA dot blot analysis demonstrated any significant reduction in mean levels 
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of collagen or fibronectin expression in OTC treated scar tissues relative to scar tissues 
from saline treated control - animals. We did not directly examine the presence of blood 
capillaries or venous outflow in the scar tissues of our experimental animals. However, 
Western blotting was performed to evaluate relative levels of VEGF protein, which might 
reflect angiogenic activity in these tissues. Due to large animal to animal variability in the 
expression levels of VEGF in both 3 and 21 day scar tissue samples, we were unable to 
establish any link between OTC treatment and improved angiogenesis. As such, the 
reasons for the reduced scar tissue wet mass in OTC treated animals remain to be 
determined. In future studies, it would be worthwhile to determine the dry weight of the 
scar tissues in addition to their wet weight, as this would shed insight as to whether OTC 
acts to reduce ECM deposition or fluid retention in the peridural scar.   
 
 
5.1.3 Systemic administration of OTC and quercetin showed no significant 
treatment effects on collagen biosynthesis and/or abundance in the peridural 
scar tissue within the rat spinal lumbar laminectomy model. 
 
A collagen-specific histochemical procedure, the picrosirius red polarization 
method, was used to determine the relative collagen abundance in the peridural scar 
tissue sections of 3 day and 21 day animals. In addition, the distribution of the sirius red 
stained fibrils within the tissue sections as visualized using circularly polarized light was 
correlated with the total collagen distribution profile of contiguous scar tissue sections as 
determined by FTIR spectroscopic mapping using a synchrotron light source.  The FTIR 
spectroscopic imaging and picrosirius red histochemical staining patterns revealed a high 
degree of correlation in detecting total collagen distribution and collagen fibrillar 
organization within the tissue sections, as was reported in our recent publication (Wiens 
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et al., 2007).   
The disadvantage of using synchrotron based FTIR mapping for collagen 
detection lies in the inherently time consuming nature of data acquisition and high 
equipment usage costs involved in mapping whole tissue sections. Moreover, the 
complex, overlapping spectral signatures of multiple biological components found within 
the tissue makes interpretation of FTIR spectral maps in tissue sections difficult, without 
first defining the spectral signatures of known biological components. Also, the FTIR 
spectral map is highly influenced by the orientation of collagen fibrils relative to the 
synchrotron light, which further contributes to the complexity of interpreting the FTIR 
spectral map generated from a heterogeneous tissue (Camacho et al., 2001; Wiens et al., 
2007). In contrast, the picrosirius red polarization method has the advantage of the 
simplicity of the histochemical staining procedure and image acquisitions using polarized 
light microscopy. 
  When the relative areas of picrosirius red stainable collagen within histological 
sections of peridural scar tissue obtained from 3-day and 21-day animals were quantified 
using NIH Image J software, no statistically significant effects of either OTC or quercetin 
treatment on total collagen fibril abundance could be detected (see Figure 14). The 
picrosirius red stainable collagen measurements showed that 3 day post-surgical scar 
tissues had a lower collagen area fraction as compared to 21 day post-surgical scar tissues 
within all treatment groups. This was consistent with FTIR map findings that showed 
reduced overall collagen levels in 3 day peridural scar tissue relative to 21 day scars 
(Wiens et al., 2007). Large individual animal to animal variation was observed in the 
collagen levels within the scar tissues from individual animals within each treatment 
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group, including the saline control group, making it impossible to demonstrate any 
statistically significant treatment effects of either OTC or quercetin on overall collagen 
abundance in the peridural scar.  
Similarly, western blot analysis revealed large animal to animal variation in the 
protein levels of collagen biosynthesis markers such as type I procollagen, hsp-47 and 
prolyl-4-hydroxylase (P4H), as well as in levels of fibronectin protein within the 
peridural scar tissue. Again, statistically significant changes in the levels of these proteins 
associated with OTC or quercetin treatment could not be demonstrated (Figures 17-20).  
Using Pearson correlation coefficient analysis, I analyzed whether there was a 
correlation in the expression levels of the various collagen biosynthesis markers (viz. 
type I procollagen, hsp-47, and P4H) within the individual animals in each treatment 
group (see Appendix 1). This analysis was performed to test whether or not the animals 
that were high responders for one specific response parameter (e.g. type I collagen) 
showed a similarly high response to another specific response parameter (e.g. hsp-47 or 
P4H). Our analysis showed that in the 21 day OTC treatment group, those individual 
animals with relatively high levels of P4H expression also exhibited high hsp-47 protein 
levels, while those animals with low P4H expression had correspondingly low expression 
of hsp-47.  This correlation was not observed in 3 day OTC treated animals or in 3 day 
and 21 day scar tissues from saline and quercetin treated animals. These findings suggest 
that as compared to quercetin and saline treatments, OTC might have the ability to 
balance expression levels of intracellular proteins involved in post-translational 
modification of collagen proteins, namely hsp-47, a procollagen chaperone protein, and 
P4H, an enzyme that catalyzes formation of 4-hydroxyproline that is essential for 3-D 
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folding of newly synthesized procollagen chains. Maintaining a proper balance between 
the proteins involved in post-translational modification of nascent procollagens is 
important, as it helps prevent accumulation of defective collagen fragments that may act 
as promoters of fibrotic scarring (Kofford et al., 1997; Meier and Nanney, 2006a).  
 
5.1.4 Systemic administration of OTC and quercetin showed inconclusive results 
as to their treatment effects on TGF-1 and TGF-3 expression within the 
peridural scar tissue obtained from rat spinal lumbar laminectomy model. 
 
It has been hypothesized that the increased expression of TGF-3 during the early 
phase of wound healing promotes increased cellular proliferation and differentiation 
following injury that leads to scarless healing (Shah et al., 1995). In contrast, expression 
of TGF-1 and TGF-2 isoforms might have deleterious effects on wound repair by 
increasing scar formation (Frank et al., 1996).  We were unable to examine changes in 
TGF-1 and -3 mRNA levels using RNA dot blot analysis on peridural scar tissues of 3- 
and 21-day laminectomized rats, due to weak hybridization signals for both transcripts 
and high levels of background noise. TGF-1 mRNA was barely detectable in scar 
tissues from 21-day post-surgery animal groups and the signal intensities were variable in 
3-day post-surgery animal groups (see Figure 21). Consistent with the large animal to 
animal variation, densiometric analysis of the dot blots revealed no effects of the 
quercetin or OTC treatments on TGF-1 mRNA levels (see Figure 22). Compared to 
TGF-1 mRNA, TGF-3 mRNA levels were conspicuously higher in both 3 day and 21 
day peridural scar tissues. However, we were again unable to demonstrate any changes in 
the levels of TGF-3 mRNA expression in OTC and quercetin treated animals relative to 
the saline control group.  
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5.1.5.  Effects of systemic administration of OTC and quercetin on mitogen-
activated protein kinase signaling. OTC reduced both p38 MAPK and ERK 
activation in 21 day peridural scar tissue.  
 
Studies have reported that the ERK1/2, JNK and p38 MAPK signaling pathways 
are strongly stimulated after injury to skeletal muscle (Aronson et al., 1998) and corneal 
tissue (Imayasu and Shimada, 2003; Li et al., 2001; Sharma et al., 2003). By western blot 
analysis, the 3 day peridural scar tissues exhibited only faint levels of active, dual 
phosphorylated p38 MAPK, while phosphorylated ERK1/2 was undetectable. In contrast, 
substantial levels of both phosphorylated p38 and phosphorylated ERK1/2 were detected 
in 21-day peridural scar tissue. This temporal pattern suggests that ERK and p38 MAPK 
activation are associated with the latter events of scar formation or wound repair in this 
system, rather than being a transient short-term response to tissue injury.  This contrasts 
with the rapid, transient activation of ERK1/2 and p38 phosphorylation was observed in 
our wounded micromass co-cultures of FR fibroblasts and L8 myoblasts (see Figures 54 
and 55). The different temporal dynamics of MAPK activation observed in our in vivo 
and in vitro wound repair models is probably attributable to the relatively complex nature 
of the in vivo peridural scar tissue compared to the in vitro micromass culture. In addition 
to fibroblasts myoblast and fibroblasts, peridural scar tissues contain macrophages, 
neutrophils and other inflammatory cell types. Proinflammatory cytokines released by 
these cells may have stimulated prolonged p38 and ERK1/2 activation.  Moreover, 
chronic re-injury of the peridural tissue resulting from local destabilization of the 
laminectomized spinal column may have also contributed to the sustained activation of 
p38 and ERK1/2 MAPK observed at 3 and 21 days post-surgery. In contrast, the 
micromass co-cultures contained only myoblast and fibroblast cells in a controlled 
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environment that is devoid of inflammatory cell influences and chronic biomechanical 
stress.  
Importantly, the 21 day peridural scar tissue from OTC treated rats showed 
significantly lower levels of both ERK activation and p38 MAPK activation when 
compared to scar tissue from saline treated control animals. In contrast, levels of 
phosphorylated ERK1/2 and p38 in peridural scar tissue from quercetin treated rats were 
similar to the saline control group. (see Figure 25 and 26). The reduction of ERK1/2 and 
p38 MAPK activation following OTC treatment was especially notable, as this was the 
only consistent tissue response to drug treatment that was observed in our in vivo spinal 
laminectomy model of peridural wound repair. The functional significance of altered 
MAPK signaling to the processes of scar formation and tissue healing in this model 
remains to be determined. It has been suggested that p38 /ß MAPK activation can 
function as a molecular switch for both satellite cell activation (Jones et al., 2005) and 
subsequent differentiation of these satellite cells to muscle fibres to repair damaged 
muscle (Chen et al., 2007).  The reduced p38 MAPK activation is thought to be essential 
for regenerating muscles tissues lost at the wound site.  
The reduced ERK1/2 and p38 MAPK activation levels in the OTC treated animals 
might also be due to the cytoprotective properties of OTC through improving cellular 
glutathione level. The improved cellular glutathione level may help attenuate effects of 
stress stimuli associated with biomechanical stress at the laminectomized region and 
inflammatory stimuli associated with muscle tissue healing (Kamencic et al., 2001; Lee 
et al., 2005; Ferreira et al., 2009). Moreover, the ability of the ERK1/2 and p38-MAPK 
pathways to cross talk (Xiao et al., 2002) suggests the possibility that specific inhibition 
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of either one of these pathway by OTC at molecular level could lead to synergistic 
inhibition of the other pathway (See Appendix 3, A).  
High doses of quercetin have been reported to delay muscle differentiation 
through its pro-mitogenic activity that disrupts the differentiation program of myoblasts 
(Orzechowski et al., 2001). Moreover high doses of quercetin also inhibit cell migration 
and proliferation of malignant cells (Huang et al., 2005), vascular endothelial smooth 
muscle cells (Tan et al., 2003) and osteoblasts (Nam et al., 2008) through inhibition of 
MAPK signaling.  
In this study, the phosphorylation levels of p38 MAPK and ERK1/2 were 
unchanged in peridural scar tissue from quercetin treated animals as compared to the 
saline control. An in vitro study demonstrated that quercetin inhibited both ERK1/2 and 
p38 MAPK activity in lipopolysaccharide treated RAW267.7 macrophage cells 
(Wadsworth et al., 2001). However, another study observed that quercetin treatment did 
not affect either p38 MAPK or ERK1/2 activation in primary rat vascular smooth muscle 
cells in vitro (Perez-Vizcaino et al., 2006). Collectively these findings suggest that 
quercetin might exert variable effects on the ERK1/2 and p38 MAPK signaling pathway 
in different cell types.  
It is interesting to note that the 30 M concentration of quercetin used by Perez-
Vizcaino et al (2006) was close to the dose (0.025 mmol/kg; or approximately 25 M) 
that was administered to animals in our in vivo experiments. However, their experiment 
demonstrated that at 30 M concentration, quercetin inhibited JNK activation in vascular 
smooth muscle cells, although it did not affect ERK or p38 MAPK. It could be possible 
that the 0.025-mmol/kg concentration of quercetin administered to the animals in our 
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study was not high enough to exert any effect on p38 MAPK or ERK1/2 activation within 
the peridural scar tissue in vivo. Due to time constraints, we did not explore the possible 
effects of quercetin and OTC on JNK activation in peridural scar tissue.  
 
 
5.1.6  Limitations of the spinal laminectomy wound repair model and possible 
reasons for the large animal to animal variation encountered. 
 
The rat spinal laminectomy model proved to be a very difficult system for 
quantifying molecular parameters of scar formation and wound repair. As noted above, 
experiments using this in vivo model of peridural scar formation revealed wide animal to 
animal variation in the expression levels of collagen biosynthesis markers and specific 
gene transcripts within each drug treatment group (OTC, quercetin, and saline).  
This problem was also encountered by our collaborators who examined the 
accumulation of mast cells, activated macrophages, CD4 and CD8 T-lymphocytes within 
peridural scar tissue of the same rats (Cox, 2008). Similarly, a previous study involving a 
rabbit model of spinal laminectomy surgery failed to demonstrate any significant 
difference in levels of fibroblasts and immune cells within the peridural granulation tissue 
in animals treated with the non-steroidal anti-inflammatory drug- aceclofenac (Sandoval 
and Hernandez-Vaquero, 2008). This was attributed to huge animal to animal variation in 
the experimental model.  Indeed, such variability may be a problem inherent to such a 
complex in vivo model of post-surgery wound healing that involves multiple cell types, 
and both incisional and excisional types of tissue injury.  
Among humans, different individuals experience different levels of inflammation 
and scarring following tissue injury based on their ethnicity, health status, environmental 
exposure and diet (Bayat et al., 2003; Robles and Berg, 2007). For example, the 
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incidence of keloidal scarring is determined by hereditary traits in humans, with greatest 
predominance in members of the African race (Bayat et al., 2003; Robles and Berg, 
2007).  
Genetic differences may have contributed to variability in cellular and molecular 
parameters of scar formation among the individual animals used in our spinal 
laminectomy experiments. Although our study used rats of the same breed and gender 
(male Wistar rats), no special precautions were taken to ensure that all animals were 
derived from the same breeding line. Moreover, the small sample size used in our animal 
study might have also contributed to type II statistical error ( error) suggesting the lack 
of anti-scarring effects of quercetin and OTC in peridural tissues. In future drug 
development studies involving similar in vivo experimental models, it would be advisable 
to ensure that all animals employed are from the same genetic breeding line, and that the 
sample size is sufficiently large. 
Secondly, the complexity of the surgically-induced wound repair model that we 
employed in our study is likely to have been a contributing factor to the animal to animal 
variation observed. The rat spinal laminectomy surgery involved multiple forms of 
incisional, excisional and blunt tissue trauma. This included damage to the vertebral bone 
laminae to expose the spinal cord, disruption of connective tissue around adjacent 
skeletal muscles and ruptured blood vessels. In such a model, it is very difficult to 
rigorously standardize the initial amount of tissue damage due to surgery among various 
animals in the test groups, which would lead to variable extents and rates of tissue 
inflammation, peridural scarring, and wound repair. Moreover, the instability generated 
in the spinal column as a result of ligament damage from surgery may have also 
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contributed to variability in the amount of scarring. In some animals this spinal 
destabilization and increased vertebral mobility may have caused biomechanical stress at 
the surgical site causing chronic re-injuring of the wound area, which could stimulate a 
prolonged inflammatory response. Thus, differences in the extent of ligament damage 
might have resulted in variability in animal responses and the degree of scarring. 
However, our experimental strategy was to select an animal model that mimicked 
peridural scarring following elective spinal surgery in a clinical setting, where some 
variability is unavoidable. 
In regards to the quercetin treated animals, the method of drug delivery may have 
been an additional source of variability. Quercetin was administered intraperitoneally as a 
suspension in normal saline. When test animals were sacrificed for tissue analysis, the 
abdominal cavities of some quercetin-treated rats were observed to retain insoluble drug 
particles.  Hence, there may have been substantial variability in the effective circulating 
dose of quercetin among different animals in the test group. 
Finally, the specific doses of quercetin (0.025 mmol/kg) and OTC (1 mmol/kg) 
that were administered to the animals in our study may not have been the optimum doses 
for eliciting treatment effects on peridural scar formation. The specific OTC and 
quercetin doses that we employed were chosen based on earlier experiments by our 
collaborators; who had demonstrated their efficacy in restoring neurological function in 
rats subjected to surgically-induced spinal cord injury (Kamencic et al., 2001; Schultke et 
al., 2003). Subjective morphological observations suggested that these drug doses might 
also ameliorate associated cutaneous and peridural tissue healing, and therefore might be 
within a potentially therapeutic range for anti-scarring effects.  
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A more thorough set of dose response experiments and collection of peridural scar 
tissues at a greater number of post-surgical time points - might have revealed more 
consistent effects of OTC and quercetin at certain concentrations, and may have revealed 
some differences in gene and protein expressions that were missed in our study. 
However, such studies -would be prohibitively expensive, labour intensive and require a 
much large number of test animals. This highlights the need for a reliable, cost-effective 
in vitro organotypic wound repair model for preliminary drug screening studies including 
determination of effective drug concentrations. Hence, the remainder of my thesis 
research focused on developing a novel three-dimensional in vitro wound repair model 
utilizing fibroblast and myoblast cells in co-culture.  
 
5.2.  Outcomes of in vitro wound repair studies in a micromass co-culture model 
 The predominantly inconclusive outcomes of the in vivo studies prompted me to 
initiate experiments aimed at developing a novel three-dimensional scaffold-free in vitro 
wound healing model that might mimic aspects of in vivo peridural scar formation and 
tissue repair. This in vitro model was used for testing the potential efficacy of OTC and 
quercetin as anti-fibrotic agents. Studies have hypothesized that excessive 
scarring/fibrosis in skeletal muscles tissues might be due to the interaction of injured 
muscle cells with fibroblast cells from the surrounding connective tissue (Ambrosio et 
al., 2008; Clark, 1996; Lehto et al., 1985a; Lehto et al., 1985b; Sasse et al., 1981).  This 
cell-cell interaction may stimulate fibroblast cells to produce cytokines such as TGF-, 
interleukins and FGFs that can initiate muscle fibrosis and poor muscle regeneration. Our 
in vivo studies showed the presence of both immature myoblasts and fibroblast cells in 
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the peridural scar tissue. Therefore, we initially tried to isolate viable primary fibroblasts 
and myoblast cells from the abdominal skin of fetal rat and gluteus muscle of the adult rat 
respectively. These tissues were treated with trypsin-EDTA solution and collagenase for 
a period of 3 - 6 h at 37C to digest of extracellular matrix proteins and chelate Ca 2+ 
ions. The tissues were then gently agitated to dissociate cells and passed through sterile 
muslin filter to remove of large cell debris. The filtrant containing dissociated cell 
suspension were immediately inoculated into sterile DMEM-F12 culture medium 
containing 20% FBS, and subsequent passaged several times in sterile culture medium 
containing 10 % FBS over the period of four month, to isolate strongly adherent dermal 
fibroblasts and adult myoblast cells.  We found that when micromass cultures of primary 
fibroblast and myoblast cultures were prepared, these cultures tended to show poor 
adherence to the culture plate. We suspect that the primary fibroblasts and myoblast cell 
cultures obtained from the fetal and adult tissues may not be pure cultures. The persistent 
problem that we encountered while isolating primary fibroblast or myoblast cells from 
both embryonic and adult rats was contamination with other primary cell types. Hence, 
we selected an in vitro model that incorporated a well-defined rat fibroblast and myoblast 
cell lines obtained from American Type Cell Culture (ATCC).  
 
5.2.1.  Micromass cultures established with a seeding ratio of 1 part FR fibroblast 
and 3 parts L8 myoblast cells form a 3-D “microtissue” that expresses MyoD 
and fibroblast marker proteins.  
  
Micromass culture technology has been widely employed in developmental 
studies of bone and cartilage formation in vitro. Its potential utility in soft tissue 
regeneration and engineering applications was discussed in Section 2.7.  The novelty of 
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our approach was the combination of cell types of two different lineages (myoblasts and 
fibroblast cells) in a high-density co-culture to generate a 3-D “microtissue” that is 
devoid of artificial scaffold. This microtissue was subjected to a single scrape wound to 
study the wound closure pattern following a laceration type injury, the interaction of 
myoblast and fibroblast cells, and molecular changes associated with scar formation and 
tissue repair.  
The western blot data from our in vivo studies had indicated that peridural scar 
tissue contained MyoD positive myogenic cells, while the expression of P4H, a fibroblast 
marker protein suggested the additional presence of fibroblast cells (see Figures 15, 16, 
23).  Therefore, our micromass co-culture model of peridural tissue repair included L8 
myoblast cells, a well characterized adult muscle derived cell line that expresses high 
levels of the myoblast marker, MyoD, and which has the ability to differentiate into 
skeletal muscle fibres when propagated in medium containing horse serum (Richler and 
Yaffe, 1970).  
Our micromass co-cultures also included FR 3T3 cells, a well-characterized line 
of fibroblastic cells derived from fetal rat skin. Since FR 3T3 cells are of fetal origin they 
may exhibit a level of cellular plasticity initiated through direct cell-cell contact 
(Fukuhara et al., 2003 and Lu et al., 2005) or may produce chemical factors that could 
prevent de-differentiation of L8 myoblast in the co-culture condition. In initial 
experiments, we generated high-density micromass co-cultures by modulating the relative 
seeding densities of L8 myoblasts and FR fibroblast cells. It was demonstrated that a 1:3 
ratio of FR fibroblasts to L8 myoblast cells developed a cohesive microtissue layer in 
vitro. The accumulation of picrosirius red stainable collagen and Alcian blue stainable 
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polysaccharides clearly demonstrated that the micromass co-culture is rich in the 
extracellular matrix components that contribute to microtissue formation (see Figure 31). 
Moreover, SEM images of the micromass co-culture may suggest the integration of the 
FR fibroblast and L8 myoblast cells into a 3-D microtissue structure in vitro (see Figure 
29). SEM images of the 8 day post wounded culture suggest integration and compaction 
of cellular and extracellular matrix components in the healed micromass culture (see 
Figure 30, Panel F).  Studies involving co-cultures of fibroblasts and hepatocytes have 
shown that the hepatocytes tend to aggregate to form a mass surrounded by fibroblast cell 
layer (Bhatia et al., 1997; Khetani and Bhatia et al., 2008). We cannot yet discount the 
possibility that some degree of cell sorting might also have occurred in our 
fibroblast:myoblast micromass co-culture system. A more detailed analysis using 
confocal fluorescent microscopy could be employed to resolve this issue.  
Micromass cultures seeded at a 1:3 ratio of FR fibroblasts to L8 myoblasts were 
also able to best withstand a scrape wound manipulation without detaching from the 
culture dish.   This ratio may have enabled optimal heterotypic cell interaction between 
the FR fibroblast and L8 myoblast cells to establish a cohesive microtissue layer with 
superior intercellular adhesion as well as cell-substrate adhesion properties.  
Micromass cultures composed of FR fibroblasts alone quickly detached from the 
culture dishes after wounding. Cultures composed of L8 myoblasts alone were initially 
able to withstand the wound manipulation, but by 5 days of culture the cell layer curled 
up and detached from the culture dish. This may be due to the ability of L8 myoblast cells 
in homogenous micromass culture to differentiate into contractile myotubes as shown by 
the contraction of 8 day post wounded cultures (see Figure 28).  
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It was observed that MyHC and tropomyosin protein (markers of differentiated 
skeletal muscle fibres) were expressed in 3-day micromass cultures containing L8 
myoblast cells alone (see Fig 36). The presence of fibroblast cells in 1:3 micromass co-
cultures appeared to inhibit differentiation of the L8 myoblast cells into myotubes as 
confirmed by the absence of myogenic differentiation markers such as MyHC, OPN and 
tropomyosin in fibroblast: myoblast co-cultures (see Figure 36). Moreover, wounding of 
the micromass co-culture did not induce the expression of MyHC or OPN proteins (see 
Figure 37).   
Previous studies have reported that the presence of fibroblast cells can prevent the 
differentiation of liver and chondrocyte cells in vitro (Bhatia et al., 1997; Gerstenfeld et 
al., 2003; Khetani and Bhatia, 2008; Lu et al., 2005). The mechanisms by which 
fibroblast cells in co-culture might inhibit myoblast differentiation is unknown, but could 
involve soluble secreted agents such as growth factors and pro-mitogenic cytokines, or 
cell surface interactions mediated by integrins or other adhesion proteins.  
 
5.2.2.  Cell proliferation and preferential migration of fibroblast cells towards the 
wound site in wounded micromass co-cultures. 
 
Our data strongly suggest that the process of in vitro wound closure in our 
micromass co-culture model is primarily dependent on cell proliferation. We 
demonstrated that wound closure was effectively blocked by treating wounded cultures 
with 10 µg/mL mitomycin, (see Figure 40-41) a DNA cross-linking drug that has been 
shown to potently inhibit cell proliferation in a wide variety of different cell types 
without disrupting cell migration (Gottrup, 2000 and Stojadinovic et al., 2005). 
Accordingly, migration of cells from the wound edges in the absence of concurrent cell 
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proliferation does not appear to be sufficient to promote closure of the wound gap in 
fibroblast:myoblast micromass co-cultures. However, a limitation of our study was that 
we did not directly confirm that mitomycin exposure inhibited DNA synthesis in our FR 
and L8 cell lines (e.g. by assaying bromodeoxyridine or 
3
H-thymidine uptake into 
mitotically dividing cells). Also, we cannot fully exclude the possibility that mitomycin 
might have exerted some direct inhibitory effect on cell motility in our micromass 
cultures in addition to its presumed effect on cell proliferation. (Gottrup, 2000 and 
Stojadinovic et al., 2005).  
When FR fibroblast and L8 myoblast cells were labeled with DiI and DiO 
lipophilic dyes to track their migration in wounded micromass co-cultures, it was 
observed that fibroblast cells as well as some myoblast cells migrated into the wound gap 
(see Figure 43). However, quantitative analysis of the relative fluorescence intensities of 
DiI labeled FR fibroblast cells versus DiO labeled L8 myoblast cells suggests that the 
fibroblast cells preferentially localize to the region of wound site and wound edges (see 
Figure 44). Similar findings have been described for in vivo wound healing. Preferential 
fibroblast migration and proliferation at the wound site is necessary for providing matrix 
components that lead to eventual closure of the denuded region following dermal injury 
(Schreier et al., 1993). Fibroblast cell migration and proliferation may also play a critical 
role in excessive scarring (Ambrosio et al., 2008; Clark, 1996; Lehto et al., 1985a; Lehto 
et al., 1985b; Sasse et al., 1981).  
The growth factors PDGF and TGF- caused increased fibroblast migration in an 
in vivo incisional model of rat dermis wound repair (Pierce et al., 1988) and TGF- 
signaling has been implicated in fibrotic scarring (Leask and Abraham, 2004). In our 
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experiments, TGF-1 treatment of wounded micromass co-cultures caused accelerated 
wound closure (see Figure 48-49) with significantly increased migration of fibroblast 
cells and decreased migration of myoblast cells into the wound gap (see Figures 50, 51).  
In micromass cultures composed of fibroblast cells alone, TGF-1 treatment 
stimulated a dose-dependent increase in total DNA and total collagen levels (see Figure 
46).  In contrast, TGF-1 led to a dose-dependent decrease in both total DNA and 
collagen levels in micromass cultures composed of L8 myoblasts alone (see Figure 47). 
Collectively, these findings suggest that the accelerated wound closure in the wounded 
micromass co-cultures exposed to exogenous TGF-1 might be due to increased 
migration and proliferation of FR fibroblasts into the wound region as opposed to the L8 
myoblast cells.  
We also observed that treatment with relatively high concentrations (0.2 - 0.4 
ng/mL) of TGF-1 resulted in a curling up and eventual detachment of the micromass co-
cultures from the culture plates (data not shown). L8 myoblast cells are reported to 
differentiate into contractile skeletal muscle fibres following exogenous TGF-1 
treatment (Endo and Nadal-Ginard, 1987). In addition to reducing L8 myoblast cell 
proliferation in the micromass co-culture, exogenous TGF-1 treatment might also 
induce differentiation of myoblast cells because of the absence of pro-mitogenic stimuli. 
Due to time constraints, we could not examine the expression of MyHC, myogenin or 
tropomyosin in TGF-1 treated cultures.  
Collectively, these experiments suggest that cell proliferation plays an important 
role in the in vitro tissue repair of wounded micromass co-cultures. There is preferential 
migration of fibroblast cells into the wound site following injury, and exogenous TGF-1 
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treatment promotes increased fibroblast migration and proliferation in the wounded 
micromass co-culture. These properties parallel features of in vivo wound repair (Clark et 
al., 2004; Mustoe et al., 1987).  
 
5.2.3.  Endogenous TGF-3 gene transcript levels were significantly higher 
compared to TGF-1 gene transcripts in both wounded and corresponding 
unwounded cultures suggesting a possible link to in vivo peridural scar 
tissue. 
 
Semi-quantitative RT-PCR analysis indicated that the micromass co-cultures 
showed higher TGF-3 mRNA levels relative to TGF-1 transcript levels at all time 
points tested in both unwounded and wounded conditions (see Figure 38, 39). Specific 
TGF- isoforms such as TGF-3 may exert either proliferative or anti-proliferative 
effects depending on cell type and oxygen levels in vitro (Halper et al., 2005; Scheid et 
al., 2002). In cultures of fetal fibroblast cells, physiologically low oxygen concentrations 
in culture media were shown to elevate TGF-3 expression (Halper et al., 2005; Scheid et 
al., 2002). Accordingly, the relatively high endogenous TGF-3 transcript levels in this 
in vitro co-culture might reflect the partially hypoxic conditions of the micromass culture 
system.  
Endogenous TGF-3 expression may provide mitogenic conditions that 
discourage L8 myoblast cells from differentiating into skeletal muscle fibres in the 
micromass co-cultures. In an earlier experiment, exogenous TGF-1 treatment was found 
to decrease DNA levels of L8 myoblast cells in the micromass co-culture (see Figure 47) 
suggesting that high TGF-1 levels in the culture media might induce differentiation of 
myoblast cells within the micromass co-culture.  
Studies have shown that TGF-3 can modulate the pro-fibrotic TGF-1 signaling 
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during the wound healing process, suggesting its potential use in anti-scarring therapy 
(Occleston et al., 2008; Shah et al., 1995). It was observed that TGF-3 inhibited 
differentiation of MyoD expressing C3H10T1/2 cells and C2C12 myoblasts (Lafyatis et 
al., 1991; Liu et al., 2001). Thus, it can be postulated that high endogenous levels of 
TGF-3 in the micromass co-culture might counteract the actions of TGF-1 in 
promoting myoblast differentiation within this in vitro wound model. Due to limitations 
of the methods used to detecting TGF- isoforms in our experiments, this postulate could 
be explored in future using more sensitive molecular detection techniques  
Interestingly, the relative expression of TGF- isoforms in the micromass co-
culture paralleled the relative expression pattern of TGF-3 versus TGF-1 isoforms in 
the peridural scar tissue isolated from the laminectomized rats. This finding suggest that 
the artificial microtissue developed by co-culturing 1:3 ratio of FR fibroblast and L8 
myoblast may have a molecular characteristics of in vivo peridural scar tissue. 
 
5.2.4.  Gene and protein expression profiling of the wounded and corresponding 
unwounded micromass co-culture suggests a potential tool for future drug 
development studies. 
 
Semi-quantitative RT-PCR analysis was used to determine whether wounding of 
the micromass co-cultures resulted in altered expression of several genes involved in 
tissue repair. The expression of TGF-1, TGF-3, CD 44, hyaluronan synthase 1 and 
hsp-47 gene transcripts were significantly higher in 2 day post wounded cultures as 
compared to their corresponding unwounded cultures (see Figure 38 and 39). TGF-3, 
RHAMM, hyaluronan synthase 1 and hsp-47 mRNA levels were also higher in 2 day post 
wounded cultures than in 4 or 8 day post wounded culture.  
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Hyaluronan synthases are involved in hyaluronan production which promotes cell 
motility through interaction with its cell surface receptors RHAMM and CD44 (Fraser et 
al., 1997; Sherman et al., 1994; Tolg et al., 2006; Toole, 1990). Both CD44 and 
RHAMM also regulate cell proliferation by regulating cell cycle progression through 
G2M, which requires hyaluronan and growth factor-mediated ERK activation (Fraser et 
al., 1997; Sherman et al., 1994; Tolg et al., 2006; Toole, 1990). Thus, the relatively high 
levels of RHAMM and Hyaluronan synthase 1 in 2 day post wounded micromass co-
cultures might be associated with more rapid cell proliferation and cell motility at this 
time point as compared to 4 day and 8 day post wounded culture, when the wound site is 
covered by cells.   
The expression of collagen, hsp-47 and hyaluronan synthase mRNAs is consistent 
with active biosynthesis of extracellular matrix collagens and polysaccharides in these 
cultures, as evidenced by their accumulation of both picrosirius red and alcian blue 
stainable matrix. The expression of TGF-3 in 2 day post wounded micromass co-
cultures was significantly higher than in corresponding unwounded cultures suggesting a 
potential role of TGF-3 in regulating the biosynthesis of collagen and polysaccharides in 
the early in vitro wound repair process.  
In all these experiments, the entire micromass culture (for both wounded and 
corresponding unwounded cultures) was used for preparing RNA as opposed to isolating 
RNA exclusively from cells located at the wound site. As such, it is possible that we 
failed to detect modest quantitative changes in gene transcript levels that were spatially 
restricted to cells within the wound site. Similarly, the magnitude of those wound-related 
changes in gene transcript levels that were detected might have been underestimated. 
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Possible approaches for determining spatially localized changes in gene transcript 
expression within the wound region would be laser capture microdissection to isolate the 
cells from the wound region for RT-PCR quantitation, or mRNA detection by whole-
mount in situ hybridization. Undoubtedly, these approaches would provide valuable 
insight on localized changes in gene activation induced by wounding in our micromass 
co-culture model. However, time and resource constraints prevented us from initiating 
further experiments in this direction. Another potential limitation of our RT-PCR analysis 
was relying on GAPDH mRNA levels alone as an internal normalization control. It may 
be advantageous to include other constitutively expressed gene transcripts as 
normalization controls in future RT-PCR analyses to more accurately estimate relative 
changes in the mRNA levels of our various specific genes of interest. 
Immunostaining experiments on wounded micromass co-cultures showed the 
presence of type I collagen protein at the wound site. Fibronectin was expressed at the 
wound edges as well as at the periphery of the micromass cultures and within the cells 
that migrate into the wound site (see Figure 32). However, the overall expression of 
fibronectin in the micromass co-culture appeared to be lower as compared to type I 
collagen, based on the much longer time taken for a positive color reaction to develop in 
the immunostaining procedure.  
Types I, III and IV collagens are common collagen proteins that play an important 
role in the formation of tissue structures and production of type I collagen is a critical 
component of any tissue repair process (McMinn, 1967). The presence of type I collagen 
at the wound site within the wounded micromass co-cultures and higher levels of type I 
collagen as opposed to types III and IV collagen gene transcripts in the wounded 
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micromass co-culture suggests a predominant role of type I collagen in the in vitro tissue 
repair process. The presence of fibronectin together with type I collagen at the wound site 
is consistent with in vivo findings that both fibronectin and type I collagen are co-
localized in scar tissue (Clark et al., 1982; Clark et al., 2004; McKeown-Longo and 
Mosher, 1984; Tamkun and Hynes, 1983). 
 
5.2.5.   Modulation of p38 MAPK and ERK1/2 signaling pathways has differential 
effects on in vitro wound closure. 
 
The ERK1/2 and p38 MAPK signaling pathways are activated in epithelium and 
muscle tissue following injury (Sharma et al., 2003; Yeow et al., 2002). Western blot 
analyses revealed that active dual phosphorylated ERK1/2 was present both in wounded 
and unwounded FR: L8 cell micromass co-cultures (see Figure 52), though there was an 
increase in levels of ERK1 and ERK2 phosphorylation at 5 min post wounding compared 
to the corresponding unwounded culture.  
Immunostaining suggested that the dual-phosphorylated ERK1/2 was most 
concentrated within the cells at the micromass culture wound edges, whereas total 
ERK1/2 protein was abundant throughout the wounded culture. This suggests that 
ERK1/2 activation is a component of the injury response in the micromass co-culture 
wound model (see Figure 53). Previous in vitro studies utilizing a 2-D skeletal muscle 
repair model have similarly reported that ERK1/2 expression is localized in the wound 
site in C2C12 muscle cell cultures (Yeow et al., 2002).  
The increased ERK1 and ERK2 phosphorylation in 5 min post-wounded cultures 
might lead to stimulation of cell proliferation and cell migration at the wound edges. 
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When the ERK1/2 signaling pathway was inhibited by treating the wounded micromass 
co-culture with 2 M of PD184352, there was a significant decrease in the rate of wound 
closure as compared to untreated cultures (see Figure 57 and 58). PD184352 is a highly 
specific inhibitor of MEK1 and MEK 2, the upstream MAPKKs that activate ERK1 and 
ERK2 in the ERK signaling cascade (Davies et al., 2000). Western blot analysis 
confirmed that 2 M of PD184352 effectively inhibited phosphorylation of ERK1/2 in 
the micromass co-culture (see Fig 56).  
Studies have suggested that ERK1/2 phosphorylation is important for maintaining 
functionality and metabolic dynamics during the wound healing process (Xiao et al., 
2002). Our findings suggest that ERK1/2 activation might be necessary for signaling cell 
proliferation and migration in the wounded micromass co-culture and that ERK 
activation is important for optimum wound closure of the wounded micromass co-culture.  
Western blot analysis for active, dual phosphorylated p38 MAPK demonstrated a 
faint band in micromass co-cultures at 5 min after wounding, while immunostaining of 
the wounded micromass co-cultures revealed dual phosphorylated p38 MAPK at the   
wound edges at both 5 min and 1 day post wounding (see Figure 54 and 55).  The 
absence of any detectable p38 MAPK phosphorylation in unwounded cultures at all time 
points might account for the lack of muscle fibre differentiation within the micromass co-
cultures. Studies have shown that p38 MAP kinases play a regulatory role in the 
promotion of the expression of muscle-specific genes that are involved in muscle 
differentiation (Lluis et al., 2006; Zetser et al., 1999).  
The activation of p38 MAPK in the micromass co-culture was brief following 
injury, which is contrary to the situation in a 2-D in vitro skeletal muscle wound model 
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where activation of p38 MAPK was observed at all time points (0-72 h) tested (Yeow et 
al., 2002). However in vivo studies have shown that muscle injury initially results in 
activation of p38 that promotes MyoD expression, and that the accumulation of MyoD in 
the injured muscles causes a subsequent down regulation of p38 activity (Wu et al., 
2000). We observed that both unwounded and wounded cultures consistently expressed 
MyoD protein (see Figure 36 and 37) which might play a dynamic role in the regulation 
of p38 MAPK signaling in our system. The p38 MAPK activation was rapid and brief in 
5 min post-injury cultures and phosphorylated p38 levels were low at subsequent time 
points.  This transient expression pattern of phosphorylated p38 MAPK in our in vitro 
model, might suggest that wounding induced p38 activation, which could stimulate 
accumulation of MyoD protein. Once the MyoD protein reached a sufficient level, the 
p38 activation was inhibited. As such, our in vitro findings may be consistent with the in 
vivo studies conducted by Wu et al (2000).  
When p38 MAPK signaling was inhibited by 10 M of SB202190 treatment in 
the wounded micromass co-cultures, it resulted in accelerated wound closure (see Figure 
60). SB202190 is a highly specific inhibitor of p38 MAPK (Davies et al., 2000) and 
western blots confirmed that 10 M of SB202190 effectively inhibited phosphorylation 
of p38 MAPK in micromass co-culture (see Figure 59). Studies have shown that during 
in vivo mammalian skeletal muscle healing, p38 MAPK might be necessary for optimum 
skeletal muscle regeneration at later stages of the tissue repair process. However,  
persistent activation of p38 MAPK in early skeletal muscle repair process may impair 
overall skeletal muscle healing (Nguyen and Witzke, 1997; Wu et al., 2000).   
The treatment of the wounded micromass co-culture with 100 ng/mL of 
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anisomycin resulted in delayed wound closure (see Figure 60). Anisomycin also caused 
eventual disruption of the integrity of the wounded micromass co-culture. A plausible 
reason for this disruption could be that protein synthesis is required to maintain the 
micromass culture integrity. Anisomycin interferes with protein synthesis by binding to 
60S ribosomal subunits and blocking peptide bond formation (Ogawa et al., 2004). This 
triggers cellular stress responses including activation of p38 and JNK signaling cascades 
(Khurana and Dey, 2003). It was observed that 100 ng/mL of anisomycin caused 
sustained expression of dual phosphorylated p38 MAPK protein in the micromass co-
cultures (see Figure 59), which served as a positive control in our experiments for 
detecting dual phosphorylated p38 MAPK in western blots. 
The observations made in our newly developed micromass co-culture based 
wound repair model suggest its superiority over other in vitro skeletal muscle wound 
models in its ability to closely mimic early in vivo skeletal muscle tissue injury response. 
Our experiments also showed that p38 MAPK inactivation resulted in accelerated wound 
closure, while sustained ERK1/2 inactivation delayed wound closure in the micromass 
co-culture. Collectively, these findings indirectly suggest that both p38 and ERK1/2 
MAP kinases might be potential drug targets for wound healing modulators.  
 
5.3.  Quercetin and OTC treatment of wounded micromass co-culture of 1: 3 ratio 
of fibroblast and L8 myoblast cells suggest that they have differential effects 
on wound closure through their activity on MAPK signaling pathway, and 
modulating expression patterns of extracellular matrix gene transcripts.  
 
The final experiments utilized the 1:3 FR fibroblast: L8 myoblast micromass co-
cultures to examine the effects of OTC and quercetin on in vitro wound repair. When 
wounded micromass co-cultures were treated with 40 M of quercetin, it promoted a 
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delay in wound closure as compared to untreated wounded cultures (see Figures 67, 68 
b). The level of p38 MAPK was unaffected by quercetin treatment, while there was 
significant decrease in the level of active, phosphorylated ERK1/2 (see Figures 70, 71).  
In contrast, treatment of the micromass co-cultures with 1.5 mM of OTC resulted 
in accelerated wound closure at the 1-4 day time points as compared to wounded cultures 
maintained in control medium (see Figures 67 and 68 a). It was observed that OTC 
significantly decreased both p38 MAPK and ERK1/2 activation (see Figures 70-71).  
These observations indicate that p38 MAPK and ERK1/2 were consistent targets 
for OTC in both our in vitro micromass culture system and in our in vivo laminectomy 
model of peridural wound healing. In contrast, quercetin had no effect on p38 MAPK 
phosphorylation in either our in vivo or in vitro studies.  
In micromass co-cultures, treatment with 40 M quercetin decreased ERK1/2 
activation. On the contrary, when quercetin was administered to the animals in vivo at 
0.025 mmol/kg, no change in ERK1/2 activation was observed within the peridural scar 
tissue as compared to saline treated control animals. The contrasting effects of quercetin 
on ERK1/2 activation in vitro versus in vivo might be attributed to the lower dose 
administered to animals in vivo. In vitro dose response studies on the effects of OTC and 
quercetin in micromass co-cultures showed changes in total DNA and total collagen 
staining starting at higher concentration (> 1.0 mM for OTC and > 25 M for quercetin) 
of these molecules (see Figure 61-66).  Micromass co-cultures treated with 1.5 mM OTC 
or 40 M quercetin showed an inhibition of collagen biosynthesis and reduction in total 
DNA levels (see Figures 61 and 64). The doses of OTC (1.0 mmol/kg or 1.0 mM) and 
quercetin (0.025 mmol/kg or 25 M) that were administered in our live animal 
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experiments might not have been adequate for exerting detectable anti-scarring effects on 
the peridural tissue.  
In addition, the in vivo peridural tissue healing process not only involves myoblast 
and fibroblast cells but also other cellular components, such as inflammatory cells, blood 
products, which might contribute to differential changes observed in ERK1/2 activation 
following quercetin treatment. Moreover, it should be noted that a xenobiotic, such as 
quercetin, when administered systemically can undergo first pass metabolism to form 
metabolites which can also influence local cellular responses (Hollman et al., 1995; Huk 
et al., 1998; Juurlink and Paterson, 1998; Theoharides et al., 2001; Wang and Joseph, 
1999). First pass metabolism was not replicated in our in vitro model; however it would 
be possible to directly test the effects of the drug’s known first-pass metabolites on in 
vitro tissue repair. 
Middleton et al. (2000) have reported that quercetin inhibits p38 MAPK 
activation and decreases stress proteins such as hsp70 in malignant tumor cells and 
UV/H2O2 sensitized cells. This study showed that quercetin can exert its p38 MAPK 
inhibitory and anti-fibrotic activity on cells that have some degree of DNA damage 
caused by external stimuli. In our experiments, quercetin had no detectable effect on p38 
MAPK activation; whereas OTC treatment affected both the p38 and ERK1/2 MAP 
kinase pathways in micromass co-culture of FR fibroblast and L8 myoblast cells.  
To summarize, our in vitro data revealed that when micromass co-cultures are 
treated with 40 M quercetin or 1.5 mM OTC: 
1. Quercetin treatment delayed wound closure in vitro and reduced ERK1/2 
phosphorylation. A similar delay in wound closure was observed in cultures that 
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were treated with a specific ERK pathway inhibitor, PD184352. This suggests that 
quercetin’s ability to inhibit ERK activity might be a mechanism through which it 
delays wound closure in the micromass co-culture model.  
2. RT-PCR data revealed that transcript levels of the hyaluronan receptor CD44 were 
significantly higher in quercetin treated cultures at 2 day post wounding as 
compared to control untreated cultures at the same time point, while CD44 
transcript levels were significantly lower in quercetin treated cultures at 4 day post 
wounding relative to controls. Transcript levels of HAS 1 and HAS 3, as well as 
hyaluronan receptor RHAMM were elevated in quercetin treated cultures as 
compared to untreated control cultures at both 2 and 4 days post-wounding. Thus 
quercetin may modulate the expression of RHAMM, HAS 1, HAS 3 and CD44 in 
vitro. 
3. Picrosirius red staining showed that both OTC at 1.5 mM and quercetin at 40 M 
concentration significantly reduced collagen synthesis in micromass co-cultures.  
4. OTC treatment accelerated wound closure in micromass co-cultures, and decreased 
p38-MAPK activity. More rapid wound closure was also observed in cultures that 
were treated with a specific p38-MAPK inhibitor SB202190. The ability of OTC to 
inhibit p38-MAPK activity might be a mechanism through which it accelerates 
wound closure in the micromass co-culture.   
5. OTC treatment caused a slight decrease in ERK1/2 activation in the micromass co-
culture at 5 min post-wounding and increased the rate of in vitro wound closure.   
In contrast, sustained ERK inhibition in the presence of PD184352 delayed wound 
closure in the micromass cultures. This suggests that the transient decline in ERK 
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phosphorylation elicited by OTC treatment was probably of insufficient duration to 
negatively affect the rate of wound closure.  
6. Expression of mRNAs for hsp-47, a collagen-specific chaperone protein was 
increased in OTC treated cultures at 2 days post wounding as compared to 
untreated cultures. OTC treated cultures at 2 day post-wounding had decreased type 
I, III, IV collagen transcript levels, while only type IV and type I collagen transcript 
levels were found to be decreased at 4 day time-point. OTC at 1.5 mM 
concentration was found to reduce collagen biosynthesis in micromass co-cultures.  
Collectively, the findings suggest that OTC may reduce collagen production during 
the early phase of in vitro wound healing. It is still unclear how the changes in various 
other gene transcript levels that we observed influence the process of wound closure in 
this in vitro model. A more comprehensive transcriptomic and proteomic analysis using 
modern microarray strategies might help uncover the exact molecular mechanisms 
through which OTC and quercetin exert their effects. Nevertheless, these RT-PCR 
experiments demonstrate the potential utility of our micromass co-culture wound repair 
model for evaluating the effects of candidate wound modulating drugs on specific gene 
expression profiles.  
 
 
5.4  As compared to quercetin, OTC might have significant potential as an anti-
scarring drug through attenuation of p38 and ERK1/2 MAPK signaling 
mediated by a cytoprotective gene regulatory pathway. 
 
As discussed in Section 5.1.5 and 5.3, OTC was found to consistently affect p38 
and ERK1/2 MAPK activation both in vivo and in vitro. Moreover, OTC was found to 
reduce collagen biosynthesis and improve wound closure in vitro. On the basis of these 
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findings, together with previous reports suggesting the cytoprotective effects of OTC, we 
propose a hypothetical model of the possible mechanism of OTC action on peridural 
wound repair. One might speculate that the ability of OTC to promote cellular glutathione 
synthesis helps to activate the expression of cytoprotective genes and/or cellular 
homeostatic mechanisms. This might in turn help prevent excessive collagen production 
and improper post-translational modifications. The consistent inhibition of p38 MAPK 
and ERK1/2 signaling pathway by OTC observed in our in vitro model may also suggest 
the synergistic potential of elevated cellular glutathione levels in attenuating MAP kinase 
pathways (see Appendix 3, A). OTC is metabolized by 5-oxoprolinase intracellularly 
into cysteine, a rate limiting amino acid in glutathione (GSH) synthesis, which favors 
improved intracellular GSH levels. The physiochemical properities of OTC, such as its 
hydrophilic nature, may favor conversion of OTC into GSH, rather than taurine or 
sulfates in myoblast cells (Banks and Stipanuk, 1994, Ferreira et al., 2009). The increased 
intracellular GSH levels will in turn promote desired beneficial pharmacological and 
cellular effects.  Based on these properties, we propose that OTC has potential as an anti-
scarring agent through its ability to improve GSH levels that attenuate oxidative stress 
responses, by activating anti-oxidant and cytoprotective gene regulatory mechanisms by 
targeting the Nrf-2/Keap 1 complex (Zipper and Mulcahy, 2000; Yamamoto et al., 2007) 
in myoblast and fibroblast cells. Activation of the Keap1/Nrf-2 pathway might cause the 
attenuation of the p38 and ERK1/2 MAPK pathways observed in our in vivo and in vitro 
experiments. However, other molecular mechanisms targeting activation of the 
antioxidant response element (ARE) and/or attenuation of NF- signaling  that in turn 
attenuate p38 and ERK1/2 MAPK pathways cannot be ruled out  (Balogun et al., 2003; 
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Vayalil  et al.,2007; Peng et al., 2010). 
Previous studies have demonstrated that quercetin and its metabolites might also 
cause activation of a cytoprotective gene regulatory pathway (Juurlink and Paterrson. 
1998; Middleton et al.2000; Wadsworth et al. 2001) through multiple targets including 
activation of phase II enzymes (see Appendix 3, B). Inactivation of ERK1/2 and p38 
MAPK pathway by quercetin could also be achieved through these cytoprotective 
mechanisms (Huk et al., 1998; Theoharides et al., 2001) . However, in our study we 
observed that quercetin did not affect p38 MAPK activation which was contrary to 
previous studies (Huk et al., 1998; Middleton et al., 2000; Phan et al., 2003; Tan et al., 
2003; Nam et al., 2008; Jiang et al., 2008). Middleton et al. (2000) has shown that 
quercetin had potent anti-MAPK properities only on cells that had some level of DNA 
damage or are made susceptible through UV irradiation or hydrogen peroxide treatment. 
One possible explanation for the consistent expression of p38 MAPK in quercetin treated 
animals and wounded micromass cultures would have been that the cells tested in our 
study were normal and did not have any level of DNA damage, and this rendered 
quercetin impotent in exerting its anti-MAPK properties as observed in previous reports. 
Hence, our overall finding from in vitro and in vivo model appear to support the findings 
of Perez-Vizcaino et al. (2006), where it has been shown that quercetin did not affect 
either p38 or ERK1/2 activation in primary smooth muscle cells, and suggests that the 
quercetin might not affect either p38 or ERK1/2 signaling pathway in peridural scar 
tissues.   
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5.5. Conclusions  
 Our live animal studies using the spinal laminectomy wound repair model 
examined the effect of OTC and quercetin treatment on collagen accumulation in 
peridural scar tissues. Neither OTC nor quercetin treatment significantly altered 
picrosirius red stainable collagen levels in the tissue sections. Moreover, RNA dot blot 
and western blot analyses revealed no statistically significant changes in the expression of 
biomarkers of collagen biosynthesis (type I and III collagen, P4H, and hsp-47), possibly 
due to huge animal to animal variation within each of the drug treatment groups. 
Collectively, these whole animal studies yielded no substantial evidence to suggest that 
either OTC or quercetin was effective in reducing peridural scarring in vivo.  
One positive outcome of our in vivo experiments was that we were able to 
successfully correlate the synchrotron FTIR spectral maps of collagen distribution and 
orientation in tissue sections with picrosirius red polarized light images. Western blot 
analyses indicated that the peridural scar tissue contained MyoD positive cells with an 
apparent absence of differentiated muscle fibres. The presence of fibroblast cells was 
suggested by the expression of a fibroblast marker protein, P4H. It was also observed that 
OTC consistently reduced both p38 MAPK and ERK1/2 activation in peridural scar 
tissue, while quercetin had no effect on either p38 MAPK or ERK1/2 activation.  
Overall our in vivo experiments revealed numerous problems associated with the 
use of whole animal models, especially animal to animal variation that might be 
attributed to: 
i.) Use of a complex wound model system that incorporates both excisional and 
incisional forms of wounding.  
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ii.) Use of animals from different genetic breeding lines.  
iii.) The complexity of the peridural wound healing process in vivo. which makes it 
difficult to predict the most appropriate biomarkers and metabolic parameters to 
assay in testing the efficacy of potential wound modulating drugs.  
iv.) The possibility that the doses of OTC and quercetin employed were not optimal 
for eliciting effects on peridural scarring.  
v.) The potentially variable pharmacological actions of drugs such as quercetin and 
OTC on different cell types in vivo. Their pharmacological efficacy might be 
masked in a heterogeneous tissue system such as the peridural wound tissue. 
The second objective of my study was to develop a novel in vitro system that 
models peridural tissue repair in general and can be specifically applied to drug 
development studies on wound healing. We have demonstrated, for the first time, the 
potential utility of micromass co-culture technology towards developing a 3-D scaffold-
free in vitro wound-healing model.  We determined that a 1:3 seeding ratio of FR 3T3 
fibroblast cells and L8 myoblast cells would form a 3-D microtissue in vitro that 
expressed myoblast and fibroblast markers such as MyoD, P4H, and -sma. The 
expression of fibroblast and myoblast biomarkers in the micromass co-culture system 
suggested molecular similarities to peridural tissue isolated from laminectomized rats.  
The microtissue obtained was subjected to a single scrape and drug effects on 
wound closure rates could be quantified by the planimetry method. By labeling myoblast 
and fibroblast cells with fluorescent tracker dyes, we demonstrated preferential migration 
of fibroblast cells to the wound site.  
The method validation studies using TGF-1, modulators of MAPK signaling, 
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OTC and quercetin on this novel micromass co-culture model suggest its potential utility 
in rapid screening of candidate therapeutic agents for effects on the rate of wound 
closure. Thus, we describe for the first time the potential utility of micromass co-culture 
technology in wound healing and subsequent drug development research.  
Studies on the micromass co-cultures revealed OTC and quercetin significantly 
reduced collagen biosynthesis in vitro in a dose-dependent manner OTC accelerated the 
rate of wound closure while quercetin delayed the rate of wound closure in the wounded 
micromass co-cultures. OTC was found to inhibit both p38 and ERK1/2 MAP kinases 
during the early in vitro wound healing process, while quercetin inhibited ERK1/2 only. 
Thus, we demonstrated that OTC and quercetin may elicit distinct biological responses in 
the micromass co-culture wound repair model. 
Collectively, both the micromass co-culture experiments and live animal studies 
suggest p38, ERK1 and ERK2 as potential molecular targets through which OTC might 
mitigate tissue fibrosis or scarring. Evidence from in vitro studies suggests that OTC 
might exert anti-scarring properties especially during the initial wound healing process 
through its inhibition of injury induced p38 MAPK activation that helps to promote 
accelerated wound closure. OTC was also found to decrease collagen gene transcript 
levels while quercetin seemed to modulate expression of the gene transcripts for 
hyaluronan receptors, RHAMM and CD44.   
Our experiments suggest that quercetin may not be effective as an anti-scarring 
agent as it delays wound closure in vitro. In contrast, OTC may have some beneficial 
anti-scarring effects since it reduces collagen gene transcript levels and collagen 
deposition in micromass co-cultures and also accelerates wound closure in vitro. 
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5.6  Future directions 
As in the case of any research, these experiments have raised more questions than 
answers and have opened up potentially fruitful avenues for future investigations. Our 
novel micromass co-culture wound repair model can be employed to determine changes 
in gene transcript and protein levels for other biomolecules implicated in tissue healing 
process such as integrins, JNK, SMADs, osteopontin, MMPs, Pax-7, and calcineurin. It 
has been suggested that integrins and JNK play a crucial role in myofibroblastic 
transition, while Pax 7 and SMADs are involved in regulating cell-cell interactions 
during skeletal muscle repair (Allbrook, 1973; Ambrosio et al., 2009; Ambrosio et al., 
2008; Baker and Margolis, 1987; Best and Hunter, 2000).  
The extent of myofibroblastic differentiation within our 3-D micromass co-culture 
system should be investigated, as previous in vitro studies have demonstrated 
myofibroblastic differentiation in the cutaneous wound using a two dimensional 
monolayer culture system (Amadeu et al., 2003). It has been proposed that the Ca
2+
 
dependent cyclic AMP mediated signaling mechanism may play a crucial role in skeletal 
muscle injury as well as myofibroblastic transition, and differentiation (Allbrook, 1973; 
Ambrosio et al., 2009; Ambrosio et al., 2008; Baker and Margolis, 1987; Best and 
Hunter, 2000). Future investigations can explore the role of Ca
2+
 dependent cyclic AMP 
mediated signaling mechanism in myofibroblastic transition utilizing our newly 
developed in vitro wound model.    
Semi-quantitative RT-PCR technique was used to determine relative gene 
expression levels in our study. In the RT-PCR technique, the relative amplification 
efficiencies of the different gene transcripts in PCR could be influenced by differences in 
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primer’s affinity for their target, differences in length of the amplicon, and the extent of 
amplification of competing non-specific PCR products. Hence, it would be important to 
confirm our findings using more rigorous methods such as quantitative real-time PCR. 
Moreover, in future experiments it would be important to specifically characterize 
changes in gene expression within cells localized at the wound site. This could be 
accomplished through application of laser directed microdissection technique, in 
conjunction with genomic, metabolomic & proteomic tools (e.g. tandem mass 
spectrometry, cDNA, and protein microarrays) to comprehensively analyze gene 
expression changes resulting from wounding and drug treatments. Confocal fluorescence 
microscopy can also be employed to better characterize drug effects on cell migration. 
The utility of our micromass co-culture model for use in wound healing research 
should be validated using anti-scarring drugs with established efficacy such as Avotermin 
(a proprietary recombinant human TGF-3 protein). Growth factor inhibitors that target 
TGF- signaling pathway (including TGF-1 or CTGF antibodies) can also be tested.  
Moreover, the efficacy of novel candidate anti-scarring drugs should be tested alongside 
established anti-scarring drugs to assess their relative therapeutic potential.  
Alternative research could involve testing the inflammatory response during in 
vitro repair in the micromass tissue layers. The inflammatory condition can be mimicked 
in the micromass co-culture system by incorporating conditioned media obtained from 
the cultures of macrophages or other inflammatory cells.  
There is a clear potential to further refine the micromass model so that it would 
more closely mimic in vivo tissue repair. It would be possible to develop “tri-culture” or 
“tetra-culture” micromass system using three or four different cell types in combination 
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to more closely match the in vivo situation. In these systems, cell types such as 
endothelial cells, macrophages, and keratinocytes could be combined along with 
myoblast and fibroblast cells under micromass conditions.  Of course, the more cell types 
that are incorporated into the micromass culture model to the study wound healing 
process, the more difficult it becomes to optimize culture conditions, and to interpret 
experimental outcomes of drug exposures or other treatments. Additionally, as an 
alternative to the FR fibroblast and L8 myoblast cell lines used in our study, it might be 
possible to use various other rat myoblast cell lines (e.g. L6; H9c2) and fibroblast cell 
lines (e.g. Rat2; C6) to develop micromass co-cultures. 
The micromass wound model could also be modified by altering the type of 
wound inflicted on the culture such as inducing a punch wound using micropipette tip 
rather than a single scrape wound across the diameter of the micromass culture as utilized 
in this study.  A focal punch wound might elicit a different wound healing response in the 
micromass culture in which it is easier to determine localized changes in protein and 
mRNA expression. Similarly a chemical injury could be inflicted on the micromass tissue 
layer, such as the application of NaOH crystals. Thus, our micromass co-culture model 
could be applied to the study of a wide range of wound healing responses. 
The micromass co-culture technology developed in this study could be extended 
towards the utilization of human primary or immortalized cell lines as well as primary 
cells derived directly from human scar tissue. The primary advantage of using a human 
cell based micromass system is that the cultured “microtissues” might better mimic 
human tissue responses under in vivo conditions. These human microtissues could help to 
accelerate preclinical drug development research in a more cost-effective and efficient 
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manner. These microtissues can be used to test pharmacological (dose-response curve, 
absorption, distribution, metabolism, excretion and toxicity) and toxicological parameters 
of the potential therapeutic drug molecules by circumventing the need to use large 
number of animals during the initial pre-clinical screening and evaluation. 
It should be possible to develop experimental microtissues from cells of cardiac, renal 
and hepatic origin by adapting the micromass co-culture strategy that was used in this 
study. This approach may help to increase the ease and precision of early drug screening 
and validation in a cost-efficient animal-free setting. This will also provide a vast window 
of opportunity for drug discovery and multiple drug analyses at tissue level. Moreover 
these experimental cardiac, renal and hepatic “microtissues” would have immense 
potential for future autologous tissue transplantation therapy too. 
 Our preliminary qualitative comparisons of cutaneous scar formation in 
laminectomized rats suggested that both quercetin and OTC might ameliorate cutaneous 
scarring after a laceration injury.  This possibility should be investigated directly using a 
cutaneous wound healing model such as that described by Gottrup (2000), where 
duplicate skin incisions are inflicted on the back of a rat and the drug to be tested is 
applied to one wound while the other wound serves as matched control. Alternatively, a 
cutaneous punch wound model could be employed. The advantages of these in vivo 
approaches are better control of initial wound trauma, a more standardized wound healing 
response and the ability to use the same animal as test and control to reduce the influence 
of individual animal to animal variability.  
 A possible direction for future research could be to develop derivatives of 
quercetin that can be administered topically rather than the systemic delivery approach 
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employed in this study. Several avenues of multidisciplinary research could be pursued, 
such as development of topical drug delivery systems for quercetin, quercetin derivatives 
and OTC which would interest pharmaceutical scientists.  
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Appendix 1 
 
Pearson Correlation Coefficient analysis of Western blot data 
 
3 day Saline treated animal group 
 
 
           Col 1         P4H 
               
hsp-47 
              
fibronectin         VEGF           MyoD 
Animal 1 0.48 1 0.022647 1.2 0.48 0.90653 
Animal 2 1.21 1.01 0.872961 1.1 0.2 0.996609 
Animal 3 0.97 0.94 0.858557 0.1 0.45 0.905149 
Animal 4 0.18 0.9 0.76962 0.43 0.1 0.798078 
Animal 5 0.18 0.95 0.598568 0.32 0.3 0.899026 
Animal 6 0.1 0.99 0.535552 0.54 0.31 0.804432 
 
Correlations 
 Col_1 P4H hsp47 fibronectin VEGF MyoD 
Col1 Pearson Correlation 1 .356 .401 .267 .163 .831
*
 
Sig. (2-tailed)  .489 .431 .609 .757 .041 
N 6 6 6 6 6 6 
P4H Pearson Correlation .356 1 -.401 .749 .369 .554 
Sig. (2-tailed) .489  .431 .087 .472 .254 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation .401 -.401 1 -.520 -.553 .116 
Sig. (2-tailed) .431 .431  .290 .255 .827 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .267 .749 -.520 1 .050 .455 
Sig. (2-tailed) .609 .087 .290  .926 .365 
N 6 6 6 6 6 6 
VEGF Pearson Correlation .163 .369 -.553 .050 1 .229 
Sig. (2-tailed) .757 .472 .255 .926  .662 
N 6 6 6 6 6 6 
MyoD Pearson Correlation .831
*
 .554 .116 .455 .229 1 
Sig. (2-tailed) .041 .254 .827 .365 .662  
N 6 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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3 day OTC treated animal group 
 
 
Col 1 P4H hsp47 fibronectin VEGF MyoD 
Animal 1 0.39 0.71 0.572898 1.1 0.5 0.80435 
Animal 2 0.29 1 0.734155 0.9 0.6 0.863152 
Animal 3 0.59 0.54 0.519904 0.9 0.9 0.612262 
Animal 4 0.2 0.92 0.333608 0.1 0.2 0.900981 
Animal 5 0.16 0.99 0.304175 0.09 0.5 0.989166 
Animal 6 0.23 0.45 0.541185 0.1 0.2 0.965582 
 
Correlations 
 Col_1 P4H Hsp-47 fibronectin VEGF MyoD 
Col 1 Pearson Correlation 1 -.517 .402 .756 .797 -.976
**
 
Sig. (2-tailed)  .293 .430 .082 .058 .001 
N 6 6 6 6 6 6 
P4H Pearson Correlation -.517 1 -.191 -.101 -.058 .379 
Sig. (2-tailed) .293  .717 .849 .913 .458 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation .402 -.191 1 .714 .327 -.328 
Sig. (2-tailed) .430 .717  .111 .527 .526 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .756 -.101 .714 1 .697 -.733 
Sig. (2-tailed) .082 .849 .111  .124 .098 
N 6 6 6 6 6 6 
VEGF Pearson Correlation .797 -.058 .327 .697 1 -.792 
Sig. (2-tailed) .058 .913 .527 .124  .061 
N 6 6 6 6 6 6 
MyoD Pearson Correlation -.976
**
 .379 -.328 -.733 -.792 1 
Sig. (2-tailed) .001 .458 .526 .098 .061  
N 6 6 6 6 6 6 
**. Correlation is significant at the 0.01 level (2-tailed). 
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3 day quercetin treated animal group 
 
 
Col 1 P4H hsp47 fibronectin VEGF MyoD 
Animal 1 0.51 0.66 0.197129 0.95 0.5 0.702755 
Animal 2 1.4 0.75 0.547358 1 0.6 0.900551 
Animal 3 0.75 1 0.758774 1 0.7 0.847534 
Animal 4 0.45 0.66 0.394814 0.2 0.2 0.835191 
Animal 5 0.37 0.89 0.852326 0.25 0.1 0.647527 
Animal 6 0.51 0.5 0.908006 0.1 0.2 0.647262 
 
Correlations 
 Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Col 1 Pearson Correlation 1 .152 -.077 .642 .674 .727 
Sig. (2-tailed)  .774 .885 .170 .142 .102 
N 6 6 6 6 6 6 
P4H Pearson Correlation .152 1 .212 .455 .411 .330 
Sig. (2-tailed) .774  .686 .365 .419 .523 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation -.077 .212 1 -.418 -.284 -.317 
Sig. (2-tailed) .885 .686  .409 .586 .540 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .642 .455 -.418 1 .946
**
 .560 
Sig. (2-tailed) .170 .365 .409  .004 .248 
N 6 6 6 6 6 6 
VEGF Pearson Correlation .674 .411 -.284 .946
**
 1 .655 
Sig. (2-tailed) .142 .419 .586 .004  .158 
N 6 6 6 6 6 6 
MyoD Pearson Correlation .727 .330 -.317 .560 .655 1 
Sig. (2-tailed) .102 .523 .540 .248 .158  
N 6 6 6 6 6 6 
**. Correlation is significant at the 0.01 level (2-tailed). 
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21 day Saline treated animal groups 
 
 
Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Animal 1 1.65 0.57 0.007813 0.8 0.2 0.632793 
Animal 2 1.15 0.7 0.516958 0.75 0.35 0.64736 
Animal 3 0.61 0.17 0.951516 0.4 1 0.71688 
Animal 4 0.21 0.61 1.106112 0.11 0.92 0.504014 
Animal 5 0.83 0.84 0.562478 0.08 0.8 0.389074 
 
Correlations 
 Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Col 1 Pearson Correlation 1 -.206 -.755 .596 -.474 -.153 
Sig. (2-tailed)  .695 .083 .212 .342 .772 
N 6 6 6 6 6 6 
P4H Pearson Correlation -.206 1 -.323 -.035 -.503 -.109 
Sig. (2-tailed) .695  .532 .947 .309 .837 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation -.755 -.323 1 -.696 .851
*
 -.130 
Sig. (2-tailed) .083 .532  .124 .032 .806 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .596 -.035 -.696 1 -.825
*
 .650 
Sig. (2-tailed) .212 .947 .124  .043 .163 
N 6 6 6 6 6 6 
VEGF Pearson Correlation -.474 -.503 .851
*
 -.825
*
 1 -.423 
Sig. (2-tailed) .342 .309 .032 .043  .403 
N 6 6 6 6 6 6 
MyoD Pearson Correlation -.153 -.109 -.130 .650 -.423 1 
Sig. (2-tailed) .772 .837 .806 .163 .403  
N 6 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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21 day OTC treated animal group 
 
 
Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Animal 1 0.55 0.22 0.751364 0.08 0.5 0.393865 
Animal 2 1.15 0.28 0.816673 0.41 0.4 0.44936 
Animal 3 0.69 0.15 0.781308 0.44 0.2 0.536934 
Animal 4 0.51 0.56 0.989381 0.08 0.53 0.746584 
Animal 5 1.56 0.63 0.990881 0.26 0.9 0.758056 
Animal 6 1.55 0.89 0.988054 0.38 0.92 0.607397 
 
Correlations 
 Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Col 1 Pearson Correlation 1 .662 .527 .510 .751 .302 
Sig. (2-tailed)  .152 .283 .301 .085 .560 
N 6 6 6 6 6 6 
P4H Pearson Correlation .662 1 .908
*
 -.024 .897
*
 .650 
Sig. (2-tailed) .152  .012 .964 .015 .162 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation .527 .908
*
 1 -.122 .773 .892
*
 
Sig. (2-tailed) .283 .012  .818 .072 .017 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .510 -.024 -.122 1 -.133 -.169 
Sig. (2-tailed) .301 .964 .818  .802 .749 
N 6 6 6 6 6 6 
VEGF Pearson Correlation .751 .897
*
 .773 -.133 1 .526 
Sig. (2-tailed) .085 .015 .072 .802  .283 
N 6 6 6 6 6 6 
MyoD Pearson Correlation .302 .650 .892
*
 -.169 .526 1 
Sig. (2-tailed) .560 .162 .017 .749 .283  
N 6 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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21 day quercetin treated animal group 
 
 
Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Animal 1 0.69 0.41 1.101024 0.13 0.6 0.744669 
Animal 2 0.62 0.35 0.739451 0.13 0.4 0.520345 
Animal 3 1.68 0.28 0.745268 0.08 0.6 0.428783 
Animal 4 0.55 0.15 0.112771 0.4 0.15 0.646695 
Animal 5 1.95 0.9 0.993065 0.64 0.99 0.643122 
 
Correlations 
 Col 1 P4H Hsp-47 fibronectin VEGF MyoD 
Col 1 Pearson Correlation 1 .572 .297 .476 .850
*
 -.375 
Sig. (2-tailed)  .235 .568 .340 .032 .464 
N 6 6 6 6 6 6 
P4H Pearson Correlation .572 1 .660 .578 .744 .274 
Sig. (2-tailed) .235  .154 .230 .090 .599 
N 6 6 6 6 6 6 
Hsp-47 Pearson Correlation .297 .660 1 -.163 .610 .205 
Sig. (2-tailed) .568 .154  .758 .198 .697 
N 6 6 6 6 6 6 
fibronectin Pearson Correlation .476 .578 -.163 1 .475 .302 
Sig. (2-tailed) .340 .230 .758  .341 .561 
N 6 6 6 6 6 6 
VEGF Pearson Correlation .850
*
 .744 .610 .475 1 -.022 
Sig. (2-tailed) .032 .090 .198 .341  .967 
N 6 6 6 6 6 6 
MyoD Pearson Correlation -.375 .274 .205 .302 -.022 1 
Sig. (2-tailed) .464 .599 .697 .561 .967  
N 6 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix 2 
 
Pearson Correlation Coefficient analysis for RNA dot blot data 
 
3 day Saline treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 1.182907 0.915435 0.272722 0.797609 0.23623 
Animal 2 1.061624 0.7258 0.238535 0.888919 0.481482 
Animal 3 0.476795 0.699922 0.456184 0.442193 0.571203 
Animal 4 0.527858 0.640204 0.218011 0.053365 0.385466 
Animal 5 0.592655 0.727128 0.176038 0.013754 0.421831 
Animal 6 0.434129 0.638079 0.208718 0.111956 0.261611 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .822
*
 -.096 .858
*
 -.242 
Sig. (2-tailed)  .045 .856 .029 .644 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .822
*
 1 .104 .654 -.339 
Sig. (2-tailed) .045  .844 .159 .510 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation -.096 .104 1 .333 .554 
Sig. (2-tailed) .856 .844  .519 .255 
N 6 6 6 6 6 
TGF-1 Pearson Correlation .858
*
 .654 .333 1 .072 
Sig. (2-tailed) .029 .159 .519  .893 
N 6 6 6 6 6 
TGF- Pearson Correlation -.242 -.339 .554 .072 1 
Sig. (2-tailed) .644 .510 .255 .893  
N 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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3 day OTC treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 0.789886 0.841988 0.268747 0.198041 0.087223 
Animal 2 1.10997 0.874313 0.32999 0.328455 0.101627 
Animal 3 0.87796 0.784144 0.29549 0.129893 0.16222 
Animal 4 0.766323 0.63338 0.26886 0.172031 0.318604 
Animal 5 0.933822 0.801254 0.269984 0.174131 0.504125 
Animal 6 0.788143 0.777029 0.222838 0.215698 0.459215 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .631 .797 .682 -.271 
Sig. (2-tailed)  .179 .058 .135 .603 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .631 1 .394 .535 -.402 
Sig. (2-tailed) .179  .439 .274 .430 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation .797 .394 1 .425 -.672 
Sig. (2-tailed) .058 .439  .401 .144 
N 6 6 6 6 6 
TGF-1 Pearson Correlation .682 .535 .425 1 -.294 
Sig. (2-tailed) .135 .274 .401  .572 
N 6 6 6 6 6 
TGF- Pearson Correlation -.271 -.402 -.672 -.294 1 
Sig. (2-tailed) .603 .430 .144 .572  
N 6 6 6 6 6 
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3 day quercetin treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 0.82493 0.987679 0.253081 0.45282 0.135093 
Animal 2 0.801673 1.050476 0.283341 0.258012 0.291367 
Animal 3 1.184472 1.20092 0.130312 0.039712 0.339177 
Animal 4 0.888079 0.84331 0.224868 0.023602 0.427502 
Animal 5 0.959709 0.839985 0.196381 0.293294 0.833568 
Animal 6 0.723855 0.720947 0.146545 0.272166 0.717922 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .668 -.475 -.564 -.075 
Sig. (2-tailed)  .147 .341 .244 .888 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .668 1 .062 -.222 -.677 
Sig. (2-tailed) .147  .907 .673 .140 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation -.475 .062 1 .408 -.485 
Sig. (2-tailed) .341 .907  .422 .329 
N 6 6 6 6 6 
TGF-1 Pearson Correlation -.564 -.222 .408 1 -.059 
Sig. (2-tailed) .244 .673 .422  .911 
N 6 6 6 6 6 
TGF- Pearson Correlation -.075 -.677 -.485 -.059 1 
Sig. (2-tailed) .888 .140 .329 .911  
N 6 6 6 6 6 
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21 day Saline treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 0.908181 0.898813 0.561958 0.095241 0.372181 
Animal 2 0.362339 0.530395 0.279121 0.02433 0.179155 
Animal 3 1.073714 1.038854 0.83908 0.024347 0.449923 
Animal 4 0.812988 0.998869 0.613319 0.075691 0.70089 
Animal 5 0.491259 0.843626 0.345556 0.027657 0.477643 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .888
*
 .962
**
 .013 .537 
Sig. (2-tailed)  .018 .002 .980 .271 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .888
*
 1 .886
*
 -.053 .831
*
 
Sig. (2-tailed) .018  .019 .921 .041 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation .962
**
 .886
*
 1 -.221 .583 
Sig. (2-tailed) .002 .019  .674 .224 
N 6 6 6 6 6 
TGF-1 Pearson Correlation .013 -.053 -.221 1 .004 
Sig. (2-tailed) .980 .921 .674  .994 
N 6 6 6 6 6 
TGF- Pearson Correlation .537 .831
*
 .583 .004 1 
Sig. (2-tailed) .271 .041 .224 .994  
N 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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21 day OTC treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 0.494146 0.613201 0.32647 0.101966 0.672425 
Animal 2 0.725564 0.764158 0.462515 0.057863 0.456295 
Animal 3 0.704049 0.708877 0.309812 0.063957 0.545579 
Animal 4 1.106218 0.944009 0.72592 0.050554 0.809321 
Animal 5 0.593757 0.728231 0.386317 0.033035 0.656581 
Animal 6 0.841547 0.71912 0.382391 0.019847 0.742962 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .911
*
 .849
*
 -.458 .494 
Sig. (2-tailed)  .012 .032 .361 .319 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .911
*
 1 .948
**
 -.391 .374 
Sig. (2-tailed) .012  .004 .443 .465 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation .849
*
 .948
**
 1 -.207 .469 
Sig. (2-tailed) .032 .004  .693 .348 
N 6 6 6 6 6 
TGF-1 Pearson Correlation -.458 -.391 -.207 1 -.250 
Sig. (2-tailed) .361 .443 .693  .633 
N 6 6 6 6 6 
TGF- Pearson Correlation .494 .374 .469 -.250 1 
Sig. (2-tailed) .319 .465 .348 .633  
N 6 6 6 6 6 
*. Correlation is significant at the 0.05 level (2-tailed). 
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21 day quercetin treated animal group 
 
 
Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Animal 1 0.317662 0.439117 0.155278 0.061763 0.278716 
Animal 2 0.329453 0.513709 0.331661 0.055727 0.455142 
Animal 3 0.270706 0.460615 0.225728 0.050907 0.349767 
Animal 4 0.911584 0.926608 0.503845 0.079827 0.517295 
Animal 5 0.912142 0.764158 0.424319 0.093002 0.447622 
 
Correlations 
 Col 1(2) Col 3 (1) Col 4(1) TGF-1 TGF- 
Col 1(2) Pearson Correlation 1 .958
**
 .622 .402 .581 
Sig. (2-tailed)  .003 .188 .430 .226 
N 6 6 6 6 6 
Col 3 (1) Pearson Correlation .958
**
 1 .692 .354 .622 
Sig. (2-tailed) .003  .128 .492 .187 
N 6 6 6 6 6 
Col 4(1) Pearson Correlation .622 .692 1 -.379 .043 
Sig. (2-tailed) .188 .128  .459 .935 
N 6 6 6 6 6 
TGF-1 Pearson Correlation .402 .354 -.379 1 .870
*
 
Sig. (2-tailed) .430 .492 .459  .024 
N 6 6 6 6 6 
TGF- Pearson Correlation .581 .622 .043 .870
*
 1 
Sig. (2-tailed) .226 .187 .935 .024  
N 6 6 6 6 6 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix 3 
 
A. Illustration suggesting why OTC might have consistently inhibited p38 
MAPK and ERK1/2 signaling pathway in our in vivo and in vitro models. 
 
 
In Section 2.4.1.2, we reviewed that OTC is a procysteine compound that is 
converted into the aminoacid, cysteine, by the action of 5-oxoprolinase and this cysteine 
is then converted to glutathione (GSH) by -glutamylcysteine synthase within the cell. 
Studies have shown that OTC treatment elevates intracellular glutathione levels. 
Increased intracellular GSH levels have been shown to inactivate ERK and p38 MAPK 
signaling pathway. Moreover, GSH inhibited NF- transcription factor, which leads to 
activation of antioxidant response element (ARE) and Nrf-1 transcription factor. The 
activation of ARE and Nrf-1 promotes the expression of cytoprotective and anti-
inflammatory cytokine genes, which help attenuate pro-inflammatory gene expression. 
Our experiments on both in vivo and in vitro model suggest consistency of OTC in 
inactivating ERK1/2 and p38 MAPK signaling pathway. This might be due to the ability 
of increased GSH level to inhibit both ERK1/2 and p38 MAPK signaling pathways 
simultaneously and we speculate that OTC through an alternate cytosolic pathway might 
induce synergistic p38 and ERK1/2 MAPK inhibitory action.  
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B. Illustration suggesting the potential mechanism by which quercetin might 
inhibit p38 MAPK and ERK1/2 signaling pathway in our in vitro model 
 
 In Section 2.4.1.1, we reviewed that quercetin is a naturally occurring flavanoid 
that has both antioxidant and antiproliferative properties. In our micromass co-culture 
wound model, 40 M quercetin treatment was found to significantly reduce 
phosphorylated (active) ERK1/2, while having no significant effect on p38 MAPK 
activation (see Figure 70 and 71). This may suggest that p38 MAPK activation could 
have promoted NF- transcription mediated signaling, which in turn promoted cytokine 
production. These cytokines might have been detrimental in the initiation of cell 
proliferative signals associated with physiochemical changes and cellular injury response 
in vitro. In addition, the quercetin inhibited ERK1/2 signaling pathway (which can also 
promote cell proliferation), that may have further contributed to the delay in wound 
closure. We speculate that quercetin might have blocked cell receptor mediated ERK1/2 
signaling pathway, which would have further contributed to reduced phosphorylated 
(active) ERK1/2 in our in vitro model system. 
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